CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: sulforaphane
Accession: CHEBI:47807
browse the term
Definition: An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Synonyms: exact_synonym: 4-isothiocyanatobutyl methyl sulfoxide
related_synonym: 1-Isothiocyanato-4-(methylsulfinyl)butane; Formula=C6H11NOS2; InChI=1S/C6H11NOS2/c1-10(8)5-3-2-4-7-6-9/h2-5H2,1H3; InChIKey=SUVMJBTUFCVSAD-UHFFFAOYSA-N; SMILES=N(=C=S)CCCCS(=O)C; Sulforafan
xref: Beilstein:1723237; CAS:4478-93-7; HMDB:HMDB0005792; LINCS:LSM-4919
xref_mesh: MESH:C016766
xref: PMID:16442570; PMID:17134937; PMID:18090122; Patent:CA2839972; Patent:CN103229711; Patent:US2013323225; Patent:WO2013179056; Patent:WO2013179057; Reaxys:1723237; Wikipedia:Sulforaphane
G
A1CF
APOBEC1 complementation factor
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of A1CF mRNA
CTD
PMID:25450479
NCBI chr10:50,799,409...50,885,627
Ensembl chr10:50,799,409...50,885,675
G
A2M
alpha-2-macroglobulin
decreases expression
EXP
sulforaphane results in decreased expression of A2M mRNA
CTD
PMID:31838189
NCBI chr12:9,067,708...9,116,229
Ensembl chr12:9,067,664...9,116,229
G
A4GALT
alpha 1,4-galactosyltransferase (P1PK blood group)
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of A4GALT mRNA
CTD
PMID:30529165
NCBI chr22:42,692,121...42,721,301
Ensembl chr22:42,692,121...42,721,298
G
AASS
aminoadipate-semialdehyde synthase
decreases expression
ISO
sulforaphane results in decreased expression of AASS mRNA
CTD
PMID:30529165
NCBI chr 7:122,073,549...122,144,249
Ensembl chr 7:122,064,583...122,144,308
G
AATK
apoptosis associated tyrosine kinase
decreases expression
EXP
sulforaphane results in decreased expression of AATK mRNA
CTD
PMID:31838189
NCBI chr17:81,117,295...81,166,221
Ensembl chr17:81,110,487...81,166,221
G
ABCA1
ATP binding cassette subfamily A member 1
multiple interactions
ISO
sulforaphane inhibits the reaction [fenamidone results in increased expression of ABCA1 mRNA]
CTD
PMID:27029645
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
G
ABCA7
ATP binding cassette subfamily A member 7
decreases expression
EXP
sulforaphane results in decreased expression of ABCA7 mRNA
CTD
PMID:31838189
NCBI chr19:1,040,107...1,065,572
Ensembl chr19:1,039,997...1,065,572
G
ABCB1
ATP binding cassette subfamily B member 1
multiple interactions decreases expression
ISO EXP
[sulforaphane co-treated with Aflatoxin B1] affects the expression of ABCB1A mRNA; sulforaphane inhibits the reaction [Genistein results in increased expression of ABCB1A mRNA] sulforaphane results in decreased expression of ABCB1 mRNA sulforaphane inhibits the reaction [ginkgolide B results in increased expression of ABCB1 mRNA]
CTD
PMID:25450479 PMID:26775663 PMID:32185415
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ABCB10
ATP binding cassette subfamily B member 10
decreases expression
EXP
sulforaphane results in decreased expression of ABCB10 mRNA
CTD
PMID:26833863
NCBI chr 1:229,516,582...229,558,707
Ensembl chr 1:229,516,582...229,558,707
G
ABCB6
ATP binding cassette subfamily B member 6 (LAN blood group)
increases expression
EXP
sulforaphane results in increased expression of ABCB6 mRNA
CTD
PMID:31838189
NCBI chr 2:219,209,772...219,218,958
Ensembl chr 2:219,209,772...219,218,994
G
ABCC1
ATP binding cassette subfamily C member 1 (ABCC1 blood group)
multiple interactions increases expression
ISO
NFE2L2 gene mutant form inhibits the reaction [sulforaphane results in increased expression of ABCC1 mRNA]; NFE2L2 gene mutant form inhibits the reaction [sulforaphane results in increased expression of and results in increased activity of ABCC1 protein]; sulforaphane results in increased expression of and results in increased activity of ABCC1 protein
CTD
PMID:26454883
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
G
ABCC2
ATP binding cassette subfamily C member 2
increases expression
ISO EXP
sulforaphane results in increased expression of ABCC2 mRNA; sulforaphane results in increased expression of ABCC2 protein
CTD
PMID:11264000 PMID:15896333 PMID:25841332 PMID:31838189 PMID:34767876
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCC3
ATP binding cassette subfamily C member 3
increases expression
EXP
sulforaphane results in increased expression of ABCC3 mRNA
CTD
PMID:31838189
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
G
ABCC4
ATP binding cassette subfamily C member 4 (PEL blood group)
increases expression
ISO
sulforaphane results in increased expression of ABCC4 mRNA; sulforaphane results in increased expression of ABCC4 protein
CTD
PMID:21803983
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
G
ABCG5
ATP binding cassette subfamily G member 5
decreases expression
EXP
sulforaphane results in decreased expression of ABCG5 mRNA
CTD
PMID:34767876
NCBI chr 2:43,806,211...43,839,231
Ensembl chr 2:43,812,472...43,838,865
G
ABHD3
abhydrolase domain containing 3, phospholipase
increases expression
EXP
sulforaphane results in increased expression of ABHD3 mRNA
CTD
PMID:31838189
NCBI chr18:21,650,901...21,704,774
Ensembl chr18:21,650,901...21,704,780
G
ABHD4
abhydrolase domain containing 4, N-acyl phospholipase B
increases expression
EXP
sulforaphane results in increased expression of ABHD4 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr14:22,598,300...22,612,963
Ensembl chr14:22,598,290...22,612,963
G
ABLIM2
actin binding LIM protein family member 2
decreases expression
EXP
sulforaphane results in decreased expression of ABLIM2 mRNA
CTD
PMID:31838189
NCBI chr 4:7,965,327...8,158,813
Ensembl chr 4:7,965,310...8,158,832
G
ABLIM3
actin binding LIM protein family member 3
increases expression
EXP
sulforaphane results in increased expression of ABLIM3 mRNA
CTD
PMID:31838189
NCBI chr 5:149,141,493...149,260,542
Ensembl chr 5:149,141,483...149,260,542
G
ACAA2
acetyl-CoA acyltransferase 2
increases expression
ISO
sulforaphane results in increased expression of ACAA2 mRNA
CTD
PMID:30529165
NCBI chr18:49,782,164...49,813,533
Ensembl chr18:49,782,164...49,813,953
G
ACADL
acyl-CoA dehydrogenase long chain
increases expression
ISO
sulforaphane results in increased expression of ACADL mRNA
CTD
PMID:30529165
NCBI chr 2:210,187,923...210,225,447
Ensembl chr 2:210,187,126...210,225,447
G
ACADM
acyl-CoA dehydrogenase medium chain
increases expression
ISO
sulforaphane results in increased expression of ACADM mRNA
CTD
PMID:30529165
NCBI chr 1:75,724,709...75,763,679
Ensembl chr 1:75,724,431...75,787,575
G
ACADVL
acyl-CoA dehydrogenase very long chain
increases expression
ISO
sulforaphane results in increased expression of ACADVL mRNA
CTD
PMID:30529165
NCBI chr17:7,217,125...7,225,266
Ensembl chr17:7,217,125...7,225,266
G
ACBD4
acyl-CoA binding domain containing 4
decreases expression
EXP
sulforaphane results in decreased expression of ACBD4 mRNA
CTD
PMID:31838189
NCBI chr17:45,131,597...45,144,176
Ensembl chr17:45,132,600...45,144,181
G
ACER2
alkaline ceramidase 2
decreases expression
ISO
sulforaphane results in decreased expression of ACER2 mRNA
CTD
PMID:30529165
NCBI chr 9:19,409,009...19,452,505
Ensembl chr 9:19,409,009...19,452,505
G
ACKR1
atypical chemokine receptor 1 (Duffy blood group)
increases expression
ISO
sulforaphane results in increased expression of DARC mRNA
CTD
PMID:30529165
NCBI chr 1:159,204,875...159,206,500
Ensembl chr 1:159,204,875...159,206,500
G
ACKR2
atypical chemokine receptor 2
decreases expression
ISO
sulforaphane results in decreased expression of ACKR2 mRNA
CTD
PMID:30529165
NCBI chr 3:42,809,445...42,867,286
Ensembl chr 3:42,804,752...42,887,974
G
ACLY
ATP citrate lyase
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of ACLY mRNA
CTD
PMID:25450479
NCBI chr17:41,866,917...41,930,545
Ensembl chr17:41,866,917...41,930,542
G
ACO2
aconitase 2
increases expression
ISO
sulforaphane results in increased expression of ACO2 mRNA
CTD
PMID:30529165
NCBI chr22:41,469,117...41,528,974
Ensembl chr22:41,447,830...41,529,273
G
ACOT1
acyl-CoA thioesterase 1
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of ACOT1 mRNA
CTD
PMID:25450479
NCBI chr14:73,490,933...73,543,796
Ensembl chr14:73,537,143...73,543,796
G
ACOT2
acyl-CoA thioesterase 2
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of ACOT2 mRNA
CTD
PMID:25450479
NCBI chr14:73,567,620...73,575,658
Ensembl chr14:73,567,620...73,575,658
G
ACOT4
acyl-CoA thioesterase 4
decreases expression
EXP
sulforaphane results in decreased expression of ACOT4 mRNA
CTD
PMID:31838189
NCBI chr14:73,591,873...73,595,766
Ensembl chr14:73,591,873...73,595,766
G
ACP5
acid phosphatase 5, tartrate resistant
increases expression
ISO
sulforaphane results in increased expression of ACP5 mRNA
CTD
PMID:30529165
NCBI chr19:11,574,660...11,578,975
Ensembl chr19:11,574,653...11,579,993
G
ACSF2
acyl-CoA synthetase family member 2
decreases expression
EXP
sulforaphane results in decreased expression of ACSF2 mRNA
CTD
PMID:31838189
NCBI chr17:50,426,218...50,474,845
Ensembl chr17:50,426,158...50,474,845
G
ACSL1
acyl-CoA synthetase long chain family member 1
increases expression
EXP ISO
sulforaphane results in increased expression of ACSL1 mRNA
CTD
PMID:26833863 PMID:30529165 PMID:31838189
NCBI chr 4:184,755,595...184,826,594
Ensembl chr 4:184,755,595...184,826,818
G
ACSM3
acyl-CoA synthetase medium chain family member 3
decreases expression
EXP
sulforaphane results in decreased expression of ACSM3 mRNA
CTD
PMID:26833863
NCBI chr16:20,674,405...20,797,581
Ensembl chr16:20,610,243...20,797,581
G
ACTA2
actin alpha 2, smooth muscle
affects binding multiple interactions
EXP ISO
ACTA2 protein binds to sulforaphane sulforaphane inhibits the reaction [fenamidone results in increased expression of ACTA2 mRNA]
CTD
PMID:21838287 PMID:27029645
NCBI chr10:88,935,074...88,991,337
Ensembl chr10:88,934,822...88,991,339
G
ACTB
actin beta
affects binding
EXP
ACTB protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr 7:5,527,148...5,530,601
Ensembl chr 7:5,526,409...5,563,902
G
ACTC1
actin alpha cardiac muscle 1
increases expression decreases expression
ISO EXP
sulforaphane results in increased expression of ACTC1 mRNA sulforaphane results in decreased expression of ACTC1 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr15:34,790,230...34,795,549
Ensembl chr15:34,790,107...34,795,589
G
ACTG2
actin gamma 2, smooth muscle
increases expression
ISO
sulforaphane results in increased expression of ACTG2 mRNA
CTD
PMID:30529165
NCBI chr 2:73,893,008...73,919,865
Ensembl chr 2:73,892,314...73,919,865
G
ACTR1A
actin related protein 1A
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ACTR1A mRNA
CTD
PMID:30529165
NCBI chr10:102,479,229...102,502,712
Ensembl chr10:102,461,881...102,502,712
G
ADA
adenosine deaminase
decreases expression
EXP
sulforaphane results in decreased expression of ADA mRNA
CTD
PMID:31838189
NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252
G
ADAM17
ADAM metallopeptidase domain 17
increases expression
EXP
sulforaphane results in increased expression of ADAM17 mRNA
CTD
PMID:31838189
NCBI chr 2:9,488,486...9,555,830
Ensembl chr 2:9,488,486...9,556,732
G
ADAM19
ADAM metallopeptidase domain 19
decreases expression multiple interactions
ISO
sulforaphane results in decreased expression of ADAM19 mRNA [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of ADAM19 mRNA
CTD
PMID:30529165
NCBI chr 5:157,477,304...157,575,775
Ensembl chr 5:157,395,534...157,575,775
G
ADAM21
ADAM metallopeptidase domain 21
increases expression
EXP
sulforaphane results in increased expression of ADAM21 mRNA
CTD
PMID:31838189
NCBI chr14:70,452,174...70,459,905
Ensembl chr14:70,417,107...70,460,427
G
ADAM22
ADAM metallopeptidase domain 22
decreases expression
EXP
sulforaphane results in decreased expression of ADAM22 mRNA
CTD
PMID:31838189
NCBI chr 7:87,934,251...88,202,889
Ensembl chr 7:87,934,143...88,202,889
G
ADAM33
ADAM metallopeptidase domain 33
decreases expression
EXP
sulforaphane results in decreased expression of ADAM33 mRNA
CTD
PMID:31838189
NCBI chr20:3,667,975...3,682,010
Ensembl chr20:3,667,965...3,682,246
G
ADAM8
ADAM metallopeptidase domain 8
increases expression
ISO
sulforaphane results in increased expression of ADAM8 mRNA
CTD
PMID:30529165
NCBI chr10:133,262,423...133,276,868
Ensembl chr10:133,262,420...133,276,868
G
ADAMTS15
ADAM metallopeptidase with thrombospondin type 1 motif 15
multiple interactions decreases expression
ISO EXP
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of ADAMTS15 mRNA sulforaphane results in decreased expression of ADAMTS15 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr11:130,448,645...130,476,645
Ensembl chr11:130,448,645...130,476,645
G
ADAMTS5
ADAM metallopeptidase with thrombospondin type 1 motif 5
decreases expression
EXP
sulforaphane results in decreased expression of ADAMTS5 mRNA
CTD
PMID:31838189
NCBI chr21:26,917,922...26,967,088
Ensembl chr21:26,917,922...26,967,088
G
ADAMTS6
ADAM metallopeptidase with thrombospondin type 1 motif 6
decreases expression
EXP
sulforaphane results in decreased expression of ADAMTS6 mRNA
CTD
PMID:31838189
NCBI chr 5:65,148,738...65,481,920
Ensembl chr 5:65,148,738...65,481,920
G
ADAMTSL4
ADAMTS like 4
decreases expression
EXP
sulforaphane results in decreased expression of ADAMTSL4 mRNA
CTD
PMID:31838189
NCBI chr 1:150,549,408...150,560,937
Ensembl chr 1:150,549,369...150,560,937
G
ADCY7
adenylate cyclase 7
decreases expression
ISO
sulforaphane results in decreased expression of ADCY7 mRNA
CTD
PMID:30529165
NCBI chr16:50,244,699...50,318,135
Ensembl chr16:50,246,137...50,318,135
G
ADCY8
adenylate cyclase 8
decreases expression
ISO
sulforaphane results in decreased expression of ADCY8 mRNA
CTD
PMID:30529165
NCBI chr 8:130,780,301...131,040,909
Ensembl chr 8:130,780,301...131,040,909
G
ADGRA2
adhesion G protein-coupled receptor A2
decreases expression
EXP
sulforaphane results in decreased expression of ADGRA2 mRNA
CTD
PMID:31838189
NCBI chr 8:37,796,883...37,844,896
Ensembl chr 8:37,784,191...37,844,896
G
ADGRD1
adhesion G protein-coupled receptor D1
decreases expression
EXP
sulforaphane results in decreased expression of ADGRD1 mRNA
CTD
PMID:31838189
NCBI chr12:130,953,907...131,141,469
Ensembl chr12:130,953,907...131,141,469
G
ADGRE4P
adhesion G protein-coupled receptor E4, pseudogene
increases expression
EXP
sulforaphane results in increased expression of ADGRE4P mRNA
CTD
PMID:26833863
NCBI chr19:6,950,758...6,997,851
Ensembl chr19:6,954,659...6,990,798
G
ADGRE5
adhesion G protein-coupled receptor E5
increases expression
EXP
sulforaphane results in increased expression of ADGRE5 mRNA
CTD
PMID:31838189
NCBI chr19:14,381,444...14,408,723
Ensembl chr19:14,380,501...14,408,725
G
ADGRG1
adhesion G protein-coupled receptor G1
decreases expression
EXP
sulforaphane results in decreased expression of ADGRG1 mRNA
CTD
PMID:31838189
NCBI chr16:57,619,738...57,665,567
Ensembl chr16:57,610,652...57,665,580
G
ADGRG3
adhesion G protein-coupled receptor G3
increases expression
EXP
sulforaphane results in increased expression of ADGRG3 mRNA
CTD
PMID:26833863
NCBI chr16:57,665,629...57,689,378
Ensembl chr16:57,668,277...57,689,378
G
ADGRL1
adhesion G protein-coupled receptor L1
decreases expression
EXP
sulforaphane results in decreased expression of ADGRL1 mRNA
CTD
PMID:31838189
NCBI chr19:14,147,743...14,206,169
Ensembl chr19:14,147,743...14,206,187
G
ADGRL3
adhesion G protein-coupled receptor L3
decreases expression
ISO
sulforaphane results in decreased expression of ADGRL3 mRNA
CTD
PMID:30529165
NCBI chr 4:61,200,326...62,078,335
Ensembl chr 4:61,200,326...62,078,335
G
ADH7
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of ADH7 mRNA
CTD
PMID:30529165
NCBI chr 4:99,412,263...99,435,342
Ensembl chr 4:99,412,261...99,435,510
G
ADIG
adipogenin
increases expression
ISO
sulforaphane results in increased expression of ADIG mRNA
CTD
PMID:30529165
NCBI chr20:38,581,197...38,588,463
Ensembl chr20:38,581,195...38,588,463
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
increases expression
ISO
sulforaphane results in increased expression of ADIPOQ mRNA
CTD
PMID:30529165
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
ADIRF
adipogenesis regulatory factor
decreases expression
EXP
sulforaphane results in decreased expression of ADIRF mRNA
CTD
PMID:31838189
NCBI chr10:86,968,482...86,970,915
Ensembl chr10:86,968,432...86,983,934
G
ADM
adrenomedullin
increases expression
EXP
sulforaphane results in increased expression of ADM mRNA
CTD
PMID:26833863
NCBI chr11:10,305,073...10,307,397
Ensembl chr11:10,305,073...10,307,397
G
ADNP
activity dependent neuroprotector homeobox
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ADNP mRNA
CTD
PMID:30529165
NCBI chr20:50,888,918...50,931,437
Ensembl chr20:50,888,916...50,931,437
G
ADORA2A
adenosine A2a receptor
increases expression
EXP
sulforaphane results in increased expression of ADORA2A mRNA
CTD
PMID:26833863
NCBI chr22:24,423,597...24,442,357
Ensembl chr22:24,417,879...24,442,357
G
ADORA2B
adenosine A2b receptor
increases expression
EXP
sulforaphane results in increased expression of ADORA2B mRNA
CTD
PMID:31838189
NCBI chr17:15,850,362...15,975,746
Ensembl chr17:15,945,130...15,975,746
G
ADORA3
adenosine A3 receptor
increases expression
EXP
sulforaphane results in increased expression of ADORA3 mRNA
CTD
PMID:26833863
NCBI chr 1:111,499,429...111,503,633
Ensembl chr 1:111,499,429...111,503,633
G
ADRB1
adrenoceptor beta 1
decreases expression increases expression
ISO EXP
sulforaphane results in decreased expression of ADRB1 mRNA sulforaphane results in increased expression of ADRB1 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr10:114,043,866...114,046,904
Ensembl chr10:114,043,866...114,046,904
G
AGFG2
ArfGAP with FG repeats 2
decreases expression
EXP
sulforaphane results in decreased expression of AGFG2 mRNA
CTD
PMID:31838189
NCBI chr 7:100,539,203...100,568,220
Ensembl chr 7:100,539,203...100,568,220
G
AGR3
anterior gradient 3, protein disulphide isomerase family member
increases expression
ISO
sulforaphane results in increased expression of AGR3 mRNA
CTD
PMID:30529165
NCBI chr 7:16,854,681...16,881,983
Ensembl chr 7:16,859,412...16,881,987
G
AGT
angiotensinogen
multiple interactions
ISO
NFE2L2 gene mutant form inhibits the reaction [sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of CCN2 protein]]; NFE2L2 gene mutant form inhibits the reaction [sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of NPPA protein]]; NFE2L2 gene mutant form inhibits the reaction [sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of SERPINE1 protein]]; NFE2L2 gene mutant form inhibits the reaction [sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of TNF protein]]; sulforaphane inhibits the reaction [AGT protein modified form results in decreased expression of CAT mRNA]; sulforaphane inhibits the reaction [AGT protein modified form results in decreased expression of CAT protein]; sulforaphane inhibits the reaction [AGT protein modified form results in decreased expression of HMOX1 mRNA]; sulforaphane inhibits the reaction [AGT protein modified form results in decreased expression of HMOX1 protein]; sulforaphane inhibits the reaction [AGT protein modified form results in decreased expression of NFE2L2 mRNA]; sulforaphane inhibits the reaction [AGT protein modified form results in decreased expression of NFE2L2 protein modified form]; sulforaphane inhibits the reaction [AGT protein modified form results in decreased expression of NFE2L2 protein]; sulforaphane inhibits the reaction [AGT protein modified form results in decreased expression of NQO1 mRNA]; sulforaphane inhibits the reaction [AGT protein modified form results in decreased expression of NQO1 protein]; sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of CCN2 protein]; sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of NPPA mRNA]; sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of NPPA protein]; sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of SERPINE1 protein]; sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of TGFB1 protein]; sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of TNF protein]
CTD
PMID:29353218
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
AGTRAP
angiotensin II receptor associated protein
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of AGTRAP mRNA
CTD
PMID:30529165
NCBI chr 1:11,736,136...11,750,769
Ensembl chr 1:11,736,084...11,754,802
G
AHR
aryl hydrocarbon receptor
multiple interactions affects binding
EXP ISO
AHR mutant form inhibits the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of HMOX1 mRNA]]; AHR mutant form inhibits the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]]; AHR mutant form inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [sulforaphane results in increased expression of HMOX1 mRNA]]; AHR mutant form inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]]; sulforaphane affects the reaction [anthracene affects the localization of AHR protein]; sulforaphane inhibits the reaction [1,2,5,6-dibenzanthracene affects the localization of AHR protein]; sulforaphane inhibits the reaction [Benzo(a)pyrene affects the localization of AHR protein] sulforaphane binds to AHR protein [sulforaphane analog inhibits the reaction [Benzo(a)pyrene binds to AHR protein]] promotes the reaction [sulforaphane analog binds to AHR protein]; sulforaphane analog inhibits the reaction [Benzo(a)pyrene binds to AHR protein] sulforaphane inhibits the reaction [Benzo(a)pyrene results in increased activity of AHR protein]
CTD
PMID:19202560 PMID:19362136 PMID:21177068 PMID:22643862 PMID:23566952 PMID:23583297 More...
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
G
AIFM1
apoptosis inducing factor mitochondria associated 1
increases expression
EXP
sulforaphane results in increased expression of AIFM1 protein
CTD
PMID:26833863
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
G
AK6
adenylate kinase 6
increases expression
EXP
sulforaphane results in increased expression of AK6 mRNA
CTD
PMID:31838189
NCBI chr 5:69,350,984...69,369,824
Ensembl chr 5:69,350,984...69,370,013
G
AK9
adenylate kinase 9
increases expression
EXP
sulforaphane results in increased expression of AK9 mRNA
CTD
PMID:31838189
NCBI chr 6:109,492,855...109,691,202
Ensembl chr 6:109,492,855...109,691,217
G
AKAP5
A-kinase anchoring protein 5
decreases expression
EXP
sulforaphane results in decreased expression of AKAP5 mRNA
CTD
PMID:31838189
NCBI chr14:64,465,499...64,474,503
Ensembl chr14:64,465,499...64,474,503
G
AKIRIN2
akirin 2
increases expression
EXP
sulforaphane results in increased expression of AKIRIN2 mRNA
CTD
PMID:31838189
NCBI chr 6:87,674,860...87,702,233
Ensembl chr 6:87,674,860...87,702,233
G
AKR1B10
aldo-keto reductase family 1 member B10
increases expression
EXP
sulforaphane results in increased expression of AKR1B10 mRNA
CTD
PMID:24383545 PMID:31518892 PMID:31838189
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
G
AKR1C1
aldo-keto reductase family 1 member C1
increases expression multiple interactions
EXP
sulforaphane results in increased expression of AKR1C1 mRNA NFE2L2 protein affects the reaction [sulforaphane results in increased expression of AKR1C1 mRNA]
CTD
PMID:24383545 PMID:25841332 PMID:31518892 PMID:31746589
NCBI chr10:4,963,415...4,983,283
Ensembl chr10:4,963,253...4,983,283
G
AKR1C2
aldo-keto reductase family 1 member C2
increases expression
EXP
sulforaphane results in increased expression of AKR1C2 mRNA
CTD
PMID:24383545 PMID:31746589
NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031
G
AKR1C3
aldo-keto reductase family 1 member C3
increases expression
EXP
sulforaphane results in increased expression of AKR1C3 mRNA; sulforaphane results in increased expression of AKR1C3 protein
CTD
PMID:24383545 PMID:31746589
NCBI chr10:5,048,781...5,107,686
Ensembl chr10:5,035,354...5,107,686
G
AKT1
AKT serine/threonine kinase 1
multiple interactions increases phosphorylation decreases phosphorylation
EXP ISO
NGF protein inhibits the reaction [sulforaphane results in decreased phosphorylation of AKT1 protein]; sulforaphane results in increased phosphorylation of and results in increased activity of AKT1 protein sulforaphane inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AKT1 protein] sulforaphane results in increased phosphorylation of AKT1 protein [dibenzoylmethane co-treated with sulforaphane] results in decreased phosphorylation of AKT1 protein
CTD
PMID:15896333 PMID:17942926 PMID:29407470 PMID:30835071 PMID:30965051
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
G
ALB
albumin
multiple interactions
ISO
sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CCND3 protein]; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CDK6 protein]; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IFNG protein]; sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IL6 protein]; sulforaphane inhibits the reaction [[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene]
CTD
PMID:33007382
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
ALCAM
activated leukocyte cell adhesion molecule
decreases expression
EXP
sulforaphane results in decreased expression of ALCAM mRNA
CTD
PMID:31838189
NCBI chr 3:105,366,909...105,576,900
Ensembl chr 3:105,366,909...105,576,900
G
ALDH1A1
aldehyde dehydrogenase 1 family member A1
multiple interactions affects binding decreases expression
EXP
sulforaphane promotes the reaction [Gemcitabine results in decreased expression of ALDH1A1 protein] ALDH1A1 protein binds to sulforaphane sulforaphane results in decreased expression of ALDH1A1 protein
CTD
PMID:20940707 PMID:21838287
NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
G
ALDH1A3
aldehyde dehydrogenase 1 family member A3
decreases expression
EXP
sulforaphane results in decreased expression of ALDH1A3 mRNA
CTD
PMID:31838189
NCBI chr15:100,879,831...100,916,626
Ensembl chr15:100,877,714...100,916,626
G
ALDH1L2
aldehyde dehydrogenase 1 family member L2
decreases expression
EXP
sulforaphane results in decreased expression of ALDH1L2 mRNA
CTD
PMID:26833863
NCBI chr12:105,019,790...105,084,458
Ensembl chr12:105,019,784...105,107,643
G
ALDH2
aldehyde dehydrogenase 2 family member
increases expression multiple interactions
EXP
sulforaphane results in increased expression of ALDH2 mRNA; sulforaphane results in increased expression of ALDH2 protein NFE2L2 protein affects the reaction [sulforaphane results in increased expression of ALDH2 protein]
CTD
PMID:31838189 PMID:35227738
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
ALDH3A2
aldehyde dehydrogenase 3 family member A2
increases expression
EXP
sulforaphane results in increased expression of ALDH3A2 mRNA
CTD
PMID:31838189
NCBI chr17:19,648,136...19,677,596
Ensembl chr17:19,648,136...19,685,760
G
ALDH4A1
aldehyde dehydrogenase 4 family member A1
decreases expression
EXP
sulforaphane results in decreased expression of ALDH4A1 mRNA
CTD
PMID:31838189
NCBI chr 1:18,871,430...18,902,555
Ensembl chr 1:18,871,430...18,902,724
G
ALG10B
ALG10 alpha-1,2-glucosyltransferase B
multiple interactions decreases expression
ISO EXP
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ALG10B mRNA sulforaphane results in decreased expression of ALG10B mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr12:38,316,687...38,329,721
Ensembl chr12:38,316,762...38,329,721
G
ALOX5AP
arachidonate 5-lipoxygenase activating protein
increases expression
EXP
sulforaphane results in increased expression of ALOX5AP mRNA
CTD
PMID:26833863
NCBI chr13:30,713,485...30,764,426
Ensembl chr13:30,713,478...30,764,426
G
ALPG
alkaline phosphatase, germ cell
decreases expression
EXP
sulforaphane results in decreased expression of ALPG mRNA
CTD
PMID:31838189
NCBI chr 2:232,406,844...232,410,714
Ensembl chr 2:232,406,844...232,410,714
G
ALPI
alkaline phosphatase, intestinal
decreases expression
EXP
sulforaphane results in decreased expression of ALPI mRNA
CTD
PMID:31838189
NCBI chr 2:232,456,153...232,460,753
Ensembl chr 2:232,456,125...232,460,753
G
ALPP
alkaline phosphatase, placental
increases expression decreases expression
EXP
sulforaphane results in increased expression of ALPP mRNA sulforaphane results in decreased expression of ALPP mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr 2:232,378,751...232,382,889
Ensembl chr 2:232,378,724...232,382,889
G
AMH
anti-Mullerian hormone
increases expression
EXP
sulforaphane results in increased expression of AMH mRNA
CTD
PMID:31838189
NCBI chr19:2,249,323...2,252,073
Ensembl chr19:2,249,309...2,252,073
G
AMOTL1
angiomotin like 1
decreases expression
EXP
sulforaphane results in decreased expression of AMOTL1 mRNA
CTD
PMID:31838189
NCBI chr11:94,706,460...94,876,748
Ensembl chr11:94,706,431...94,876,748
G
ANAPC4
anaphase promoting complex subunit 4
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ANAPC4 mRNA
CTD
PMID:30529165
NCBI chr 4:25,377,263...25,418,498
Ensembl chr 4:25,377,263...25,418,498
G
ANG
angiogenin
decreases expression
ISO
sulforaphane results in decreased expression of ANG mRNA
CTD
PMID:30529165
NCBI chr14:20,684,177...20,694,186
Ensembl chr14:20,684,177...20,698,971
G
ANGPTL4
angiopoietin like 4
increases expression
EXP
sulforaphane results in increased expression of ANGPTL4 mRNA
CTD
PMID:31838189
NCBI chr19:8,364,155...8,374,370
Ensembl chr19:8,363,289...8,374,370
G
ANK2
ankyrin 2
increases expression
ISO EXP
sulforaphane results in increased expression of ANK2 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 4:112,705,622...113,383,736
Ensembl chr 4:112,818,032...113,384,221
G
ANKH
ANKH inorganic pyrophosphate transport regulator
decreases expression
EXP
sulforaphane results in decreased expression of ANKH mRNA
CTD
PMID:31838189
NCBI chr 5:14,704,800...14,871,778
Ensembl chr 5:14,704,800...14,871,778
G
ANKHD1
ankyrin repeat and KH domain containing 1
increases methylation
EXP
sulforaphane results in increased methylation of ANKHD1 gene
CTD
PMID:31838189
NCBI chr 5:140,401,833...140,539,849
Ensembl chr 5:140,401,814...140,539,856
G
ANKRD2
ankyrin repeat domain 2
decreases expression
EXP
sulforaphane results in decreased expression of ANKRD2 mRNA
CTD
PMID:31838189
NCBI chr10:97,572,441...97,583,884
Ensembl chr10:97,572,499...97,583,884
G
ANKRD20A11P
ankyrin repeat domain 20 family member A11, pseudogene
decreases expression
EXP
sulforaphane results in decreased expression of ANKRD20A11P mRNA
CTD
PMID:26833863
NCBI chr21:13,943,769...13,980,444
Ensembl chr21:13,937,946...13,980,437 Ensembl chr21:13,937,946...13,980,437
G
ANKRD22
ankyrin repeat domain 22
increases expression
EXP
sulforaphane results in increased expression of ANKRD22 mRNA
CTD
PMID:26833863
NCBI chr10:88,819,896...88,851,844
Ensembl chr10:88,819,896...88,851,844
G
ANKRD29
ankyrin repeat domain 29
decreases expression
ISO
sulforaphane results in decreased expression of ANKRD29 mRNA
CTD
PMID:30529165
NCBI chr18:23,598,926...23,662,911
Ensembl chr18:23,598,926...23,662,911
G
ANKRD49
ankyrin repeat domain 49
decreases expression
ISO
sulforaphane results in decreased expression of ANKRD49 mRNA
CTD
PMID:30529165
NCBI chr11:94,493,984...94,499,578
Ensembl chr11:94,493,979...94,499,578
G
ANO2
anoctamin 2
decreases expression
EXP
sulforaphane results in decreased expression of ANO2 mRNA
CTD
PMID:31838189
NCBI chr12:5,562,655...5,946,232
Ensembl chr12:5,531,869...5,946,232
G
ANO9
anoctamin 9
decreases expression
EXP
sulforaphane results in decreased expression of ANO9 mRNA
CTD
PMID:31838189
NCBI chr11:417,938...442,011
Ensembl chr11:417,933...442,011
G
ANTKMT
adenine nucleotide translocase lysine methyltransferase
decreases expression
EXP
sulforaphane results in decreased expression of ANTKMT mRNA
CTD
PMID:31838189
NCBI chr16:721,146...722,590
Ensembl chr16:720,581...722,590
G
ANTXR2
ANTXR cell adhesion molecule 2
increases expression
EXP
sulforaphane results in increased expression of ANTXR2 mRNA
CTD
PMID:26833863
NCBI chr 4:79,901,146...80,073,472
Ensembl chr 4:79,901,146...80,125,454
G
ANXA1
annexin A1
increases expression
EXP
sulforaphane results in increased expression of ANXA1 mRNA
CTD
PMID:26833863
NCBI chr 9:73,151,865...73,170,393
Ensembl chr 9:73,151,865...73,170,393
G
ANXA8
annexin A8
increases expression decreases expression
ISO EXP
sulforaphane results in increased expression of ANXA8 mRNA sulforaphane results in decreased expression of ANXA8 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr10:47,467,993...47,991,796
Ensembl chr10:47,460,162...47,484,158
G
ANXA8L1
annexin A8 like 1
decreases expression
EXP
sulforaphane results in decreased expression of ANXA8L1 mRNA
CTD
PMID:31838189
NCBI chr10:46,375,776...46,391,778
Ensembl chr10:46,375,627...46,391,784
G
AOC2
amine oxidase copper containing 2
increases expression
EXP
sulforaphane results in increased expression of AOC2 mRNA
CTD
PMID:31838189
NCBI chr17:42,844,580...42,850,707
Ensembl chr17:42,844,580...42,850,707
G
AP3M1
adaptor related protein complex 3 subunit mu 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of AP3M1 mRNA
CTD
PMID:30529165
NCBI chr10:74,120,255...74,150,828
Ensembl chr10:74,120,255...74,150,842
G
APBB1IP
amyloid beta precursor protein binding family B member 1 interacting protein
decreases expression
EXP
sulforaphane results in decreased expression of APBB1IP mRNA
CTD
PMID:31838189
NCBI chr10:26,438,341...26,567,803
Ensembl chr10:26,438,341...26,567,803
G
APCDD1
APC down-regulated 1
decreases expression
EXP
sulforaphane results in decreased expression of APCDD1 mRNA
CTD
PMID:31838189
NCBI chr18:10,454,635...10,489,949
Ensembl chr18:10,454,635...10,489,949
G
APLP1
amyloid beta precursor like protein 1
decreases expression
EXP
sulforaphane results in decreased expression of APLP1 mRNA
CTD
PMID:31838189
NCBI chr19:35,868,574...35,879,792
Ensembl chr19:35,867,899...35,879,792
G
APOBEC3B
apolipoprotein B mRNA editing enzyme catalytic subunit 3B
increases expression
EXP
sulforaphane results in increased expression of APOBEC3B mRNA
CTD
PMID:26833863
NCBI chr22:38,982,347...38,992,779
Ensembl chr22:38,982,347...38,992,804
G
APOL1
apolipoprotein L1
increases expression
EXP
sulforaphane results in increased expression of APOL1 mRNA
CTD
PMID:31838189
NCBI chr22:36,253,133...36,267,525
Ensembl chr22:36,253,071...36,267,530
G
APOL6
apolipoprotein L6
increases expression
ISO
sulforaphane results in increased expression of APOL6 mRNA
CTD
PMID:30529165
NCBI chr22:35,648,446...35,668,404
Ensembl chr22:35,648,446...35,668,404
G
APOO
apolipoprotein O
increases expression
ISO
sulforaphane results in increased expression of APOO mRNA
CTD
PMID:30529165
NCBI chr X:23,833,353...23,907,938
Ensembl chr X:23,833,353...23,907,938
G
AQP3
aquaporin 3 (Gill blood group)
decreases expression
EXP
sulforaphane results in decreased expression of AQP3 mRNA
CTD
PMID:31838189
NCBI chr 9:33,441,160...33,447,593
Ensembl chr 9:33,441,156...33,447,596
G
AQP4
aquaporin 4
increases expression
ISO
sulforaphane results in increased expression of AQP4 mRNA
CTD
PMID:30529165
NCBI chr18:26,852,038...26,865,803
Ensembl chr18:26,852,043...26,865,771
G
AR
androgen receptor
multiple interactions increases expression
EXP
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sulforaphane results in decreased expression of AR protein]; HDAC6 protein inhibits the reaction [sulforaphane results in decreased expression of AR protein]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of AR protein]; sulforaphane inhibits the reaction [AR protein binds to ERG enhancer]; sulforaphane inhibits the reaction [AR protein binds to KLK3 enhancer]; sulforaphane inhibits the reaction [HSP90AA1 protein binds to AR protein]; sulforaphane results in increased degradation of and results in decreased expression of and results in decreased activity of AR protein
CTD
PMID:19805354 PMID:35227738
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
G
AREG
amphiregulin
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of AREG mRNA
CTD
PMID:30529165
NCBI chr 4:74,445,136...74,455,005
Ensembl chr 4:74,445,136...74,455,005
G
ARFGEF3
ARFGEF family member 3
decreases expression
ISO
sulforaphane results in decreased expression of ARFGEF3 mRNA
CTD
PMID:30529165
NCBI chr 6:138,161,939...138,344,663
Ensembl chr 6:138,161,939...138,344,663
G
ARG2
arginase 2
decreases expression
EXP
sulforaphane results in decreased expression of ARG2 mRNA
CTD
PMID:31838189
NCBI chr14:67,619,920...67,651,708
Ensembl chr14:67,619,920...67,651,708
G
ARHGAP20
Rho GTPase activating protein 20
decreases expression
EXP
sulforaphane results in decreased expression of ARHGAP20 mRNA
CTD
PMID:31838189
NCBI chr11:110,577,043...110,713,189
Ensembl chr11:110,577,042...110,713,189
G
ARHGAP26
Rho GTPase activating protein 26
increases expression
EXP
sulforaphane results in increased expression of ARHGAP26 mRNA
CTD
PMID:26833863
NCBI chr 5:142,770,377...143,229,011
Ensembl chr 5:142,770,377...143,229,011
G
ARHGAP28
Rho GTPase activating protein 28
decreases expression
EXP
sulforaphane results in decreased expression of ARHGAP28 mRNA
CTD
PMID:31838189
NCBI chr18:6,729,716...6,915,716
Ensembl chr18:6,729,716...6,915,716
G
ARHGAP31
Rho GTPase activating protein 31
decreases expression
ISO
sulforaphane results in decreased expression of ARHGAP31 mRNA
CTD
PMID:30529165
NCBI chr 3:119,294,383...119,420,714
Ensembl chr 3:119,294,383...119,420,714
G
ARHGDIB
Rho GDP dissociation inhibitor beta
decreases expression
EXP
sulforaphane results in decreased expression of ARHGDIB mRNA
CTD
PMID:31838189
NCBI chr12:14,942,015...14,961,601
Ensembl chr12:14,942,031...14,961,728
G
ARHGEF10L
Rho guanine nucleotide exchange factor 10 like
increases expression
ISO
sulforaphane results in increased expression of ARHGEF10L mRNA
CTD
PMID:30529165
NCBI chr 1:17,513,435...17,697,875
Ensembl chr 1:17,539,698...17,697,874
G
ARHGEF26
Rho guanine nucleotide exchange factor 26
decreases expression
ISO
sulforaphane results in decreased expression of ARHGEF26 mRNA
CTD
PMID:30529165
NCBI chr 3:154,121,003...154,257,825
Ensembl chr 3:154,121,003...154,257,827
G
ARHGEF39
Rho guanine nucleotide exchange factor 39
increases expression
EXP
sulforaphane results in increased expression of ARHGEF39 mRNA
CTD
PMID:31838189
NCBI chr 9:35,659,343...35,665,195
Ensembl chr 9:35,658,875...35,675,866
G
ARHGEF9
Cdc42 guanine nucleotide exchange factor 9
decreases expression
EXP
sulforaphane results in decreased expression of ARHGEF9 mRNA
CTD
PMID:31838189
NCBI chr X:63,634,967...63,785,214
Ensembl chr X:63,634,967...63,809,274
G
ARID3A
AT-rich interaction domain 3A
increases expression
EXP
sulforaphane results in increased expression of ARID3A mRNA
CTD
PMID:31838189
NCBI chr19:925,732...975,939
Ensembl chr19:925,781...975,939
G
ARID5B
AT-rich interaction domain 5B
decreases expression
EXP
sulforaphane results in decreased expression of ARID5B mRNA
CTD
PMID:31838189
NCBI chr10:61,901,699...62,096,944
Ensembl chr10:61,901,684...62,096,944
G
ARSJ
arylsulfatase family member J
increases expression
EXP
sulforaphane results in increased expression of ARSJ mRNA
CTD
PMID:31838189
NCBI chr 4:113,900,284...113,979,647
Ensembl chr 4:113,900,284...113,979,727
G
ART3
ADP-ribosyltransferase 3 (inactive)
increases expression
ISO
sulforaphane results in increased expression of ART3 mRNA
CTD
PMID:30529165
NCBI chr 4:76,011,190...76,112,786
Ensembl chr 4:76,011,184...76,114,048
G
ASB2
ankyrin repeat and SOCS box containing 2
increases expression
ISO
sulforaphane results in increased expression of ASB2 mRNA
CTD
PMID:30529165
NCBI chr14:93,934,166...93,976,570
Ensembl chr14:93,934,166...93,976,739
G
ASB9
ankyrin repeat and SOCS box containing 9
decreases expression
EXP
sulforaphane results in decreased expression of ASB9 mRNA
CTD
PMID:31838189
NCBI chr X:15,243,987...15,270,467
Ensembl chr X:15,235,288...15,270,467
G
ASF1A
anti-silencing function 1A histone chaperone
increases expression
EXP
sulforaphane results in increased expression of ASF1A mRNA
CTD
PMID:31838189
NCBI chr 6:118,894,152...118,909,171
Ensembl chr 6:118,894,152...118,909,171
G
ASNS
asparagine synthetase (glutamine-hydrolyzing)
increases expression
EXP
sulforaphane results in increased expression of ASNS mRNA
CTD
PMID:31838189
NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
G
ASPH
aspartate beta-hydroxylase
increases expression
EXP
sulforaphane results in increased expression of ASPH mRNA
CTD
PMID:31838189
NCBI chr 8:61,500,556...61,714,592
Ensembl chr 8:61,500,556...61,714,640
G
ASPN
asporin
decreases expression
ISO
sulforaphane results in decreased expression of ASPN mRNA
CTD
PMID:30529165
NCBI chr 9:92,456,205...92,482,506
Ensembl chr 9:92,456,205...92,482,506
G
ASS1
argininosuccinate synthase 1
decreases expression
EXP
sulforaphane results in decreased expression of ASS1 mRNA
CTD
PMID:26833863
NCBI chr 9:130,444,707...130,501,274
Ensembl chr 9:130,444,961...130,501,274
G
ASS1P11
argininosuccinate synthetase 1 pseudogene 11
decreases expression
EXP
sulforaphane results in decreased expression of ASS1P11 mRNA
CTD
PMID:26833863
NCBI chr 7:21,219,978...21,221,530
Ensembl chr 7:21,220,213...21,221,428
G
ATF4
activating transcription factor 4
multiple interactions increases expression
ISO
sulforaphane inhibits the reaction [Streptozocin results in increased expression of ATF4 protein] sulforaphane results in increased expression of ATF4 protein
CTD
PMID:24967692 PMID:37385402
NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,683
G
ATG12
autophagy related 12
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ATG12 mRNA
CTD
PMID:30529165
NCBI chr 5:115,828,200...115,841,565
Ensembl chr 5:115,828,200...115,841,837
G
ATOH8
atonal bHLH transcription factor 8
decreases expression
EXP
sulforaphane results in decreased expression of ATOH8 mRNA
CTD
PMID:31838189
NCBI chr 2:85,753,991...85,791,383
Ensembl chr 2:85,751,344...85,791,383
G
ATP13A2
ATPase cation transporting 13A2
increases expression
EXP
sulforaphane results in increased expression of ATP13A2 mRNA
CTD
PMID:26833863
NCBI chr 1:16,985,958...17,011,928
Ensembl chr 1:16,985,958...17,011,928
G
ATP1A3
ATPase Na+/K+ transporting subunit alpha 3
decreases expression
EXP
sulforaphane results in decreased expression of ATP1A3 mRNA
CTD
PMID:26833863
NCBI chr19:41,966,582...41,994,230
Ensembl chr19:41,966,582...41,997,497
G
ATP2A2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
increases expression
ISO
sulforaphane results in increased expression of ATP2A2 mRNA
CTD
PMID:30529165
NCBI chr12:110,280,616...110,351,093
Ensembl chr12:110,280,756...110,351,093
G
ATP2B4
ATPase plasma membrane Ca2+ transporting 4
decreases expression
EXP
sulforaphane results in decreased expression of ATP2B4 mRNA
CTD
PMID:31838189
NCBI chr 1:203,626,832...203,744,081
Ensembl chr 1:203,626,832...203,744,081
G
ATP5F1B
ATP synthase F1 subunit beta
affects binding
EXP
ATP5F1B protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr12:56,638,175...56,645,984
Ensembl chr12:56,638,175...56,645,984
G
ATP5MC1
ATP synthase membrane subunit c locus 1
increases expression
ISO
sulforaphane results in increased expression of ATP5MC1 mRNA
CTD
PMID:30529165
NCBI chr17:48,892,787...48,895,871
Ensembl chr17:48,892,765...48,895,871
G
ATP5ME
ATP synthase membrane subunit e
increases expression
ISO
sulforaphane results in increased expression of ATP5ME mRNA
CTD
PMID:30529165
NCBI chr 4:672,436...674,276
Ensembl chr 4:672,436...674,330
G
ATP6V0D2
ATPase H+ transporting V0 subunit d2
decreases expression multiple interactions
ISO
sulforaphane results in decreased expression of ATP6V0D2 mRNA [sulforaphane affects the susceptibility to Oxygen] which affects the expression of ATP6V0D2 mRNA
CTD
PMID:30529165
NCBI chr 8:86,098,910...86,154,225
Ensembl chr 8:85,987,323...86,154,225
G
ATXN10
ataxin 10
decreases expression
EXP
sulforaphane results in decreased expression of ATXN10 mRNA
CTD
PMID:31838189
NCBI chr22:45,671,834...45,845,307
Ensembl chr22:45,671,798...45,845,307
G
AURKA
aurora kinase A
increases expression
EXP
sulforaphane results in increased expression of AURKA mRNA
CTD
PMID:31838189
NCBI chr20:56,369,390...56,392,215
Ensembl chr20:56,369,389...56,392,337
G
B3GALT4
beta-1,3-galactosyltransferase 4
decreases expression
EXP
sulforaphane results in decreased expression of B3GALT4 mRNA
CTD
PMID:31838189
NCBI chr 6:33,277,123...33,278,825
Ensembl chr 6:33,277,123...33,284,832
G
B3GAT3
beta-1,3-glucuronyltransferase 3
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of B3GAT3 mRNA
CTD
PMID:30529165
NCBI chr11:62,615,296...62,621,986
Ensembl chr11:62,615,296...62,622,154
G
B3GNT5
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5
increases expression
EXP
sulforaphane results in increased expression of B3GNT5 mRNA
CTD
PMID:31838189
NCBI chr 3:183,253,253...183,273,385
Ensembl chr 3:183,253,253...183,298,504
G
B4GALNT1
beta-1,4-N-acetyl-galactosaminyltransferase 1
increases expression
EXP
sulforaphane results in increased expression of B4GALNT1 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr12:57,623,409...57,633,201
Ensembl chr12:57,623,409...57,633,239
G
B4GALT1
beta-1,4-galactosyltransferase 1
increases expression
EXP
sulforaphane results in increased expression of B4GALT1 mRNA
CTD
PMID:35724838
NCBI chr 9:33,104,077...33,185,089
Ensembl chr 9:33,104,082...33,167,356
G
B4GALT6
beta-1,4-galactosyltransferase 6
increases expression
ISO
sulforaphane results in increased expression of B4GALT6 mRNA
CTD
PMID:30529165
NCBI chr18:31,622,246...31,724,641
Ensembl chr18:31,622,246...31,685,836
G
BACH1
BTB domain and CNC homolog 1
increases expression
EXP
sulforaphane results in increased expression of BACH1 mRNA; sulforaphane results in increased expression of BACH1 protein
CTD
PMID:31518892
NCBI chr21:29,298,922...29,361,894
Ensembl chr21:29,194,071...29,630,751
G
BAD
BCL2 associated agonist of cell death
decreases expression
EXP
sulforaphane results in decreased expression of BAD mRNA
CTD
PMID:31838189
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
G
BAG1
BAG cochaperone 1
decreases expression
EXP
sulforaphane results in decreased expression of BAG1 mRNA
CTD
PMID:31838189
NCBI chr 9:33,252,471...33,264,708
Ensembl chr 9:33,247,820...33,264,720
G
BAG3
BAG cochaperone 3
multiple interactions increases expression
ISO EXP
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of BAG3 mRNA sulforaphane results in increased expression of BAG3 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr10:119,651,380...119,677,819
Ensembl chr10:119,651,380...119,677,819
G
BANP
BTG3 associated nuclear protein
decreases expression
ISO
sulforaphane results in decreased expression of BANP mRNA
CTD
PMID:30529165
NCBI chr16:87,949,238...88,077,318
Ensembl chr16:87,949,244...88,077,318
G
BAP1
BRCA1 associated protein 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of BAP1 mRNA
CTD
PMID:30529165
NCBI chr 3:52,401,008...52,410,008
Ensembl chr 3:52,401,008...52,410,008
G
BASP1
brain abundant membrane attached signal protein 1
increases expression
ISO
sulforaphane results in increased expression of BASP1 mRNA
CTD
PMID:30529165
NCBI chr 5:17,216,823...17,276,834
Ensembl chr 5:17,065,598...17,276,843
G
BATF3
basic leucine zipper ATF-like transcription factor 3
increases expression
EXP
sulforaphane results in increased expression of BATF3 mRNA
CTD
PMID:31838189
NCBI chr 1:212,686,417...212,699,840
Ensembl chr 1:212,686,417...212,699,840
G
BAX
BCL2 associated X, apoptosis regulator
increases expression multiple interactions
ISO EXP
sulforaphane results in increased expression of BAX protein sulforaphane inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BAX mRNA] sulforaphane results in increased expression of BAX mRNA; sulforaphane results in increased expression of BAX protein sulforaphane inhibits the reaction [Streptozocin results in increased expression of BAX protein]
CTD
PMID:17942926 PMID:24967692 PMID:26833863 PMID:27878984 PMID:27993529 PMID:30835071 More...
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BBC3
BCL2 binding component 3
multiple interactions increases expression
ISO EXP
sulforaphane inhibits the reaction [ochratoxin A results in increased expression of BBC3 mRNA] sulforaphane results in increased expression of BBC3 mRNA; sulforaphane results in increased expression of BBC3 protein
CTD
PMID:27878984 PMID:28710020 PMID:35724838
NCBI chr19:47,220,824...47,232,860
Ensembl chr19:47,220,822...47,232,766
G
BCAM
basal cell adhesion molecule (Lutheran blood group)
decreases expression
EXP
sulforaphane results in decreased expression of BCAM mRNA
CTD
PMID:31838189
NCBI chr19:44,809,059...44,821,421
Ensembl chr19:44,809,071...44,821,421
G
BCHE
butyrylcholinesterase
increases expression
ISO
sulforaphane results in increased expression of BCHE mRNA
CTD
PMID:30529165
NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462
G
BCKDHA
branched chain keto acid dehydrogenase E1 subunit alpha
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of BCKDHA mRNA
CTD
PMID:30529165
NCBI chr19:41,397,818...41,425,002
Ensembl chr19:41,397,808...41,425,002
G
BCL10
BCL10 immune signaling adaptor
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of BCL10 mRNA
CTD
PMID:30529165
NCBI chr 1:85,265,776...85,276,632
Ensembl chr 1:85,265,776...85,276,632
G
BCL2
BCL2 apoptosis regulator
multiple interactions decreases expression increases expression
EXP ISO
[Eugenol results in increased activity of sulforaphane] which results in decreased expression of BCL2; [sulforaphane results in increased activity of Eugenol] which results in decreased expression of BCL2 sulforaphane inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BCL2 mRNA] sulforaphane results in decreased expression of BCL2 mRNA; sulforaphane results in decreased expression of BCL2 protein sulforaphane inhibits the reaction [Ethanol results in decreased expression of BCL2 mRNA]; sulforaphane inhibits the reaction [Ethanol results in decreased expression of BCL2 protein] sulforaphane results in increased expression of BCL2 mRNA; sulforaphane results in increased expression of BCL2 protein
CTD
PMID:21382956 PMID:27878984 PMID:29069573 PMID:30835071
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BCL2A1
BCL2 related protein A1
increases expression
EXP
sulforaphane results in increased expression of BCL2A1 mRNA
CTD
PMID:26833863
NCBI chr15:79,960,892...79,971,196
Ensembl chr15:79,960,892...79,971,196
G
BCL2L1
BCL2 like 1
multiple interactions decreases expression
ISO EXP
sulforaphane inhibits the reaction [sulforaphane results in decreased expression of BCL2L1 protein]
CTD
PMID:21684301 PMID:26833863
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
G
BCL3
BCL3 transcription coactivator
decreases expression
EXP
sulforaphane results in decreased expression of BCL3 mRNA
CTD
PMID:31838189
NCBI chr19:44,747,705...44,760,044
Ensembl chr19:44,747,705...44,760,044
G
BCL6
BCL6 transcription repressor
increases expression decreases expression
EXP
sulforaphane results in increased expression of BCL6 mRNA sulforaphane results in decreased expression of BCL6 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr 3:187,721,377...187,745,468
Ensembl chr 3:187,721,377...187,745,725
G
BDH1
3-hydroxybutyrate dehydrogenase 1
increases expression
ISO
sulforaphane results in increased expression of BDH1 mRNA
CTD
PMID:30529165
NCBI chr 3:197,509,783...197,573,343
Ensembl chr 3:197,509,783...197,573,323
G
BDKRB2
bradykinin receptor B2
decreases expression
EXP
sulforaphane results in decreased expression of BDKRB2 mRNA
CTD
PMID:31838189
NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
G
BDNF
brain derived neurotrophic factor
multiple interactions decreases expression increases expression
EXP
sulforaphane promotes the reaction [Pyruvaldehyde results in increased expression of BDNF protein] sulforaphane results in decreased expression of BDNF mRNA sulforaphane results in increased expression of BDNF protein
CTD
PMID:25933243 PMID:31838189
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
BECN1
beclin 1
multiple interactions
ISO
sulforaphane inhibits the reaction [Methamphetamine results in increased expression of BECN1 protein]
CTD
PMID:37567421
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
G
BEND6
BEN domain containing 6
increases expression
ISO
sulforaphane results in increased expression of BEND6 mRNA
CTD
PMID:30529165
NCBI chr 6:56,955,107...57,027,346
Ensembl chr 6:56,955,107...57,027,346
G
BEX4
brain expressed X-linked 4
decreases expression
ISO
sulforaphane results in decreased expression of BEX4 mRNA
CTD
PMID:30529165
NCBI chr X:103,215,092...103,217,246
Ensembl chr X:103,215,108...103,217,246
G
BHLHE40
basic helix-loop-helix family member e40
increases expression
EXP
sulforaphane results in increased expression of BHLHE40 mRNA
CTD
PMID:26833863
NCBI chr 3:4,979,437...4,985,323
Ensembl chr 3:4,979,437...4,985,323
G
BID
BH3 interacting domain death agonist
multiple interactions increases expression
ISO EXP
sulforaphane inhibits the reaction [sulforaphane results in increased expression of BID protein] [sulforaphane co-treated with TNFSF10 protein] results in increased cleavage of BID protein
CTD
PMID:21684301 PMID:26833863 PMID:29792947
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
G
BIN2
bridging integrator 2
increases expression
EXP
sulforaphane results in increased expression of BIN2 mRNA
CTD
PMID:26833863
NCBI chr12:51,281,038...51,324,668
Ensembl chr12:51,281,038...51,324,668
G
BIN2P1
bridging integrator 2 pseudogene 1
increases expression
EXP
sulforaphane results in increased expression of BIN2P1 mRNA
CTD
PMID:26833863
NCBI chr 4:82,274,849...82,276,800
Ensembl chr 4:82,275,071...82,276,600
G
BIRC3
baculoviral IAP repeat containing 3
increases expression
EXP
sulforaphane results in increased expression of BIRC3 mRNA
CTD
PMID:35724838
NCBI chr11:102,317,484...102,339,403
Ensembl chr11:102,317,484...102,339,403
G
BMF
Bcl2 modifying factor
decreases expression
EXP
sulforaphane results in decreased expression of BMF mRNA
CTD
PMID:31838189
NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892
G
BMP2
bone morphogenetic protein 2
decreases expression
EXP
sulforaphane results in decreased expression of BMP2 mRNA
CTD
PMID:31838189
NCBI chr20:6,767,686...6,780,246
Ensembl chr20:6,767,686...6,780,246
G
BMP4
bone morphogenetic protein 4
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of BMP4 mRNA
CTD
PMID:30529165
NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761
G
BORA
BORA aurora kinase A activator
increases expression
EXP
sulforaphane results in increased expression of BORA mRNA
CTD
PMID:31838189
NCBI chr13:72,727,923...72,756,196
Ensembl chr13:72,727,749...72,756,198
G
BRINP3
BMP/retinoic acid inducible neural specific 3
decreases expression
EXP
sulforaphane results in decreased expression of BRINP3 mRNA
CTD
PMID:31838189
NCBI chr 1:190,097,658...190,477,864
Ensembl chr 1:190,097,658...190,478,404
G
BROX
BRO1 domain and CAAX motif containing
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of BROX mRNA
CTD
PMID:30529165
NCBI chr 1:222,712,564...222,735,187
Ensembl chr 1:222,712,553...222,735,196
G
BRSK2
BR serine/threonine kinase 2
decreases expression
EXP
sulforaphane results in decreased expression of BRSK2 mRNA
CTD
PMID:31838189
NCBI chr11:1,389,934...1,462,689
Ensembl chr11:1,389,899...1,462,689
G
BST1
bone marrow stromal cell antigen 1
increases expression
EXP
sulforaphane results in increased expression of BST1 mRNA
CTD
PMID:26833863
NCBI chr 4:15,703,065...15,774,173
Ensembl chr 4:15,703,065...15,738,313
G
BTAF1
B-TFIID TATA-box binding protein associated factor 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of BTAF1 mRNA
CTD
PMID:30529165
NCBI chr10:91,923,770...92,031,437
Ensembl chr10:91,923,770...92,031,437
G
BTG2
BTG anti-proliferation factor 2
increases expression
EXP
sulforaphane results in increased expression of BTG2 mRNA
CTD
PMID:26833863
NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602
G
BTN3A3
butyrophilin subfamily 3 member A3
decreases expression
EXP
sulforaphane results in decreased expression of BTN3A3 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr 6:26,440,504...26,453,415
Ensembl chr 6:26,440,472...26,453,415
G
BTNL9
butyrophilin like 9
multiple interactions increases expression
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of BTNL9 mRNA sulforaphane results in increased expression of BTNL9 mRNA
CTD
PMID:30529165
NCBI chr 5:181,040,266...181,061,521
Ensembl chr 5:181,040,225...181,061,521
G
BUB1
BUB1 mitotic checkpoint serine/threonine kinase
increases expression
EXP
sulforaphane results in increased expression of BUB1 mRNA
CTD
PMID:31838189
NCBI chr 2:110,637,528...110,678,063
Ensembl chr 2:110,637,528...110,678,063
G
C11orf86
chromosome 11 open reading frame 86
decreases expression
EXP
sulforaphane results in decreased expression of C11ORF86 mRNA
CTD
PMID:31838189
NCBI chr11:66,975,304...66,977,009
Ensembl chr11:66,975,277...66,977,009
G
C1orf115
chromosome 1 open reading frame 115
decreases expression
EXP
sulforaphane results in decreased expression of C1ORF115 mRNA
CTD
PMID:31838189
NCBI chr 1:220,690,363...220,699,153
Ensembl chr 1:220,690,363...220,699,153
G
C1orf198
chromosome 1 open reading frame 198
decreases expression
EXP
sulforaphane results in decreased expression of C1ORF198 mRNA
CTD
PMID:31838189
NCBI chr 1:230,837,119...230,869,591
Ensembl chr 1:230,837,119...230,869,589
G
C1orf53
chromosome 1 open reading frame 53
decreases expression
EXP
sulforaphane results in decreased expression of C1ORF53 mRNA
CTD
PMID:31838189
NCBI chr 1:197,902,630...197,907,362
Ensembl chr 1:197,902,630...197,907,367
G
C1QL1
complement C1q like 1
decreases expression
EXP
sulforaphane results in decreased expression of C1QL1 mRNA
CTD
PMID:31838189
NCBI chr17:44,959,693...44,968,303
Ensembl chr17:44,959,693...44,968,303
G
C1QTNF1
C1q and TNF related 1
decreases expression
EXP
sulforaphane results in decreased expression of C1QTNF1 mRNA
CTD
PMID:31838189
NCBI chr17:79,022,934...79,049,788
Ensembl chr17:79,022,814...79,049,788
G
C1QTNF6
C1q and TNF related 6
decreases expression
EXP
sulforaphane results in decreased expression of C1QTNF6 mRNA
CTD
PMID:31838189
NCBI chr22:37,180,166...37,199,423
Ensembl chr22:37,180,166...37,199,385
G
C1R
complement C1r
decreases expression
EXP
sulforaphane results in decreased expression of C1R mRNA
CTD
PMID:31838189
NCBI chr12:7,080,219...7,092,445
Ensembl chr12:7,080,214...7,092,540
G
C22orf39
chromosome 22 open reading frame 39
decreases expression
EXP
sulforaphane results in decreased expression of C22ORF39 mRNA
CTD
PMID:31838189
NCBI chr22:19,440,886...19,447,711
Ensembl chr22:19,351,368...19,447,711
G
C2orf15
chromosome 2 open reading frame 15
decreases expression
EXP
sulforaphane results in decreased expression of C2ORF15 mRNA
CTD
PMID:31838189
NCBI chr 2:99,141,707...99,151,669
Ensembl chr 2:99,141,707...99,151,669
G
C3
complement C3
increases expression decreases expression
EXP
sulforaphane results in increased expression of C3 mRNA sulforaphane results in decreased expression of C3 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
C3AR1
complement C3a receptor 1
increases expression
EXP
sulforaphane results in increased expression of C3AR1 mRNA
CTD
PMID:26833863
NCBI chr12:8,056,844...8,066,359
Ensembl chr12:8,056,844...8,066,359
G
C4BPA
complement component 4 binding protein alpha
decreases expression
EXP
sulforaphane results in decreased expression of C4BPA mRNA
CTD
PMID:31838189
NCBI chr 1:207,104,233...207,144,972
Ensembl chr 1:207,104,233...207,144,972
G
C5
complement C5
decreases expression
ISO
sulforaphane results in decreased expression of HC mRNA
CTD
PMID:30529165
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
G
C6orf132
chromosome 6 open reading frame 132
decreases expression
EXP
sulforaphane results in decreased expression of C6ORF132 mRNA
CTD
PMID:31838189
NCBI chr 6:42,101,119...42,142,620
Ensembl chr 6:42,092,233...42,142,620
G
CA3
carbonic anhydrase 3
increases expression
ISO
sulforaphane results in increased expression of CAR3 mRNA
CTD
PMID:30529165
NCBI chr 8:85,438,859...85,449,040
Ensembl chr 8:85,373,436...85,449,040
G
CAB39L
calcium binding protein 39 like
increases expression
EXP
sulforaphane results in increased expression of CAB39L mRNA
CTD
PMID:31838189
NCBI chr13:49,308,650...49,444,064
Ensembl chr13:49,308,650...49,444,064
G
CABYR
calcium binding tyrosine phosphorylation regulated
increases expression
EXP
sulforaphane results in increased expression of CABYR mRNA
CTD
PMID:31838189
NCBI chr18:24,139,062...24,161,600
Ensembl chr18:24,138,987...24,161,600
G
CACNB1
calcium voltage-gated channel auxiliary subunit beta 1
decreases expression
EXP
sulforaphane results in decreased expression of CACNB1 mRNA
CTD
PMID:26833863
NCBI chr17:39,173,453...39,197,669
Ensembl chr17:39,173,453...39,197,702
G
CADPS2
calcium dependent secretion activator 2
decreases expression
EXP
sulforaphane results in decreased expression of CADPS2 mRNA
CTD
PMID:31838189
NCBI chr 7:122,318,411...122,886,460
Ensembl chr 7:122,318,411...122,886,759
G
CALCR
calcitonin receptor
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of CALCR mRNA
CTD
PMID:30529165
NCBI chr 7:93,424,486...93,574,724
Ensembl chr 7:93,424,486...93,574,730
G
CALML3
calmodulin like 3
increases expression
ISO
sulforaphane results in increased expression of CALML3 mRNA
CTD
PMID:30529165
NCBI chr10:5,524,961...5,526,771
Ensembl chr10:5,524,961...5,526,771
G
CAMK1D
calcium/calmodulin dependent protein kinase ID
decreases expression
EXP
sulforaphane results in decreased expression of CAMK1D mRNA
CTD
PMID:31838189
NCBI chr10:12,349,547...12,835,545
Ensembl chr10:12,349,547...12,835,545
G
CAMK2N1
calcium/calmodulin dependent protein kinase II inhibitor 1
decreases expression
EXP
sulforaphane results in decreased expression of CAMK2N1 mRNA
CTD
PMID:31838189
NCBI chr 1:20,482,391...20,486,210
Ensembl chr 1:20,482,391...20,486,210
G
CAPG
capping actin protein, gelsolin like
increases expression
EXP
sulforaphane results in increased expression of CAPG mRNA
CTD
PMID:26833863
NCBI chr 2:85,391,602...85,419,540
Ensembl chr 2:85,394,753...85,418,432
G
CAPNS1
calpain small subunit 1
affects binding
EXP
CAPNS1 protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr19:36,140,066...36,150,353
Ensembl chr19:36,139,953...36,150,353
G
CARD19
caspase recruitment domain family member 19
increases expression
EXP
sulforaphane results in increased expression of CARD19 mRNA
CTD
PMID:31838189
NCBI chr 9:93,096,217...93,113,283
Ensembl chr 9:93,096,217...93,113,283
G
CARHSP1
calcium regulated heat stable protein 1
decreases expression
EXP
sulforaphane results in decreased expression of CARHSP1 mRNA
CTD
PMID:31838189
NCBI chr16:8,852,942...8,869,006
Ensembl chr16:8,852,942...8,869,012
G
CARMIL1
capping protein regulator and myosin 1 linker 1
decreases expression
ISO
sulforaphane results in decreased expression of CARMIL1 mRNA
CTD
PMID:30529165
NCBI chr 6:25,279,374...25,620,530
Ensembl chr 6:25,279,078...25,620,530
G
CARS1
cysteinyl-tRNA synthetase 1
increases expression
EXP
sulforaphane results in increased expression of CARS1 mRNA
CTD
PMID:31838189
NCBI chr11:3,000,929...3,057,423
Ensembl chr11:3,000,922...3,057,613
G
CASK
calcium/calmodulin dependent serine protein kinase
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of CASK mRNA
CTD
PMID:25450479
NCBI chr X:41,514,934...41,923,554
Ensembl chr X:41,514,934...41,923,554
G
CASP1
caspase 1
multiple interactions
ISO
sulforaphane inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CASP1 protein]
CTD
PMID:36988325
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
G
CASP12
caspase 12 (gene/pseudogene)
multiple interactions
ISO
sulforaphane inhibits the reaction [Streptozocin results in increased cleavage of CASP12 protein]
CTD
PMID:24967692
NCBI chr11:104,883,286...104,898,460
Ensembl chr11:104,885,718...104,898,670
G
CASP3
caspase 3
multiple interactions increases activity
EXP ISO
[sulforaphane co-treated with Arsenic Trioxide] results in increased cleavage of CASP3 protein; [sulforaphane co-treated with TNFSF10 protein] results in decreased expression of CASP3 protein; Acetylcysteine inhibits the reaction [[sulforaphane co-treated with Arsenic Trioxide] results in increased cleavage of CASP3 protein]; Acetylcysteine inhibits the reaction [sulforaphane promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]]; NGF protein inhibits the reaction [sulforaphane results in increased activity of CASP3 protein]; sulforaphane inhibits the reaction [Oxidopamine results in increased activity of CASP3 protein]; sulforaphane inhibits the reaction [Pyruvaldehyde results in increased activity of CASP3 protein]; sulforaphane promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein] [sulforaphane co-treated with Diatrizoate Meglumine] results in increased activity of CASP3 protein; NFE2L2 protein affects the reaction [[sulforaphane co-treated with Diatrizoate Meglumine] results in increased activity of CASP3 protein]; sulforaphane inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CASP3 protein] sulforaphane inhibits the reaction [cyanoginosin LR results in increased activity of CASP3 protein]; sulforaphane inhibits the reaction [Dinitrochlorobenzene results in increased expression of CASP3 mRNA]; sulforaphane inhibits the reaction [Dinitrochlorobenzene results in increased expression of CASP3 protein]; sulforaphane inhibits the reaction [Ethanol results in increased expression of CASP3 protein modified form]; sulforaphane inhibits the reaction [Oxidopamine results in increased activity of CASP3 protein]; sulforaphane inhibits the reaction [Streptozocin results in increased cleavage of CASP3 protein]
CTD
PMID:19780897 PMID:21684301 PMID:22922937 PMID:23518299 PMID:24967692 PMID:25933243 PMID:26833863 PMID:29069573 PMID:29407470 PMID:29792947 PMID:30835071 PMID:31173751 PMID:34651546 More...
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP4
caspase 4
multiple interactions
EXP
[sulforaphane co-treated with Arsenic Trioxide] results in increased cleavage of CASP4 protein; Acetylcysteine inhibits the reaction [[sulforaphane co-treated with Arsenic Trioxide] results in increased cleavage of CASP4 protein]
CTD
PMID:22922937
NCBI chr11:104,942,866...104,968,574
Ensembl chr11:104,942,866...104,969,366
G
CASP7
caspase 7
increases activity
ISO
sulforaphane results in increased activity of CASP7 protein
CTD
PMID:17942926
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
G
CASP8
caspase 8
multiple interactions increases expression
EXP
[sulforaphane co-treated with TNFSF10 protein] results in decreased expression of CASP8 protein; sulforaphane results in increased expression of and results in increased activity of CASP8 protein sulforaphane results in increased expression of CASP8 mRNA
CTD
PMID:26833863 PMID:29792947 PMID:31838189
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
G
CASP9
caspase 9
multiple interactions decreases expression increases expression increases activity
EXP ISO
[sulforaphane co-treated with TNFSF10 protein] results in decreased expression of CASP9 protein; sulforaphane inhibits the reaction [Oxidopamine results in increased activity of CASP9 protein] sulforaphane inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CASP9 protein] sulforaphane results in decreased expression of CASP9 mRNA sulforaphane results in increased expression of CASP9 protein sulforaphane results in increased activity of CASP9 protein
CTD
PMID:19780897 PMID:26833863 PMID:27878984 PMID:29792947 PMID:30835071 PMID:31838189 More...
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
G
CASQ2
calsequestrin 2
increases expression
ISO
sulforaphane results in increased expression of CASQ2 mRNA
CTD
PMID:30529165
NCBI chr 1:115,700,021...115,768,714
Ensembl chr 1:115,698,038...115,793,195
G
CASTOR3P
CASTOR family member 3, pseudogene
decreases expression
EXP
sulforaphane results in decreased expression of CASTOR3P mRNA
CTD
PMID:31838189
NCBI chr 7:100,200,653...100,272,232
Ensembl chr 7:100,200,653...100,272,218 Ensembl chr 7:100,200,653...100,272,218
G
CASZ1
castor zinc finger 1
decreases expression
EXP
sulforaphane results in decreased expression of CASZ1 mRNA
CTD
PMID:31838189
NCBI chr 1:10,636,604...10,796,646
Ensembl chr 1:10,636,604...10,796,650
G
CAT
catalase
multiple interactions increases expression increases activity
ISO
sulforaphane inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased activity of CAT protein]; sulforaphane inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CAT mRNA]; sulforaphane inhibits the reaction [Cisplatin results in decreased expression of CAT protein] sulforaphane results in increased expression of CAT mRNA; sulforaphane results in increased expression of CAT protein sulforaphane inhibits the reaction [AGT protein modified form results in decreased expression of CAT mRNA]; sulforaphane inhibits the reaction [AGT protein modified form results in decreased expression of CAT protein]; sulforaphane inhibits the reaction [Carbon Tetrachloride results in decreased activity of CAT protein]; sulforaphane inhibits the reaction [Dinitrochlorobenzene results in decreased expression of CAT protein]; sulforaphane inhibits the reaction [Streptozocin results in decreased expression of CAT mRNA]; sulforaphane inhibits the reaction [Streptozocin results in decreased expression of CAT protein] sulforaphane results in increased activity of CAT protein
CTD
PMID:19913604 PMID:22664424 PMID:24967692 PMID:29353218 PMID:29964319 PMID:30835071 PMID:34651546 More...
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CBLB
Cbl proto-oncogene B
increases expression
EXP
sulforaphane results in increased expression of CBLB mRNA
CTD
PMID:31838189
NCBI chr 3:105,655,461...105,869,449
Ensembl chr 3:105,655,461...105,869,552
G
CBR3
carbonyl reductase 3
multiple interactions increases expression
ISO EXP
[sulforaphane co-treated with dibenzoylmethane] results in increased expression of CBR3 mRNA sulforaphane results in increased expression of CBR3 mRNA
CTD
PMID:17942926 PMID:20806931 PMID:31838189
NCBI chr21:36,135,079...36,146,562
Ensembl chr21:36,135,079...36,146,562
G
CBX6
chromobox 6
increases expression
EXP
sulforaphane results in increased expression of CBX6 mRNA
CTD
PMID:31838189
NCBI chr22:38,861,422...38,872,216
Ensembl chr22:38,861,422...38,872,249
G
CCDC102A
coiled-coil domain containing 102A
decreases expression
EXP
sulforaphane results in decreased expression of CCDC102A mRNA
CTD
PMID:31838189
NCBI chr16:57,512,181...57,537,016
Ensembl chr16:57,512,181...57,536,571
G
CCDC13
coiled-coil domain containing 13
increases expression
ISO
sulforaphane results in increased expression of CCDC13 mRNA
CTD
PMID:30529165
NCBI chr 3:42,704,118...42,773,253
Ensembl chr 3:42,705,756...42,773,253
G
CCDC18
coiled-coil domain containing 18
increases expression
EXP
sulforaphane results in increased expression of CCDC18 mRNA
CTD
PMID:31838189
NCBI chr 1:93,179,913...93,278,730
Ensembl chr 1:93,179,919...93,278,730
G
CCDC24
coiled-coil domain containing 24
increases expression
ISO
sulforaphane results in increased expression of CCDC24 mRNA
CTD
PMID:30529165
NCBI chr 1:43,991,599...43,996,528
Ensembl chr 1:43,991,359...43,996,528
G
CCDC28B
coiled-coil domain containing 28B
decreases expression
EXP
sulforaphane results in decreased expression of CCDC28B mRNA
CTD
PMID:31838189
NCBI chr 1:32,196,011...32,205,387
Ensembl chr 1:32,200,595...32,205,453
G
CCDC3
coiled-coil domain containing 3
decreases expression
EXP
sulforaphane results in decreased expression of CCDC3 mRNA
CTD
PMID:31838189
NCBI chr10:12,896,625...13,099,989
Ensembl chr10:12,896,625...13,099,652
G
CCDC80
coiled-coil domain containing 80
increases expression decreases expression
ISO EXP
sulforaphane results in increased expression of CCDC80 mRNA sulforaphane results in decreased expression of CCDC80 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 3:112,596,797...112,641,143
Ensembl chr 3:112,596,797...112,649,530
G
CCL11
C-C motif chemokine ligand 11
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of CCL11 mRNA
CTD
PMID:30529165
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
G
CCL2
C-C motif chemokine ligand 2
multiple interactions decreases expression increases expression
ISO EXP
sulforaphane inhibits the reaction [Cyclosporine results in increased expression of CCL2 mRNA]; sulforaphane inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA] sulforaphane inhibits the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of CCL2 mRNA]; sulforaphane metabolite inhibits the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of CCL2 mRNA] sulforaphane metabolite results in decreased expression of CCL2 mRNA; sulforaphane results in decreased expression of CCL2 mRNA sulforaphane results in increased expression of CCL2 mRNA
CTD
PMID:23958496 PMID:26833863 PMID:32387680 PMID:35724838
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL20
C-C motif chemokine ligand 20
increases expression multiple interactions
EXP ISO
sulforaphane results in increased expression of CCL20 mRNA [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of CCL20 mRNA
CTD
PMID:26833863 PMID:30529165
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
G
CCL5
C-C motif chemokine ligand 5
multiple interactions
ISO
sulforaphane inhibits the reaction [Cyclosporine results in increased expression of CCL5 mRNA]; sulforaphane inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]
CTD
PMID:23958496
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCN2
cellular communication network factor 2
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] affects the reaction [Oxygen deficiency results in increased expression of CCN2 protein]; NFE2L2 gene mutant form inhibits the reaction [sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of CCN2 protein]]; sulforaphane inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of CCN2 protein]; sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of CCN2 protein]; sulforaphane inhibits the reaction [Oxygen deficiency results in increased expression of CCN2 protein]; sulforaphane inhibits the reaction [Streptozocin results in increased expression of CCN2 protein]
CTD
PMID:24707343 PMID:24967692 PMID:29353218 PMID:30096613
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
G
CCN5
cellular communication network factor 5
decreases expression
EXP
sulforaphane results in decreased expression of CCN5 mRNA
CTD
PMID:31838189
NCBI chr20:44,714,861...44,727,811
Ensembl chr20:44,714,844...44,728,509
G
CCNB1
cyclin B1
increases expression
EXP
sulforaphane results in increased expression of CCNB1 mRNA; sulforaphane results in increased expression of CCNB1 protein
CTD
PMID:15231455 PMID:31838189
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
G
CCNB2
cyclin B2
increases expression
EXP
sulforaphane results in increased expression of CCNB2 mRNA
CTD
PMID:31838189
NCBI chr15:59,105,146...59,125,045
Ensembl chr15:59,105,126...59,125,045
G
CCND1
cyclin D1
increases expression
ISO EXP
sulforaphane results in increased expression of CCND1 protein sulforaphane results in increased expression of CCND1 mRNA
CTD
PMID:17942926 PMID:31838189
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
G
CCND3
cyclin D3
increases expression multiple interactions
EXP ISO
sulforaphane results in increased expression of CCND3 mRNA sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CCND3 protein]
CTD
PMID:26833863 PMID:33007382
NCBI chr 6:41,934,933...42,050,035
Ensembl chr 6:41,934,934...42,050,357
G
CCNE1
cyclin E1
increases expression
ISO
sulforaphane results in increased expression of CCNE1 mRNA
CTD
PMID:30529165
NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
G
CCNE2
cyclin E2
decreases expression
EXP
sulforaphane results in decreased expression of CCNE2 mRNA
CTD
PMID:31838189
NCBI chr 8:94,880,224...94,896,693
Ensembl chr 8:94,879,770...94,896,678
G
CCNJ
cyclin J
decreases expression multiple interactions
ISO
sulforaphane results in decreased expression of CCNJ mRNA [sulforaphane affects the susceptibility to Oxygen] which affects the expression of CCNJ mRNA
CTD
PMID:30529165
NCBI chr10:96,043,068...96,060,870
Ensembl chr10:96,043,394...96,060,870
G
CCNJL
cyclin J like
increases expression
EXP
sulforaphane results in increased expression of CCNJL mRNA
CTD
PMID:26833863
NCBI chr 5:160,249,083...160,339,570
Ensembl chr 5:160,249,083...160,345,396
G
CCNYL1
cyclin Y like 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CCNYL1 mRNA
CTD
PMID:30529165
NCBI chr 2:207,711,640...207,756,174
Ensembl chr 2:207,711,540...207,761,839
G
CCPG1
cell cycle progression 1
increases expression
EXP
sulforaphane results in increased expression of CCPG1 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr15:55,355,239...55,408,359
Ensembl chr15:55,340,032...55,408,510
G
CCR2
C-C motif chemokine receptor 2
decreases expression
EXP
sulforaphane results in decreased expression of CCR2 mRNA
CTD
PMID:26833863
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CCR4
C-C motif chemokine receptor 4
affects methylation
EXP
sulforaphane affects the methylation of CCR4 promoter
CTD
PMID:24466240
NCBI chr 3:32,951,644...32,956,349
Ensembl chr 3:32,951,644...32,956,349
G
CCT2
chaperonin containing TCP1 subunit 2
affects binding multiple interactions
EXP ISO
CCT2 protein binds to sulforaphane [sulforaphane affects the susceptibility to Oxygen] which affects the expression of CCT2 mRNA
CTD
PMID:21838287 PMID:30529165
NCBI chr12:69,585,459...69,601,570
Ensembl chr12:69,585,426...69,601,570
G
CCT8
chaperonin containing TCP1 subunit 8
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CCT8 mRNA
CTD
PMID:30529165
NCBI chr21:29,056,326...29,073,648
Ensembl chr21:29,055,805...29,073,797
G
CD14
CD14 molecule
increases expression
EXP
sulforaphane results in increased expression of CD14 mRNA
CTD
PMID:26833863
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CD163
CD163 molecule
increases expression
ISO
sulforaphane results in increased expression of CD163 mRNA
CTD
PMID:30529165
NCBI chr12:7,470,811...7,503,777
Ensembl chr12:7,470,811...7,503,893
G
CD180
CD180 molecule
decreases expression
EXP
sulforaphane results in decreased expression of CD180 mRNA
CTD
PMID:26833863
NCBI chr 5:67,179,613...67,196,799
Ensembl chr 5:67,179,613...67,196,799
G
CD22
CD22 molecule
increases expression
EXP
sulforaphane results in increased expression of CD22 mRNA
CTD
PMID:31838189
NCBI chr19:35,329,187...35,347,361
Ensembl chr19:35,319,261...35,347,361
G
CD24
CD24 molecule
decreases expression
EXP
sulforaphane results in decreased expression of CD24 mRNA
CTD
PMID:31838189
NCBI chr 6:106,969,831...106,976,855
Ensembl chr 6:106,969,831...106,975,627
G
CD300LF
CD300 molecule like family member f
increases expression
EXP
sulforaphane results in increased expression of CD300LF mRNA
CTD
PMID:26833863
NCBI chr17:74,694,317...74,712,923
Ensembl chr17:74,694,311...74,712,978
G
CD58
CD58 molecule
increases expression
EXP
sulforaphane results in increased expression of CD58 mRNA
CTD
PMID:26833863
NCBI chr 1:116,514,534...116,571,026
Ensembl chr 1:116,514,534...116,571,039
G
CD68
CD68 molecule
increases expression
EXP
sulforaphane results in increased expression of CD68 mRNA
CTD
PMID:26833863
NCBI chr17:7,579,638...7,582,111
Ensembl chr17:7,579,491...7,582,111
G
CD70
CD70 molecule
decreases expression
EXP
sulforaphane results in decreased expression of CD70 mRNA
CTD
PMID:31838189
NCBI chr19:6,581,648...6,591,150
Ensembl chr19:6,583,183...6,604,103
G
CD74
CD74 molecule
decreases expression
EXP
sulforaphane results in decreased expression of CD74 mRNA
CTD
PMID:26833863
NCBI chr 5:150,401,639...150,412,910
Ensembl chr 5:150,401,637...150,412,969
G
CD82
CD82 molecule
decreases expression
EXP
sulforaphane results in decreased expression of CD82 mRNA
CTD
PMID:31838189
NCBI chr11:44,564,409...44,620,358
Ensembl chr11:44,564,427...44,620,358
G
CD83
CD83 molecule
decreases expression
EXP
sulforaphane results in decreased expression of CD83 mRNA
CTD
PMID:31838189
NCBI chr 6:14,117,256...14,136,918
Ensembl chr 6:14,117,256...14,136,918
G
CD84
CD84 molecule
decreases expression increases expression
EXP
sulforaphane results in decreased expression of CD84 mRNA sulforaphane results in increased expression of CD84 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr 1:160,541,098...160,579,496
Ensembl chr 1:160,541,095...160,579,516
G
CDA
cytidine deaminase
increases expression decreases expression
EXP
sulforaphane results in increased expression of CDA mRNA sulforaphane results in decreased expression of CDA mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr 1:20,589,097...20,618,903
Ensembl chr 1:20,589,086...20,618,903
G
CDC16
cell division cycle 16
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CDC16 mRNA
CTD
PMID:30529165
NCBI chr13:114,234,897...114,272,723
Ensembl chr13:114,234,887...114,272,723
G
CDC20
cell division cycle 20
increases expression
EXP
sulforaphane results in increased expression of CDC20 mRNA
CTD
PMID:31838189
NCBI chr 1:43,358,981...43,363,203
Ensembl chr 1:43,358,981...43,363,203
G
CDC42BPG
CDC42 binding protein kinase gamma
decreases expression
EXP
sulforaphane results in decreased expression of CDC42BPG mRNA
CTD
PMID:31838189
NCBI chr11:64,823,052...64,844,653
Ensembl chr11:64,823,052...64,844,653
G
CDH1
cadherin 1
multiple interactions decreases expression increases methylation increases expression
ISO EXP
sulforaphane inhibits the reaction [Paraquat results in decreased expression of CDH1 protein] sulforaphane results in decreased expression of CDH1 mRNA sulforaphane results in increased methylation of CDH1 gene sulforaphane results in increased expression of CDH1
CTD
PMID:28624451 PMID:29899271 PMID:31838189
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
G
CDH10
cadherin 10
decreases expression
EXP
sulforaphane results in decreased expression of CDH10 mRNA
CTD
PMID:31838189
NCBI chr 5:24,487,100...24,644,978
Ensembl chr 5:24,487,100...24,644,978
G
CDH2
cadherin 2
increases expression
ISO
sulforaphane results in increased expression of CDH2 mRNA
CTD
PMID:30529165
NCBI chr18:27,932,879...28,177,130
Ensembl chr18:27,932,879...28,177,946
G
CDH5
cadherin 5
decreases expression
EXP
sulforaphane results in decreased expression of CDH5 mRNA
CTD
PMID:31838189
NCBI chr16:66,366,691...66,404,784
Ensembl chr16:66,366,690...66,404,784
G
CDHR4
cadherin related family member 4
increases expression
ISO
sulforaphane results in increased expression of CDHR4 mRNA
CTD
PMID:30529165
NCBI chr 3:49,790,732...49,802,914
Ensembl chr 3:49,790,732...49,799,873
G
CDK1
cyclin dependent kinase 1
increases expression
EXP
sulforaphane results in increased expression of CDK1 mRNA
CTD
PMID:31838189
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
G
CDK18
cyclin dependent kinase 18
decreases expression
EXP
sulforaphane results in decreased expression of CDK18 mRNA
CTD
PMID:31838189
NCBI chr 1:205,504,669...205,532,790
Ensembl chr 1:205,504,596...205,532,793
G
CDK6
cyclin dependent kinase 6
multiple interactions
ISO
sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased expression of CDK6 protein]
CTD
PMID:33007382
NCBI chr 7:92,604,921...92,836,573
Ensembl chr 7:92,604,921...92,836,573
G
CDKL4
cyclin dependent kinase like 4
increases expression
ISO
sulforaphane results in increased expression of CDKL4 mRNA
CTD
PMID:30529165
NCBI chr 2:39,168,045...39,247,120
Ensembl chr 2:39,168,045...39,243,983
G
CDKN1A
cyclin dependent kinase inhibitor 1A
increases expression multiple interactions
EXP
sulforaphane results in increased expression of CDKN1A mRNA; sulforaphane results in increased expression of CDKN1A protein sulforaphane inhibits the reaction [triptolide affects the expression of CDKN1A protein]
CTD
PMID:15231455 PMID:17937621 PMID:31838189 PMID:36990132
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CDKN1C
cyclin dependent kinase inhibitor 1C
decreases expression
EXP
sulforaphane results in decreased expression of CDKN1C mRNA
CTD
PMID:31838189
NCBI chr11:2,883,218...2,885,775
Ensembl chr11:2,883,213...2,885,775
G
CDKN2A
cyclin dependent kinase inhibitor 2A
multiple interactions decreases expression
ISO
sulforaphane inhibits the reaction [[NFE2L2 protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of CDKN2A mRNA]; sulforaphane promotes the reaction [1,2-Dimethylhydrazine results in increased expression of CDKN2A mRNA]; sulforaphane promotes the reaction [1,2-Dimethylhydrazine results in increased expression of CDKN2A protein] sulforaphane results in decreased expression of CDKN2A mRNA
CTD
PMID:26388957 PMID:30529165
NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
G
CDKN2AIP
CDKN2A interacting protein
decreases expression
EXP
sulforaphane results in decreased expression of CDKN2AIP mRNA
CTD
PMID:31838189
NCBI chr 4:183,444,636...183,449,064
Ensembl chr 4:183,444,635...183,449,064
G
CDKN2AIPNL
CDKN2A interacting protein N-terminal like
decreases expression
EXP
sulforaphane results in decreased expression of CDKN2AIPNL mRNA
CTD
PMID:31838189
NCBI chr 5:134,402,065...134,411,881
Ensembl chr 5:134,402,065...134,411,881
G
CEBPD
CCAAT enhancer binding protein delta
decreases expression
EXP
sulforaphane results in decreased expression of CEBPD mRNA
CTD
PMID:31838189
NCBI chr 8:47,736,913...47,738,164
Ensembl chr 8:47,736,913...47,738,164
G
CEBPE
CCAAT enhancer binding protein epsilon
increases expression
EXP
sulforaphane results in increased expression of CEBPE mRNA
CTD
PMID:26833863
NCBI chr14:23,117,306...23,119,255
Ensembl chr14:23,117,036...23,120,256
G
CENATAC
centrosomal AT-AC splicing factor
decreases expression multiple interactions
ISO
sulforaphane results in decreased expression of CENATAC mRNA [sulforaphane affects the susceptibility to Oxygen] which affects the expression of CENATAC mRNA
CTD
PMID:30529165
NCBI chr11:118,998,138...119,015,793
Ensembl chr11:118,998,138...119,015,793
G
CENPI
centromere protein I
increases expression
ISO
sulforaphane results in increased expression of CENPI mRNA
CTD
PMID:30529165
NCBI chr X:101,098,204...101,181,859
Ensembl chr X:101,098,188...101,166,126
G
CENPJ
centromere protein J
increases expression decreases methylation
EXP
sulforaphane results in increased expression of CENPJ mRNA sulforaphane results in decreased methylation of CENPJ gene
CTD
PMID:31838189
NCBI chr13:24,882,279...24,934,000
Ensembl chr13:24,882,279...24,922,889
G
CEP20
centrosomal protein 20
increases expression
EXP
sulforaphane results in increased expression of CEP20 mRNA
CTD
PMID:31838189
NCBI chr16:15,865,719...15,888,603
Ensembl chr16:15,865,719...15,888,625
G
CEP55
centrosomal protein 55
increases expression
EXP
sulforaphane results in increased expression of CEP55 mRNA
CTD
PMID:31838189
NCBI chr10:93,496,612...93,529,092
Ensembl chr10:93,496,612...93,529,092
G
CEP70
centrosomal protein 70
decreases expression
EXP
sulforaphane results in decreased expression of CEP70 mRNA
CTD
PMID:26833863
NCBI chr 3:138,494,344...138,594,260
Ensembl chr 3:138,494,344...138,594,538
G
CES1
carboxylesterase 1
multiple interactions increases expression
EXP
NFE2L2 protein affects the reaction [sulforaphane results in increased expression of CES1 mRNA alternative form]; sulforaphane promotes the reaction [[NFE2L2 protein binds to CES1 promoter] which results in increased expression of CES1 mRNA alternative form]; sulforaphane promotes the reaction [NFE2L2 protein binds to CES1 promoter]; sulforaphane results in increased expression of and results in increased activity of CES1 protein alternative form sulforaphane results in increased expression of CES1 mRNA; sulforaphane results in increased expression of CES1 mRNA alternative form
CTD
PMID:19715681 PMID:26833863
NCBI chr16:55,802,851...55,833,096
Ensembl chr16:55,802,851...55,833,337
G
CES3
carboxylesterase 3
decreases expression
EXP
sulforaphane results in decreased expression of CES3 mRNA
CTD
PMID:31838189
NCBI chr16:66,961,266...66,975,149
Ensembl chr16:66,961,245...66,975,149
G
CFAP144
cilia and flagella associated protein 144
increases expression
ISO
sulforaphane results in increased expression of CFAP144 mRNA
CTD
PMID:30529165
NCBI chr 1:43,142,962...43,156,396
Ensembl chr 1:43,145,153...43,156,396
G
CFAP251
cilia and flagella associated protein 251
increases expression
EXP
sulforaphane results in increased expression of CFAP251 mRNA
CTD
PMID:31838189
NCBI chr12:121,918,592...122,003,919
Ensembl chr12:121,918,592...122,003,927
G
CFD
complement factor D
increases expression
ISO
sulforaphane results in increased expression of CFD mRNA
CTD
PMID:30529165
NCBI chr19:859,664...863,641
Ensembl chr19:859,453...867,884
G
CFP
complement factor properdin
increases expression
EXP
sulforaphane results in increased expression of CFP mRNA
CTD
PMID:26833863
NCBI chr X:47,623,282...47,630,305
Ensembl chr X:47,623,172...47,630,305
G
CFTR
CF transmembrane conductance regulator
decreases expression
ISO
sulforaphane results in decreased expression of CFTR mRNA
CTD
PMID:30529165
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
G
CHAC1
ChaC glutathione specific gamma-glutamylcyclotransferase 1
decreases expression
ISO
sulforaphane results in decreased expression of CHAC1 mRNA
CTD
PMID:30529165
NCBI chr15:40,953,471...40,956,512
Ensembl chr15:40,952,962...40,956,512
G
CHIA
chitinase acidic
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of CHIA mRNA
CTD
PMID:30529165
NCBI chr 1:111,290,851...111,320,563
Ensembl chr 1:111,290,851...111,320,566
G
CHN1
chimerin 1
increases expression
EXP
sulforaphane results in increased expression of CHN1 mRNA
CTD
PMID:31838189
NCBI chr 2:174,798,809...175,005,381
Ensembl chr 2:174,798,809...175,005,381
G
CHORDC1
cysteine and histidine rich domain containing 1
increases expression
EXP
sulforaphane results in increased expression of CHORDC1 mRNA
CTD
PMID:31838189
NCBI chr11:90,200,429...90,223,049
Ensembl chr11:90,200,429...90,223,077
G
CHRNB1
cholinergic receptor nicotinic beta 1 subunit
decreases expression
EXP
sulforaphane results in decreased expression of CHRNB1 mRNA
CTD
PMID:31838189
NCBI chr17:7,445,061...7,457,710
Ensembl chr17:7,445,061...7,457,710
G
CHST13
carbohydrate sulfotransferase 13
decreases expression
EXP
sulforaphane results in decreased expression of CHST13 mRNA
CTD
PMID:31838189
NCBI chr 3:126,524,155...126,543,291
Ensembl chr 3:126,524,155...126,543,291
G
CHST15
carbohydrate sulfotransferase 15
increases expression
EXP
sulforaphane results in increased expression of CHST15 mRNA
CTD
PMID:31838189
NCBI chr10:124,007,668...124,093,598
Ensembl chr10:124,007,668...124,093,598
G
CHST2
carbohydrate sulfotransferase 2
decreases expression
EXP
sulforaphane results in decreased expression of CHST2 mRNA
CTD
PMID:31838189
NCBI chr 3:143,119,771...143,124,014
Ensembl chr 3:143,119,771...143,124,014
G
CIDEA
cell death inducing DFFA like effector a
increases expression
ISO
sulforaphane results in increased expression of CIDEA mRNA
CTD
PMID:30529165
NCBI chr18:12,254,361...12,277,595
Ensembl chr18:12,254,361...12,277,595
G
CILP2
cartilage intermediate layer protein 2
increases expression
ISO EXP
sulforaphane results in increased expression of CILP2 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr19:19,538,265...19,546,659
Ensembl chr19:19,538,248...19,546,659
G
CITED2
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2
decreases expression
EXP
sulforaphane results in decreased expression of CITED2 mRNA
CTD
PMID:31838189
NCBI chr 6:139,371,807...139,374,648
Ensembl chr 6:139,371,807...139,374,648
G
CITED4
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4
decreases expression
EXP
sulforaphane results in decreased expression of CITED4 mRNA
CTD
PMID:31838189
NCBI chr 1:40,861,054...40,862,363
Ensembl chr 1:40,861,054...40,862,363
G
CKB
creatine kinase B
decreases expression
EXP
sulforaphane results in decreased expression of CKB mRNA
CTD
PMID:31838189
NCBI chr14:103,519,667...103,522,830
Ensembl chr14:103,519,667...103,522,833
G
CKS2
CDC28 protein kinase regulatory subunit 2
increases expression
EXP
sulforaphane results in increased expression of CKS2 mRNA
CTD
PMID:31838189
NCBI chr 9:89,311,195...89,316,703
Ensembl chr 9:89,311,195...89,316,703
G
CLCN4
chloride voltage-gated channel 4
increases expression
EXP
sulforaphane results in increased expression of CLCN4 mRNA
CTD
PMID:31838189
NCBI chr X:10,156,975...10,237,660
Ensembl chr X:10,156,975...10,237,660
G
CLDN4
claudin 4
increases expression
ISO
sulforaphane results in increased expression of CLDN4 mRNA
CTD
PMID:30529165
NCBI chr 7:73,830,996...73,832,690
Ensembl chr 7:73,799,542...73,832,690
G
CLDN7
claudin 7
decreases expression
EXP
sulforaphane results in decreased expression of CLDN7 mRNA
CTD
PMID:31838189
NCBI chr17:7,259,903...7,263,213
Ensembl chr17:7,259,903...7,263,983
G
CLEC10A
C-type lectin domain containing 10A
increases expression
ISO
sulforaphane results in increased expression of CLEC10A mRNA
CTD
PMID:30529165
NCBI chr17:7,074,537...7,080,251
Ensembl chr17:7,074,537...7,080,307
G
CLEC2B
C-type lectin domain family 2 member B
increases expression
EXP
sulforaphane results in increased expression of CLEC2B mRNA
CTD
PMID:31838189
NCBI chr12:9,852,369...9,869,354
Ensembl chr12:9,852,369...9,869,386
G
CLEC4D
C-type lectin domain family 4 member D
increases expression
EXP
sulforaphane results in increased expression of CLEC4D mRNA
CTD
PMID:26833863
NCBI chr12:8,513,503...8,531,696
Ensembl chr12:8,509,475...8,522,366
G
CLEC4E
C-type lectin domain family 4 member E
increases expression
EXP
sulforaphane results in increased expression of CLEC4E mRNA
CTD
PMID:26833863
NCBI chr12:8,533,275...8,540,905
Ensembl chr12:8,533,305...8,540,905
G
CLGN
calmegin
increases expression
EXP
sulforaphane results in increased expression of CLGN mRNA
CTD
PMID:31838189
NCBI chr 4:140,388,453...140,427,648
Ensembl chr 4:140,388,453...140,427,661
G
CLIC3
chloride intracellular channel 3
decreases expression
EXP
sulforaphane results in decreased expression of CLIC3 mRNA
CTD
PMID:31838189
NCBI chr 9:136,994,608...136,996,568
Ensembl chr 9:136,994,608...136,996,568
G
CLIC6
chloride intracellular channel 6
increases expression
ISO
sulforaphane results in increased expression of CLIC6 mRNA
CTD
PMID:30529165
NCBI chr21:34,668,994...34,718,223
Ensembl chr21:34,668,994...34,718,227
G
CLPTM1
CLPTM1 regulator of GABA type A receptor forward trafficking
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CLPTM1 mRNA
CTD
PMID:30529165
NCBI chr19:44,954,585...44,993,341
Ensembl chr19:44,954,585...44,993,341
G
CLSTN2
calsyntenin 2
decreases expression
ISO
sulforaphane results in decreased expression of CLSTN2 mRNA
CTD
PMID:30529165
NCBI chr 3:139,935,185...140,577,397
Ensembl chr 3:139,935,185...140,577,397
G
CLU
clusterin
multiple interactions
ISO
[sulforaphane co-treated with dibenzoylmethane] results in decreased expression of CLU mRNA
CTD
PMID:17942926
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
G
CLUH
clustered mitochondria homolog
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CLUH mRNA
CTD
PMID:30529165
NCBI chr17:2,689,387...2,712,020
Ensembl chr17:2,689,386...2,712,663
G
CLYBL
citramalyl-CoA lyase
increases expression
ISO
sulforaphane results in increased expression of CLYBL mRNA
CTD
PMID:30529165
NCBI chr13:99,606,690...99,909,444
Ensembl chr13:99,606,669...99,909,459
G
CNFN
cornifelin
decreases expression
EXP
sulforaphane results in decreased expression of CNFN mRNA
CTD
PMID:31838189
NCBI chr19:42,387,019...42,390,297
Ensembl chr19:42,387,019...42,390,297
G
CNGB1
cyclic nucleotide gated channel subunit beta 1
decreases expression
EXP
sulforaphane results in decreased expression of CNGB1 mRNA
CTD
PMID:31838189
NCBI chr16:57,882,340...57,971,128
Ensembl chr16:57,882,340...57,971,128
G
CNIH2
cornichon family AMPA receptor auxiliary protein 2
increases expression
EXP
sulforaphane results in increased expression of CNIH2 mRNA
CTD
PMID:31838189
NCBI chr11:66,278,175...66,284,206
Ensembl chr11:66,278,175...66,285,301
G
CNN1
calponin 1
increases expression
ISO
sulforaphane results in increased expression of CNN1 mRNA
CTD
PMID:30529165
NCBI chr19:11,538,851...11,550,323
Ensembl chr19:11,538,767...11,550,323
G
CNN3
calponin 3
decreases expression
EXP
sulforaphane results in decreased expression of CNN3 mRNA
CTD
PMID:31838189
NCBI chr 1:94,896,957...94,927,110
Ensembl chr 1:94,896,949...94,927,223
G
CNOT6
CCR4-NOT transcription complex subunit 6
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CNOT6 mRNA
CTD
PMID:30529165
NCBI chr 5:180,494,379...180,578,358
Ensembl chr 5:180,494,379...180,578,358
G
CNOT9
CCR4-NOT transcription complex subunit 9
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CNOT9 mRNA
CTD
PMID:30529165
NCBI chr 2:218,568,839...218,597,080
Ensembl chr 2:218,568,580...218,597,080
G
CNR2
cannabinoid receptor 2
multiple interactions
ISO
[LEPR protein affects the susceptibility to sulforaphane] which affects the expression of CNR2 protein
CTD
PMID:29143802
NCBI chr 1:23,870,515...23,913,362
Ensembl chr 1:23,870,515...23,913,362
G
CNTNAP1
contactin associated protein 1
decreases expression
EXP
sulforaphane results in decreased expression of CNTNAP1 mRNA
CTD
PMID:31838189
NCBI chr17:42,682,531...42,699,993
Ensembl chr17:42,682,531...42,699,993
G
CNTNAP3
contactin associated protein family member 3
decreases expression
EXP
sulforaphane results in decreased expression of CNTNAP3 mRNA
CTD
PMID:31838189
NCBI chr 9:39,064,710...39,288,167
Ensembl chr 9:39,064,710...39,288,315
G
COA6
cytochrome c oxidase assembly factor 6
increases expression
EXP
sulforaphane results in increased expression of COA6 mRNA
CTD
PMID:31838189
NCBI chr 1:234,373,456...234,385,080
Ensembl chr 1:234,373,456...234,385,080
G
COBLL1
cordon-bleu WH2 repeat protein like 1
decreases expression
EXP
sulforaphane results in decreased expression of COBLL1 mRNA
CTD
PMID:31838189
NCBI chr 2:164,657,931...164,842,076
Ensembl chr 2:164,653,624...164,843,679
G
COL1A1
collagen type I alpha 1 chain
decreases expression
EXP
sulforaphane results in decreased expression of COL1A1 mRNA
CTD
PMID:31838189
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
G
COL4A5
collagen type IV alpha 5 chain
decreases expression increases methylation
EXP
sulforaphane results in decreased expression of COL4A5 mRNA sulforaphane results in increased methylation of COL4A5 gene
CTD
PMID:31838189
NCBI chr X:108,439,838...108,697,545
Ensembl chr X:108,439,838...108,697,545
G
COL4A6
collagen type IV alpha 6 chain
decreases expression
EXP
sulforaphane results in decreased expression of COL4A6 mRNA
CTD
PMID:31838189
NCBI chr X:108,155,614...108,439,458
Ensembl chr X:108,155,607...108,439,497
G
COL5A1
collagen type V alpha 1 chain
increases methylation decreases expression
EXP
sulforaphane results in increased methylation of COL5A1 gene sulforaphane results in decreased expression of COL5A1 mRNA
CTD
PMID:31838189
NCBI chr 9:134,641,803...134,844,843
Ensembl chr 9:134,641,803...134,844,843
G
COL9A3
collagen type IX alpha 3 chain
decreases expression
EXP
sulforaphane results in decreased expression of COL9A3 mRNA
CTD
PMID:31838189
NCBI chr20:62,816,213...62,841,159
Ensembl chr20:62,816,244...62,841,159
G
COMT
catechol-O-methyltransferase
multiple interactions
EXP
sulforaphane inhibits the reaction [DNMT3B protein binds to COMT promoter]; sulforaphane inhibits the reaction [EP300 protein binds to COMT promoter]; sulforaphane inhibits the reaction [Estradiol promotes the reaction [DNMT3B protein binds to COMT promoter]]; sulforaphane inhibits the reaction [Estradiol promotes the reaction [HDAC1 protein binds to COMT promoter]]; sulforaphane inhibits the reaction [Estradiol promotes the reaction [MBD2 protein binds to COMT promoter]]; sulforaphane inhibits the reaction [Estradiol results in decreased expression of COMT mRNA]; sulforaphane inhibits the reaction [Estradiol results in increased methylation of COMT promoter]; sulforaphane inhibits the reaction [Genistein promotes the reaction [HDAC1 protein binds to COMT promoter]]; sulforaphane inhibits the reaction [Genistein promotes the reaction [MBD2 protein binds to COMT promoter]]; sulforaphane inhibits the reaction [Genistein results in decreased expression of COMT mRNA]; sulforaphane inhibits the reaction [Genistein results in increased methylation of COMT promoter]; sulforaphane inhibits the reaction [HDAC1 protein binds to COMT promoter]
CTD
PMID:30684530
NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975
G
COQ9
coenzyme Q9
increases expression
ISO
sulforaphane results in increased expression of COQ9 mRNA
CTD
PMID:30529165
NCBI chr16:57,447,479...57,461,270
Ensembl chr16:57,447,425...57,461,270
G
CORIN
corin, serine peptidase
increases expression
ISO
sulforaphane results in increased expression of CORIN mRNA
CTD
PMID:30529165
NCBI chr 4:47,594,001...47,838,067
Ensembl chr 4:47,593,999...47,838,106
G
CORO6
coronin 6
decreases expression
EXP
sulforaphane results in decreased expression of CORO6 mRNA
CTD
PMID:31838189
NCBI chr17:29,614,762...29,622,912
Ensembl chr17:29,614,756...29,622,912
G
COX5A
cytochrome c oxidase subunit 5A
increases expression
ISO
sulforaphane results in increased expression of COX5A mRNA
CTD
PMID:30529165
NCBI chr15:74,919,791...74,938,073
Ensembl chr15:74,919,791...74,938,083
G
COX5B
cytochrome c oxidase subunit 5B
increases expression
ISO
sulforaphane results in increased expression of COX5B mRNA
CTD
PMID:30529165
NCBI chr 2:97,646,062...97,648,383
Ensembl chr 2:97,646,062...97,648,383
G
COX6A2
cytochrome c oxidase subunit 6A2
increases expression
ISO
sulforaphane results in increased expression of COX6A2 mRNA
CTD
PMID:30529165
NCBI chr16:31,427,731...31,428,360
Ensembl chr16:31,427,731...31,428,360
G
COX7A1
cytochrome c oxidase subunit 7A1
increases expression
ISO
sulforaphane results in increased expression of COX7A1 mRNA
CTD
PMID:30529165
NCBI chr19:36,150,922...36,152,447
Ensembl chr19:36,150,922...36,152,449
G
COX8BP
cytochrome c oxidase subunit 8B, pseudogene
increases expression
ISO
sulforaphane results in increased expression of COX8B mRNA
CTD
PMID:30529165
NCBI chr11:253,417...256,972
Ensembl chr11:253,446...253,558
G
CPA4
carboxypeptidase A4
decreases expression
EXP
sulforaphane results in decreased expression of CPA4 mRNA
CTD
PMID:31838189
NCBI chr 7:130,293,161...130,324,180
Ensembl chr 7:130,293,134...130,324,180
G
CPD
carboxypeptidase D
increases expression
EXP
sulforaphane results in increased expression of CPD mRNA
CTD
PMID:26833863
NCBI chr17:30,378,927...30,469,989
Ensembl chr17:30,378,927...30,469,989
G
CPEB2
cytoplasmic polyadenylation element binding protein 2
decreases methylation
EXP
sulforaphane results in decreased methylation of CPEB2 gene
CTD
PMID:31838189
NCBI chr 4:15,002,481...15,070,151
Ensembl chr 4:15,002,481...15,070,153
G
CPEB4
cytoplasmic polyadenylation element binding protein 4
decreases expression
EXP
sulforaphane results in decreased expression of CPEB4 mRNA
CTD
PMID:31838189
NCBI chr 5:173,888,349...173,961,980
Ensembl chr 5:173,888,349...173,961,980
G
CPED1
cadherin like and PC-esterase domain containing 1
decreases expression
EXP
sulforaphane results in decreased expression of CPED1 mRNA
CTD
PMID:31838189
NCBI chr 7:120,988,711...121,297,442
Ensembl chr 7:120,988,697...121,297,442
G
CPLANE1
ciliogenesis and planar polarity effector complex subunit 1
decreases expression
EXP
sulforaphane results in decreased expression of CPLANE1 mRNA
CTD
PMID:31838189
NCBI chr 5:37,075,669...37,249,376
Ensembl chr 5:37,106,228...37,249,376
G
CPM
carboxypeptidase M
decreases expression
ISO EXP
sulforaphane results in decreased expression of CPM mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr12:68,842,197...68,963,469
Ensembl chr12:68,842,197...68,971,570
G
CPS1
carbamoyl-phosphate synthase 1
decreases expression
EXP
sulforaphane results in decreased expression of CPS1 mRNA
CTD
PMID:31838189
NCBI chr 2:210,477,685...210,679,107
Ensembl chr 2:210,477,682...210,679,107
G
CPT1A
carnitine palmitoyltransferase 1A
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of CPT1A mRNA
CTD
PMID:25450479
NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
G
CPT2
carnitine palmitoyltransferase 2
increases expression
ISO
sulforaphane results in increased expression of CPT2 mRNA
CTD
PMID:30529165
NCBI chr 1:53,196,824...53,214,197
Ensembl chr 1:53,196,792...53,214,197
G
CPZ
carboxypeptidase Z
increases expression
ISO
sulforaphane results in increased expression of CPZ mRNA
CTD
PMID:30529165
NCBI chr 4:8,592,765...8,619,752
Ensembl chr 4:8,592,660...8,619,759
G
CR1L
complement C3b/C4b receptor 1 like
increases expression
EXP
sulforaphane results in increased expression of CR1L mRNA
CTD
PMID:26833863
NCBI chr 1:207,645,133...207,723,703
Ensembl chr 1:207,645,113...207,738,416
G
CRABP2
cellular retinoic acid binding protein 2
decreases expression
EXP
sulforaphane results in decreased expression of CRABP2 mRNA
CTD
PMID:31838189
NCBI chr 1:156,699,606...156,705,784
Ensembl chr 1:156,699,606...156,705,816
G
CRACDL
CRACD like
increases expression
EXP
sulforaphane results in increased expression of CRACDL mRNA
CTD
PMID:31838189
NCBI chr 2:98,793,846...98,936,225
Ensembl chr 2:98,793,846...98,936,259
G
CRAT
carnitine O-acetyltransferase
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of CRAT mRNA
CTD
PMID:25450479
NCBI chr 9:129,094,794...129,110,793
Ensembl chr 9:129,094,142...129,111,189
G
CRB3
crumbs cell polarity complex component 3
decreases expression
EXP
sulforaphane results in decreased expression of CRB3 mRNA
CTD
PMID:31838189
NCBI chr19:6,463,777...6,467,221
Ensembl chr19:6,463,777...6,467,221
G
CREB5
cAMP responsive element binding protein 5
decreases expression
EXP
sulforaphane results in decreased expression of CREB5 mRNA
CTD
PMID:31838189
NCBI chr 7:28,299,321...28,825,894
Ensembl chr 7:28,299,321...28,825,894
G
CREG1
cellular repressor of E1A stimulated genes 1
increases expression
EXP
sulforaphane results in increased expression of CREG1 mRNA
CTD
PMID:31838189
NCBI chr 1:167,541,013...167,553,762
Ensembl chr 1:167,529,117...167,553,805
G
CRIP2
cysteine rich protein 2
decreases expression
EXP
sulforaphane results in decreased expression of CRIP2 mRNA
CTD
PMID:31838189
NCBI chr14:105,472,945...105,480,170
Ensembl chr14:105,472,962...105,480,162
G
CRISPLD2
cysteine rich secretory protein LCCL domain containing 2
decreases expression
EXP
sulforaphane results in decreased expression of CRISPLD2 mRNA
CTD
PMID:31838189
NCBI chr16:84,819,985...84,909,508
Ensembl chr16:84,819,985...84,920,768
G
CRTC3
CREB regulated transcription coactivator 3
decreases expression
EXP
sulforaphane results in decreased expression of CRTC3 mRNA
CTD
PMID:31838189
NCBI chr15:90,529,923...90,645,345
Ensembl chr15:90,529,923...90,645,345
G
CRYAB
crystallin alpha B
decreases expression
EXP
sulforaphane results in decreased expression of CRYAB mRNA
CTD
PMID:31838189
NCBI chr11:111,908,564...111,923,740
Ensembl chr11:111,908,564...111,923,722
G
CS
citrate synthase
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CS mRNA
CTD
PMID:30529165
NCBI chr12:56,271,699...56,300,330
Ensembl chr12:56,271,699...56,300,391
G
CSDC2
cold shock domain containing C2
decreases expression
EXP
sulforaphane results in decreased expression of CSDC2 mRNA
CTD
PMID:31838189
NCBI chr22:41,561,010...41,576,666
Ensembl chr22:41,561,010...41,577,741
G
CSF2
colony stimulating factor 2
multiple interactions
EXP
sulforaphane inhibits the reaction [Vehicle Emissions analog results in increased expression of CSF2 protein]
CTD
PMID:16905640
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
G
CSPG4
chondroitin sulfate proteoglycan 4
decreases expression
EXP
sulforaphane results in decreased expression of CSPG4 mRNA
CTD
PMID:31838189
NCBI chr15:75,674,322...75,713,466
Ensembl chr15:75,674,322...75,712,848
G
CSRP1
cysteine and glycine rich protein 1
decreases expression
EXP
sulforaphane results in decreased expression of CSRP1 mRNA
CTD
PMID:31838189
NCBI chr 1:201,483,530...201,507,123
Ensembl chr 1:201,483,530...201,509,456
G
CSRP3
cysteine and glycine rich protein 3
increases expression
ISO
sulforaphane results in increased expression of CSRP3 mRNA
CTD
PMID:30529165
NCBI chr11:19,182,030...19,201,983
Ensembl chr11:19,182,030...19,210,571
G
CST3
cystatin C
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CST3 mRNA
CTD
PMID:30529165
NCBI chr20:23,626,706...23,637,955
Ensembl chr20:23,626,706...23,638,473
G
CTDNEP1
CTD nuclear envelope phosphatase 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CTDNEP1 mRNA
CTD
PMID:30529165
NCBI chr17:7,243,591...7,251,978
Ensembl chr17:7,243,591...7,252,491
G
CTDSP1
CTD small phosphatase 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CTDSP1 mRNA
CTD
PMID:30529165
NCBI chr 2:218,396,351...218,405,941
Ensembl chr 2:218,397,136...218,405,941
G
CTDSPL
CTD small phosphatase like
decreases expression
ISO
sulforaphane results in decreased expression of CTDSPL mRNA
CTD
PMID:30529165
NCBI chr 3:37,861,880...37,984,469
Ensembl chr 3:37,861,880...37,984,469
G
CTDSPL2
CTD small phosphatase like 2
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CTDSPL2 mRNA
CTD
PMID:30529165
NCBI chr15:44,427,629...44,529,038
Ensembl chr15:44,427,622...44,529,038
G
CTH
cystathionine gamma-lyase
increases response to substance decreases expression
ISO
CTH protein results in increased susceptibility to sulforaphane sulforaphane results in decreased expression of CTH mRNA
CTD
PMID:22005276 PMID:30529165
NCBI chr 1:70,411,268...70,439,851
Ensembl chr 1:70,411,218...70,439,851
G
CTNND1
catenin delta 1
increases expression
EXP
sulforaphane results in increased expression of CTNND1 mRNA
CTD
PMID:26833863
NCBI chr11:57,761,802...57,819,540
Ensembl chr11:57,753,243...57,819,546
G
CTSG
cathepsin G
decreases expression
EXP
sulforaphane results in decreased expression of CTSG mRNA
CTD
PMID:26833863
NCBI chr14:24,573,518...24,576,250
Ensembl chr14:24,573,518...24,576,250
G
CTSL
cathepsin L
increases expression
EXP
sulforaphane results in increased expression of CTSL mRNA
CTD
PMID:31838189
NCBI chr 9:87,726,119...87,731,469
Ensembl chr 9:87,724,051...87,731,469
G
CTSO
cathepsin O
increases expression
EXP
sulforaphane results in increased expression of CTSO mRNA
CTD
PMID:31838189
NCBI chr 4:155,924,118...155,953,866
Ensembl chr 4:155,921,580...155,953,912
G
CTTNBP2NL
CTTNBP2 N-terminal like
decreases expression
ISO
sulforaphane results in decreased expression of CTTNBP2NL mRNA
CTD
PMID:30529165
NCBI chr 1:112,391,087...112,461,164
Ensembl chr 1:112,396,214...112,463,456
G
CTXN1
cortexin 1
decreases expression
EXP
sulforaphane results in decreased expression of CTXN1 mRNA
CTD
PMID:31838189
NCBI chr19:7,924,491...7,926,135
Ensembl chr19:7,924,491...7,926,135
G
CUL3
cullin 3
multiple interactions
EXP ISO
sulforaphane inhibits the reaction [KEAP1 protein binds to CUL3 protein]
CTD
PMID:18417180 PMID:30261176
NCBI chr 2:224,470,150...224,585,363
Ensembl chr 2:224,470,150...224,585,397
G
CXCL1
C-X-C motif chemokine ligand 1
multiple interactions increases expression decreases expression
EXP
sulforaphane inhibits the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of CXCL1 mRNA]; sulforaphane metabolite inhibits the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of CXCL1 mRNA] sulforaphane results in increased expression of CXCL1 mRNA sulforaphane metabolite results in decreased expression of CXCL1 mRNA; sulforaphane results in decreased expression of CXCL1 mRNA
CTD
PMID:32387680 PMID:35724838
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCL17
C-X-C motif chemokine ligand 17
increases expression
ISO
sulforaphane results in increased expression of CXCL17 mRNA
CTD
PMID:30529165
NCBI chr19:42,428,278...42,442,946
Ensembl chr19:42,428,278...42,442,946
G
CXCL2
C-X-C motif chemokine ligand 2
increases expression
EXP
sulforaphane results in increased expression of CXCL2 mRNA
CTD
PMID:35724838
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL8
C-X-C motif chemokine ligand 8
multiple interactions decreases expression increases expression
EXP
sulforaphane inhibits the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of and results in increased secretion of CXCL8 protein]; sulforaphane inhibits the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of CXCL8 mRNA]; sulforaphane inhibits the reaction [macrophage stimulatory lipopeptide 2 results in increased secretion of CXCL8 protein]; sulforaphane inhibits the reaction [Vehicle Emissions analog results in increased expression of CXCL8 protein]; sulforaphane metabolite inhibits the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of and results in increased secretion of CXCL8 protein]; sulforaphane metabolite inhibits the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of CXCL8 mRNA]; tin protoporphyrin IX inhibits the reaction [sulforaphane inhibits the reaction [macrophage stimulatory lipopeptide 2 results in increased secretion of CXCL8 protein]] sulforaphane metabolite results in decreased expression of CXCL8 mRNA; sulforaphane results in decreased expression of CXCL8 mRNA sulforaphane results in increased expression of CXCL8 mRNA
CTD
PMID:16905640 PMID:26833863 PMID:30965051 PMID:32387680
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CXCR5
C-X-C motif chemokine receptor 5
increases expression
EXP
sulforaphane results in increased expression of CXCR5 mRNA
CTD
PMID:26833863
NCBI chr11:118,883,892...118,897,787
Ensembl chr11:118,883,892...118,897,787
G
CYBB
cytochrome b-245 beta chain
increases expression
EXP
sulforaphane results in increased expression of CYBB mRNA
CTD
PMID:26833863
NCBI chr X:37,780,059...37,813,461
Ensembl chr X:37,780,018...37,813,461
G
CYC1
cytochrome c1
increases expression
ISO
sulforaphane results in increased expression of CYC1 mRNA
CTD
PMID:30529165
NCBI chr 8:144,095,076...144,097,525
Ensembl chr 8:144,095,039...144,097,525
G
CYCS
cytochrome c, somatic
increases expression
ISO
sulforaphane results in increased expression of CYCS mRNA
CTD
PMID:30529165
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
G
CYFIP2
cytoplasmic FMR1 interacting protein 2
increases expression
ISO
sulforaphane results in increased expression of CYFIP2 mRNA
CTD
PMID:30529165
NCBI chr 5:157,266,123...157,395,594
Ensembl chr 5:157,266,079...157,395,595
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
increases expression affects binding affects expression multiple interactions
ISO EXP
sulforaphane results in increased expression of CYP1A1 protein sulforaphane binds to CYP1A1 protein sulforaphane analog affects the expression of CYP1A1 mRNA sulforaphane inhibits the reaction [anthracene results in increased activity of CYP1A1 protein]; sulforaphane inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein] sulforaphane analog inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; sulforaphane inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; sulforaphane results in decreased activity of [CYP1A2 protein co-treated with CYP1A1 protein]
CTD
PMID:18823965 PMID:19202560 PMID:19362136 PMID:22643862 PMID:22664424 PMID:23566952 More...
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
increases expression multiple interactions decreases expression
ISO EXP
sulforaphane results in increased expression of CYP1A2 protein sulforaphane results in decreased activity of [CYP1A2 protein co-treated with CYP1A1 protein] sulforaphane inhibits the reaction [1,2,5,6-dibenzanthracene results in increased activity of CYP1A2 protein]; sulforaphane inhibits the reaction [anthracene results in increased activity of CYP1A2 protein]; sulforaphane inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A2 protein] sulforaphane results in decreased expression of CYP1A2 mRNA
CTD
PMID:15906351 PMID:19202560 PMID:19362136 PMID:20442190 PMID:22664424
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
increases expression
ISO EXP
sulforaphane results in increased expression of CYP1B1 protein sulforaphane results in increased expression of CYP1B1 mRNA
CTD
PMID:18823965 PMID:26833863
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
G
CYP26B1
cytochrome P450 family 26 subfamily B member 1
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of CYP26B1 mRNA
CTD
PMID:30529165
NCBI chr 2:72,129,238...72,147,862
Ensembl chr 2:72,129,238...72,147,862
G
CYP2A6
cytochrome P450 family 2 subfamily A member 6
multiple interactions
EXP
[sulforaphane results in increased activity of NFE2L2 protein] which results in increased expression of CYP2A6 mRNA
CTD
PMID:20887713
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
multiple interactions increases expression
ISO
sulforaphane inhibits the reaction [cyanoginosin LR results in increased expression of CYP2E1 mRNA]; sulforaphane inhibits the reaction [cyanoginosin LR results in increased expression of CYP2E1 protein] sulforaphane results in increased expression of CYP2E1 mRNA
CTD
PMID:21684301 PMID:30529165
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
CYP39A1
cytochrome P450 family 39 subfamily A member 1
increases expression
EXP
sulforaphane results in increased expression of CYP39A1 mRNA
CTD
PMID:31838189
NCBI chr 6:46,549,580...46,652,818
Ensembl chr 6:46,549,580...46,652,830
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
decreases expression multiple interactions decreases activity increases expression
EXP ISO
sulforaphane results in decreased expression of CYP3A4 mRNA sulforaphane results in decreased expression of and results in decreased activity of CYP3A2 protein sulforaphane results in decreased activity of CYP3A2 protein sulforaphane results in increased expression of CYP3A2 protein sulforaphane inhibits the reaction [ginkgolide B results in increased expression of CYP3A4 mRNA]; sulforaphane inhibits the reaction [Rifampin results in increased expression of CYP3A4]
CTD
PMID:15906351 PMID:18823965 PMID:20442190 PMID:22664424 PMID:23153560 PMID:26775663 More...
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
CYP4F11
cytochrome P450 family 4 subfamily F member 11
increases expression
EXP
sulforaphane results in increased expression of CYP4F11 mRNA
CTD
PMID:31838189
NCBI chr19:15,912,377...15,934,867
Ensembl chr19:15,912,367...15,934,867
G
CYP4F2
cytochrome P450 family 4 subfamily F member 2
increases expression
EXP
sulforaphane results in increased expression of CYP4F2 mRNA
CTD
PMID:26833863
NCBI chr19:15,878,023...15,898,074
Ensembl chr19:15,878,023...15,898,077
G
CYP4F3
cytochrome P450 family 4 subfamily F member 3
increases expression
EXP
sulforaphane results in increased expression of CYP4F3 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr19:15,640,897...15,662,825
Ensembl chr19:15,640,897...15,662,825
G
CYP7A1
cytochrome P450 family 7 subfamily A member 1
decreases expression
EXP
sulforaphane results in decreased expression of CYP7A1 mRNA
CTD
PMID:34767876
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
G
CYP8B1
cytochrome P450 family 8 subfamily B member 1
decreases expression
EXP
sulforaphane results in decreased expression of CYP8B1 mRNA
CTD
PMID:34767876
NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
G
DAB2
DAB adaptor protein 2
decreases expression
EXP
sulforaphane results in decreased expression of DAB2 mRNA
CTD
PMID:31838189
NCBI chr 5:39,371,677...39,424,980
Ensembl chr 5:39,371,675...39,462,300
G
DAPP1
dual adaptor of phosphotyrosine and 3-phosphoinositides 1
decreases expression
EXP
sulforaphane results in decreased expression of DAPP1 mRNA
CTD
PMID:31838189
NCBI chr 4:99,816,827...99,872,333
Ensembl chr 4:99,816,827...99,870,190
G
DCAF7
DDB1 and CUL4 associated factor 7
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of DCAF7 mRNA
CTD
PMID:30529165
NCBI chr17:63,550,477...63,594,266
Ensembl chr17:63,550,222...63,594,286
G
DCN
decorin
increases expression decreases expression
ISO EXP
sulforaphane results in increased expression of DCN mRNA sulforaphane results in decreased expression of DCN mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr12:91,140,484...91,182,817
Ensembl chr12:91,140,484...91,183,217
G
DCSTAMP
dendrocyte expressed seven transmembrane protein
increases expression
ISO
sulforaphane results in increased expression of DCSTAMP mRNA
CTD
PMID:30529165
NCBI chr 8:104,339,796...104,356,689
Ensembl chr 8:104,339,087...104,356,689
G
DDAH1
dimethylarginine dimethylaminohydrolase 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of DDAH1 mRNA
CTD
PMID:30529165
NCBI chr 1:85,318,485...85,578,200
Ensembl chr 1:85,318,481...85,578,363
G
DDAH2
DDAH family member 2, ADMA-independent
decreases expression
EXP
sulforaphane results in decreased expression of DDAH2 mRNA
CTD
PMID:31838189
NCBI chr 6:31,727,040...31,730,263
Ensembl chr 6:31,727,038...31,730,617
G
DDB2
damage specific DNA binding protein 2
decreases expression
EXP
sulforaphane results in decreased expression of DDB2 mRNA
CTD
PMID:31838189
NCBI chr11:47,214,454...47,239,217
Ensembl chr11:47,214,465...47,239,217
G
DDIAS
DNA damage induced apoptosis suppressor
increases expression
EXP
sulforaphane results in increased expression of DDIAS mRNA
CTD
PMID:31838189
NCBI chr11:82,901,736...82,934,659
Ensembl chr11:82,899,975...82,958,277
G
DDIT3
DNA damage inducible transcript 3
multiple interactions increases expression
ISO EXP
sulforaphane inhibits the reaction [bisphenol A results in increased expression of DDIT3 protein]; sulforaphane inhibits the reaction [Streptozocin results in increased expression of DDIT3 protein] sulforaphane results in increased expression of DDIT3 protein sulforaphane inhibits the reaction [bisphenol A results in increased expression of DDIT3 protein]; sulforaphane promotes the reaction [Arsenic Trioxide results in increased expression of DDIT3 protein]
CTD
PMID:22922937 PMID:24967692 PMID:35724838 PMID:36670177
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
DDN
dendrin
decreases expression
EXP
sulforaphane results in decreased expression of DDN mRNA
CTD
PMID:31838189
NCBI chr12:48,995,149...48,999,375
Ensembl chr12:48,995,149...48,999,375
G
DECR1
2,4-dienoyl-CoA reductase 1
increases expression
ISO
sulforaphane results in increased expression of DECR1 mRNA
CTD
PMID:30529165
NCBI chr 8:90,001,477...90,053,633
Ensembl chr 8:90,001,405...90,053,633
G
DEDD
death effector domain containing
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of DEDD mRNA
CTD
PMID:25450479
NCBI chr 1:161,120,974...161,132,667
Ensembl chr 1:161,120,974...161,132,688
G
DEDD2
death effector domain containing 2
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of DEDD2 mRNA
CTD
PMID:30529165
NCBI chr19:42,198,598...42,220,134
Ensembl chr19:42,198,598...42,220,140
G
DENND2B
DENN domain containing 2B
decreases expression
EXP
sulforaphane results in decreased expression of DENND2B mRNA
CTD
PMID:31838189
NCBI chr11:8,693,352...8,910,951
Ensembl chr11:8,693,351...8,910,951
G
DENND3
DENN domain containing 3
decreases expression
EXP
sulforaphane results in decreased expression of DENND3 mRNA
CTD
PMID:31838189
NCBI chr 8:141,128,589...141,195,804
Ensembl chr 8:141,117,278...141,195,808
G
DEPDC1
DEP domain containing 1
increases expression
EXP
sulforaphane results in increased expression of DEPDC1 mRNA
CTD
PMID:31838189
NCBI chr 1:68,474,152...68,497,082
Ensembl chr 1:68,474,152...68,497,221
G
DEPTOR
DEP domain containing MTOR interacting protein
decreases expression
EXP
sulforaphane results in decreased expression of DEPTOR mRNA
CTD
PMID:26833863
NCBI chr 8:119,873,722...120,050,918
Ensembl chr 8:119,873,717...120,050,918
G
DES
desmin
affects binding increases expression
EXP ISO
DES protein binds to sulforaphane sulforaphane results in increased expression of DES mRNA
CTD
PMID:21838287 PMID:30529165
NCBI chr 2:219,418,377...219,426,734
Ensembl chr 2:219,418,377...219,426,735
G
DEUP1
deuterosome assembly protein 1
increases expression
ISO
sulforaphane results in increased expression of DEUP1 mRNA
CTD
PMID:30529165
NCBI chr11:93,329,998...93,438,470
Ensembl chr11:93,329,971...93,438,487
G
DGAT1
diacylglycerol O-acyltransferase 1
multiple interactions
EXP
sulforaphane inhibits the reaction [bisphenol A results in increased expression of DGAT1 mRNA]
CTD
PMID:36670177
NCBI chr 8:144,314,584...144,326,852
Ensembl chr 8:144,314,584...144,326,910
G
DGAT2
diacylglycerol O-acyltransferase 2
increases expression
ISO
sulforaphane results in increased expression of DGAT2 mRNA
CTD
PMID:30529165
NCBI chr11:75,768,778...75,801,534
Ensembl chr11:75,759,512...75,801,535
G
DGCR8
DGCR8 microprocessor complex subunit
decreases expression
EXP
sulforaphane results in decreased expression of DGCR8 mRNA
CTD
PMID:31838189
NCBI chr22:20,080,241...20,111,872
Ensembl chr22:20,080,221...20,111,877
G
DHCR24
24-dehydrocholesterol reductase
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of DHCR24 mRNA
CTD
PMID:30529165
NCBI chr 1:54,849,627...54,887,195
Ensembl chr 1:54,849,627...54,887,195
G
DHRS11
dehydrogenase/reductase 11
increases expression decreases expression
ISO EXP
sulforaphane results in increased expression of DHRS11 mRNA sulforaphane results in decreased expression of DHRS11 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr17:36,591,879...36,600,804
Ensembl chr17:36,591,879...36,600,804
G
DHRS7C
dehydrogenase/reductase 7C
increases expression
ISO
sulforaphane results in increased expression of DHRS7C mRNA
CTD
PMID:30529165
NCBI chr17:9,771,438...9,791,592
Ensembl chr17:9,771,434...9,791,592
G
DIMT1
DIM1 rRNA methyltransferase and ribosome maturation factor
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of DIMT1 mRNA
CTD
PMID:30529165
NCBI chr 5:62,387,254...62,403,905
Ensembl chr 5:62,347,284...62,403,943
G
DIO2
iodothyronine deiodinase 2
decreases expression
EXP
sulforaphane results in decreased expression of DIO2 mRNA
CTD
PMID:31838189
NCBI chr14:80,197,526...80,231,057
Ensembl chr14:80,197,526...80,387,757
G
DKK1
dickkopf WNT signaling pathway inhibitor 1
increases methylation decreases expression
EXP
sulforaphane results in increased methylation of DKK1 gene sulforaphane results in decreased expression of DKK1 mRNA
CTD
PMID:31838189
NCBI chr10:52,314,281...52,317,657
Ensembl chr10:52,314,281...52,318,042
G
DKK3
dickkopf WNT signaling pathway inhibitor 3
decreases expression
EXP
sulforaphane results in decreased expression of DKK3 mRNA
CTD
PMID:31838189
NCBI chr11:11,963,036...12,009,745
Ensembl chr11:11,956,207...12,009,769
G
DLAT
dihydrolipoamide S-acetyltransferase
multiple interactions increases expression
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of DLAT mRNA sulforaphane results in increased expression of DLAT mRNA
CTD
PMID:25450479 PMID:30529165
NCBI chr11:112,025,408...112,064,404
Ensembl chr11:112,025,033...112,064,404
G
DLG1
discs large MAGUK scaffold protein 1
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of DLG1 mRNA
CTD
PMID:25450479
NCBI chr 3:197,042,560...197,299,321
Ensembl chr 3:197,042,560...197,299,330
G
DLG3
discs large MAGUK scaffold protein 3
decreases expression
EXP
sulforaphane results in decreased expression of DLG3 mRNA
CTD
PMID:31838189
NCBI chr X:70,444,835...70,505,490
Ensembl chr X:70,444,835...70,505,490
G
DLGAP5
DLG associated protein 5
increases expression
EXP
sulforaphane results in increased expression of DLGAP5 mRNA
CTD
PMID:31838189
NCBI chr14:55,148,135...55,191,585
Ensembl chr14:55,148,112...55,191,608
G
DLK2
delta like non-canonical Notch ligand 2
decreases expression
EXP
sulforaphane results in decreased expression of DLK2 mRNA
CTD
PMID:31838189
NCBI chr 6:43,450,352...43,456,632
Ensembl chr 6:43,450,352...43,456,632
G
DLX3
distal-less homeobox 3
decreases expression
EXP
sulforaphane results in decreased expression of DLX3 mRNA
CTD
PMID:31838189
NCBI chr17:49,990,005...49,995,224
Ensembl chr17:49,990,005...49,995,224
G
DLX4
distal-less homeobox 4
decreases expression
EXP
sulforaphane results in decreased expression of DLX4 mRNA
CTD
PMID:31838189
NCBI chr17:49,968,572...49,974,959
Ensembl chr17:49,968,588...49,974,959
G
DMAC2L
distal membrane arm assembly component 2 like
decreases expression
EXP
sulforaphane results in decreased expression of DMAC2L mRNA
CTD
PMID:31838189
NCBI chr14:50,311,516...50,327,957
Ensembl chr14:50,312,324...50,335,558
G
DMKN
dermokine
increases expression
ISO
sulforaphane results in increased expression of DMKN mRNA
CTD
PMID:30529165
NCBI chr19:35,497,220...35,513,649
Ensembl chr19:35,497,220...35,513,658
G
DMRT2
doublesex and mab-3 related transcription factor 2
increases expression
ISO
sulforaphane results in increased expression of DMRT2 mRNA
CTD
PMID:30529165
NCBI chr 9:1,050,357...1,057,552
Ensembl chr 9:1,049,858...1,057,552
G
DMTF1
cyclin D binding myb like transcription factor 1
decreases expression
ISO
sulforaphane results in decreased expression of DMTF1 mRNA
CTD
PMID:30529165
NCBI chr 7:87,152,453...87,196,325
Ensembl chr 7:87,152,409...87,196,337
G
DMXL2
Dmx like 2
decreases expression
ISO
sulforaphane results in decreased expression of DMXL2 mRNA
CTD
PMID:30529165
NCBI chr15:51,447,791...51,622,771
Ensembl chr15:51,447,711...51,622,833
G
DNAI3
dynein axonemal intermediate chain 3
increases expression
ISO
sulforaphane results in increased expression of DNAI3 mRNA
CTD
PMID:30529165
NCBI chr 1:85,062,327...85,133,138
Ensembl chr 1:84,999,147...85,133,138
G
DNAJB1
DnaJ heat shock protein family (Hsp40) member B1
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of DNAJB1 mRNA
CTD
PMID:30529165
NCBI chr19:14,514,769...14,560,391
Ensembl chr19:14,514,769...14,560,391
G
DNAJB13
DnaJ heat shock protein family (Hsp40) member B13
increases expression
ISO EXP
sulforaphane results in increased expression of DNAJB13 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr11:73,951,026...73,970,281
Ensembl chr11:73,951,026...73,970,366
G
DNAJB4
DnaJ heat shock protein family (Hsp40) member B4
increases expression
EXP
sulforaphane results in increased expression of DNAJB4 mRNA
CTD
PMID:31838189
NCBI chr 1:77,979,175...78,017,964
Ensembl chr 1:77,979,175...78,017,964
G
DNAJC15
DnaJ heat shock protein family (Hsp40) member C15
increases expression
ISO
sulforaphane results in increased expression of DNAJC15 mRNA
CTD
PMID:30529165
NCBI chr13:43,023,586...43,114,213
Ensembl chr13:43,023,203...43,114,213
G
DNAJC17
DnaJ heat shock protein family (Hsp40) member C17
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of DNAJC17 mRNA
CTD
PMID:30529165
NCBI chr15:40,765,161...40,807,473
Ensembl chr15:40,765,161...40,807,478
G
DNM1L
dynamin 1 like
increases expression
EXP
sulforaphane results in increased expression of DNM1L protein alternative form
CTD
PMID:27993529
NCBI chr12:32,679,301...32,745,650
Ensembl chr12:32,679,200...32,745,650
G
DNM3OS
DNM3 opposite strand/antisense RNA
decreases expression
ISO
sulforaphane results in decreased expression of DNM3OS mRNA
CTD
PMID:30529165
NCBI chr 1:172,136,879...172,144,835
Ensembl chr 1:172,138,397...172,144,840
G
DNMT1
DNA methyltransferase 1
decreases expression multiple interactions
EXP
sulforaphane results in decreased expression of DNMT1 mRNA sulforaphane inhibits the reaction [Estradiol results in increased expression of DNMT1 mRNA]; sulforaphane inhibits the reaction [Genistein results in increased expression of DNMT1 mRNA]
CTD
PMID:24466240 PMID:30684530
NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286
G
DNMT3A
DNA methyltransferase 3 alpha
increases expression
EXP
sulforaphane results in increased expression of DNMT3A mRNA
CTD
PMID:30684530
NCBI chr 2:25,227,874...25,342,590
Ensembl chr 2:25,227,855...25,342,590
G
DNMT3B
DNA methyltransferase 3 beta
decreases expression multiple interactions
EXP
sulforaphane results in decreased expression of DNMT3B mRNA sulforaphane inhibits the reaction [DNMT3B protein binds to COMT promoter]; sulforaphane inhibits the reaction [Estradiol promotes the reaction [DNMT3B protein binds to COMT promoter]]; sulforaphane inhibits the reaction [Estradiol results in increased expression of DNMT3B mRNA]
CTD
PMID:24466240 PMID:30684530
NCBI chr20:32,762,385...32,809,356
Ensembl chr20:32,762,385...32,809,359
G
DNTTIP2
deoxynucleotidyltransferase terminal interacting protein 2
increases expression
EXP
sulforaphane results in increased expression of DNTTIP2 mRNA
CTD
PMID:31838189
NCBI chr 1:93,866,284...93,879,206
Ensembl chr 1:93,866,284...93,879,918
G
DOCK4
dedicator of cytokinesis 4
decreases expression
EXP
sulforaphane results in decreased expression of DOCK4 mRNA
CTD
PMID:31838189
NCBI chr 7:111,726,110...112,206,399
Ensembl chr 7:111,726,110...112,206,407
G
DOCK8
dedicator of cytokinesis 8
decreases expression
EXP
sulforaphane results in decreased expression of DOCK8 mRNA
CTD
PMID:31838189
NCBI chr 9:211,257...465,255
Ensembl chr 9:214,854...465,259
G
DOK7
docking protein 7
increases expression
EXP
sulforaphane results in increased expression of DOK7 mRNA
CTD
PMID:31838189
NCBI chr 4:3,463,306...3,501,482
Ensembl chr 4:3,463,306...3,501,473
G
DPH5
diphthamide biosynthesis 5
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of DPH5 mRNA
CTD
PMID:30529165
NCBI chr 1:100,989,623...101,025,784
Ensembl chr 1:100,989,623...101,026,088
G
DPYD
dihydropyrimidine dehydrogenase
increases expression
EXP
sulforaphane results in increased expression of DPYD mRNA
CTD
PMID:26833863
NCBI chr 1:97,077,743...97,921,059
Ensembl chr 1:97,077,743...97,995,000
G
DRAM1
DNA damage regulated autophagy modulator 1
decreases expression
EXP
sulforaphane results in decreased expression of DRAM1 mRNA
CTD
PMID:31838189
NCBI chr12:101,877,580...101,923,612
Ensembl chr12:101,877,580...102,012,130
G
DRC12
dynein regulatory complex subunit 12 homolog
increases expression
ISO
sulforaphane results in increased expression of CCDC153 mRNA
CTD
PMID:30529165
NCBI chr11:119,190,254...119,195,841
Ensembl chr11:119,190,250...119,196,769
G
DSC2
desmocollin 2
increases expression
ISO
sulforaphane results in increased expression of DSC2 mRNA
CTD
PMID:30529165
NCBI chr18:31,058,840...31,102,421
Ensembl chr18:31,058,545...31,102,600
G
DSG2
desmoglein 2
increases expression
ISO
sulforaphane results in increased expression of DSG2 mRNA
CTD
PMID:30529165
NCBI chr18:31,498,177...31,549,008
Ensembl chr18:31,497,624...31,551,351
G
DSP
desmoplakin
increases expression
ISO
sulforaphane results in increased expression of DSP mRNA
CTD
PMID:30529165
NCBI chr 6:7,541,671...7,586,714
Ensembl chr 6:7,541,326...7,586,717
G
DUBR
DPPA2 upstream binding RNA
decreases expression
ISO
sulforaphane results in decreased expression of DUBR mRNA
CTD
PMID:30529165
NCBI chr 3:107,240,692...107,326,964
Ensembl chr 3:107,220,744...107,348,464
G
DUSP10
dual specificity phosphatase 10
decreases expression
EXP
sulforaphane results in decreased expression of DUSP10 mRNA
CTD
PMID:31838189
NCBI chr 1:221,701,424...221,742,089
Ensembl chr 1:221,701,424...221,742,089
G
DUSP16
dual specificity phosphatase 16
increases expression decreases expression
EXP
sulforaphane results in increased expression of DUSP16 mRNA sulforaphane results in decreased expression of DUSP16 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr12:12,473,282...12,562,863
Ensembl chr12:12,473,282...12,562,863
G
DUSP4
dual specificity phosphatase 4
increases expression
EXP
sulforaphane results in increased expression of DUSP4 mRNA
CTD
PMID:31838189
NCBI chr 8:29,333,064...29,350,684
Ensembl chr 8:29,333,064...29,350,684
G
DUSP5
dual specificity phosphatase 5
increases expression
EXP
sulforaphane results in increased expression of DUSP5 mRNA
CTD
PMID:26833863
NCBI chr10:110,497,907...110,511,533
Ensembl chr10:110,497,907...110,511,533
G
DUSP5P1
dual specificity phosphatase 5 pseudogene 1
decreases expression
EXP
sulforaphane results in decreased expression of DUSP5P1 mRNA
CTD
PMID:26833863
NCBI chr 1:228,644,910...228,652,425
Ensembl chr 1:228,650,241...228,651,379
G
DUSP6
dual specificity phosphatase 6
increases expression
EXP
sulforaphane results in increased expression of DUSP6 mRNA
CTD
PMID:31838189
NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501
G
DUSP8
dual specificity phosphatase 8
decreases expression
EXP
sulforaphane results in decreased expression of DUSP8 mRNA
CTD
PMID:31838189
NCBI chr11:1,554,051...1,572,848
Ensembl chr11:1,554,051...1,572,271
G
DUSP9
dual specificity phosphatase 9
decreases expression
EXP
sulforaphane results in decreased expression of DUSP9 mRNA
CTD
PMID:31838189
NCBI chr X:153,642,441...153,651,326
Ensembl chr X:153,642,492...153,651,326
G
DYNC1H1
dynein cytoplasmic 1 heavy chain 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of DYNC1H1 mRNA
CTD
PMID:30529165
NCBI chr14:101,964,573...102,056,443
Ensembl chr14:101,964,573...102,056,443
G
DYNC2I2
dynein 2 intermediate chain 2
decreases expression
EXP
sulforaphane results in decreased expression of DYNC2I2 mRNA
CTD
PMID:31838189
NCBI chr 9:128,633,653...128,684,460
Ensembl chr 9:128,633,653...128,656,847
G
DYNLT3
dynein light chain Tctex-type 3
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of DYNLT3 mRNA
CTD
PMID:30529165
NCBI chr X:37,838,836...37,847,571
Ensembl chr X:37,836,757...37,847,571
G
E2F1
E2F transcription factor 1
decreases expression
EXP
sulforaphane results in decreased expression of E2F1 mRNA
CTD
PMID:31838189
NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
G
E2F3
E2F transcription factor 3
increases methylation
EXP
sulforaphane results in increased methylation of E2F3 gene
CTD
PMID:31838189
NCBI chr 6:20,401,879...20,493,714
Ensembl chr 6:20,401,879...20,493,714
G
EBF2
EBF transcription factor 2
increases expression
ISO
sulforaphane results in increased expression of EBF2 mRNA
CTD
PMID:30529165
NCBI chr 8:25,841,725...26,045,413
Ensembl chr 8:25,841,725...26,045,413
G
ECH1
enoyl-CoA hydratase 1
multiple interactions increases expression
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of ECH1 mRNA sulforaphane results in increased expression of ECH1 mRNA
CTD
PMID:25450479 PMID:30529165
NCBI chr19:38,815,422...38,831,794
Ensembl chr19:38,815,422...38,831,841
G
EDNRA
endothelin receptor type A
decreases expression
EXP
sulforaphane results in decreased expression of EDNRA mRNA
CTD
PMID:31838189
NCBI chr 4:147,481,097...147,544,954
Ensembl chr 4:147,480,917...147,544,954
G
EEF1A2
eukaryotic translation elongation factor 1 alpha 2
increases expression
ISO
sulforaphane results in increased expression of EEF1A2 mRNA
CTD
PMID:30529165
NCBI chr20:63,488,014...63,499,083
Ensembl chr20:63,488,013...63,499,239
G
EEF2K
eukaryotic elongation factor 2 kinase
decreases expression
EXP
sulforaphane results in decreased expression of EEF2K mRNA
CTD
PMID:31838189
NCBI chr16:22,206,278...22,288,738
Ensembl chr16:22,206,278...22,288,738
G
EFHD1
EF-hand domain family member D1
decreases expression
EXP
sulforaphane results in decreased expression of EFHD1 mRNA
CTD
PMID:31838189
NCBI chr 2:232,606,057...232,682,776
Ensembl chr 2:232,606,057...232,682,776
G
EFNA1
ephrin A1
decreases expression
EXP
sulforaphane results in decreased expression of EFNA1 mRNA
CTD
PMID:31838189
NCBI chr 1:155,127,876...155,134,899
Ensembl chr 1:155,127,876...155,134,899
G
EFNB2
ephrin B2
decreases expression
EXP
sulforaphane results in decreased expression of EFNB2 mRNA
CTD
PMID:31838189
NCBI chr13:106,489,745...106,535,662
Ensembl chr13:106,489,745...106,535,662
G
EFR3B
EFR3 homolog B
decreases expression
EXP
sulforaphane results in decreased expression of EFR3B mRNA
CTD
PMID:31838189
NCBI chr 2:25,042,076...25,159,135
Ensembl chr 2:25,042,076...25,159,135
G
EGFL6
EGF like domain multiple 6
decreases expression
ISO
sulforaphane results in decreased expression of EGFL6 mRNA
CTD
PMID:30529165
NCBI chr X:13,569,601...13,633,575
Ensembl chr X:13,569,601...13,633,575
G
EHF
ETS homologous factor
decreases expression
EXP
sulforaphane results in decreased expression of EHF mRNA
CTD
PMID:31838189
NCBI chr11:34,621,093...34,663,288
Ensembl chr11:34,621,093...34,663,288
G
EID3
EP300 interacting inhibitor of differentiation 3
increases expression
EXP
sulforaphane results in increased expression of EID3 mRNA
CTD
PMID:31838189
NCBI chr12:104,303,739...104,305,205
Ensembl chr12:104,303,739...104,305,205
G
EIF2AK3
eukaryotic translation initiation factor 2 alpha kinase 3
multiple interactions increases expression
EXP
sulforaphane promotes the reaction [Arsenic Trioxide results in increased expression of EIF2AK3 protein modified form] sulforaphane results in increased expression of EIF2AK3 protein modified form
CTD
PMID:22922937
NCBI chr 2:88,556,741...88,628,145
Ensembl chr 2:88,556,741...88,691,518
G
EIF2AK4
eukaryotic translation initiation factor 2 alpha kinase 4
decreases expression
ISO
sulforaphane results in decreased expression of EIF2AK4 mRNA
CTD
PMID:30529165
NCBI chr15:39,934,115...40,035,591
Ensembl chr15:39,934,115...40,035,591
G
EIF2S1
eukaryotic translation initiation factor 2 subunit alpha
multiple interactions increases expression
EXP ISO
sulforaphane inhibits the reaction [bisphenol A results in increased phosphorylation of EIF2S1 protein]; sulforaphane promotes the reaction [Arsenic Trioxide results in increased expression of EIF2S1 protein modified form] sulforaphane results in increased expression of EIF2S1 protein modified form
CTD
PMID:22922937 PMID:36670177
NCBI chr14:67,360,328...67,386,516
Ensembl chr14:67,360,328...67,386,516
G
EIF4E3
eukaryotic translation initiation factor 4E family member 3
increases expression
EXP
sulforaphane results in increased expression of EIF4E3 mRNA
CTD
PMID:26833863
NCBI chr 3:71,659,363...71,754,773
Ensembl chr 3:71,675,414...71,754,773
G
EIF5
eukaryotic translation initiation factor 5
increases expression
EXP
sulforaphane results in increased expression of EIF5 mRNA
CTD
PMID:31838189
NCBI chr14:103,334,237...103,345,025
Ensembl chr14:103,333,544...103,345,025
G
EIF5A
eukaryotic translation initiation factor 5A
affects binding
EXP
EIF5A protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr17:7,306,999...7,312,463
Ensembl chr17:7,306,999...7,312,463
G
EIF5A2
eukaryotic translation initiation factor 5A2
increases expression
EXP
sulforaphane results in increased expression of EIF5A2 mRNA
CTD
PMID:31838189
NCBI chr 3:170,888,418...170,908,637
Ensembl chr 3:170,888,418...170,908,644
G
ELF3
E74 like ETS transcription factor 3
decreases expression
EXP
sulforaphane results in decreased expression of ELF3 mRNA
CTD
PMID:31838189
NCBI chr 1:202,010,587...202,017,183
Ensembl chr 1:202,007,945...202,017,183
G
ELFN1
extracellular leucine rich repeat and fibronectin type III domain containing 1
decreases expression
ISO
sulforaphane results in decreased expression of ELFN1 mRNA
CTD
PMID:30529165
NCBI chr 7:1,666,064...1,747,946
Ensembl chr 7:1,665,745...1,747,946
G
ELFN2
extracellular leucine rich repeat and fibronectin type III domain containing 2
decreases expression
EXP
sulforaphane results in decreased expression of ELFN2 mRNA
CTD
PMID:31838189
NCBI chr22:37,340,644...37,427,479
Ensembl chr22:37,367,960...37,427,479 Ensembl chr22:37,367,960...37,427,479
G
ELL2
elongation factor for RNA polymerase II 2
increases expression
EXP
sulforaphane results in increased expression of ELL2 mRNA
CTD
PMID:26833863
NCBI chr 5:95,885,098...95,961,851
Ensembl chr 5:95,885,098...95,961,851
G
ELOVL6
ELOVL fatty acid elongase 6
multiple interactions increases expression
ISO EXP
[sulforaphane co-treated with Aflatoxin B1] affects the expression of ELOVL6 mRNA sulforaphane results in increased expression of ELOVL6 mRNA
CTD
PMID:25450479 PMID:31838189
NCBI chr 4:110,045,846...110,199,202
Ensembl chr 4:110,045,846...110,199,199
G
EMP2
epithelial membrane protein 2
decreases expression
EXP
sulforaphane results in decreased expression of EMP2 mRNA
CTD
PMID:31838189
NCBI chr16:10,528,422...10,580,598
Ensembl chr16:10,528,422...10,580,632
G
EMP3
epithelial membrane protein 3 (MAM blood group)
decreases expression
EXP
sulforaphane results in decreased expression of EMP3 mRNA
CTD
PMID:31838189
NCBI chr19:48,325,552...48,330,553
Ensembl chr19:48,321,509...48,330,553
G
ENC1
ectodermal-neural cortex 1
increases expression
EXP
sulforaphane results in increased expression of ENC1 mRNA
CTD
PMID:31838189
NCBI chr 5:74,627,409...74,640,728
Ensembl chr 5:74,627,406...74,641,424
G
ENDOG
endonuclease G
increases expression
EXP
sulforaphane results in increased expression of ENDOG protein
CTD
PMID:26833863
NCBI chr 9:128,818,500...128,822,676
Ensembl chr 9:128,818,500...128,822,676
G
ENKUR
enkurin, TRPC channel interacting protein
increases expression
ISO
sulforaphane results in increased expression of ENKUR mRNA
CTD
PMID:30529165
NCBI chr10:24,981,985...25,062,327
Ensembl chr10:24,981,979...25,062,279
G
ENO3
enolase 3
decreases expression
EXP
sulforaphane results in decreased expression of ENO3 mRNA
CTD
PMID:31838189
NCBI chr17:4,948,710...4,957,129
Ensembl chr17:4,948,092...4,957,131
G
ENPEP
glutamyl aminopeptidase
decreases expression
ISO
sulforaphane results in decreased expression of ENPEP mRNA
CTD
PMID:30529165
NCBI chr 4:110,476,155...110,565,285
Ensembl chr 4:110,365,733...110,565,285
G
ENPP2
ectonucleotide pyrophosphatase/phosphodiesterase 2
decreases expression
EXP
sulforaphane results in decreased expression of ENPP2 mRNA
CTD
PMID:26833863
NCBI chr 8:119,557,086...119,673,390
Ensembl chr 8:119,557,086...119,673,453
G
ENTPD2
ectonucleoside triphosphate diphosphohydrolase 2
increases expression decreases expression
ISO EXP
sulforaphane results in increased expression of ENTPD2 mRNA sulforaphane results in decreased expression of ENTPD2 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 9:137,048,107...137,054,061
Ensembl chr 9:137,048,107...137,054,061
G
ENTPD5
ectonucleoside triphosphate diphosphohydrolase 5 (inactive)
increases expression
ISO
sulforaphane results in increased expression of ENTPD5 mRNA
CTD
PMID:30529165
NCBI chr14:73,955,329...74,019,288
Ensembl chr14:73,958,010...74,019,399
G
ENTREP1
endosomal transmembrane epsin interactor 1
decreases expression
EXP
sulforaphane results in decreased expression of ENTREP1 mRNA
CTD
PMID:31838189
NCBI chr 9:69,324,567...69,392,456
Ensembl chr 9:69,324,567...69,392,558
G
EP300
E1A binding protein p300
multiple interactions
EXP
sulforaphane inhibits the reaction [EP300 protein binds to COMT promoter]
CTD
PMID:30684530
NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,092,510...41,180,077
G
EPB41L1
erythrocyte membrane protein band 4.1 like 1
decreases expression
EXP
sulforaphane results in decreased expression of EPB41L1 mRNA
CTD
PMID:31838189
NCBI chr20:36,091,414...36,232,799
Ensembl chr20:36,091,504...36,232,799
G
EPB41L4A
erythrocyte membrane protein band 4.1 like 4A
decreases expression
EXP
sulforaphane results in decreased expression of EPB41L4A mRNA
CTD
PMID:31838189
NCBI chr 5:112,141,829...112,419,935
Ensembl chr 5:112,142,441...112,419,313
G
EPDR1
ependymin related 1
increases expression
EXP
sulforaphane results in increased expression of EPDR1 mRNA
CTD
PMID:31838189
NCBI chr 7:37,920,640...37,951,936
Ensembl chr 7:37,920,640...37,951,936
G
EPGN
epithelial mitogen
increases expression
EXP
sulforaphane results in increased expression of EPGN mRNA
CTD
PMID:31838189
NCBI chr 4:74,308,470...74,316,789
Ensembl chr 4:74,308,470...74,316,789
G
EPHA7
EPH receptor A7
decreases expression
EXP
sulforaphane results in decreased expression of EPHA7 mRNA
CTD
PMID:31838189
NCBI chr 6:93,240,020...93,419,559
Ensembl chr 6:93,240,020...93,419,687
G
EPHX1
epoxide hydrolase 1
increases expression multiple interactions
ISO EXP
sulforaphane results in increased expression of EPHX1 mRNA sulforaphane results in increased expression of EPHX1 exon; sulforaphane results in increased expression of EPHX1 mRNA; sulforaphane results in increased expression of EPHX1 protein; sulforaphane results in increased expression of EPHX1 protein alternative form sulforaphane promotes the reaction [NFE2L2 protein binds to EPHX1 enhancer] [sulforaphane co-treated with dibenzoylmethane] results in increased expression of EPHX1 mRNA
CTD
PMID:17942926 PMID:24704207 PMID:31838189
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
G
EPHX2
epoxide hydrolase 2
increases expression
ISO
sulforaphane results in increased expression of EPHX2 mRNA
CTD
PMID:30529165
NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564
G
ERCC4
ERCC excision repair 4, endonuclease catalytic subunit
increases expression
EXP
sulforaphane results in increased expression of ERCC4 mRNA
CTD
PMID:20442190
NCBI chr16:13,920,154...13,952,348
Ensembl chr16:13,920,138...13,952,348
G
ERCC5
ERCC excision repair 5, endonuclease
increases expression
EXP
sulforaphane results in increased expression of ERCC5 mRNA
CTD
PMID:20442190
NCBI chr13:102,846,032...102,875,995
Ensembl chr13:102,845,831...102,875,995
G
ERF
ETS2 repressor factor
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of ERF mRNA
CTD
PMID:25450479
NCBI chr19:42,247,569...42,255,128
Ensembl chr19:42,247,569...42,255,128
G
ERG
ETS transcription factor ERG
decreases expression multiple interactions
EXP
sulforaphane results in decreased expression of ERG mRNA; sulforaphane results in decreased expression of ERG protein sulforaphane inhibits the reaction [AR protein binds to ERG enhancer]
CTD
PMID:19805354
NCBI chr21:38,367,261...38,661,783
Ensembl chr21:38,380,027...38,661,780
G
ERO1A
endoplasmic reticulum oxidoreductase 1 alpha
increases expression
ISO
sulforaphane results in increased expression of ERO1A protein
CTD
PMID:37385402
NCBI chr14:52,639,915...52,695,558
Ensembl chr14:52,639,915...52,695,900
G
ERRFI1
ERBB receptor feedback inhibitor 1
decreases expression
ISO
sulforaphane results in decreased expression of ERRFI1 mRNA
CTD
PMID:30529165
NCBI chr 1:8,011,727...8,026,309
Ensembl chr 1:8,004,404...8,026,309
G
ESPN
espin
decreases expression
EXP
sulforaphane results in decreased expression of ESPN mRNA
CTD
PMID:31838189
NCBI chr 1:6,424,776...6,461,370
Ensembl chr 1:6,424,776...6,461,367
G
ESR1
estrogen receptor 1
multiple interactions
EXP
ESR1 mutant form promotes the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of HMOX1 mRNA]]
CTD
PMID:23583297
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
G
ESYT2
extended synaptotagmin 2
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ESYT2 mRNA
CTD
PMID:30529165
NCBI chr 7:158,730,997...158,829,509
Ensembl chr 7:158,730,995...158,830,253
G
ETF1
eukaryotic translation termination factor 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ETF1 mRNA
CTD
PMID:30529165
NCBI chr 5:138,506,095...138,543,236
Ensembl chr 5:138,506,095...138,543,236
G
ETFA
electron transfer flavoprotein subunit alpha
increases expression
ISO
sulforaphane results in increased expression of ETFA mRNA
CTD
PMID:30529165
NCBI chr15:76,215,353...76,311,469
Ensembl chr15:76,188,555...76,311,730
G
ETFB
electron transfer flavoprotein subunit beta
increases expression
ISO
sulforaphane results in increased expression of ETFB mRNA
CTD
PMID:30529165
NCBI chr19:51,345,155...51,366,388
Ensembl chr19:51,345,169...51,366,388
G
ETFDH
electron transfer flavoprotein dehydrogenase
increases expression
ISO
sulforaphane results in increased expression of ETFDH mRNA
CTD
PMID:30529165
NCBI chr 4:158,672,296...158,709,623
Ensembl chr 4:158,671,968...158,710,742
G
ETNK2
ethanolamine kinase 2
decreases expression
EXP
sulforaphane results in decreased expression of ETNK2 mRNA
CTD
PMID:31838189
NCBI chr 1:204,131,062...204,152,044
Ensembl chr 1:204,131,062...204,152,044
G
ETNPPL
ethanolamine-phosphate phospho-lyase
decreases expression
EXP
sulforaphane results in decreased expression of ETNPPL mRNA
CTD
PMID:31838189
NCBI chr 4:108,742,053...108,763,053
Ensembl chr 4:108,742,048...108,763,054
G
ETS2
ETS proto-oncogene 2, transcription factor
decreases expression
EXP
sulforaphane results in decreased expression of ETS2 mRNA
CTD
PMID:31838189
NCBI chr21:38,805,183...38,824,955
Ensembl chr21:38,805,183...38,824,955
G
ETV4
ETS variant transcription factor 4
increases expression
EXP
sulforaphane results in increased expression of ETV4 mRNA
CTD
PMID:31838189
NCBI chr17:43,527,846...43,546,340
Ensembl chr17:43,527,844...43,579,620
G
ETV5
ETS variant transcription factor 5
decreases expression increases expression
ISO EXP
sulforaphane results in decreased expression of ETV5 mRNA sulforaphane results in increased expression of ETV5 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 3:186,046,314...186,109,089
Ensembl chr 3:186,046,314...186,110,318
G
EXOC1
exocyst complex component 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of EXOC1 mRNA
CTD
PMID:30529165
NCBI chr 4:55,853,648...55,905,086
Ensembl chr 4:55,853,648...55,905,086
G
EXT2
exostosin glycosyltransferase 2
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of EXT2 mRNA
CTD
PMID:30529165
NCBI chr11:44,095,678...44,251,962
Ensembl chr11:44,095,648...44,251,962
G
EYA4
EYA transcriptional coactivator and phosphatase 4
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of EYA4 mRNA
CTD
PMID:30529165
NCBI chr 6:133,240,593...133,532,128
Ensembl chr 6:133,240,514...133,532,128
G
F11R
F11 receptor
decreases expression
EXP
sulforaphane results in decreased expression of F11R mRNA
CTD
PMID:31838189
NCBI chr 1:160,995,211...161,021,152
Ensembl chr 1:160,995,211...161,021,175
G
F12
coagulation factor XII
decreases expression
EXP
sulforaphane results in decreased expression of F12 mRNA
CTD
PMID:31838189
NCBI chr 5:177,402,141...177,409,564
Ensembl chr 5:177,402,133...177,416,583
G
F13A1
coagulation factor XIII A chain
decreases expression
EXP
sulforaphane results in decreased expression of F13A1 mRNA
CTD
PMID:26833863
NCBI chr 6:6,144,084...6,320,662
Ensembl chr 6:6,144,084...6,321,013
G
F3
coagulation factor III, tissue factor
increases expression
EXP
sulforaphane results in increased expression of F3 mRNA; sulforaphane results in increased expression of F3 protein
CTD
PMID:31838189 PMID:33814512
NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
G
F7
coagulation factor VII
decreases expression
ISO
sulforaphane results in decreased expression of F7 mRNA
CTD
PMID:30529165
NCBI chr13:113,105,788...113,120,685
Ensembl chr13:113,105,788...113,120,685
G
FA2H
fatty acid 2-hydroxylase
decreases expression
EXP
sulforaphane results in decreased expression of FA2H mRNA
CTD
PMID:31838189
NCBI chr16:74,712,969...74,774,820
Ensembl chr16:74,712,955...74,774,831
G
FAAH2
fatty acid amide hydrolase 2
decreases expression
EXP
sulforaphane results in decreased expression of FAAH2 mRNA
CTD
PMID:31838189
NCBI chr X:57,121,591...57,489,196
Ensembl chr X:57,286,706...57,489,193
G
FABP3
fatty acid binding protein 3
increases expression decreases expression
ISO EXP
sulforaphane results in increased expression of FABP3 mRNA sulforaphane results in decreased expression of FABP3 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 1:31,359,588...31,373,076
Ensembl chr 1:31,365,253...31,376,850
G
FABP4
fatty acid binding protein 4
increases expression
ISO
sulforaphane results in increased expression of FABP4 mRNA
CTD
PMID:30529165
NCBI chr 8:81,478,419...81,483,233
Ensembl chr 8:81,478,419...81,483,236
G
FAM13C
family with sequence similarity 13 member C
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of FAM13C mRNA
CTD
PMID:30529165
NCBI chr10:59,246,129...59,363,181
Ensembl chr10:59,246,130...59,363,181
G
FAM161A
FAM161 centrosomal protein A
decreases expression
EXP
sulforaphane results in decreased expression of FAM161A mRNA
CTD
PMID:26833863
NCBI chr 2:61,800,240...61,854,060
Ensembl chr 2:61,824,848...61,854,143
G
FAM167B
family with sequence similarity 167 member B
decreases expression
EXP
sulforaphane results in decreased expression of FAM167B mRNA
CTD
PMID:31838189
NCBI chr 1:32,247,222...32,248,856
Ensembl chr 1:32,247,222...32,248,856
G
FAM216B
family with sequence similarity 216 member B
increases expression
ISO
sulforaphane results in increased expression of FAM216B mRNA
CTD
PMID:30529165
NCBI chr13:42,781,584...42,791,549
Ensembl chr13:42,781,550...42,791,549
G
FAM43A
family with sequence similarity 43 member A
increases expression
EXP
sulforaphane results in increased expression of FAM43A mRNA
CTD
PMID:31838189
NCBI chr 3:194,685,883...194,689,037
Ensembl chr 3:194,685,883...194,689,037
G
FAM72A
family with sequence similarity 72 member A
increases expression
EXP
sulforaphane results in increased expression of FAM72A mRNA
CTD
PMID:31838189
NCBI chr 1:206,186,179...206,205,773
Ensembl chr 1:206,186,179...206,204,414
G
FAM72B
family with sequence similarity 72 member B
increases expression
EXP
sulforaphane results in increased expression of FAM72B mRNA
CTD
PMID:31838189
NCBI chr 1:121,167,646...121,184,340
Ensembl chr 1:121,167,646...121,185,539
G
FAM81A
family with sequence similarity 81 member A
increases expression
ISO
sulforaphane results in increased expression of FAM81A mRNA
CTD
PMID:30529165
NCBI chr15:59,397,981...59,523,555
Ensembl chr15:59,372,693...59,523,555
G
FAM83A
family with sequence similarity 83 member A
decreases expression
EXP
sulforaphane results in decreased expression of FAM83A mRNA
CTD
PMID:31838189
NCBI chr 8:123,179,047...123,210,079
Ensembl chr 8:123,178,960...123,210,079
G
FAM83E
family with sequence similarity 83 member E
increases expression
ISO
sulforaphane results in increased expression of FAM83E mRNA
CTD
PMID:30529165
NCBI chr19:48,599,961...48,615,076
Ensembl chr19:48,599,961...48,615,076
G
FANCA
FA complementation group A
increases expression
ISO
sulforaphane results in increased expression of FANCA mRNA
CTD
PMID:30529165
NCBI chr16:89,737,549...89,816,647
Ensembl chr16:89,726,683...89,816,977
G
FARP1
FERM, ARH/RhoGEF and pleckstrin domain protein 1
decreases expression
EXP
sulforaphane results in decreased expression of FARP1 mRNA
CTD
PMID:31838189
NCBI chr13:98,142,589...98,455,176
Ensembl chr13:98,142,562...98,455,176
G
FAS
Fas cell surface death receptor
increases expression
EXP
sulforaphane results in increased expression of FAS mRNA; sulforaphane results in increased expression of FAS protein
CTD
PMID:26833863 PMID:31838189
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FASLG
Fas ligand
increases expression
EXP
sulforaphane results in increased expression of FASLG protein
CTD
PMID:26833863
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
G
FASN
fatty acid synthase
multiple interactions
ISO EXP
[sulforaphane co-treated with Aflatoxin B1] affects the expression of FASN mRNA sulforaphane inhibits the reaction [bisphenol A results in increased expression of FASN mRNA]
CTD
PMID:25450479 PMID:36670177
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
G
FBLN1
fibulin 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of FBLN1 mRNA
CTD
PMID:30529165
NCBI chr22:45,502,883...45,601,135
Ensembl chr22:45,502,238...45,601,135
G
FBN2
fibrillin 2
decreases expression
EXP
sulforaphane results in decreased expression of FBN2 mRNA
CTD
PMID:31838189
NCBI chr 5:128,257,909...128,538,245
Ensembl chr 5:128,257,909...128,659,185
G
FBXL12
F-box and leucine rich repeat protein 12
decreases expression
ISO
sulforaphane results in decreased expression of FBXL12 mRNA
CTD
PMID:30529165
NCBI chr19:9,810,270...9,819,079
Ensembl chr19:9,810,267...9,827,816
G
FBXO11
F-box protein 11
decreases expression
ISO
sulforaphane results in decreased expression of FBXO11 mRNA
CTD
PMID:30529165
NCBI chr 2:47,806,920...47,906,498
Ensembl chr 2:47,789,316...47,906,498
G
FBXO2
F-box protein 2
decreases expression
EXP
sulforaphane results in decreased expression of FBXO2 mRNA
CTD
PMID:31838189
NCBI chr 1:11,648,387...11,654,429
Ensembl chr 1:11,637,018...11,655,785
G
FBXO32
F-box protein 32
decreases expression
EXP
sulforaphane results in decreased expression of FBXO32 mRNA
CTD
PMID:31838189
NCBI chr 8:123,497,889...123,541,206
Ensembl chr 8:123,497,889...123,541,206
G
FBXO4
F-box protein 4
decreases expression
EXP
sulforaphane results in decreased expression of FBXO4 mRNA
CTD
PMID:31838189
NCBI chr 5:41,925,281...42,040,404
Ensembl chr 5:41,925,254...41,941,743
G
FCAR
Fc alpha receptor
increases expression
EXP
sulforaphane results in increased expression of FCAR mRNA
CTD
PMID:26833863
NCBI chr19:54,874,235...54,891,420
Ensembl chr19:54,874,235...54,891,420
G
FCHO2
FCH and mu domain containing endocytic adaptor 2
decreases expression
ISO
sulforaphane results in decreased expression of FCHO2 mRNA
CTD
PMID:30529165
NCBI chr 5:72,956,041...73,090,522
Ensembl chr 5:72,956,041...73,090,522
G
FCMR
Fc mu receptor
increases expression
EXP
sulforaphane results in increased expression of FCMR mRNA
CTD
PMID:31838189
NCBI chr 1:206,903,317...206,923,196
Ensembl chr 1:206,903,317...206,923,247
G
FCN3
ficolin 3
increases expression
ISO
sulforaphane results in increased expression of FCNA mRNA
CTD
PMID:30529165
NCBI chr 1:27,369,110...27,374,824
Ensembl chr 1:27,369,110...27,374,824
G
FECH
ferrochelatase
increases expression
EXP
sulforaphane results in increased expression of FECH mRNA
CTD
PMID:31838189
NCBI chr18:57,544,377...57,586,702
Ensembl chr18:57,544,377...57,586,732
G
FETUB
fetuin B
increases expression
ISO
sulforaphane results in increased expression of FETUB mRNA
CTD
PMID:30529165
NCBI chr 3:186,635,969...186,653,141
Ensembl chr 3:186,635,969...186,653,141
G
FFAR2
free fatty acid receptor 2
increases expression
EXP
sulforaphane results in increased expression of FFAR2 mRNA
CTD
PMID:26833863
NCBI chr19:35,448,257...35,451,767
Ensembl chr19:35,443,907...35,451,767
G
FGD6
FYVE, RhoGEF and PH domain containing 6
decreases expression
ISO
sulforaphane results in decreased expression of FGD6 mRNA
CTD
PMID:30529165
NCBI chr12:95,076,749...95,217,467
Ensembl chr12:95,076,749...95,217,482
G
FGF1
fibroblast growth factor 1
decreases expression
EXP
sulforaphane results in decreased expression of FGF1 mRNA
CTD
PMID:31838189
NCBI chr 5:142,592,178...142,698,070
Ensembl chr 5:142,592,178...142,698,070
G
FGFBP1
fibroblast growth factor binding protein 1
decreases expression
EXP
sulforaphane results in decreased expression of FGFBP1 mRNA
CTD
PMID:31838189
NCBI chr 4:15,935,577...15,938,740
Ensembl chr 4:15,935,577...15,938,740
G
FGFR3
fibroblast growth factor receptor 3
decreases expression
EXP
sulforaphane results in decreased expression of FGFR3 mRNA
CTD
PMID:31838189
NCBI chr 4:1,793,293...1,808,867
Ensembl chr 4:1,793,293...1,808,872
G
FGL2
fibrinogen like 2
increases expression
ISO
sulforaphane results in increased expression of FGL2 mRNA
CTD
PMID:30529165
NCBI chr 7:77,193,369...77,199,819
Ensembl chr 7:77,193,369...77,199,848
G
FHL1
four and a half LIM domains 1
decreases expression
EXP
sulforaphane results in decreased expression of FHL1 mRNA
CTD
PMID:31838189
NCBI chr X:136,146,702...136,211,359
Ensembl chr X:136,146,702...136,211,359
G
FHL2
four and a half LIM domains 2
decreases expression
EXP
sulforaphane results in decreased expression of FHL2 mRNA
CTD
PMID:31838189
NCBI chr 2:105,357,712...105,438,529
Ensembl chr 2:105,357,712...105,438,513
G
FHOD3
formin homology 2 domain containing 3
increases expression
ISO
sulforaphane results in increased expression of FHOD3 mRNA
CTD
PMID:30529165
NCBI chr18:36,297,713...36,780,220
Ensembl chr18:36,297,713...36,780,220
G
FIGLA
folliculogenesis specific bHLH transcription factor
increases expression
ISO
sulforaphane results in increased expression of FIGLA mRNA
CTD
PMID:30529165
NCBI chr 2:70,777,310...70,790,643
Ensembl chr 2:70,777,310...70,790,643
G
FIS1
fission, mitochondrial 1
increases expression
EXP
sulforaphane results in increased expression of FIS1 protein
CTD
PMID:27993529
NCBI chr 7:101,239,472...101,245,081
Ensembl chr 7:101,239,458...101,252,316
G
FLVCR2
FLVCR choline and putative heme transporter 2
decreases expression
EXP
sulforaphane results in decreased expression of FLVCR2 mRNA
CTD
PMID:31838189
NCBI chr14:75,578,620...75,648,167
Ensembl chr14:75,578,620...75,663,214
G
FNDC3B
fibronectin type III domain containing 3B
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of FNDC3B mRNA
CTD
PMID:25450479
NCBI chr 3:172,039,578...172,401,669
Ensembl chr 3:172,039,578...172,401,669
G
FNDC5
fibronectin type III domain containing 5
multiple interactions increases expression
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of FNDC5 mRNA sulforaphane results in increased expression of FNDC5 mRNA
CTD
PMID:30529165
NCBI chr 1:32,862,268...32,872,484
Ensembl chr 1:32,862,268...32,872,482
G
FOLR1
folate receptor alpha
decreases expression
EXP
sulforaphane results in decreased expression of FOLR1 mRNA
CTD
PMID:31838189
NCBI chr11:72,189,709...72,196,323
Ensembl chr11:72,189,558...72,196,323
G
FOLR2
folate receptor beta
increases expression
ISO
sulforaphane results in increased expression of FOLR2 mRNA
CTD
PMID:30529165
NCBI chr11:72,216,794...72,221,950
Ensembl chr11:72,216,601...72,221,950
G
FOSL1
FOS like 1, AP-1 transcription factor subunit
increases expression increases methylation
EXP
sulforaphane results in increased expression of FOSL1 mRNA sulforaphane results in increased methylation of FOSL1 gene
CTD
PMID:31838189
NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
G
FOXA3
forkhead box A3
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of FOXA3 mRNA
CTD
PMID:25450479
NCBI chr19:45,864,326...45,873,797
Ensembl chr19:45,863,989...45,873,797
G
FOXC2
forkhead box C2
decreases expression
EXP
sulforaphane results in decreased expression of FOXC2 mRNA
CTD
PMID:31838189
NCBI chr16:86,566,829...86,569,728
Ensembl chr16:86,566,829...86,569,728
G
FOXQ1
forkhead box Q1
decreases expression
EXP
sulforaphane results in decreased expression of FOXQ1 mRNA
CTD
PMID:31838189
NCBI chr 6:1,312,098...1,314,758
Ensembl chr 6:1,312,098...1,314,758
G
FPR1
formyl peptide receptor 1
increases expression
EXP
sulforaphane results in increased expression of FPR1 mRNA
CTD
PMID:26833863
NCBI chr19:51,745,172...51,751,878
Ensembl chr19:51,745,172...51,804,115
G
FPR2
formyl peptide receptor 2
increases expression
EXP
sulforaphane results in increased expression of FPR2 mRNA
CTD
PMID:26833863
NCBI chr19:51,761,180...51,770,531
Ensembl chr19:51,752,026...51,770,531
G
FRAS1
Fraser extracellular matrix complex subunit 1
decreases expression
EXP
sulforaphane results in decreased expression of FRAS1 mRNA
CTD
PMID:31838189
NCBI chr 4:78,057,323...78,544,269
Ensembl chr 4:78,057,323...78,544,269
G
FRRS1
ferric chelate reductase 1
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of FRRS1 mRNA
CTD
PMID:30529165
NCBI chr 1:99,703,970...99,766,635
Ensembl chr 1:99,703,970...99,766,635
G
FTH1
ferritin heavy chain 1
increases expression
EXP
sulforaphane results in increased expression of FTH1 mRNA
CTD
PMID:26833863
NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
G
FTH1P2
ferritin heavy chain 1 pseudogene 2
increases expression
EXP
sulforaphane results in increased expression of FTH1P2 mRNA
CTD
PMID:26833863
NCBI chr 1:228,687,417...228,687,879
Ensembl chr 1:228,687,415...228,687,826
G
FTH1P3
ferritin heavy chain 1 pseudogene 3
increases expression
EXP
sulforaphane results in increased expression of FTH1P3 mRNA
CTD
PMID:26833863
NCBI chr 2:27,392,623...27,393,576
Ensembl chr 2:27,392,784...27,393,367
G
FTL
ferritin light chain
increases expression
EXP
sulforaphane results in increased expression of FTL mRNA
CTD
PMID:31838189
NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879
G
FUOM
fucose mutarotase
increases expression
ISO
sulforaphane results in increased expression of FUOM mRNA
CTD
PMID:30529165
NCBI chr10:133,352,773...133,358,019
Ensembl chr10:133,355,158...133,358,025
G
FXR2
FMR1 autosomal homolog 2
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of FXR2 mRNA
CTD
PMID:30529165
NCBI chr17:7,591,230...7,614,897
Ensembl chr17:7,591,230...7,614,897
G
FZD7
frizzled class receptor 7
increases expression
EXP
sulforaphane results in increased expression of FZD7 mRNA
CTD
PMID:31838189
NCBI chr 2:202,033,855...202,038,441
Ensembl chr 2:202,033,855...202,038,441
G
G3BP2
G3BP stress granule assembly factor 2
decreases methylation
EXP
sulforaphane results in decreased methylation of G3BP2 gene
CTD
PMID:31838189
NCBI chr 4:75,642,786...75,724,437
Ensembl chr 4:75,641,849...75,724,589
G
G6PD
glucose-6-phosphate dehydrogenase
increases expression
EXP
sulforaphane results in increased expression of G6PD mRNA
CTD
PMID:26833863
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
G
GAB2
GRB2 associated binding protein 2
decreases expression
EXP
sulforaphane results in decreased expression of GAB2 mRNA
CTD
PMID:31838189
NCBI chr11:78,215,293...78,417,820
Ensembl chr11:78,215,293...78,418,348
G
GABARAPL1
GABA type A receptor associated protein like 1
increases expression
EXP
sulforaphane results in increased expression of GABARAPL1 mRNA
CTD
PMID:26833863
NCBI chr12:10,212,877...10,223,128
Ensembl chr12:10,212,458...10,223,128
G
GABPB2
GA binding protein transcription factor subunit beta 2
increases expression
EXP
sulforaphane results in increased expression of GABPB2 mRNA
CTD
PMID:31838189
NCBI chr 1:151,070,761...151,125,542
Ensembl chr 1:151,070,578...151,125,542
G
GADD45A
growth arrest and DNA damage inducible alpha
increases expression
EXP
sulforaphane results in increased expression of GADD45A mRNA
CTD
PMID:17937621 PMID:26833863
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
G
GALNT12
polypeptide N-acetylgalactosaminyltransferase 12
increases expression
ISO
sulforaphane results in increased expression of GALNT12 mRNA
CTD
PMID:30529165
NCBI chr 9:98,807,670...98,850,081
Ensembl chr 9:98,807,670...98,850,081
G
GALNTL6
polypeptide N-acetylgalactosaminyltransferase like 6
decreases expression
EXP
sulforaphane results in decreased expression of GALNTL6 mRNA
CTD
PMID:31838189
NCBI chr 4:171,813,404...173,041,559
Ensembl chr 4:171,812,254...173,041,559
G
GARS1
glycyl-tRNA synthetase 1
increases expression
EXP
sulforaphane results in increased expression of GARS1 mRNA
CTD
PMID:31838189
NCBI chr 7:30,594,735...30,634,033
Ensembl chr 7:30,580,533...30,634,033
G
GAS1
growth arrest specific 1
decreases expression
EXP
sulforaphane results in decreased expression of GAS1 mRNA
CTD
PMID:31838189
NCBI chr 9:86,944,362...86,947,506
Ensembl chr 9:86,944,362...86,947,506
G
GAS7
growth arrest specific 7
increases expression
EXP
sulforaphane results in increased expression of GAS7 mRNA
CTD
PMID:26833863
NCBI chr17:9,910,606...10,198,606
Ensembl chr17:9,910,606...10,198,606
G
GATC
glutamyl-tRNA amidotransferase subunit C
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of GATC mRNA
CTD
PMID:30529165
NCBI chr12:120,446,444...120,463,749
Ensembl chr12:120,446,444...120,463,749
G
GATM
glycine amidinotransferase
decreases expression
EXP
sulforaphane results in decreased expression of GATM mRNA
CTD
PMID:26833863
NCBI chr15:45,361,124...45,402,227
Ensembl chr15:45,361,124...45,402,327
G
GCHFR
GTP cyclohydrolase I feedback regulator
decreases expression
EXP
sulforaphane results in decreased expression of GCHFR mRNA
CTD
PMID:31838189
NCBI chr15:40,764,068...40,767,708
Ensembl chr15:40,764,068...40,767,708
G
GCLC
glutamate-cysteine ligase catalytic subunit
multiple interactions decreases expression decreases methylation increases expression
ISO EXP
[sulforaphane co-treated with dibenzoylmethane] results in increased expression of GCLC mRNA; NFE2L2 protein promotes the reaction [sulforaphane results in increased expression of GCLC mRNA]; sulforaphane inhibits the reaction [Acetaminophen results in decreased expression of GCLC mRNA]; sulforaphane inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLC mRNA] sulforaphane results in decreased expression of GCLC mRNA sulforaphane results in decreased methylation of GCLC gene sulforaphane results in increased expression of GCLC mRNA; sulforaphane results in increased expression of GCLC protein N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [sulforaphane results in increased expression of GCLC mRNA] alpha-methylepinine promotes the reaction [sulforaphane results in increased expression of GCLC mRNA]; NFE2L2 mutant form inhibits the reaction [sulforaphane results in increased expression of GCLC mRNA]; sulforaphane promotes the reaction [alpha-methylepinine results in increased expression of GCLC mRNA]; sulforaphane promotes the reaction [Cisplatin results in increased expression of GCLC mRNA]
CTD
PMID:17942926 PMID:19071154 PMID:19303893 PMID:20442190 PMID:20932822 PMID:21871945 PMID:22558124 PMID:22807314 PMID:24184564 PMID:25818464 PMID:27777014 PMID:28959534 PMID:29964319 PMID:31518892 PMID:31838189 PMID:34767876 PMID:35724838 More...
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
G
GCLM
glutamate-cysteine ligase modifier subunit
multiple interactions decreases expression increases expression
ISO EXP
NFE2L2 protein promotes the reaction [sulforaphane results in increased expression of GCLM mRNA]; sulforaphane inhibits the reaction [Acetaminophen results in decreased expression of GCLM mRNA]; sulforaphane inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLM protein] sulforaphane results in decreased expression of GCLM mRNA NFE2L2 protein affects the reaction [sulforaphane results in increased expression of GCLM protein] sulforaphane results in increased expression of GCLM mRNA; sulforaphane results in increased expression of GCLM protein sulforaphane results in increased expression of GCLM; sulforaphane results in increased expression of GCLM mRNA; sulforaphane results in increased expression of GCLM protein
CTD
PMID:19071154 PMID:19303893 PMID:20442190 PMID:20932822 PMID:21539383 PMID:21723306 PMID:25818464 PMID:26833863 PMID:27777014 PMID:29964319 PMID:31299238 PMID:31838189 PMID:34767876 PMID:35227738 PMID:35724838 More...
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GCNT3
glucosaminyl (N-acetyl) transferase 3, mucin type
increases expression
EXP
sulforaphane results in increased expression of GCNT3 mRNA
CTD
PMID:31838189
NCBI chr15:59,549,039...59,622,723
Ensembl chr15:59,594,875...59,640,239
G
GDF11
growth differentiation factor 11
decreases expression
EXP
sulforaphane results in decreased expression of GDF11 mRNA
CTD
PMID:31838189
NCBI chr12:55,743,122...55,757,264
Ensembl chr12:55,743,122...55,757,264
G
GDPD5
glycerophosphodiester phosphodiesterase domain containing 5
decreases expression
EXP
sulforaphane results in decreased expression of GDPD5 mRNA
CTD
PMID:31838189
NCBI chr11:75,434,640...75,525,941
Ensembl chr11:75,434,640...75,525,941
G
GIPC3
GIPC PDZ domain containing family member 3
decreases expression
EXP
sulforaphane results in decreased expression of GIPC3 mRNA
CTD
PMID:31838189
NCBI chr19:3,585,478...3,593,541
Ensembl chr19:3,585,478...3,593,541
G
GJA5
gap junction protein alpha 5
decreases expression
EXP
sulforaphane results in decreased expression of GJA5 mRNA
CTD
PMID:31838189
NCBI chr 1:147,756,199...147,773,351
Ensembl chr 1:147,756,199...147,773,362
G
GLA
galactosidase alpha
increases expression
EXP
sulforaphane results in increased expression of GLA mRNA
CTD
PMID:31838189
NCBI chr X:101,397,803...101,407,925
Ensembl chr X:101,393,273...101,408,012
G
GLB1L3
galactosidase beta 1 like 3
decreases expression
ISO
sulforaphane results in decreased expression of GLB1L3 mRNA
CTD
PMID:30529165
NCBI chr11:134,275,767...134,325,304
Ensembl chr11:134,274,245...134,319,564
G
GLO1
glyoxalase I
multiple interactions increases expression
EXP
sulforaphane inhibits the reaction [Pyruvaldehyde results in decreased expression of GLO1 protein] sulforaphane results in increased expression of GLO1 protein
CTD
PMID:25933243
NCBI chr 6:38,675,925...38,703,145
Ensembl chr 6:38,675,925...38,703,145
G
GLRX
glutaredoxin
increases expression
EXP
sulforaphane results in increased expression of GLRX mRNA
CTD
PMID:26833863
NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,726
G
GMDS
GDP-mannose 4,6-dehydratase
decreases expression
EXP
sulforaphane results in decreased expression of GMDS mRNA
CTD
PMID:31838189
NCBI chr 6:1,623,806...2,245,605
Ensembl chr 6:1,623,806...2,245,605
G
GMNN
geminin DNA replication inhibitor
increases expression
ISO
sulforaphane results in increased expression of GMNN mRNA
CTD
PMID:30529165
NCBI chr 6:24,774,937...24,786,099
Ensembl chr 6:24,774,931...24,786,099
G
GMPR2
guanosine monophosphate reductase 2
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of GMPR2 mRNA
CTD
PMID:30529165
NCBI chr14:24,232,622...24,239,242
Ensembl chr14:24,232,422...24,239,242
G
GNPDA1
glucosamine-6-phosphate deaminase 1
increases expression
EXP
sulforaphane results in increased expression of GNPDA1 mRNA
CTD
PMID:31838189
NCBI chr 5:142,000,671...142,013,027
Ensembl chr 5:141,991,749...142,013,041
G
GPAT3
glycerol-3-phosphate acyltransferase 3
increases expression
EXP
sulforaphane results in increased expression of GPAT3 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr 4:83,535,587...83,605,875
Ensembl chr 4:83,535,914...83,605,875
G
GPC1
glypican 1
increases expression
EXP
sulforaphane results in increased expression of GPC1 mRNA
CTD
PMID:31838189
NCBI chr 2:240,435,663...240,468,076
Ensembl chr 2:240,435,663...240,468,076
G
GPC5
glypican 5
decreases expression
EXP
sulforaphane results in decreased expression of GPC5 mRNA
CTD
PMID:31838189
NCBI chr13:91,398,621...92,867,237
Ensembl chr13:91,398,621...92,873,682
G
GPER1
G protein-coupled estrogen receptor 1
decreases expression
EXP
sulforaphane results in decreased expression of GPER1 mRNA
CTD
PMID:31838189
NCBI chr 7:1,087,118...1,093,810
Ensembl chr 7:1,082,208...1,093,815
G
GPLD1
glycosylphosphatidylinositol specific phospholipase D1
decreases expression
EXP
sulforaphane results in decreased expression of GPLD1 mRNA
CTD
PMID:31838189
NCBI chr 6:24,423,969...24,495,287
Ensembl chr 6:24,424,565...24,495,205
G
GPM6B
glycoprotein M6B
decreases expression
EXP
sulforaphane results in decreased expression of GPM6B mRNA
CTD
PMID:31838189
NCBI chr X:13,770,939...13,938,638
Ensembl chr X:13,770,939...13,938,638
G
GPR135
G protein-coupled receptor 135
increases expression
EXP
sulforaphane results in increased expression of GPR135 mRNA
CTD
PMID:31838189
NCBI chr14:59,452,783...59,465,380
Ensembl chr14:59,429,022...59,465,380
G
GPR137C
G protein-coupled receptor 137C
decreases expression
EXP
sulforaphane results in decreased expression of GPR137C mRNA
CTD
PMID:31838189
NCBI chr14:52,552,836...52,637,713
Ensembl chr14:52,552,836...52,637,713
G
GPR153
G protein-coupled receptor 153
decreases expression
EXP
sulforaphane results in decreased expression of GPR153 mRNA
CTD
PMID:31838189
NCBI chr 1:6,247,353...6,261,098
Ensembl chr 1:6,247,353...6,261,098
G
GPR22
G protein-coupled receptor 22
increases expression
ISO
sulforaphane results in increased expression of GPR22 mRNA
CTD
PMID:30529165
NCBI chr 7:107,470,057...107,477,845
Ensembl chr 7:107,470,018...107,475,684
G
GPR3
G protein-coupled receptor 3
increases expression
EXP
sulforaphane results in increased expression of GPR3 mRNA
CTD
PMID:31838189
NCBI chr 1:27,392,622...27,395,814
Ensembl chr 1:27,392,622...27,395,814
G
GPR37L1
G protein-coupled receptor 37 like 1
decreases expression
EXP
sulforaphane results in decreased expression of GPR37L1 mRNA
CTD
PMID:31838189
NCBI chr 1:202,122,917...202,133,592
Ensembl chr 1:202,122,886...202,133,592
G
GPR65
G protein-coupled receptor 65
decreases expression
EXP
sulforaphane results in decreased expression of GPR65 mRNA
CTD
PMID:26833863
NCBI chr14:88,005,135...88,014,811
Ensembl chr14:88,005,135...88,014,811
G
GPR84
G protein-coupled receptor 84
increases expression
EXP
sulforaphane results in increased expression of GPR84 mRNA
CTD
PMID:26833863
NCBI chr12:54,350,698...54,364,486
Ensembl chr12:54,362,445...54,364,487
G
GPR85
G protein-coupled receptor 85
decreases expression
EXP
sulforaphane results in decreased expression of GPR85 mRNA
CTD
PMID:26833863
NCBI chr 7:113,082,285...113,087,724
Ensembl chr 7:113,078,331...113,087,778
G
GPRC5A
G protein-coupled receptor class C group 5 member A
decreases expression
EXP
sulforaphane results in decreased expression of GPRC5A mRNA
CTD
PMID:31838189
NCBI chr12:12,891,562...12,917,937
Ensembl chr12:12,890,782...12,917,937
G
GPRC5B
G protein-coupled receptor class C group 5 member B
decreases expression
EXP
sulforaphane results in decreased expression of GPRC5B mRNA
CTD
PMID:31838189
NCBI chr16:19,856,691...19,885,634
Ensembl chr16:19,856,691...19,886,167
G
GPRIN2
G protein regulated inducer of neurite outgrowth 2
decreases expression
EXP
sulforaphane results in decreased expression of GPRIN2 mRNA
CTD
PMID:31838189
NCBI chr10:46,541,736...46,557,596
Ensembl chr10:46,541,736...46,556,658
G
GPSM3
G protein signaling modulator 3
decreases expression
EXP
sulforaphane results in decreased expression of GPSM3 mRNA
CTD
PMID:31838189
NCBI chr 6:32,190,766...32,195,523
Ensembl chr 6:32,190,766...32,195,523
G
GPT2
glutamic--pyruvic transaminase 2
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of GPT2 mRNA
CTD
PMID:25450479
NCBI chr16:46,884,362...46,931,289
Ensembl chr16:46,884,362...46,931,289
G
GPX1
glutathione peroxidase 1
decreases expression
EXP
sulforaphane results in decreased expression of GPX1 mRNA
CTD
PMID:31838189
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
GPX2
glutathione peroxidase 2
increases expression
ISO
sulforaphane results in increased expression of GPX2 mRNA
CTD
PMID:30529165
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
G
GPX4
glutathione peroxidase 4
decreases expression increases expression multiple interactions
EXP ISO
sulforaphane results in decreased expression of GPX4 mRNA sulforaphane results in increased expression of GPX4 protein sulforaphane inhibits the reaction [Busulfan results in decreased expression of and results in decreased activity of GPX4 protein]
CTD
PMID:31838189 PMID:32416107
NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,982...1,106,791
G
GRAMD2B
GRAM domain containing 2B
decreases expression
EXP
sulforaphane results in decreased expression of GRAMD2B mRNA
CTD
PMID:31838189
NCBI chr 5:126,360,120...126,494,364
Ensembl chr 5:126,360,132...126,496,494
G
GRB10
growth factor receptor bound protein 10
increases expression
EXP
sulforaphane results in increased expression of GRB10 mRNA
CTD
PMID:31838189
NCBI chr 7:50,590,068...50,793,453
Ensembl chr 7:50,590,063...50,793,462
G
GRIA3
glutamate ionotropic receptor AMPA type subunit 3
decreases expression
ISO
sulforaphane results in decreased expression of GRIA3 mRNA
CTD
PMID:30529165
NCBI chr X:123,184,278...123,490,915
Ensembl chr X:123,184,153...123,490,915
G
GSK3B
glycogen synthase kinase 3 beta
multiple interactions
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sulforaphane results in increased phosphorylation of and results in decreased activity of GSK3B protein]; sulforaphane results in increased phosphorylation of and results in decreased activity of GSK3B protein
CTD
PMID:29353218
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
G
GSN
gelsolin
decreases expression increases methylation
EXP
sulforaphane results in decreased expression of GSN mRNA sulforaphane results in increased methylation of GSN gene
CTD
PMID:31838189
NCBI chr 9:121,201,483...121,332,842
Ensembl chr 9:121,207,794...121,332,843
G
GSR
glutathione-disulfide reductase
decreases activity multiple interactions increases expression increases activity
EXP ISO
sulforaphane results in decreased activity of GSR protein sulforaphane inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased activity of GSR protein] sulforaphane results in increased expression of GSR mRNA sulforaphane inhibits the reaction [Oxidopamine results in decreased activity of GSR protein] sulforaphane results in increased activity of GSR protein
CTD
PMID:17937621 PMID:19303893 PMID:22664424 PMID:23518299 PMID:26833863 PMID:28710020 PMID:30835071 PMID:31838189 PMID:37385402 More...
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
GSTA1
glutathione S-transferase alpha 1
multiple interactions increases expression decreases expression
EXP ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sulforaphane results in increased expression of GSTA1 mRNA]; SN50 peptide inhibits the reaction [sulforaphane results in increased expression of GSTA1 mRNA] sulforaphane results in increased expression of GSTA1 mRNA; sulforaphane results in increased expression of GSTA1 protein sulforaphane results in decreased expression of GSTA1 mRNA
CTD
PMID:11264000 PMID:12151360 PMID:12756216 PMID:12949046 PMID:15090468 PMID:18823965 More...
NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860
G
GSTA2
glutathione S-transferase alpha 2
multiple interactions increases expression
ISO
Hydrocortisone inhibits the reaction [sulforaphane results in increased expression of GSTA2 mRNA]
CTD
PMID:11264000 PMID:22606287
NCBI chr 6:52,750,087...52,763,475
Ensembl chr 6:52,750,087...52,763,475
G
GSTA3
glutathione S-transferase alpha 3
increases expression multiple interactions increases activity
ISO
sulforaphane results in increased expression of GSTA1 mRNA; sulforaphane results in increased expression of GSTA1 protein; sulforaphane results in increased expression of GSTA3 mRNA; sulforaphane results in increased expression of GSTA3 protein NFE2L2 protein promotes the reaction [sulforaphane results in increased expression of GSTA1 mRNA]; Tetradecanoylphorbol Acetate promotes the reaction [sulforaphane results in increased expression of GSTA1 mRNA] sulforaphane results in increased activity of GSTA3 promoter
CTD
PMID:7568053 PMID:11309284 PMID:14573750 PMID:19232536 PMID:20932822
NCBI chr 6:52,896,646...52,909,698
Ensembl chr 6:52,896,639...52,909,698
G
GSTM1
glutathione S-transferase mu 1
affects response to substance multiple interactions increases expression affects metabolic processing
EXP ISO
GSTM1 gene polymorphism affects the susceptibility to sulforaphane [sulforaphane co-treated with dibenzoylmethane] results in increased expression of GSTM1 mRNA; NFE2L2 protein promotes the reaction [sulforaphane results in increased expression of GSTM1 mRNA]; sulforaphane inhibits the reaction [fenamidone results in increased expression of GSTM1 mRNA] sulforaphane results in increased expression of GSTM1 protein sulforaphane results in increased expression of GSTM1 mRNA; sulforaphane results in increased expression of GSTM1 protein sulforaphane inhibits the reaction [alpha-methylepinine results in increased expression of GSTM1 mRNA] GSTM1 protein affects the metabolism of sulforaphane
CTD
PMID:7826396 PMID:11309284 PMID:15623468 PMID:16905640 PMID:17942926 PMID:18823965 PMID:19071154 PMID:19303893 PMID:20932822 PMID:21871945 PMID:24184564 PMID:27029645 More...
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
GSTM3
glutathione S-transferase mu 3
increases expression multiple interactions
ISO
sulforaphane results in increased expression of GSTM3 mRNA [sulforaphane co-treated with dibenzoylmethane] results in increased expression of GSTM3 mRNA
CTD
PMID:17942926
NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038
G
GSTO1
glutathione S-transferase omega 1
increases expression
ISO
sulforaphane results in increased expression of GSTO1 mRNA
CTD
PMID:30529165
NCBI chr10:104,254,173...104,267,455
Ensembl chr10:104,235,356...104,267,459
G
GSTP1
glutathione S-transferase pi 1
affects metabolic processing increases expression multiple interactions affects binding decreases activity
EXP ISO
GSTP1 protein affects the metabolism of sulforaphane sulforaphane results in increased expression of GSTP1 mRNA; sulforaphane results in increased expression of GSTP1 protein NFE2L2 protein promotes the reaction [sulforaphane results in increased expression of GSTP1 mRNA] GSTP1 protein binds to sulforaphane [sulforaphane promotes the reaction [JUN protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA; [sulforaphane promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA; N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [sulforaphane results in increased expression of GSTP1 mRNA]; sulforaphane inhibits the reaction [N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GSTP1 mRNA]; sulforaphane promotes the reaction [JUN protein binds to GSTP1 enhancer]; sulforaphane promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]; sulforaphane results in increased expression of and results in increased activity of GSTP1 protein sulforaphane results in decreased activity of GSTP1 protein
CTD
PMID:7826396 PMID:17937621 PMID:19303893 PMID:20237067 PMID:20932822 PMID:21838287 PMID:21871945 More...
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
G
GSTT1
glutathione S-transferase theta 1
decreases expression multiple interactions increases expression
EXP ISO
sulforaphane results in decreased expression of GSTT1 mRNA [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of GSTT1 mRNA sulforaphane analog results in increased expression of GSTT1 protein
CTD
PMID:9855024 PMID:20442190 PMID:30529165
G
GTPBP4
GTP binding protein 4
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of GTPBP4 mRNA
CTD
PMID:30529165
NCBI chr10:988,434...1,019,932
Ensembl chr10:988,434...1,019,932
G
GXYLT2
glucoside xylosyltransferase 2
decreases expression
EXP
sulforaphane results in decreased expression of GXYLT2 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr 3:72,888,046...72,976,915
Ensembl chr 3:72,888,046...72,998,138
G
H1-0
H1.0 linker histone
decreases expression
EXP
sulforaphane results in decreased expression of H1-0 mRNA
CTD
PMID:31838189
NCBI chr22:37,805,229...37,807,432
Ensembl chr22:37,805,229...37,807,432
G
H2AC1
H2A clustered histone 1
affects binding
EXP
H2AC1 protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr 6:25,726,063...25,726,562
Ensembl chr 6:25,723,397...25,726,562
G
HADHB
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
increases expression
ISO
sulforaphane results in increased expression of HADHB mRNA
CTD
PMID:30529165
NCBI chr 2:26,244,939...26,290,465
Ensembl chr 2:26,243,170...26,290,465
G
HAMP
hepcidin antimicrobial peptide
multiple interactions
ISO
sulforaphane inhibits the reaction [Lipopolysaccharides results in increased expression of HAMP mRNA] [sulforaphane co-treated with Aflatoxin B1] affects the expression of HAMP mRNA
CTD
PMID:21303654 PMID:25450479
NCBI chr19:35,282,528...35,285,143
Ensembl chr19:35,280,716...35,285,143
G
HAVCR1
hepatitis A virus cellular receptor 1
multiple interactions
ISO
sulforaphane inhibits the reaction [Methamphetamine results in increased expression of HAVCR1 protein]
CTD
PMID:37567421
NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396
G
HCK
HCK proto-oncogene, Src family tyrosine kinase
increases expression
EXP
sulforaphane results in increased expression of HCK mRNA
CTD
PMID:26833863
NCBI chr20:32,052,242...32,101,856
Ensembl chr20:32,052,197...32,101,856
G
HDAC1
histone deacetylase 1
decreases expression multiple interactions
EXP
sulforaphane results in decreased expression of HDAC1 mRNA sulforaphane inhibits the reaction [Estradiol promotes the reaction [HDAC1 protein binds to COMT promoter]]; sulforaphane inhibits the reaction [Estradiol results in increased expression of HDAC1 mRNA]; sulforaphane inhibits the reaction [Genistein promotes the reaction [HDAC1 protein binds to COMT promoter]]; sulforaphane inhibits the reaction [HDAC1 protein binds to COMT promoter]
CTD
PMID:30684530
NCBI chr 1:32,292,083...32,333,626
Ensembl chr 1:32,292,083...32,333,635
G
HDAC11
histone deacetylase 11
decreases expression
EXP
sulforaphane results in decreased expression of HDAC11 mRNA
CTD
PMID:31838189
NCBI chr 3:13,480,306...13,506,416
Ensembl chr 3:13,479,724...13,506,424
G
HDAC2
histone deacetylase 2
decreases expression multiple interactions
EXP
sulforaphane results in decreased expression of HDAC2 mRNA [Genistein co-treated with sulforaphane] results in decreased expression of HDAC2 mRNA
CTD
PMID:29899271 PMID:30684530
NCBI chr 6:113,933,028...113,971,148
Ensembl chr 6:113,933,028...114,011,308
G
HDAC3
histone deacetylase 3
multiple interactions decreases expression
ISO EXP
NFE2L2 protein affects the reaction [sulforaphane affects the reaction [1,2-Dimethylhydrazine affects the expression of HDAC3 protein]]; sulforaphane affects the reaction [1,2-Dimethylhydrazine affects the expression of HDAC3 protein] [Genistein co-treated with sulforaphane] results in decreased expression of HDAC3 mRNA sulforaphane results in decreased expression of HDAC3 protein
CTD
PMID:26388957 PMID:29899271
NCBI chr 5:141,620,881...141,636,849
Ensembl chr 5:141,620,876...141,636,849
G
HDAC5
histone deacetylase 5
decreases expression
EXP
sulforaphane results in decreased expression of HDAC5 mRNA
CTD
PMID:31838189
NCBI chr17:44,076,753...44,123,641
Ensembl chr17:44,076,746...44,123,702
G
HDAC6
histone deacetylase 6
multiple interactions decreases activity
EXP
HDAC6 protein inhibits the reaction [sulforaphane results in decreased expression of AR protein]; sulforaphane inhibits the reaction [Estradiol results in increased expression of HDAC6 mRNA]; sulforaphane inhibits the reaction [Genistein results in increased expression of HDAC6 mRNA] sulforaphane results in decreased activity of HDAC6 protein
CTD
PMID:19805354 PMID:30684530
NCBI chr X:48,801,398...48,824,982
Ensembl chr X:48,801,377...48,824,982
G
HDAC9
histone deacetylase 9
decreases expression
EXP
sulforaphane results in decreased expression of HDAC9 mRNA
CTD
PMID:26833863
NCBI chr 7:18,086,825...19,002,416
Ensembl chr 7:18,086,949...19,002,416
G
HECW1
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1
increases expression
EXP
sulforaphane results in increased expression of HECW1 mRNA
CTD
PMID:31838189
NCBI chr 7:43,112,647...43,566,001
Ensembl chr 7:43,112,629...43,566,001
G
HECW2
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2
decreases expression
ISO
sulforaphane results in decreased expression of HECW2 mRNA
CTD
PMID:30529165
NCBI chr 2:196,194,072...196,593,554
Ensembl chr 2:196,189,099...196,593,684
G
HEPACAM2
HEPACAM family member 2
decreases expression
ISO
sulforaphane results in decreased expression of HEPACAM2 mRNA
CTD
PMID:30529165
NCBI chr 7:93,188,534...93,232,285
Ensembl chr 7:93,188,534...93,226,469
G
HERC5
HECT and RLD domain containing E3 ubiquitin protein ligase 5
increases expression
EXP
sulforaphane results in increased expression of HERC5 mRNA
CTD
PMID:31838189
NCBI chr 4:88,457,119...88,506,163
Ensembl chr 4:88,457,119...88,506,163
G
HERC6
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6
increases expression
EXP
sulforaphane results in increased expression of HERC6 mRNA
CTD
PMID:31838189
NCBI chr 4:88,378,852...88,443,097
Ensembl chr 4:88,378,739...88,443,097
G
HERPUD1
homocysteine inducible ER protein with ubiquitin like domain 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of HERPUD1 mRNA
CTD
PMID:30529165
NCBI chr16:56,932,142...56,944,864
Ensembl chr16:56,932,142...56,944,864
G
HES2
hes family bHLH transcription factor 2
decreases expression
EXP
sulforaphane results in decreased expression of HES2 mRNA
CTD
PMID:31838189
NCBI chr 1:6,415,232...6,419,919
Ensembl chr 1:6,412,418...6,424,670
G
HEY1
hes related family bHLH transcription factor with YRPW motif 1
decreases expression
ISO
sulforaphane results in decreased expression of HEY1 mRNA
CTD
PMID:30529165
NCBI chr 8:79,764,010...79,767,767
Ensembl chr 8:79,762,371...79,767,857
G
HHATL
hedgehog acyltransferase like
increases expression
ISO
sulforaphane results in increased expression of HHATL mRNA
CTD
PMID:30529165
NCBI chr 3:42,692,663...42,702,798
Ensembl chr 3:42,692,663...42,702,824
G
HHEX
hematopoietically expressed homeobox
increases expression
EXP
sulforaphane results in increased expression of HHEX mRNA
CTD
PMID:31838189
NCBI chr10:92,689,955...92,695,647
Ensembl chr10:92,689,955...92,695,647
G
HHIP
hedgehog interacting protein
decreases expression
ISO
sulforaphane results in decreased expression of HHIP mRNA
CTD
PMID:30529165
NCBI chr 4:144,646,156...144,745,271
Ensembl chr 4:144,646,156...144,745,271
G
HIBCH
3-hydroxyisobutyryl-CoA hydrolase
increases expression
ISO
sulforaphane results in increased expression of HIBCH mRNA
CTD
PMID:30529165
NCBI chr 2:190,189,735...190,319,826
Ensembl chr 2:190,189,735...190,344,193
G
HIC2
HIC ZBTB transcriptional repressor 2
increases expression
EXP
sulforaphane results in increased expression of HIC2 mRNA
CTD
PMID:31838189
NCBI chr22:21,417,371...21,451,463
Ensembl chr22:21,417,371...21,451,463
G
HIF1A
hypoxia inducible factor 1 subunit alpha
decreases expression
EXP
sulforaphane results in decreased expression of HIF1A protein
CTD
PMID:27993529
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
G
HIGD1C
HIG1 hypoxia inducible domain family member 1C
decreases expression
ISO
sulforaphane results in decreased expression of HIGD1C mRNA
CTD
PMID:30529165
NCBI chr12:50,931,110...50,972,592
Ensembl chr12:50,952,538...50,970,607
G
HIVEP3
HIVEP zinc finger 3
decreases expression
EXP
sulforaphane results in decreased expression of HIVEP3 mRNA
CTD
PMID:31838189
NCBI chr 1:41,506,365...42,035,934
Ensembl chr 1:41,506,365...42,035,925
G
HKDC1
hexokinase domain containing 1
increases expression
EXP
sulforaphane results in increased expression of HKDC1 mRNA
CTD
PMID:31838189
NCBI chr10:69,220,332...69,267,552
Ensembl chr10:69,220,332...69,267,552
G
HLA-B
major histocompatibility complex, class I, B
decreases expression
EXP
sulforaphane results in decreased expression of HLA-B mRNA
CTD
PMID:31838189
NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
G
HLA-C
major histocompatibility complex, class I, C
decreases expression
EXP
sulforaphane results in decreased expression of HLA-C mRNA
CTD
PMID:31838189
NCBI chr 6:31,268,749...31,272,092
Ensembl chr 6:31,268,749...31,272,130
G
HLA-DMA
major histocompatibility complex, class II, DM alpha
decreases expression
EXP
sulforaphane results in decreased expression of HLA-DMA mRNA
CTD
PMID:26833863
NCBI chr 6:32,948,618...32,953,097
Ensembl chr 6:32,948,613...32,969,094
G
HLA-DPA1
major histocompatibility complex, class II, DP alpha 1
decreases expression
EXP
sulforaphane results in decreased expression of HLA-DPA1 mRNA
CTD
PMID:26833863
NCBI chr 6:33,064,569...33,080,748
Ensembl chr 6:33,064,569...33,080,775
G
HLA-DPB1
major histocompatibility complex, class II, DP beta 1
decreases expression
EXP
sulforaphane results in decreased expression of HLA-DPB1 mRNA
CTD
PMID:26833863
NCBI chr 6:33,075,990...33,089,696
Ensembl chr 6:33,075,936...33,089,696
G
HLA-DRA
major histocompatibility complex, class II, DR alpha
decreases expression
EXP
sulforaphane results in decreased expression of HLA-DRA mRNA
CTD
PMID:26833863
NCBI chr 6:32,439,887...32,445,046
Ensembl chr 6:32,439,878...32,445,046
G
HLA-DRB4
major histocompatibility complex, class II, DR beta 4
decreases expression
EXP
sulforaphane results in decreased expression of HLA-DRB4 mRNA
CTD
PMID:26833863
G
HLA-DRB5
major histocompatibility complex, class II, DR beta 5
decreases expression
EXP
sulforaphane results in decreased expression of HLA-DRB5 mRNA
CTD
PMID:26833863
NCBI chr 6:32,517,353...32,530,287
Ensembl chr 6:32,517,353...32,530,287
G
HLA-G
major histocompatibility complex, class I, G
decreases expression
EXP
sulforaphane results in decreased expression of HLA-G mRNA
CTD
PMID:31838189
NCBI chr 6:29,826,474...29,831,021
Ensembl chr 6:29,826,967...29,831,125
G
HMGA2
high mobility group AT-hook 2
increases expression
EXP
sulforaphane results in increased expression of HMGA2 mRNA
CTD
PMID:31838189
NCBI chr12:65,824,460...65,966,291
Ensembl chr12:65,824,460...65,966,291
G
HMGB1
high mobility group box 1
increases methylation
EXP
sulforaphane results in increased methylation of HMG1 gene
CTD
PMID:31838189
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
G
HMMR
hyaluronan mediated motility receptor
increases expression decreases methylation
EXP
sulforaphane results in increased expression of HMMR mRNA sulforaphane results in decreased methylation of HMMR gene
CTD
PMID:31838189
NCBI chr 5:163,460,632...163,491,941
Ensembl chr 5:163,460,203...163,491,941
G
HMOX1
heme oxygenase 1
multiple interactions decreases expression increases expression increases activity
EXP ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sulforaphane results in increased expression of HMOX1 protein]; 3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of HMOX1 mRNA]; Acetylcysteine inhibits the reaction [sulforaphane results in increased expression of HMOX1 protein]; AHR mutant form inhibits the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of HMOX1 mRNA]]; AHR mutant form inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [sulforaphane results in increased expression of HMOX1 mRNA]]; cyanoginosin LR promotes the reaction [sulforaphane results in increased expression of HMOX1 protein]; Deferoxamine inhibits the reaction [sulforaphane results in increased expression of HMOX1 mRNA]; ESR1 mutant form promotes the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of HMOX1 mRNA]]; Estradiol inhibits the reaction [sulforaphane results in increased expression of HMOX1 mRNA]; ferrous sulfate inhibits the reaction [Deferoxamine inhibits the reaction [sulforaphane results in increased expression of HMOX1 mRNA]]; NFE2L2 mutant form inhibits the reaction [sulforaphane results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of HMOX1]; Reactive Oxygen Species affects the reaction [sulforaphane promotes the reaction [NFE2L2 protein results in increased expression of HMOX1 protein]]; sulforaphane metabolite promotes the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of HMOX1 mRNA]; sulforaphane promotes the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of HMOX1 mRNA]; sulforaphane promotes the reaction [NFE2L2 protein results in increased expression of HMOX1 protein]; sulforaphane results in increased expression of and results in increased activity of HMOX1 protein; Tetrachlorodibenzodioxin promotes the reaction [sulforaphane results in increased expression of HMOX1 mRNA] sulforaphane results in decreased expression of HMOX1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sulforaphane results in increased expression of HMOX1 protein]; Nitroprusside inhibits the reaction [sulforaphane results in increased expression of HMOX1 protein]; sulforaphane inhibits the reaction [Streptozocin results in decreased expression of HMOX1 mRNA] sulforaphane results in increased expression of HMOX1; sulforaphane results in increased expression of HMOX1 mRNA; sulforaphane results in increased expression of HMOX1 protein sulforaphane analog results in increased expression of HMOX1 protein; sulforaphane metabolite results in increased expression of HMOX1 mRNA; sulforaphane results in increased expression of HMOX1 mRNA; sulforaphane results in increased expression of HMOX1 protein sulforaphane results in increased activity of HMOX1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sulforaphane results in increased expression of HMOX1 protein]; [Streptozocin co-treated with sulforaphane] results in increased expression of HMOX1; [sulforaphane co-treated with Dibutyl Phthalate] results in increased expression of HMOX1 protein; NFE2L2 gene mutant form inhibits the reaction [sulforaphane results in increased expression of HMOX1 protein]; NFE2L2 mutant form inhibits the reaction [sulforaphane results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of HMOX1 protein]; Nitroprusside inhibits the reaction [sulforaphane results in increased expression of HMOX1 protein]; sulforaphane inhibits the reaction [Acetaminophen results in decreased expression of HMOX1 mRNA]; sulforaphane inhibits the reaction [AGT protein modified form results in decreased expression of HMOX1 mRNA]; sulforaphane inhibits the reaction [AGT protein modified form results in decreased expression of HMOX1 protein]; sulforaphane inhibits the reaction [Carbon Tetrachloride results in decreased expression of HMOX1 mRNA]; sulforaphane inhibits the reaction [fenamidone results in increased expression of HMOX1 mRNA]; sulforaphane inhibits the reaction [Streptozocin results in decreased expression of HMOX1 mRNA]; sulforaphane inhibits the reaction [Streptozocin results in decreased expression of HMOX1 protein]; sulforaphane inhibits the reaction [Trichloroethylene results in decreased expression of HMOX1 protein]; sulforaphane promotes the reaction [Methamphetamine results in increased expression of HMOX1 protein]
CTD
PMID:16890772 PMID:18417180 PMID:18619545 PMID:19033392 PMID:19071154 PMID:19558496 PMID:19715681 PMID:20600217 PMID:21684301 PMID:22019695 PMID:22023613 PMID:22664424 PMID:23583297 PMID:23899529 PMID:23942037 PMID:23958496 PMID:24184564 PMID:24603300 PMID:24801890 PMID:24967692 PMID:25111660 PMID:25683455 PMID:25818464 PMID:26945724 PMID:27029645 PMID:27777014 PMID:28295950 PMID:28710020 PMID:28790194 PMID:29353218 PMID:29792947 PMID:29950142 PMID:29964319 PMID:30703377 PMID:30965051 PMID:31173751 PMID:31838189 PMID:32073640 PMID:32111854 PMID:32238698 PMID:32387680 PMID:33007382 PMID:33741493 PMID:33894213 PMID:35724838 PMID:37385402 PMID:37567421 More...
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HNRNPC
heterogeneous nuclear ribonucleoprotein C
increases methylation
EXP
sulforaphane results in increased methylation of HNRNPC gene
CTD
PMID:31838189
NCBI chr14:21,209,147...21,269,442
Ensembl chr14:21,209,136...21,269,494
G
HNRNPF
heterogeneous nuclear ribonucleoprotein F
affects binding
EXP
HNRNPF protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr10:43,385,618...43,409,186
Ensembl chr10:43,385,617...43,409,186
G
HNRNPH1
heterogeneous nuclear ribonucleoprotein H1
affects binding
EXP
HNRNPH1 protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr 5:179,614,178...179,634,784
Ensembl chr 5:179,614,178...179,634,784
G
HNRNPK
heterogeneous nuclear ribonucleoprotein K
affects binding
EXP
HNRNPK protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr 9:83,968,083...83,980,615
Ensembl chr 9:83,968,083...83,980,631
G
HNRNPL
heterogeneous nuclear ribonucleoprotein L
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of HNRNPL mRNA
CTD
PMID:30529165
NCBI chr19:38,836,370...38,852,347
Ensembl chr19:38,836,370...38,852,347
G
HNRNPLL
heterogeneous nuclear ribonucleoprotein L like
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of HNRNPLL mRNA
CTD
PMID:30529165
NCBI chr 2:38,561,969...38,602,928
Ensembl chr 2:38,561,969...38,603,586
G
HOGA1
4-hydroxy-2-oxoglutarate aldolase 1
decreases expression
EXP
sulforaphane results in decreased expression of HOGA1 mRNA
CTD
PMID:31838189
NCBI chr10:97,584,389...97,612,802
Ensembl chr10:97,584,323...97,612,802
G
HOXC4
homeobox C4
decreases expression
EXP
sulforaphane results in decreased expression of HOXC4 mRNA
CTD
PMID:31838189
NCBI chr12:54,016,888...54,056,030
Ensembl chr12:54,016,931...54,056,030
G
HOXC6
homeobox C6
decreases expression
EXP
sulforaphane results in decreased expression of HOXC6 mRNA
CTD
PMID:31838189
NCBI chr12:54,016,888...54,030,823
Ensembl chr12:53,990,624...54,030,823
G
HP
haptoglobin
increases expression
EXP
sulforaphane results in increased expression of HP mRNA
CTD
PMID:26833863
NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
G
HPGD
15-hydroxyprostaglandin dehydrogenase
decreases expression
EXP
sulforaphane results in decreased expression of HPGD mRNA
CTD
PMID:31838189
NCBI chr 4:174,490,175...174,522,893
Ensembl chr 4:174,490,175...174,523,154
G
HPGDS
hematopoietic prostaglandin D synthase
decreases expression
EXP
sulforaphane results in decreased expression of HPGDS mRNA
CTD
PMID:26833863
NCBI chr 4:94,298,535...94,342,836
Ensembl chr 4:94,298,535...94,342,876
G
HPR
haptoglobin-related protein
increases expression
EXP
sulforaphane results in increased expression of HPR mRNA
CTD
PMID:26833863
NCBI chr16:72,063,226...72,077,246
Ensembl chr16:72,063,148...72,077,246
G
HPSE
heparanase
increases expression decreases expression
EXP
sulforaphane results in increased expression of HPSE mRNA sulforaphane results in decreased expression of HPSE mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr 4:83,292,461...83,335,153
Ensembl chr 4:83,292,461...83,335,153
G
HR
HR lysine demethylase and nuclear receptor corepressor
decreases expression
EXP
sulforaphane results in decreased expression of HR mRNA
CTD
PMID:31838189
NCBI chr 8:22,114,419...22,131,052
Ensembl chr 8:22,114,419...22,133,384
G
HRC
histidine rich calcium binding protein
increases expression
ISO
sulforaphane results in increased expression of HRC mRNA
CTD
PMID:30529165
NCBI chr19:49,151,198...49,155,396
Ensembl chr19:49,151,198...49,155,396
G
HSD11B1
hydroxysteroid 11-beta dehydrogenase 1
multiple interactions
EXP
[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]; [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]]
CTD
PMID:22606287
NCBI chr 1:209,686,179...209,734,929
Ensembl chr 1:209,686,178...209,734,949
G
HSF1
heat shock transcription factor 1
increases activity
EXP
sulforaphane results in increased activity of HSF1 protein
CTD
PMID:34170685
NCBI chr 8:144,291,604...144,314,720
Ensembl chr 8:144,291,591...144,314,720
G
HSP90AA1
heat shock protein 90 alpha family class A member 1
multiple interactions increases expression increases acetylation
EXP
sulforaphane inhibits the reaction [HSP90AA1 protein binds to AR protein]; sulforaphane promotes the reaction [Arsenic Trioxide results in increased expression of HSP90AA1 protein] sulforaphane results in increased expression of HSP90AA1 mRNA sulforaphane results in increased acetylation of HSP90AA1 protein
CTD
PMID:19805354 PMID:22922937 PMID:31838189
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
G
HSP90B1
heat shock protein 90 beta family member 1
decreases expression
ISO
sulforaphane results in decreased expression of HSP90B1 protein
CTD
PMID:37385402
NCBI chr12:103,930,410...103,947,926
Ensembl chr12:103,930,107...103,953,931
G
HSPA13
heat shock protein family A (Hsp70) member 13
increases expression
EXP
sulforaphane results in increased expression of HSPA13 mRNA
CTD
PMID:31838189
NCBI chr21:14,371,115...14,383,146
Ensembl chr21:14,371,115...14,383,484
G
HSPA1B
heat shock protein family A (Hsp70) member 1B
increases expression
EXP
sulforaphane results in increased expression of HSPA1B mRNA
CTD
PMID:31838189
NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
G
HSPA1L
heat shock protein family A (Hsp70) member 1 like
affects binding
EXP
HSPA1L protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr 6:31,809,619...31,815,283
Ensembl chr 6:31,809,619...31,815,283
G
HSPA2
heat shock protein family A (Hsp70) member 2
decreases expression
EXP
sulforaphane results in decreased expression of HSPA2 mRNA
CTD
PMID:31838189
NCBI chr14:64,535,905...64,543,237
Ensembl chr14:64,535,905...64,546,173
G
HSPA4
heat shock protein family A (Hsp70) member 4
affects binding
EXP
HSPA4 protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr 5:133,052,013...133,106,449
Ensembl chr 5:133,052,013...133,106,449
G
HSPA5
heat shock protein family A (Hsp70) member 5
multiple interactions
ISO
sulforaphane inhibits the reaction [Streptozocin results in increased expression of HSPA5 protein]
CTD
PMID:24967692
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
G
HSPA9
heat shock protein family A (Hsp70) member 9
affects binding
EXP
HSPA9 protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr 5:138,553,756...138,575,401
Ensembl chr 5:138,553,756...138,575,675
G
HSPB3
heat shock protein family B (small) member 3
decreases expression
EXP
sulforaphane results in decreased expression of HSPB3 mRNA
CTD
PMID:31838189
NCBI chr 5:54,455,699...54,456,377
Ensembl chr 5:54,455,699...54,456,377
G
HSPB7
heat shock protein family B (small) member 7
increases expression decreases expression
ISO EXP
sulforaphane results in increased expression of HSPB7 mRNA sulforaphane results in decreased expression of HSPB7 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 1:16,014,029...16,019,594
Ensembl chr 1:16,014,028...16,019,594
G
HSPD1
heat shock protein family D (Hsp60) member 1
affects binding
EXP
HSPD1 protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
G
HSPH1
heat shock protein family H (Hsp110) member 1
increases expression
EXP
sulforaphane results in increased expression of HSPH1 mRNA
CTD
PMID:31838189
NCBI chr13:31,134,973...31,162,388
Ensembl chr13:31,134,973...31,162,388
G
HTRA3
HtrA serine peptidase 3
increases expression
ISO
sulforaphane results in increased expression of HTRA3 mRNA
CTD
PMID:30529165
NCBI chr 4:8,269,754...8,307,098
Ensembl chr 4:8,269,754...8,307,098
G
ICAM1
intercellular adhesion molecule 1
multiple interactions increases expression
ISO EXP
sulforaphane inhibits the reaction [Streptozocin results in increased expression of ICAM1 protein] sulforaphane inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ICAM1 protein] sulforaphane inhibits the reaction [IL1B protein results in increased expression of ICAM1 protein]; sulforaphane inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]; sulforaphane inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; sulforaphane inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] sulforaphane results in increased expression of ICAM1 mRNA
CTD
PMID:16890772 PMID:24967692 PMID:26833863 PMID:30835071 PMID:33894213 PMID:35724838 More...
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
ICAM2
intercellular adhesion molecule 2
decreases expression
EXP
sulforaphane results in decreased expression of ICAM2 mRNA
CTD
PMID:26833863
NCBI chr17:64,002,595...64,020,633
Ensembl chr17:64,002,594...64,020,634
G
ICAM3
intercellular adhesion molecule 3
increases expression
EXP
sulforaphane results in increased expression of ICAM3 mRNA
CTD
PMID:26833863
NCBI chr19:10,333,776...10,339,624
Ensembl chr19:10,333,776...10,339,661
G
ID2
inhibitor of DNA binding 2
decreases expression
EXP
sulforaphane results in decreased expression of ID2 mRNA
CTD
PMID:31838189
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
G
ID3
inhibitor of DNA binding 3
decreases expression
EXP
sulforaphane results in decreased expression of ID3 mRNA
CTD
PMID:31838189
NCBI chr 1:23,557,926...23,559,501
Ensembl chr 1:23,557,926...23,559,501
G
IDH3A
isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha
increases expression
ISO
sulforaphane results in increased expression of IDH3A mRNA
CTD
PMID:30529165
NCBI chr15:78,149,362...78,171,945
Ensembl chr15:78,131,498...78,171,945
G
IFI27L2
interferon alpha inducible protein 27 like 2
increases expression
ISO
sulforaphane results in increased expression of IFI27L2A mRNA
CTD
PMID:30529165
NCBI chr14:94,127,781...94,129,604
Ensembl chr14:94,127,779...94,130,253
G
IFI30
IFI30 lysosomal thiol reductase
increases expression
EXP
sulforaphane results in increased expression of IFI30 mRNA
CTD
PMID:26833863
NCBI chr19:18,173,813...18,178,117
Ensembl chr19:18,173,162...18,178,117
G
IFI44
interferon induced protein 44
increases expression
EXP
sulforaphane results in increased expression of IFI44 mRNA
CTD
PMID:31838189
NCBI chr 1:78,649,789...78,664,078
Ensembl chr 1:78,649,796...78,664,078
G
IFIH1
interferon induced with helicase C domain 1
increases expression
EXP
sulforaphane results in increased expression of IFIH1 mRNA
CTD
PMID:31838189
NCBI chr 2:162,267,074...162,318,684
Ensembl chr 2:162,267,074...162,318,684
G
IFIT1
interferon induced protein with tetratricopeptide repeats 1
increases expression
EXP
sulforaphane results in increased expression of IFIT1 mRNA
CTD
PMID:31838189
NCBI chr10:89,392,623...89,406,487
Ensembl chr10:89,392,546...89,406,487
G
IFIT2
interferon induced protein with tetratricopeptide repeats 2
increases expression
EXP
sulforaphane results in increased expression of IFIT2 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr10:89,302,046...89,309,271
Ensembl chr10:89,283,694...89,309,271
G
IFIT3
interferon induced protein with tetratricopeptide repeats 3
increases expression
EXP
sulforaphane results in increased expression of IFIT3 mRNA
CTD
PMID:31838189
NCBI chr10:89,327,997...89,340,968
Ensembl chr10:89,327,307...89,377,473
G
IFITM2
interferon induced transmembrane protein 2
decreases expression
EXP
sulforaphane results in decreased expression of IFITM2 mRNA
CTD
PMID:31838189
NCBI chr11:307,816...309,395
Ensembl chr11:303,655...309,397
G
IFITM3
interferon induced transmembrane protein 3
decreases expression
EXP
sulforaphane results in decreased expression of IFITM3 mRNA
CTD
PMID:31838189
NCBI chr11:319,676...320,860
Ensembl chr11:319,676...329,475
G
IFNG
interferon gamma
multiple interactions decreases activity
ISO
sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IFNG protein]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of NFKB1 protein]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of RELA protein]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Dinoprostone]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Hydrogen Peroxide]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitrites]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of PTGS2 mRNA]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of PTGS2 protein]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased phosphorylation of NFKBIA protein]; sulforaphane inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CASP1 protein]; sulforaphane inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B protein]; sulforaphane inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL6 protein]; sulforaphane inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of ITGAM protein]; sulforaphane inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NLRP3 protein]; sulforaphane inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PYCARD protein]; sulforaphane inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]; sulforaphane inhibits the reaction [IFNG protein results in increased abundance of Nitrites]; tin protoporphyrin IX inhibits the reaction [sulforaphane inhibits the reaction [IFNG protein results in increased abundance of Nitrites]] sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Dinoprostone]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitrites]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of PTGS2 mRNA]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of PTGS2 protein] sulforaphane results in decreased activity of IFNG protein
CTD
PMID:19071154 PMID:23942037 PMID:33007382 PMID:36988325
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IFT81
intraflagellar transport 81
increases expression
ISO
sulforaphane results in increased expression of IFT81 mRNA
CTD
PMID:30529165
NCBI chr12:110,124,357...110,218,793
Ensembl chr12:110,124,335...110,218,793
G
IGF2R
insulin like growth factor 2 receptor
increases expression
EXP
sulforaphane results in increased expression of IGF2R mRNA
CTD
PMID:31838189
NCBI chr 6:159,969,082...160,111,504
Ensembl chr 6:159,969,082...160,113,507
G
IGFBP4
insulin like growth factor binding protein 4
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of IGFBP4 mRNA
CTD
PMID:30529165
NCBI chr17:40,443,450...40,457,725
Ensembl chr17:40,443,450...40,457,725
G
IGFN1
immunoglobulin like and fibronectin type III domain containing 1
increases expression
EXP
sulforaphane results in increased expression of IGFN1 mRNA
CTD
PMID:31838189
NCBI chr 1:201,190,824...201,228,952
Ensembl chr 1:201,190,824...201,228,952
G
IGKV2D-29
immunoglobulin kappa variable 2D-29
increases expression
EXP
sulforaphane results in increased expression of IGKV2D-29 mRNA
CTD
PMID:26833863
NCBI chr 2:89,947,542...89,948,271
Ensembl chr 2:89,947,512...89,948,269
G
IGLL1
immunoglobulin lambda like polypeptide 1
decreases expression
EXP
sulforaphane results in decreased expression of IGLL1 mRNA
CTD
PMID:26833863
NCBI chr22:23,573,125...23,580,290
Ensembl chr22:23,573,125...23,580,302
G
IKBKG
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
increases expression
EXP
sulforaphane results in increased expression of IKBKG mRNA
CTD
PMID:31838189
NCBI chr X:154,541,238...154,565,046
Ensembl chr X:154,541,199...154,565,046
G
IKZF2
IKAROS family zinc finger 2
decreases expression
EXP
sulforaphane results in decreased expression of IKZF2 mRNA
CTD
PMID:31838189
NCBI chr 2:212,999,698...213,152,456
Ensembl chr 2:212,999,691...213,152,427
G
IL10
interleukin 10
multiple interactions
ISO
sulforaphane inhibits the reaction [Dinitrochlorobenzene results in decreased expression of IL10 mRNA]; sulforaphane inhibits the reaction [Dinitrochlorobenzene results in decreased expression of IL10 protein]
CTD
PMID:34651546
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL11
interleukin 11
increases expression
EXP
sulforaphane results in increased expression of IL11 mRNA
CTD
PMID:31838189
NCBI chr19:55,364,382...55,370,463
Ensembl chr19:55,364,382...55,370,463
G
IL12B
interleukin 12B
multiple interactions
EXP ISO
NFE2L2 protein affects the reaction [sulforaphane inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B protein]]; sulforaphane inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B protein] sulforaphane inhibits the reaction [Trichloroethylene results in increased expression of IL12B mRNA]
CTD
PMID:16890772 PMID:33930529
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
G
IL18R1
interleukin 18 receptor 1
increases expression
EXP
sulforaphane results in increased expression of IL18R1 mRNA
CTD
PMID:26833863
NCBI chr 2:102,355,796...102,398,776
Ensembl chr 2:102,311,529...102,398,777
G
IL18RAP
interleukin 18 receptor accessory protein
increases expression
EXP
sulforaphane results in increased expression of IL18RAP mRNA
CTD
PMID:26833863
NCBI chr 2:102,418,621...102,452,565
Ensembl chr 2:102,418,689...102,452,565
G
IL1B
interleukin 1 beta
multiple interactions decreases expression increases expression decreases activity
EXP ISO
[Eugenol results in increased activity of sulforaphane] which results in decreased expression of IL1B; [sulforaphane results in increased activity of Eugenol] which results in decreased expression of IL1B; sulforaphane inhibits the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of IL1B mRNA]; sulforaphane inhibits the reaction [IL1B protein affects the localization of NFKBIA protein]; sulforaphane inhibits the reaction [IL1B protein affects the localization of RELA protein]; sulforaphane inhibits the reaction [IL1B protein results in increased expression of ICAM1 protein]; sulforaphane inhibits the reaction [IL1B protein results in increased expression of TNFAIP3 protein]; sulforaphane inhibits the reaction [macrophage stimulatory lipopeptide 2 results in increased secretion of IL1B protein]; sulforaphane inhibits the reaction [Vehicle Emissions analog results in increased expression of IL1B protein]; sulforaphane metabolite inhibits the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of IL1B mRNA]; tin protoporphyrin IX inhibits the reaction [sulforaphane inhibits the reaction [macrophage stimulatory lipopeptide 2 results in increased secretion of IL1B protein]] sulforaphane metabolite results in decreased expression of IL1B mRNA; sulforaphane results in decreased expression of IL1B mRNA sulforaphane results in increased expression of IL1B mRNA sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Dinoprostone]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitrites]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of PTGS2 mRNA]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of PTGS2 protein] sulforaphane results in decreased activity of IL1B protein sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of NFKB1 protein]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of RELA protein]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Dinoprostone]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Hydrogen Peroxide]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased abundance of Nitrites]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of PTGS2 mRNA]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of PTGS2 protein]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased phosphorylation of NFKBIA protein]; sulforaphane inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B protein]; sulforaphane inhibits the reaction [ochratoxin A results in increased expression of IL1B mRNA]
CTD
PMID:16905640 PMID:19071154 PMID:21382956 PMID:26833863 PMID:28710020 PMID:30965051 PMID:32387680 PMID:35724838 PMID:36988325 More...
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1R1
interleukin 1 receptor type 1
increases expression decreases expression
EXP
sulforaphane results in increased expression of IL1R1 mRNA sulforaphane results in decreased expression of IL1R1 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874
G
IL2
interleukin 2
multiple interactions
ISO
sulforaphane results in decreased expression of and results in decreased secretion of IL2 protein
CTD
PMID:19761891
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
G
IL32
interleukin 32
decreases expression
EXP
sulforaphane results in decreased expression of IL32 mRNA
CTD
PMID:31838189
NCBI chr16:3,065,403...3,069,530
Ensembl chr16:3,065,297...3,082,192
G
IL33
interleukin 33
decreases expression
ISO
sulforaphane results in decreased expression of IL33 mRNA
CTD
PMID:30529165
NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
G
IL3RA
interleukin 3 receptor subunit alpha
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of IL3RA mRNA
CTD
PMID:30529165
NCBI chr X:1,336,785...1,382,689 NCBI chr Y:1,336,785...1,382,689
Ensembl chr Y:1,336,616...1,382,689 Ensembl chr X:1,336,616...1,382,689
G
IL4
interleukin 4
multiple interactions
ISO
sulforaphane inhibits the reaction [Dinitrochlorobenzene results in decreased expression of IL4 mRNA]; sulforaphane inhibits the reaction [Dinitrochlorobenzene results in decreased expression of IL4 protein]
CTD
PMID:34651546
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL4R
interleukin 4 receptor
increases expression
EXP
sulforaphane results in increased expression of IL4R mRNA
CTD
PMID:26833863
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
IL6
interleukin 6
multiple interactions decreases expression
EXP ISO
sulforaphane inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased secretion of IL6 protein]; sulforaphane inhibits the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of and results in increased secretion of IL6 protein]; sulforaphane inhibits the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of IL6 mRNA]; sulforaphane inhibits the reaction [Cadmium Chloride results in increased expression of and results in increased secretion of IL6 protein]; sulforaphane inhibits the reaction [Norepinephrine results in increased expression of and results in increased secretion of IL6 protein]; sulforaphane metabolite inhibits the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of and results in increased secretion of IL6 protein]; sulforaphane metabolite inhibits the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of IL6 mRNA] sulforaphane metabolite results in decreased expression of IL6 mRNA; sulforaphane results in decreased expression of IL6 mRNA NFE2L2 protein affects the reaction [sulforaphane inhibits the reaction [Diatrizoate Meglumine results in increased expression of IL6 protein]]; sulforaphane inhibits the reaction [Diatrizoate Meglumine results in increased expression of IL6 protein] sulforaphane inhibits the reaction [[[ALB protein binds to 4-hydroxy-2-nonenal] which results in increased susceptibility to Trichloroethylene] which results in increased secretion of IL6 protein]; sulforaphane inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL6 protein]; sulforaphane inhibits the reaction [Cyclosporine results in increased expression of IL6 mRNA]; sulforaphane inhibits the reaction [ochratoxin A results in increased expression of IL6 mRNA]; sulforaphane inhibits the reaction [Tacrolimus results in increased expression of IL6 mRNA]
CTD
PMID:18636164 PMID:23958496 PMID:25305463 PMID:28710020 PMID:31173751 PMID:32387680 PMID:33007382 PMID:35122928 PMID:36988325 More...
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
INA
internexin neuronal intermediate filament protein alpha
affects binding
EXP
INA protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr10:103,277,138...103,290,346
Ensembl chr10:103,277,138...103,290,346
G
INAVA
innate immunity activator
decreases expression
EXP
sulforaphane results in decreased expression of INAVA mRNA
CTD
PMID:31838189
NCBI chr 1:200,891,531...200,915,742
Ensembl chr 1:200,891,048...200,915,742
G
INHA
inhibin subunit alpha
decreases expression
EXP
sulforaphane results in decreased expression of INHA mRNA
CTD
PMID:31838189
NCBI chr 2:219,572,310...219,575,711
Ensembl chr 2:219,569,162...219,575,711
G
INHBB
inhibin subunit beta B
increases expression
EXP
sulforaphane results in increased expression of INHBB mRNA
CTD
PMID:31838189
NCBI chr 2:120,346,136...120,351,803
Ensembl chr 2:120,346,136...120,351,803
G
INPP1
inositol polyphosphate-1-phosphatase
increases expression
EXP
sulforaphane results in increased expression of INPP1 mRNA
CTD
PMID:26833863
NCBI chr 2:190,343,589...190,371,665
Ensembl chr 2:190,343,570...190,371,665
G
INPP5J
inositol polyphosphate-5-phosphatase J
decreases expression
EXP
sulforaphane results in decreased expression of INPP5J mRNA
CTD
PMID:31838189
NCBI chr22:31,122,614...31,134,697
Ensembl chr22:31,122,731...31,134,697
G
INS
insulin
multiple interactions
EXP
sulforaphane inhibits the reaction [INS protein results in increased phosphorylation of RPS6 protein]
CTD
PMID:28790194
NCBI chr11:2,159,779...2,161,209
Ensembl chr11:2,159,779...2,161,221
G
INS-IGF2
INS-IGF2 readthrough
multiple interactions
ISO
sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] inhibits the reaction [Glucose results in increased secretion of INS1 protein]] sulforaphane inhibits the reaction [Streptozocin results in decreased expression of INS1 protein]
CTD
PMID:19071154
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
G
INSL4
insulin like 4
decreases expression
EXP
sulforaphane results in decreased expression of INSL4 mRNA
CTD
PMID:31838189
NCBI chr 9:5,231,419...5,235,304
Ensembl chr 9:5,231,419...5,235,304
G
INSL6
insulin like 6
increases expression
ISO
sulforaphane results in increased expression of INSL6 mRNA
CTD
PMID:30529165
NCBI chr 9:4,991,976...5,185,639
Ensembl chr 9:5,123,880...5,185,647
G
IPCEF1
interaction protein for cytohesin exchange factors 1
increases expression
EXP
sulforaphane results in increased expression of IPCEF1 mRNA
CTD
PMID:26833863
NCBI chr 6:154,154,496...154,356,803
Ensembl chr 6:154,154,496...154,356,803
G
IQCG
IQ motif containing G
increases expression
ISO
sulforaphane results in increased expression of IQCG mRNA
CTD
PMID:30529165
NCBI chr 3:197,889,077...197,960,177
Ensembl chr 3:197,889,077...197,960,142
G
IRAK4
interleukin 1 receptor associated kinase 4
multiple interactions
ISO
sulforaphane inhibits the reaction [Trichloroethylene results in increased expression of IRAK4 protein]
CTD
PMID:33007382
NCBI chr12:43,758,951...43,789,541
Ensembl chr12:43,758,944...43,798,307
G
IRF7
interferon regulatory factor 7
decreases expression
EXP
sulforaphane results in decreased expression of IRF7 mRNA
CTD
PMID:31838189
NCBI chr11:612,555...615,950
Ensembl chr11:612,553...615,983
G
IRF8
interferon regulatory factor 8
decreases expression
EXP
sulforaphane results in decreased expression of IRF8 mRNA
CTD
PMID:26833863
NCBI chr16:85,899,162...85,922,609
Ensembl chr16:85,899,116...85,922,606
G
IRS2
insulin receptor substrate 2
decreases expression
ISO
sulforaphane results in decreased expression of IRS2 mRNA
CTD
PMID:30529165
NCBI chr13:109,752,695...109,786,583
Ensembl chr13:109,752,695...109,786,583
G
ISG20
interferon stimulated exonuclease gene 20
increases expression
EXP
sulforaphane results in increased expression of ISG20 mRNA
CTD
PMID:31838189
NCBI chr15:88,635,632...88,656,483
Ensembl chr15:88,635,670...88,656,483
G
ISLR
immunoglobulin superfamily containing leucine rich repeat
increases expression
ISO
sulforaphane results in increased expression of ISLR mRNA
CTD
PMID:30529165
NCBI chr15:74,173,710...74,176,871
Ensembl chr15:74,173,710...74,176,872
G
ITGA2
integrin subunit alpha 2
increases expression
EXP
sulforaphane results in increased expression of ITGA2 mRNA
CTD
PMID:31838189
NCBI chr 5:52,989,352...53,094,779
Ensembl chr 5:52,989,340...53,094,779
G
ITGA6
integrin subunit alpha 6
increases expression
EXP
sulforaphane results in increased expression of ITGA6 mRNA
CTD
PMID:26833863
NCBI chr 2:172,427,336...172,506,459
Ensembl chr 2:172,234,216...172,506,459
G
ITGAM
integrin subunit alpha M
increases expression multiple interactions
EXP ISO
sulforaphane results in increased expression of ITGAM mRNA sulforaphane inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of ITGAM protein]
CTD
PMID:26833863 PMID:36988325
NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
G
ITGAX
integrin subunit alpha X
increases expression
EXP
sulforaphane results in increased expression of ITGAX mRNA
CTD
PMID:26833863
NCBI chr16:31,355,176...31,382,999
Ensembl chr16:31,355,134...31,382,999
G
ITGB2
integrin subunit beta 2
increases expression
EXP
sulforaphane results in increased expression of ITGB2 mRNA
CTD
PMID:26833863
NCBI chr21:44,885,953...44,928,815
Ensembl chr21:44,885,953...44,931,989
G
ITGB7
integrin subunit beta 7
increases expression
EXP
sulforaphane results in increased expression of ITGB7 mRNA
CTD
PMID:26833863
NCBI chr12:53,191,323...53,207,251
Ensembl chr12:53,191,323...53,207,282
G
ITPRIP
inositol 1,4,5-trisphosphate receptor interacting protein
increases expression
EXP
sulforaphane results in increased expression of ITPRIP mRNA
CTD
PMID:26833863
NCBI chr10:104,309,700...104,338,465
Ensembl chr10:104,309,698...104,338,465
G
IZUMO4
IZUMO family member 4
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of IZUMO4 mRNA
CTD
PMID:30529165
NCBI chr19:2,096,915...2,099,590
Ensembl chr19:2,096,429...2,099,593
G
JADE3
jade family PHD finger 3
decreases expression
ISO
sulforaphane results in decreased expression of JADE3 mRNA
CTD
PMID:30529165
NCBI chr X:46,912,301...47,061,242
Ensembl chr X:46,912,276...47,061,242
G
JAK2
Janus kinase 2
multiple interactions
ISO
sulforaphane inhibits the reaction [Cyclosporine results in increased phosphorylation of JAK2 protein]
CTD
PMID:23958496
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
G
JHY
junctional cadherin complex regulator
increases expression
EXP
sulforaphane results in increased expression of JHY mRNA
CTD
PMID:31838189
NCBI chr11:122,882,759...122,963,862
Ensembl chr11:122,882,683...122,963,862
G
JPH2
junctophilin 2
increases expression decreases expression
ISO EXP
sulforaphane results in increased expression of JPH2 mRNA sulforaphane results in decreased expression of JPH2 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr20:44,106,590...44,187,188
Ensembl chr20:44,106,590...44,187,188
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression increases activity
ISO
[sulforaphane promotes the reaction [JUN protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA; sulforaphane promotes the reaction [JUN protein binds to GSTP1 enhancer] sulforaphane results in increased expression of JUN protein sulforaphane results in increased activity of JUN protein
CTD
PMID:20237067
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
JUND
JunD proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
sulforaphane results in decreased expression of JUND mRNA
CTD
PMID:31838189
NCBI chr19:18,279,694...18,281,622
Ensembl chr19:18,279,694...18,281,622
G
JUP
junction plakoglobin
decreases expression
EXP
sulforaphane results in decreased expression of JUP mRNA
CTD
PMID:26833863
NCBI chr17:41,754,609...41,786,711
Ensembl chr17:41,754,604...41,786,931
G
KANK3
KN motif and ankyrin repeat domains 3
decreases expression
ISO
sulforaphane results in decreased expression of KANK3 mRNA
CTD
PMID:30529165
NCBI chr19:8,322,584...8,343,262
Ensembl chr19:8,322,584...8,343,262
G
KAT2B
lysine acetyltransferase 2B
increases expression
EXP
sulforaphane results in increased expression of KAT2B mRNA
CTD
PMID:26833863
NCBI chr 3:20,040,446...20,154,404
Ensembl chr 3:20,040,446...20,154,404
G
KCNA3
potassium voltage-gated channel subfamily A member 3
decreases expression
EXP
sulforaphane results in decreased expression of KCNA3 mRNA
CTD
PMID:26833863
NCBI chr 1:110,653,560...110,674,940
Ensembl chr 1:110,653,560...110,674,940
G
KCNAB2
potassium voltage-gated channel subfamily A regulatory beta subunit 2
increases expression
EXP
sulforaphane results in increased expression of KCNAB2 mRNA
CTD
PMID:31838189
NCBI chr 1:5,992,676...6,101,180
Ensembl chr 1:5,990,927...6,101,193
G
KCND1
potassium voltage-gated channel subfamily D member 1
decreases expression
EXP
sulforaphane results in decreased expression of KCND1 mRNA
CTD
PMID:31838189
NCBI chr X:48,961,380...48,971,844
Ensembl chr X:48,961,378...48,971,844
G
KCND2
potassium voltage-gated channel subfamily D member 2
increases expression
ISO
sulforaphane results in increased expression of KCND2 mRNA
CTD
PMID:30529165
NCBI chr 7:120,272,908...120,750,337
Ensembl chr 7:120,273,175...120,750,337
G
KCNE2
potassium voltage-gated channel subfamily E regulatory subunit 2
decreases expression
ISO
sulforaphane results in decreased expression of KCNE2 mRNA
CTD
PMID:30529165
NCBI chr21:34,364,006...34,371,381
Ensembl chr21:34,364,006...34,371,381
G
KCNG2
potassium voltage-gated channel modifier subfamily G member 2
increases expression
ISO
sulforaphane results in increased expression of KCNG2 mRNA
CTD
PMID:30529165
NCBI chr18:79,797,938...79,900,100
Ensembl chr18:79,797,938...79,900,184
G
KCNH2
potassium voltage-gated channel subfamily H member 2
increases expression
ISO
sulforaphane results in increased expression of KCNH2 mRNA
CTD
PMID:30529165
NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
G
KCNH3
potassium voltage-gated channel subfamily H member 3
multiple interactions
ISO
sulforaphane inhibits the reaction [fenamidone results in decreased expression of KCNH3 mRNA]
CTD
PMID:27029645
NCBI chr12:49,539,030...49,558,337
Ensembl chr12:49,539,030...49,558,337
G
KCNH5
potassium voltage-gated channel subfamily H member 5
decreases expression
EXP
sulforaphane results in decreased expression of KCNH5 mRNA
CTD
PMID:31838189
NCBI chr14:62,699,464...63,045,458
Ensembl chr14:62,699,464...63,102,037
G
KCNIP2
potassium voltage-gated channel interacting protein 2
increases expression
ISO
sulforaphane results in increased expression of KCNIP2 mRNA
CTD
PMID:30529165
NCBI chr10:101,825,974...101,843,800
Ensembl chr10:101,825,974...101,843,920
G
KCNIP3
potassium voltage-gated channel interacting protein 3
decreases expression
EXP
sulforaphane results in decreased expression of KCNIP3 mRNA
CTD
PMID:31838189
NCBI chr 2:95,297,347...95,386,077
Ensembl chr 2:95,297,327...95,386,077
G
KCNJ14
potassium inwardly rectifying channel subfamily J member 14
increases expression
EXP
sulforaphane results in increased expression of KCNJ14 mRNA
CTD
PMID:31838189
NCBI chr19:48,455,574...48,466,980
Ensembl chr19:48,455,574...48,466,980
G
KCNJ2
potassium inwardly rectifying channel subfamily J member 2
increases expression
EXP
sulforaphane results in increased expression of KCNJ2 mRNA
CTD
PMID:31838189
NCBI chr17:70,169,532...70,180,044
Ensembl chr17:70,168,673...70,180,044
G
KCNJ8
potassium inwardly rectifying channel subfamily J member 8
decreases expression
EXP
sulforaphane results in decreased expression of KCNJ8 mRNA
CTD
PMID:31838189
NCBI chr12:21,764,955...21,774,706
Ensembl chr12:21,764,955...21,775,600
G
KCNK15
potassium two pore domain channel subfamily K member 15
decreases expression
EXP
sulforaphane results in decreased expression of KCNK15 mRNA
CTD
PMID:31838189
NCBI chr20:44,745,865...44,752,313
Ensembl chr20:44,745,865...44,752,313
G
KCNK7
potassium two pore domain channel subfamily K member 7
increases expression
ISO
sulforaphane results in increased expression of KCNK7 mRNA
CTD
PMID:30529165
NCBI chr11:65,592,836...65,595,800
Ensembl chr11:65,592,836...65,595,996
G
KCNN4
potassium calcium-activated channel subfamily N member 4
increases expression
ISO
sulforaphane results in increased expression of KCNN4 mRNA
CTD
PMID:30529165
NCBI chr19:43,766,533...43,780,973
Ensembl chr19:43,766,533...43,780,976
G
KCNQ1
potassium voltage-gated channel subfamily Q member 1
decreases expression
EXP
sulforaphane results in decreased expression of KCNQ1 mRNA
CTD
PMID:31838189
NCBI chr11:2,445,008...2,849,105
Ensembl chr11:2,444,654...2,849,105
G
KCNQ3
potassium voltage-gated channel subfamily Q member 3
decreases expression
EXP
sulforaphane results in decreased expression of KCNQ3 mRNA
CTD
PMID:26833863
NCBI chr 8:132,120,861...132,481,095
Ensembl chr 8:132,120,861...132,481,095
G
KCTD12
potassium channel tetramerization domain containing 12
decreases expression
EXP
sulforaphane results in decreased expression of KCTD12 mRNA
CTD
PMID:31838189
NCBI chr13:76,880,175...76,886,405
Ensembl chr13:76,880,175...76,886,405
G
KEAP1
kelch like ECH associated protein 1
increases expression decreases expression decreases response to substance multiple interactions increases response to substance increases metabolic processing
EXP ISO
sulforaphane results in increased expression of KEAP1 protein sulforaphane results in decreased expression of KEAP1 mRNA KEAP1 protein mutant form results in decreased susceptibility to sulforaphane sulforaphane inhibits the reaction [Carbon Tetrachloride results in increased expression of KEAP1 protein]; sulforaphane inhibits the reaction [KEAP1 protein binds to CUL3 protein]; sulforaphane inhibits the reaction [Trichloroethylene results in increased expression of KEAP1 mRNA]; sulforaphane promotes the reaction [4-(2-pyridylazo)resorcinol inhibits the reaction [Zinc binds to KEAP1 protein]] sulforaphane promotes the reaction [NFE2L2 protein binds to KEAP1 protein] KEAP1 protein results in increased susceptibility to sulforaphane Iodoacetamide inhibits the reaction [sulforaphane results in increased metabolism of KEAP1 protein]; KEAP1 protein mutant form inhibits the reaction [sulforaphane results in increased expression of and results in increased activity of NFE2L2 protein]; KEAP1 protein promotes the reaction [sulforaphane results in increased expression of and results in increased activity of NFE2L2 protein]; sulforaphane inhibits the reaction [KEAP1 protein binds to CUL3 protein]; sulforaphane inhibits the reaction [sodium arsenite affects the localization of KEAP1 protein]; sulforaphane promotes the reaction [KEAP1 protein binds to NFE2L2 protein]; sulforaphane promotes the reaction [NFE2L2 protein binds to KEAP1 protein]
CTD
PMID:15865434 PMID:18417180 PMID:19033392 PMID:21391649 PMID:22558124 PMID:23589329 PMID:29964319 PMID:30261176 PMID:32073640 PMID:35724838 More...
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
G
KIAA0319
KIAA0319
increases expression
EXP
sulforaphane results in increased expression of KIAA0319 mRNA
CTD
PMID:31838189
NCBI chr 6:24,540,141...24,646,191
Ensembl chr 6:24,544,104...24,646,191
G
KIAA0513
KIAA0513
decreases expression
EXP
sulforaphane results in decreased expression of KIAA0513 mRNA
CTD
PMID:31838189
NCBI chr16:85,027,795...85,094,230
Ensembl chr16:85,027,782...85,094,230
G
KIAA0825
KIAA0825
decreases expression
EXP
sulforaphane results in decreased expression of KIAA0825 mRNA
CTD
PMID:31838189
NCBI chr 5:94,150,851...94,618,604
Ensembl chr 5:94,150,851...94,618,604
G
KIF13A
kinesin family member 13A
decreases expression
EXP
sulforaphane results in decreased expression of KIF13A mRNA
CTD
PMID:31838189
NCBI chr 6:17,759,126...17,987,635
Ensembl chr 6:17,759,183...17,987,635
G
KIF14
kinesin family member 14
increases expression
EXP
sulforaphane results in increased expression of KIF14 mRNA
CTD
PMID:31838189
NCBI chr 1:200,551,497...200,620,751
Ensembl chr 1:200,551,497...200,620,751
G
KIF18A
kinesin family member 18A
increases expression
EXP
sulforaphane results in increased expression of KIF18A mRNA
CTD
PMID:31838189
NCBI chr11:28,020,619...28,108,156
Ensembl chr11:28,020,619...28,108,156
G
KIT
KIT proto-oncogene, receptor tyrosine kinase
decreases expression
ISO
sulforaphane results in decreased expression of KIT mRNA
CTD
PMID:30529165
NCBI chr 4:54,657,957...54,740,715
Ensembl chr 4:54,657,267...54,740,783
G
KLF10
KLF transcription factor 10
increases expression
EXP
sulforaphane results in increased expression of KLF10 mRNA
CTD
PMID:26833863
NCBI chr 8:102,648,784...102,655,725
Ensembl chr 8:102,648,784...102,655,725
G
KLF4
KLF transcription factor 4
multiple interactions
EXP
[Genistein co-treated with sulforaphane] results in decreased expression of KLF4 mRNA
CTD
PMID:29899271
NCBI chr 9:107,484,852...107,489,769
Ensembl chr 9:107,484,852...107,490,482
G
KLF7
KLF transcription factor 7
decreases expression
EXP
sulforaphane results in decreased expression of KLF7 mRNA
CTD
PMID:31838189
NCBI chr 2:207,074,137...207,173,851
Ensembl chr 2:207,074,137...207,173,856
G
KLF9
KLF transcription factor 9
multiple interactions decreases expression
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of KLF9 mRNA sulforaphane results in decreased expression of KLF9 mRNA
CTD
PMID:25450479 PMID:30529165
NCBI chr 9:70,384,604...70,414,657
Ensembl chr 9:70,384,604...70,414,657
G
KLHL13
kelch like family member 13
decreases expression
EXP
sulforaphane results in decreased expression of KLHL13 mRNA
CTD
PMID:31838189
NCBI chr X:117,897,813...118,117,340
Ensembl chr X:117,897,813...118,117,340
G
KLHL2
kelch like family member 2
decreases expression
ISO
sulforaphane results in decreased expression of KLHL2 mRNA
CTD
PMID:30529165
NCBI chr 4:165,207,561...165,323,156
Ensembl chr 4:165,207,561...165,323,156
G
KLHL21
kelch like family member 21
increases expression
EXP
sulforaphane results in increased expression of KLHL21 mRNA
CTD
PMID:31838189
NCBI chr 1:6,590,724...6,602,869
Ensembl chr 1:6,590,724...6,614,607
G
KLHL29
kelch like family member 29
decreases expression
ISO EXP
sulforaphane results in decreased expression of KLHL29 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 2:23,385,179...23,708,606
Ensembl chr 2:23,385,179...23,708,611
G
KLK11
kallikrein related peptidase 11
increases expression
ISO
sulforaphane results in increased expression of KLK11 mRNA
CTD
PMID:30529165
NCBI chr19:51,022,236...51,027,991
Ensembl chr19:51,022,216...51,028,039
G
KLK3
kallikrein related peptidase 3
decreases expression multiple interactions
EXP
sulforaphane results in decreased expression of KLK3 mRNA sulforaphane inhibits the reaction [AR protein binds to KLK3 enhancer]
CTD
PMID:19805354
NCBI chr19:50,854,915...50,860,764
Ensembl chr19:50,854,915...50,860,764
G
KMT5C
lysine methyltransferase 5C
decreases expression
EXP
sulforaphane results in decreased expression of KMT5C mRNA
CTD
PMID:31838189
NCBI chr19:55,339,876...55,348,121
Ensembl chr19:55,339,853...55,348,121
G
KNG1
kininogen 1
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of KNG1 mRNA
CTD
PMID:25450479
NCBI chr 3:186,717,359...186,744,410
Ensembl chr 3:186,717,348...186,744,410
G
KNSTRN
kinetochore localized astrin (SPAG5) binding protein
increases expression
EXP
sulforaphane results in increased expression of KNSTRN mRNA
CTD
PMID:31838189
NCBI chr15:40,382,721...40,394,288
Ensembl chr15:40,382,721...40,394,288
G
KRCC1
lysine rich coiled-coil 1
increases expression
EXP
sulforaphane results in increased expression of KRCC1 mRNA
CTD
PMID:31838189
NCBI chr 2:88,027,205...88,055,783
Ensembl chr 2:88,027,205...88,064,252
G
KRI1
KRI1 homolog
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of KRI1 mRNA
CTD
PMID:30529165
NCBI chr19:10,553,085...10,566,010
Ensembl chr19:10,553,085...10,566,031
G
KRR1
KRR1 small subunit processome component homolog
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of KRR1 mRNA
CTD
PMID:30529165
NCBI chr12:75,490,863...75,511,609
Ensembl chr12:75,490,863...75,511,636
G
KRT15
keratin 15
increases expression
ISO
sulforaphane results in increased expression of KRT15 mRNA
CTD
PMID:30529165
NCBI chr17:41,513,745...41,518,890
Ensembl chr17:41,513,745...41,522,529
G
KRT17
keratin 17
decreases expression
EXP
sulforaphane results in decreased expression of KRT17 mRNA
CTD
PMID:31838189
NCBI chr17:41,619,442...41,624,575
Ensembl chr17:41,619,442...41,624,842
G
KRT18P49
keratin 18 pseudogene 49
decreases expression
EXP
sulforaphane results in decreased expression of KRT18P49 mRNA
CTD
PMID:26833863
NCBI chr X:107,428,627...107,429,520
Ensembl chr X:107,428,630...107,429,461
G
KRT4
keratin 4
decreases expression
EXP
sulforaphane results in decreased expression of KRT4 mRNA
CTD
PMID:31838189
NCBI chr12:52,806,549...52,814,116
Ensembl chr12:52,806,549...52,814,116
G
KRT7
keratin 7
decreases expression
EXP
sulforaphane results in decreased expression of KRT7 mRNA
CTD
PMID:31838189
NCBI chr12:52,233,243...52,255,853
Ensembl chr12:52,232,520...52,252,186
G
KRT8
keratin 8
increases methylation decreases expression
EXP
sulforaphane results in increased methylation of KRT8 gene sulforaphane results in decreased expression of KRT8 mRNA
CTD
PMID:31838189
NCBI chr12:52,897,191...52,949,860
Ensembl chr12:52,897,187...52,949,954
G
KRT80
keratin 80
decreases expression
EXP
sulforaphane results in decreased expression of KRT80 mRNA
CTD
PMID:31838189
NCBI chr12:52,168,996...52,192,014
Ensembl chr12:52,168,996...52,192,014
G
KRT86
keratin 86
decreases expression
EXP
sulforaphane results in decreased expression of KRT86 mRNA
CTD
PMID:31838189
NCBI chr12:52,274,645...52,309,163
Ensembl chr12:52,249,300...52,309,163
G
KRTAP17-1
keratin associated protein 17-1
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of KRTAP17-1 mRNA
CTD
PMID:30529165
NCBI chr17:41,314,912...41,315,710
Ensembl chr17:41,314,912...41,315,710
G
KYNU
kynureninase
decreases expression
EXP
sulforaphane results in decreased expression of KYNU mRNA
CTD
PMID:26833863
NCBI chr 2:142,877,664...143,055,833
Ensembl chr 2:142,877,657...143,055,833
G
L3HYPDH
trans-L-3-hydroxyproline dehydratase
increases expression
EXP
sulforaphane results in increased expression of L3HYPDH mRNA
CTD
PMID:31838189
NCBI chr14:59,465,478...59,505,273
Ensembl chr14:59,460,363...59,484,408
G
LAMA1
laminin subunit alpha 1
increases expression
EXP
sulforaphane results in increased expression of LAMA1 mRNA
CTD
PMID:31838189
NCBI chr18:6,941,742...7,117,797
Ensembl chr18:6,941,742...7,117,797
G
LAMA3
laminin subunit alpha 3
decreases expression
ISO
sulforaphane results in decreased expression of LAMA3 mRNA
CTD
PMID:30529165
NCBI chr18:23,689,453...23,955,066
Ensembl chr18:23,689,453...23,956,222
G
LAMB3
laminin subunit beta 3
increases expression
EXP
sulforaphane results in increased expression of LAMB3 mRNA
CTD
PMID:26833863
NCBI chr 1:209,614,870...209,652,425
Ensembl chr 1:209,614,870...209,652,425
G
LAMP2
lysosomal associated membrane protein 2
multiple interactions increases expression
ISO EXP
NFE2L2 protein affects the reaction [sulforaphane results in increased expression of LAMP2 protein alternative form] sulforaphane results in increased expression of LAMP2 mRNA alternative form; sulforaphane results in increased expression of LAMP2 protein alternative form
CTD
PMID:29950142
NCBI chr X:120,426,148...120,469,349
Ensembl chr X:120,426,148...120,469,365
G
LAMP5
lysosomal associated membrane protein family member 5
decreases expression
EXP
sulforaphane results in decreased expression of LAMP5 mRNA
CTD
PMID:26833863
NCBI chr20:9,514,590...9,530,524
Ensembl chr20:9,514,358...9,530,524
G
LANCL3
LanC like family member 3
increases expression
EXP
sulforaphane results in increased expression of LANCL3 mRNA
CTD
PMID:31838189
NCBI chr X:37,571,661...37,684,463
Ensembl chr X:37,571,569...37,684,463
G
LCORL
ligand dependent nuclear receptor corepressor like
decreases expression
ISO
sulforaphane results in decreased expression of LCORL mRNA
CTD
PMID:30529165
NCBI chr 4:17,841,187...18,021,875
Ensembl chr 4:17,841,187...18,021,876
G
LDB3
LIM domain binding 3
increases expression
ISO
sulforaphane results in increased expression of LDB3 mRNA
CTD
PMID:30529165
NCBI chr10:86,666,788...86,736,072
Ensembl chr10:86,666,785...86,736,072
G
LDHD
lactate dehydrogenase D
decreases expression
EXP
sulforaphane results in decreased expression of LDHD mRNA
CTD
PMID:31838189
NCBI chr16:75,111,864...75,116,780
Ensembl chr16:75,111,860...75,116,780
G
LEPR
leptin receptor
decreases expression affects response to substance multiple interactions
ISO
sulforaphane results in decreased expression of LEPR mRNA LEPR protein affects the susceptibility to sulforaphane [LEPR protein affects the susceptibility to sulforaphane] which affects the expression of CNR2 protein
CTD
PMID:29143802 PMID:30529165
NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
G
LFNG
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
decreases expression
EXP
sulforaphane results in decreased expression of LFNG mRNA
CTD
PMID:31838189
NCBI chr 7:2,512,529...2,529,177
Ensembl chr 7:2,512,529...2,529,177
G
LGALS1
galectin 1
affects binding decreases expression
EXP
LGALS1 protein binds to sulforaphane sulforaphane results in decreased expression of LGALS1 mRNA
CTD
PMID:21838287 PMID:31838189
NCBI chr22:37,675,636...37,679,802
Ensembl chr22:37,675,636...37,679,802
G
LGALS12
galectin 12
increases expression
EXP
sulforaphane results in increased expression of LGALS12 mRNA
CTD
PMID:26833863
NCBI chr11:63,506,084...63,516,772
Ensembl chr11:63,506,052...63,516,774
G
LGI3
leucine rich repeat LGI family member 3
decreases expression
ISO
sulforaphane results in decreased expression of LGI3 mRNA
CTD
PMID:30529165
NCBI chr 8:22,146,830...22,156,806
Ensembl chr 8:22,146,830...22,157,084
G
LGSN
lengsin, lens protein with glutamine synthetase domain
decreases expression
EXP
sulforaphane results in decreased expression of LGSN mRNA
CTD
PMID:31838189
NCBI chr 6:63,275,951...63,573,607
Ensembl chr 6:63,275,951...63,319,983
G
LHX2
LIM homeobox 2
decreases expression
EXP
sulforaphane results in decreased expression of LHX2 mRNA
CTD
PMID:31838189
NCBI chr 9:124,011,768...124,033,301
Ensembl chr 9:124,001,670...124,033,301
G
LILRB4
leukocyte immunoglobulin like receptor B4
decreases expression
EXP
sulforaphane results in decreased expression of LILRB4 mRNA
CTD
PMID:26833863
NCBI chr19:54,662,985...54,668,718
Ensembl chr19:54,643,889...54,670,359
G
LIMA1
LIM domain and actin binding 1
multiple interactions decreases expression
ISO EXP
sulforaphane inhibits the reaction [fenamidone results in increased expression of LIMA1 mRNA] sulforaphane results in decreased expression of LIMA1 mRNA
CTD
PMID:27029645 PMID:31838189
NCBI chr12:50,175,788...50,283,520
Ensembl chr12:50,175,788...50,283,520
G
LIMS2
LIM zinc finger domain containing 2
decreases expression
ISO
sulforaphane results in decreased expression of LIMS2 mRNA
CTD
PMID:30529165
NCBI chr 2:127,638,426...127,681,786
Ensembl chr 2:127,638,381...127,681,786
G
LITAF
lipopolysaccharide induced TNF factor
increases expression
EXP
sulforaphane results in increased expression of LITAF mRNA
CTD
PMID:26833863
NCBI chr16:11,547,722...11,640,317
Ensembl chr16:11,547,722...11,636,381
G
LMF2
lipase maturation factor 2
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of LMF2 mRNA
CTD
PMID:30529165
NCBI chr22:50,502,949...50,507,702
Ensembl chr22:50,502,949...50,507,702
G
LMO1
LIM domain only 1
decreases expression
EXP
sulforaphane results in decreased expression of LMO1 mRNA
CTD
PMID:31838189
NCBI chr11:8,224,309...8,268,787
Ensembl chr11:8,224,309...8,268,716
G
LMO4
LIM domain only 4
decreases expression
EXP
sulforaphane results in decreased expression of LMO4 mRNA
CTD
PMID:31838189
NCBI chr 1:87,328,880...87,348,923
Ensembl chr 1:87,328,880...87,348,923
G
LNX1
ligand of numb-protein X 1
increases expression
ISO
sulforaphane results in increased expression of LNX1 mRNA
CTD
PMID:30529165
NCBI chr 4:53,459,301...53,652,477
Ensembl chr 4:53,459,301...53,701,405
G
LOX
lysyl oxidase
decreases expression
ISO
sulforaphane results in decreased expression of LOX mRNA
CTD
PMID:30529165
NCBI chr 5:122,063,195...122,078,259
Ensembl chr 5:122,063,195...122,078,413
G
LPCAT2
lysophosphatidylcholine acyltransferase 2
increases expression
EXP
sulforaphane results in increased expression of LPCAT2 mRNA
CTD
PMID:31838189
NCBI chr16:55,509,072...55,586,666
Ensembl chr16:55,509,072...55,586,666
G
LPIN2
lipin 2
decreases expression
ISO
sulforaphane results in decreased expression of LPIN2 mRNA
CTD
PMID:30529165
NCBI chr18:2,916,994...3,013,144
Ensembl chr18:2,885,296...3,013,144
G
LPL
lipoprotein lipase
increases expression
ISO
sulforaphane results in increased expression of LPL mRNA
CTD
PMID:30529165
NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
G
LRG1
leucine rich alpha-2-glycoprotein 1
increases expression
EXP
sulforaphane results in increased expression of LRG1 mRNA
CTD
PMID:26833863
NCBI chr19:4,536,402...4,540,036
Ensembl chr19:4,536,402...4,540,036
G
LRIG1
leucine rich repeats and immunoglobulin like domains 1
increases expression
EXP
sulforaphane results in increased expression of LRIG1 mRNA
CTD
PMID:31838189
NCBI chr 3:66,378,797...66,501,121
Ensembl chr 3:66,378,797...66,501,263
G
LRP1
LDL receptor related protein 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of LRP1 mRNA
CTD
PMID:30529165
NCBI chr12:57,128,483...57,213,361
Ensembl chr12:57,128,483...57,213,361
G
LRP10
LDL receptor related protein 10
increases expression
EXP
sulforaphane results in increased expression of LRP10 mRNA
CTD
PMID:26833863
NCBI chr14:22,871,740...22,881,713
Ensembl chr14:22,871,740...22,881,713
G
LRP12
LDL receptor related protein 12
increases expression
EXP
sulforaphane results in increased expression of LRP12 mRNA
CTD
PMID:26833863
NCBI chr 8:104,489,236...104,589,258
Ensembl chr 8:104,489,231...104,589,258
G
LRP2
LDL receptor related protein 2
decreases expression
ISO
sulforaphane results in decreased expression of LRP2 mRNA
CTD
PMID:30529165
NCBI chr 2:169,127,109...169,362,534
Ensembl chr 2:169,127,109...169,362,534
G
LRP8
LDL receptor related protein 8
increases expression
EXP
sulforaphane results in increased expression of LRP8 mRNA
CTD
PMID:31838189
NCBI chr 1:53,242,364...53,328,070
Ensembl chr 1:53,242,364...53,328,469
G
LRRC14B
leucine rich repeat containing 14B
decreases expression
EXP
sulforaphane results in decreased expression of LRRC14B mRNA
CTD
PMID:26833863
NCBI chr 5:191,495...196,334
Ensembl chr 5:191,495...196,334
G
LRRC20
leucine rich repeat containing 20
decreases expression
EXP
sulforaphane results in decreased expression of LRRC20 mRNA
CTD
PMID:31838189
NCBI chr10:70,298,975...70,382,625
Ensembl chr10:70,298,970...70,382,650
G
LRRC34
leucine rich repeat containing 34
increases expression
ISO
sulforaphane results in increased expression of LRRC34 mRNA
CTD
PMID:30529165
NCBI chr 3:169,793,003...169,812,904
Ensembl chr 3:169,793,003...169,812,986
G
LRRC3B
leucine rich repeat containing 3B
increases expression
ISO
sulforaphane results in increased expression of LRRC3B mRNA
CTD
PMID:30529165
NCBI chr 3:26,622,772...26,710,776
Ensembl chr 3:26,622,772...26,717,537
G
LRRC45
leucine rich repeat containing 45
decreases expression
EXP
sulforaphane results in decreased expression of LRRC45 mRNA
CTD
PMID:31838189
NCBI chr17:82,023,305...82,031,151
Ensembl chr17:82,023,305...82,031,151
G
LRRC51
leucine rich repeat containing 51
increases expression
ISO
sulforaphane results in increased expression of LRRC51 mRNA
CTD
PMID:30529165
NCBI chr11:72,080,850...72,096,895
Ensembl chr11:72,080,337...72,096,895
G
LRRC73
leucine rich repeat containing 73
decreases expression
EXP
sulforaphane results in decreased expression of LRRC73 mRNA
CTD
PMID:31838189
NCBI chr 6:43,506,968...43,510,346
Ensembl chr 6:43,506,968...43,510,346
G
LRRK2
leucine rich repeat kinase 2
decreases expression
ISO
sulforaphane results in decreased expression of LRRK2 mRNA
CTD
PMID:30529165
NCBI chr12:40,224,997...40,369,285
Ensembl chr12:40,196,744...40,369,285
G
LSP1
lymphocyte specific protein 1
increases expression
EXP
sulforaphane results in increased expression of LSP1 mRNA
CTD
PMID:26833863
NCBI chr11:1,853,084...1,892,263
Ensembl chr11:1,850,904...1,892,267
G
LSS
lanosterol synthase
decreases expression
EXP
sulforaphane results in decreased expression of LSS mRNA
CTD
PMID:34767876
NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824
G
LST1
leukocyte specific transcript 1
increases expression
EXP
sulforaphane results in increased expression of LST1 mRNA
CTD
PMID:26833863
NCBI chr 6:31,586,277...31,588,909
Ensembl chr 6:31,586,124...31,588,909
G
LTA4H
leukotriene A4 hydrolase
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of LTA4H mRNA
CTD
PMID:30529165
NCBI chr12:96,000,753...96,043,520
Ensembl chr12:96,000,753...96,043,520
G
LTF
lactotransferrin
increases expression
ISO
sulforaphane results in increased expression of LTF mRNA
CTD
PMID:30529165
NCBI chr 3:46,435,645...46,485,234
Ensembl chr 3:46,435,645...46,485,234
G
LUM
lumican
decreases expression
EXP
sulforaphane results in decreased expression of LUM mRNA
CTD
PMID:31838189
NCBI chr12:91,102,629...91,111,494
Ensembl chr12:91,102,629...91,111,494
G
LXN
latexin
decreases expression
EXP
sulforaphane results in decreased expression of LXN mRNA
CTD
PMID:31838189
NCBI chr 3:158,666,414...158,672,648
Ensembl chr 3:158,645,822...158,672,648
G
LYNX1
Ly6/neurotoxin 1
increases expression
ISO
sulforaphane results in increased expression of LYNX1 mRNA
CTD
PMID:30529165
NCBI chr 8:142,771,197...142,777,872
Ensembl chr 8:142,771,197...142,777,810
G
LYPD6
LY6/PLAUR domain containing 6
decreases expression
EXP
sulforaphane results in decreased expression of LYPD6 mRNA
CTD
PMID:31838189
NCBI chr 2:149,329,985...149,486,378
Ensembl chr 2:149,329,985...149,474,138
G
LYSMD2
LysM domain containing 2
increases expression
EXP
sulforaphane results in increased expression of LYSMD2 mRNA
CTD
PMID:31838189
NCBI chr15:51,723,011...51,751,451
Ensembl chr15:51,723,011...51,751,585
G
M1AP
meiosis 1 associated protein
decreases expression
ISO
sulforaphane results in decreased expression of M1AP mRNA
CTD
PMID:30529165
NCBI chr 2:74,557,883...74,648,330
Ensembl chr 2:74,557,883...74,648,338
G
MACC1
MET transcriptional regulator MACC1
decreases expression
ISO
sulforaphane results in decreased expression of MACC1 mRNA
CTD
PMID:30529165
NCBI chr 7:20,134,655...20,217,384
Ensembl chr 7:20,134,655...20,217,404
G
MACROD1
mono-ADP ribosylhydrolase 1
increases expression
ISO
sulforaphane results in increased expression of MACROD1 mRNA
CTD
PMID:30529165
NCBI chr11:63,998,558...64,166,113
Ensembl chr11:63,998,558...64,166,113
G
MAFG
MAF bZIP transcription factor G
increases expression affects expression
EXP
sulforaphane results in increased expression of MAFG mRNA sulforaphane affects the expression of MAFG mRNA
CTD
PMID:31838189 PMID:35724838
NCBI chr17:81,918,270...81,931,244
Ensembl chr17:81,918,270...81,927,735
G
MAGEB2
MAGE family member B2
decreases expression
EXP
sulforaphane results in decreased expression of MAGEB2 mRNA
CTD
PMID:26833863
NCBI chr X:30,215,563...30,220,089
Ensembl chr X:30,215,563...30,220,089
G
MAGI3
membrane associated guanylate kinase, WW and PDZ domain containing 3
decreases expression
EXP
sulforaphane results in decreased expression of MAGI3 mRNA
CTD
PMID:31838189
NCBI chr 1:113,390,515...113,685,923
Ensembl chr 1:113,390,515...113,685,923
G
MAMDC2
MAM domain containing 2
decreases expression
EXP
sulforaphane results in decreased expression of MAMDC2 mRNA
CTD
PMID:31838189
NCBI chr 9:70,043,581...70,226,972
Ensembl chr 9:70,043,848...70,226,972
G
MAMDC4
MAM domain containing 4
decreases expression
EXP
sulforaphane results in decreased expression of MAMDC4 mRNA
CTD
PMID:31838189
NCBI chr 9:136,852,346...136,860,799
Ensembl chr 9:136,850,943...136,860,799
G
MAP1B
microtubule associated protein 1B
decreases expression
EXP
sulforaphane results in decreased expression of MAP1B mRNA
CTD
PMID:31838189
NCBI chr 5:72,107,475...72,209,565
Ensembl chr 5:72,107,234...72,209,565
G
MAP1LC3B
microtubule associated protein 1 light chain 3 beta
increases expression multiple interactions
EXP ISO
sulforaphane results in increased expression of MAP1LC3B mRNA sulforaphane inhibits the reaction [Methamphetamine results in increased expression of MAP1LC3B protein]
CTD
PMID:32111854 PMID:37567421
NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
G
MAP2
microtubule associated protein 2
increases expression
EXP
sulforaphane results in increased expression of MAP2 mRNA
CTD
PMID:31838189
NCBI chr 2:209,424,047...209,734,112
Ensembl chr 2:209,424,047...209,734,147
G
MAP2K4
mitogen-activated protein kinase kinase 4
increases expression
EXP
sulforaphane results in increased expression of MAP2K4 mRNA
CTD
PMID:31838189
NCBI chr17:12,020,877...12,143,828
Ensembl chr17:12,020,829...12,143,830
G
MAP2K6
mitogen-activated protein kinase kinase 6
decreases expression
EXP
sulforaphane results in decreased expression of MAP2K6 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr17:69,414,697...69,553,865
Ensembl chr17:69,414,697...69,553,865
G
MAP3K12
mitogen-activated protein kinase kinase kinase 12
decreases expression
EXP
sulforaphane results in decreased expression of MAP3K12 mRNA
CTD
PMID:31838189
NCBI chr12:53,479,669...53,501,539
Ensembl chr12:53,479,669...53,500,063
G
MAP3K6
mitogen-activated protein kinase kinase kinase 6
decreases expression multiple interactions
ISO
sulforaphane results in decreased expression of MAP3K6 mRNA [sulforaphane affects the susceptibility to Oxygen] which affects the expression of MAP3K6 mRNA
CTD
PMID:30529165
NCBI chr 1:27,355,184...27,366,961
Ensembl chr 1:27,355,184...27,366,961
G
MAP3K8
mitogen-activated protein kinase kinase kinase 8
decreases expression
ISO EXP
sulforaphane results in decreased expression of MAP3K8 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr10:30,434,021...30,461,833
Ensembl chr10:30,434,021...30,461,833
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions increases phosphorylation
EXP ISO
sulforaphane inhibits the reaction [Pyruvaldehyde results in increased phosphorylation of MAPK1 protein]; sulforaphane metabolite promotes the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased phosphorylation of MAPK1 protein]; sulforaphane promotes the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased phosphorylation of MAPK1 protein]; sulforaphane results in increased phosphorylation of and results in increased activity of MAPK1 protein sulforaphane results in increased phosphorylation of MAPK1 protein sulforaphane inhibits the reaction [Oxidopamine results in increased phosphorylation of MAPK1 protein]; sulforaphane inhibits the reaction [Trichloroethylene results in increased phosphorylation of MAPK1 protein]
CTD
PMID:15896333 PMID:22005276 PMID:23518299 PMID:25933243 PMID:32387680 PMID:33930529 More...
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions increases phosphorylation
EXP ISO
sulforaphane inhibits the reaction [Pyruvaldehyde results in increased phosphorylation of MAPK3 protein]; sulforaphane metabolite promotes the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased phosphorylation of MAPK3 protein]; sulforaphane promotes the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased phosphorylation of MAPK3 protein]; sulforaphane results in increased phosphorylation of and results in increased activity of MAPK3 protein sulforaphane results in increased phosphorylation of MAPK3 protein sulforaphane inhibits the reaction [Oxidopamine results in increased phosphorylation of MAPK3 protein]; sulforaphane inhibits the reaction [Trichloroethylene results in increased phosphorylation of MAPK3 protein]
CTD
PMID:15896333 PMID:22005276 PMID:23518299 PMID:25933243 PMID:32387680 PMID:33930529 More...
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MAPK4
mitogen-activated protein kinase 4
decreases expression
EXP
sulforaphane results in decreased expression of MAPK4 mRNA
CTD
PMID:31838189
NCBI chr18:50,559,612...50,731,826
Ensembl chr18:50,560,087...50,731,826
G
MAPK8
mitogen-activated protein kinase 8
increases activity multiple interactions
EXP
sulforaphane results in increased activity of MAPK8 protein sulforaphane inhibits the reaction [Pyruvaldehyde results in increased phosphorylation of MAPK8 protein]; sulforaphane metabolite promotes the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased phosphorylation of MAPK8 protein]; sulforaphane promotes the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased phosphorylation of MAPK8 protein]
CTD
PMID:16201852 PMID:25933243 PMID:32387680
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
G
MAPK9
mitogen-activated protein kinase 9
multiple interactions
EXP
sulforaphane inhibits the reaction [Pyruvaldehyde results in increased phosphorylation of MAPK9 protein]; sulforaphane metabolite promotes the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased phosphorylation of MAPK9 protein]; sulforaphane promotes the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased phosphorylation of MAPK9 protein]
CTD
PMID:25933243 PMID:32387680
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
G
MAPKAPK2
MAPK activated protein kinase 2
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MAPKAPK2 mRNA
CTD
PMID:30529165
NCBI chr 1:206,684,905...206,734,281
Ensembl chr 1:206,684,905...206,734,281
G
MAPRE3
microtubule associated protein RP/EB family member 3
increases expression
EXP
sulforaphane results in increased expression of MAPRE3 mRNA
CTD
PMID:26833863
NCBI chr 2:26,970,637...27,027,219
Ensembl chr 2:26,970,637...27,027,219
G
MARCKS
myristoylated alanine rich protein kinase C substrate
decreases expression
EXP
sulforaphane results in decreased expression of MARCKS mRNA
CTD
PMID:31838189
NCBI chr 6:113,857,345...113,863,475
Ensembl chr 6:113,857,345...113,863,475
G
MARCOL
MARCO like
decreases expression
EXP
sulforaphane results in decreased expression of MARCOL mRNA
CTD
PMID:31838189
NCBI chr 5:148,238,525...148,243,580
Ensembl chr 5:148,221,650...148,243,580
G
MATCAP1
microtubule associated tyrosine carboxypeptidase 1
decreases expression
EXP
sulforaphane results in decreased expression of MATCAP1 mRNA
CTD
PMID:31838189
NCBI chr16:67,175,599...67,183,963
Ensembl chr16:67,175,599...67,184,040
G
MB
myoglobin
decreases expression
EXP
sulforaphane results in decreased expression of MB mRNA
CTD
PMID:31838189
NCBI chr22:35,606,764...35,623,354
Ensembl chr22:35,606,764...35,637,951
G
MBD2
methyl-CpG binding domain protein 2
multiple interactions
EXP
sulforaphane inhibits the reaction [Estradiol promotes the reaction [MBD2 protein binds to COMT promoter]]; sulforaphane inhibits the reaction [Estradiol results in increased activity of MBD2 protein]; sulforaphane inhibits the reaction [Estradiol results in increased expression of MBD2 mRNA]; sulforaphane inhibits the reaction [Genistein promotes the reaction [MBD2 protein binds to COMT promoter]]; sulforaphane inhibits the reaction [Genistein results in increased activity of MBD2 protein]
CTD
PMID:30684530
NCBI chr18:54,151,606...54,224,669
Ensembl chr18:54,151,606...54,224,669
G
MBD3
methyl-CpG binding domain protein 3
increases expression
EXP
sulforaphane results in increased expression of MBD3 mRNA
CTD
PMID:30684530
NCBI chr19:1,573,596...1,592,865
Ensembl chr19:1,573,596...1,592,865
G
MBIP
MAP3K12 binding inhibitory protein 1
decreases expression
ISO
sulforaphane results in decreased expression of MBIP mRNA
CTD
PMID:30529165
NCBI chr14:36,298,564...36,320,637
Ensembl chr14:36,298,564...36,320,637
G
MCCC1
methylcrotonyl-CoA carboxylase subunit 1
decreases expression
EXP
sulforaphane results in decreased expression of MCCC1 mRNA
CTD
PMID:31838189
NCBI chr 3:183,015,218...183,116,196
Ensembl chr 3:183,015,218...183,116,075
G
MCEE
methylmalonyl-CoA epimerase
decreases expression
EXP
sulforaphane results in decreased expression of MCEE mRNA
CTD
PMID:31838189
NCBI chr 2:71,109,687...71,130,229
Ensembl chr 2:71,109,684...71,130,239
G
MCOLN2
mucolipin TRP cation channel 2
decreases expression
EXP
sulforaphane results in decreased expression of MCOLN2 mRNA
CTD
PMID:26833863
NCBI chr 1:84,925,583...84,997,113
Ensembl chr 1:84,925,583...84,997,113
G
MCOLN3
mucolipin TRP cation channel 3
decreases expression
ISO
sulforaphane results in decreased expression of MCOLN3 mRNA
CTD
PMID:30529165
NCBI chr 1:85,018,082...85,048,500
Ensembl chr 1:85,018,082...85,048,500
G
MCRIP2
MAPK regulated corepressor interacting protein 2
increases expression
ISO
sulforaphane results in increased expression of MCRIP2 mRNA
CTD
PMID:30529165
NCBI chr16:641,828...648,474
Ensembl chr16:636,817...648,474
G
MCTP1
multiple C2 and transmembrane domain containing 1
increases expression
EXP
sulforaphane results in increased expression of MCTP1 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr 5:94,703,690...95,285,094
Ensembl chr 5:94,703,690...95,285,094
G
MCTP2
multiple C2 and transmembrane domain containing 2
increases expression decreases expression
EXP
sulforaphane results in increased expression of MCTP2 mRNA sulforaphane results in decreased expression of MCTP2 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr15:94,231,366...94,483,952
Ensembl chr15:94,231,538...94,483,952
G
MDH1
malate dehydrogenase 1
multiple interactions increases expression
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of MDH1 mRNA sulforaphane results in increased expression of MDH1 mRNA
CTD
PMID:25450479 PMID:30529165
NCBI chr 2:63,588,963...63,607,197
Ensembl chr 2:63,588,609...63,607,197
G
ME1
malic enzyme 1
increases expression
EXP
sulforaphane results in increased expression of ME1 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
G
ME3
malic enzyme 3
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of ME3 mRNA [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of ME3 mRNA
CTD
PMID:25450479 PMID:30529165
NCBI chr11:86,434,930...86,672,616
Ensembl chr11:86,441,108...86,672,636
G
MEGF9
multiple EGF like domains 9
increases expression
EXP
sulforaphane results in increased expression of MEGF9 mRNA
CTD
PMID:26833863
NCBI chr 9:120,600,811...120,714,470
Ensembl chr 9:120,600,811...120,714,470
G
MEOX1
mesenchyme homeobox 1
decreases expression
EXP
sulforaphane results in decreased expression of MEOX1 mRNA
CTD
PMID:31838189
NCBI chr17:43,640,389...43,661,922
Ensembl chr17:43,640,389...43,661,922
G
MERTK
MER proto-oncogene, tyrosine kinase
decreases expression
ISO
sulforaphane results in decreased expression of MERTK mRNA
CTD
PMID:30529165
NCBI chr 2:111,898,607...112,029,561
Ensembl chr 2:111,898,607...112,029,561
G
METAP1D
methionyl aminopeptidase type 1D, mitochondrial
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of METAP1D mRNA
CTD
PMID:30529165
NCBI chr 2:171,999,953...172,082,430
Ensembl chr 2:171,999,943...172,082,430
G
MFAP2
microfibril associated protein 2
decreases expression
EXP
sulforaphane results in decreased expression of MFAP2 mRNA
CTD
PMID:31838189
NCBI chr 1:16,974,502...16,981,583
Ensembl chr 1:16,974,502...16,980,632
G
MFAP4
microfibril associated protein 4
decreases expression
EXP
sulforaphane results in decreased expression of MFAP4 mRNA
CTD
PMID:26833863
NCBI chr17:19,383,445...19,387,190
Ensembl chr17:19,383,442...19,387,190
G
MGAM
maltase-glucoamylase
increases expression
EXP
sulforaphane results in increased expression of MGAM mRNA
CTD
PMID:26833863
NCBI chr 7:141,986,518...142,106,747
Ensembl chr 7:141,907,813...142,106,747
G
MGAT5
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase
increases expression
EXP
sulforaphane results in increased expression of MGAT5 mRNA
CTD
PMID:31838189
NCBI chr 2:134,119,935...134,454,621
Ensembl chr 2:134,119,983...134,454,621
G
MGLL
monoglyceride lipase
decreases expression
EXP
sulforaphane results in decreased expression of MGLL mRNA
CTD
PMID:31838189
NCBI chr 3:127,689,066...127,823,185
Ensembl chr 3:127,689,062...128,052,190
G
MGMT
O-6-methylguanine-DNA methyltransferase
multiple interactions
EXP
sulforaphane results in increased expression of and results in increased activity of MGMT protein
CTD
PMID:16950796
NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983
G
MIA2
MIA SH3 domain ER export factor 2
increases expression
EXP
sulforaphane results in increased expression of MIA2 mRNA
CTD
PMID:31838189
NCBI chr14:39,233,915...39,388,522
Ensembl chr14:39,230,231...39,388,513
G
MICAL2
microtubule associated monooxygenase, calponin and LIM domain containing 2
decreases expression
EXP
sulforaphane results in decreased expression of MICAL2 mRNA
CTD
PMID:31838189
NCBI chr11:12,110,590...12,362,140
Ensembl chr11:12,094,008...12,359,144
G
MINDY1
MINDY lysine 48 deubiquitinase 1
decreases expression
EXP
sulforaphane results in decreased expression of MINDY1 mRNA
CTD
PMID:31838189
NCBI chr 1:150,996,536...151,008,393
Ensembl chr 1:150,996,549...151,008,376
G
MIR142
microRNA 142
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MIR142 mRNA
CTD
PMID:30529165
NCBI chr17:58,331,232...58,331,318
Ensembl chr17:58,331,232...58,331,318
G
MIR34A
microRNA 34a
multiple interactions
ISO
sulforaphane inhibits the reaction [ochratoxin A results in increased expression of MIR34A mRNA]
CTD
PMID:28710020
NCBI chr 1:9,151,668...9,151,777
Ensembl chr 1:9,151,668...9,151,777
G
MIR382
microRNA 382
multiple interactions
ISO
sulforaphane inhibits the reaction [ochratoxin A results in increased expression of MIR382 mRNA]
CTD
PMID:28710020
NCBI chr14:101,054,306...101,054,381
Ensembl chr14:101,054,306...101,054,381
G
MLC1
modulator of VRAC current 1
decreases expression
ISO
sulforaphane results in decreased expression of MLC1 mRNA
CTD
PMID:30529165
NCBI chr22:50,059,391...50,085,875
Ensembl chr22:50,059,391...50,085,426
G
MLF1
myeloid leukemia factor 1
increases expression
ISO
sulforaphane results in increased expression of MLF1 mRNA
CTD
PMID:30529165
NCBI chr 3:158,571,194...158,606,456
Ensembl chr 3:158,571,163...158,607,252
G
MLIP
muscular LMNA interacting protein
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of MLIP mRNA
CTD
PMID:30529165
NCBI chr 6:54,018,970...54,266,280
Ensembl chr 6:53,929,982...54,266,280
G
MLXIPL
MLX interacting protein like
increases expression
EXP
sulforaphane results in increased expression of MLXIPL mRNA
CTD
PMID:31838189
NCBI chr 7:73,593,202...73,647,907
Ensembl chr 7:73,593,194...73,624,543
G
MME
membrane metalloendopeptidase
decreases expression
ISO
sulforaphane results in decreased expression of MME mRNA
CTD
PMID:30529165
NCBI chr 3:155,024,202...155,183,729
Ensembl chr 3:155,024,124...155,183,704
G
MMP2
matrix metallopeptidase 2
increases expression
EXP
sulforaphane results in increased expression of MMP2 mRNA
CTD
PMID:26833863
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP28
matrix metallopeptidase 28
decreases expression
EXP
sulforaphane results in decreased expression of MMP28 mRNA
CTD
PMID:31838189
NCBI chr17:35,756,249...35,795,641
Ensembl chr17:35,756,249...35,795,707
G
MMRN2
multimerin 2
decreases expression
EXP
sulforaphane results in decreased expression of MMRN2 mRNA
CTD
PMID:31838189
NCBI chr10:86,935,540...86,957,615
Ensembl chr10:86,935,540...86,969,481
G
MNAT1
MNAT1 component of CDK activating kinase
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of MNAT1 mRNA
CTD
PMID:25450479
NCBI chr14:60,734,761...60,969,965
Ensembl chr14:60,734,742...60,969,965
G
MNDA
myeloid cell nuclear differentiation antigen
increases expression
EXP
sulforaphane results in increased expression of MNDA mRNA
CTD
PMID:26833863
NCBI chr 1:158,831,351...158,849,502
Ensembl chr 1:158,831,351...158,849,506
G
MNS1
meiosis specific nuclear structural 1
decreases expression
EXP
sulforaphane results in decreased expression of MNS1 mRNA
CTD
PMID:26833863
NCBI chr15:56,428,724...56,465,137
Ensembl chr15:56,421,544...56,465,137
G
MOB3B
MOB kinase activator 3B
decreases expression
EXP
sulforaphane results in decreased expression of MOB3B mRNA
CTD
PMID:31838189
NCBI chr 9:27,325,209...27,529,814
Ensembl chr 9:27,325,209...27,529,814
G
MOB4
MOB family member 4, phocein
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MOB4 mRNA
CTD
PMID:30529165
NCBI chr 2:197,515,554...197,553,699
Ensembl chr 2:197,515,571...197,553,699
G
MOSMO
modulator of smoothened
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MOSMO mRNA
CTD
PMID:30529165
NCBI chr16:22,008,111...22,092,652
Ensembl chr16:22,007,638...22,087,534
G
MOXD1
monooxygenase DBH like 1
decreases expression
EXP
sulforaphane results in decreased expression of MOXD1 mRNA
CTD
PMID:31838189
NCBI chr 6:132,296,055...132,401,475
Ensembl chr 6:132,296,055...132,401,475
G
MPEG1
macrophage expressed 1
decreases expression
EXP
sulforaphane results in decreased expression of MPEG1 mRNA
CTD
PMID:26833863
NCBI chr11:59,208,510...59,212,927
Ensembl chr11:59,208,510...59,212,927
G
MPHOSPH6
M-phase phosphoprotein 6
increases expression
EXP
sulforaphane results in increased expression of MPHOSPH6 mRNA
CTD
PMID:31838189
NCBI chr16:82,148,162...82,170,224
Ensembl chr16:82,147,798...82,170,224
G
MPND
MPN domain containing
decreases expression
EXP
sulforaphane results in decreased expression of MPND mRNA
CTD
PMID:31838189
NCBI chr19:4,343,562...4,360,078
Ensembl chr19:4,343,527...4,360,086
G
MPP2
MAGUK p55 scaffold protein 2
decreases expression
EXP
sulforaphane results in decreased expression of MPP2 mRNA
CTD
PMID:31838189
NCBI chr17:43,875,360...43,909,711
Ensembl chr17:43,875,357...43,909,711
G
MPP7
MAGUK p55 scaffold protein 7
decreases expression
EXP
sulforaphane results in decreased expression of MPP7 mRNA
CTD
PMID:31838189
NCBI chr10:28,050,993...28,335,203
Ensembl chr10:28,050,993...28,334,486
G
MPZL1
myelin protein zero like 1
decreases expression
EXP
sulforaphane results in decreased expression of MPZL1 mRNA
CTD
PMID:26833863
NCBI chr 1:167,721,982...167,791,919
Ensembl chr 1:167,721,192...167,791,919
G
MPZL2
myelin protein zero like 2
decreases expression
EXP
sulforaphane results in decreased expression of MPZL2 mRNA
CTD
PMID:31838189
NCBI chr11:118,253,416...118,264,297
Ensembl chr11:118,253,416...118,264,536
G
MPZL3
myelin protein zero like 3
increases expression
EXP
sulforaphane results in increased expression of MPZL3 mRNA
CTD
PMID:26833863
NCBI chr11:118,226,690...118,252,365
Ensembl chr11:118,226,690...118,252,365
G
MRAP
melanocortin 2 receptor accessory protein
increases expression
ISO
sulforaphane results in increased expression of MRAP mRNA
CTD
PMID:30529165
NCBI chr21:32,291,813...32,314,784
Ensembl chr21:32,291,813...32,314,784
G
MRO
maestro
increases expression
EXP
sulforaphane results in increased expression of MRO mRNA
CTD
PMID:31838189
NCBI chr18:50,795,130...50,825,380
Ensembl chr18:50,795,120...50,825,402
G
MRPL13
mitochondrial ribosomal protein L13
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MRPL13 mRNA
CTD
PMID:30529165
NCBI chr 8:120,395,437...120,445,150
Ensembl chr 8:120,380,761...120,445,402
G
MRPL28
mitochondrial ribosomal protein L28
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MRPL28 mRNA
CTD
PMID:30529165
NCBI chr16:366,969...370,538
Ensembl chr16:366,969...371,289
G
MRPL53
mitochondrial ribosomal protein L53
increases expression
EXP
sulforaphane results in increased expression of MRPL53 mRNA
CTD
PMID:31838189
NCBI chr 2:74,471,982...74,472,680
Ensembl chr 2:74,471,982...74,472,687
G
MRPS24
mitochondrial ribosomal protein S24
decreases expression
EXP
sulforaphane results in decreased expression of MRPS24 mRNA
CTD
PMID:31838189
NCBI chr 7:43,866,558...43,869,517
Ensembl chr 7:43,866,558...43,869,893
G
MS4A6A
membrane spanning 4-domains A6A
decreases expression
EXP
sulforaphane results in decreased expression of MS4A6A mRNA
CTD
PMID:26833863
NCBI chr11:60,171,607...60,184,666
Ensembl chr11:60,172,015...60,184,666
G
MSC
musculin
increases expression
EXP
sulforaphane results in increased expression of MSC mRNA
CTD
PMID:26833863
NCBI chr 8:71,841,560...71,844,412
Ensembl chr 8:71,841,560...71,844,412
G
MSRB1
methionine sulfoxide reductase B1
increases expression
EXP
sulforaphane results in increased expression of MSRB1 mRNA
CTD
PMID:26833863
NCBI chr16:1,938,229...1,943,199
Ensembl chr16:1,938,229...1,943,199
G
MST1
macrophage stimulating 1
increases expression
ISO
sulforaphane results in increased expression of MST1 mRNA
CTD
PMID:30529165
NCBI chr 3:49,683,947...49,689,474
Ensembl chr 3:49,683,947...49,689,501
G
MT-CO1
mitochondrially encoded cytochrome c oxidase I
multiple interactions
ISO
[sulforaphane co-treated with Oxygen] results in increased expression of COX1 protein; NFE2L2 protein affects the reaction [[sulforaphane co-treated with Oxygen] results in increased expression of COX1 protein]
CTD
PMID:30529165
NCBI chr MT:5,904...7,445
Ensembl chr MT:5,904...7,445
G
MT-ND1
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1
increases expression
EXP
sulforaphane results in increased expression of ND1 protein
CTD
PMID:27993529
NCBI chr MT:3,307...4,262
Ensembl chr MT:3,307...4,262
G
MT1E
metallothionein 1E
decreases expression
EXP
sulforaphane results in decreased expression of MT1E mRNA
CTD
PMID:31838189
NCBI chr16:56,625,781...56,627,112
Ensembl chr16:56,625,475...56,627,112
G
MT1G
metallothionein 1G
decreases expression
EXP
sulforaphane results in decreased expression of MT1G mRNA
CTD
PMID:26833863
NCBI chr16:56,666,730...56,668,065
Ensembl chr16:56,666,730...56,668,065
G
MT2A
metallothionein 2A
increases expression
ISO
sulforaphane results in increased expression of MT2 mRNA
CTD
PMID:30529165
NCBI chr16:56,608,584...56,609,497
Ensembl chr16:56,608,584...56,609,497
G
MT3
metallothionein 3
increases expression
ISO
sulforaphane results in increased expression of MT3 mRNA
CTD
PMID:30529165
NCBI chr16:56,589,528...56,591,085
Ensembl chr16:56,589,074...56,591,088
G
MTCL1
microtubule crosslinking factor 1
decreases expression
ISO
sulforaphane results in decreased expression of SOGA2 mRNA
CTD
PMID:30529165
NCBI chr18:8,705,556...8,832,778
Ensembl chr18:8,705,556...8,832,778
G
MTFP1
mitochondrial fission process 1
increases expression
ISO
sulforaphane results in increased expression of MTFP1 mRNA
CTD
PMID:30529165
NCBI chr22:30,425,768...30,429,054
Ensembl chr22:30,425,623...30,429,054
G
MTMR10
myotubularin related protein 10
multiple interactions decreases expression
ISO EXP
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MTMR10 mRNA sulforaphane results in decreased expression of MTMR10 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr15:30,918,716...30,991,628
Ensembl chr15:30,938,941...30,991,628
G
MTMR11
myotubularin related protein 11
decreases expression
EXP
sulforaphane results in decreased expression of MTMR11 mRNA
CTD
PMID:31838189
NCBI chr 1:149,928,651...149,936,879
Ensembl chr 1:149,928,651...149,936,879
G
MTR
5-methyltetrahydrofolate-homocysteine methyltransferase
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of MTR mRNA
CTD
PMID:30529165
NCBI chr 1:236,795,281...236,903,981
Ensembl chr 1:236,795,260...236,921,278
G
MTREX
Mtr4 exosome RNA helicase
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SKIV2L2 mRNA
CTD
PMID:30529165
NCBI chr 5:55,307,989...55,425,579
Ensembl chr 5:55,307,989...55,425,579
G
MTUS2
microtubule associated scaffold protein 2
increases expression
ISO
sulforaphane results in increased expression of MTUS2 mRNA
CTD
PMID:30529165
NCBI chr13:28,819,963...29,505,947
Ensembl chr13:28,820,339...29,505,947
G
MUC1
mucin 1, cell surface associated
decreases expression
EXP
sulforaphane results in decreased expression of MUC1 mRNA
CTD
PMID:31838189
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
G
MUC19
mucin 19, oligomeric
decreases expression
EXP
sulforaphane results in decreased expression of MUC19 mRNA
CTD
PMID:26833863
NCBI chr12:40,393,394...40,570,757
Ensembl chr12:40,393,395...40,570,832
G
MUC3A
mucin 3A, cell surface associated
decreases expression
EXP
sulforaphane results in decreased expression of MUC3A mRNA
CTD
PMID:31838189
NCBI chr 7:100,949,534...100,968,347
Ensembl chr 7:100,949,534...100,968,347
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
increases expression multiple interactions
ISO
sulforaphane results in increased expression of MUC5AC mRNA NFE2L2 protein affects the reaction [sulforaphane inhibits the reaction [Oxygen results in increased secretion of MUC5AC protein]]; sulforaphane affects the reaction [NFE2L2 protein affects the secretion of MUC5AC protein]; sulforaphane inhibits the reaction [Oxygen results in increased secretion of MUC5AC protein]
CTD
PMID:30529165
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
G
MUC5B
mucin 5B, oligomeric mucus/gel-forming
increases expression
ISO
sulforaphane results in increased expression of MUC5B mRNA
CTD
PMID:30529165
NCBI chr11:1,223,066...1,262,172
Ensembl chr11:1,223,066...1,262,172
G
MVK
mevalonate kinase
decreases expression
EXP
sulforaphane results in decreased expression of MVK mRNA
CTD
PMID:34767876
NCBI chr12:109,573,272...109,598,125
Ensembl chr12:109,573,255...109,598,125
G
MVP
major vault protein
decreases expression
EXP
sulforaphane results in decreased expression of MVP mRNA
CTD
PMID:31838189
NCBI chr16:29,820,394...29,848,039
Ensembl chr16:29,820,394...29,848,039
G
MXD1
MAX dimerization protein 1
increases expression
EXP
sulforaphane results in increased expression of MXD1 mRNA
CTD
PMID:26833863
NCBI chr 2:69,915,109...69,942,945
Ensembl chr 2:69,897,688...69,942,945
G
MXD4
MAX dimerization protein 4
decreases expression
EXP
sulforaphane results in decreased expression of MXD4 mRNA
CTD
PMID:31838189
NCBI chr 4:2,247,432...2,262,109
Ensembl chr 4:2,247,432...2,262,109
G
MYB
MYB proto-oncogene, transcription factor
increases expression decreases expression
ISO EXP
sulforaphane results in increased expression of MYB mRNA sulforaphane results in decreased expression of MYB mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 6:135,181,308...135,219,172
Ensembl chr 6:135,181,308...135,219,173
G
MYBL2
MYB proto-oncogene like 2
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of MYBL2 mRNA
CTD
PMID:25450479
NCBI chr20:43,667,114...43,716,482
Ensembl chr20:43,667,019...43,716,495
G
MYBPC3
myosin binding protein C3
increases expression
ISO
sulforaphane results in increased expression of MYBPC3 mRNA
CTD
PMID:30529165
NCBI chr11:47,331,406...47,352,702
Ensembl chr11:47,331,406...47,352,702
G
MYC
MYC proto-oncogene, bHLH transcription factor
multiple interactions
ISO
sulforaphane inhibits the reaction [ochratoxin A results in increased expression of MYC mRNA]
CTD
PMID:28710020
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
G
MYD88
MYD88 innate immune signal transduction adaptor
multiple interactions
ISO
sulforaphane inhibits the reaction [Trichloroethylene results in increased expression of MYD88 protein]
CTD
PMID:33007382
NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024
G
MYEOV
myeloma overexpressed
increases expression
EXP
sulforaphane results in increased expression of MYEOV mRNA
CTD
PMID:31838189
NCBI chr11:69,294,155...69,297,287
Ensembl chr11:69,294,151...69,341,682
G
MYH6
myosin heavy chain 6
increases expression
ISO
sulforaphane results in increased expression of MYH6 mRNA
CTD
PMID:30529165
NCBI chr14:23,381,987...23,408,273
Ensembl chr14:23,381,982...23,408,273
G
MYL3
myosin light chain 3
increases expression
ISO
sulforaphane results in increased expression of MYL3 mRNA
CTD
PMID:30529165
NCBI chr 3:46,857,872...46,882,182
Ensembl chr 3:46,835,110...46,882,178
G
MYLK
myosin light chain kinase
decreases expression
EXP
sulforaphane results in decreased expression of MYLK mRNA
CTD
PMID:31838189
NCBI chr 3:123,610,049...123,884,332
Ensembl chr 3:123,610,049...123,884,332
G
MYLK3
myosin light chain kinase 3
increases expression decreases expression multiple interactions
ISO EXP
sulforaphane results in increased expression of MYLK3 mRNA sulforaphane results in decreased expression of MYLK3 mRNA [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of MYLK3 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr16:46,702,282...46,763,246
Ensembl chr16:46,702,282...46,790,407
G
MYO1B
myosin IB
decreases expression
ISO
sulforaphane results in decreased expression of MYO1B mRNA
CTD
PMID:30529165
NCBI chr 2:191,245,404...191,425,386
Ensembl chr 2:191,245,185...191,425,389
G
MYO1D
myosin ID
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MYO1D mRNA
CTD
PMID:30529165
NCBI chr17:32,492,522...32,877,124
Ensembl chr17:32,492,522...32,877,177
G
MYO1G
myosin IG
decreases expression
EXP
sulforaphane results in decreased expression of MYO1G mRNA
CTD
PMID:31838189
NCBI chr 7:44,962,662...44,979,015
Ensembl chr 7:44,962,662...44,979,088
G
MYOCD
myocardin
decreases expression
EXP
sulforaphane results in decreased expression of MYOCD mRNA
CTD
PMID:31838189
NCBI chr17:12,665,890...12,768,949
Ensembl chr17:12,665,890...12,768,949
G
MYOM1
myomesin 1
increases expression
ISO
sulforaphane results in increased expression of MYOM1 mRNA
CTD
PMID:30529165
NCBI chr18:3,066,807...3,247,376
Ensembl chr18:3,066,807...3,219,968
G
MYOM2
myomesin 2
increases expression
ISO
sulforaphane results in increased expression of MYOM2 mRNA
CTD
PMID:30529165
NCBI chr 8:2,045,046...2,145,456
Ensembl chr 8:2,045,046...2,165,552
G
MYOZ2
myozenin 2
increases expression multiple interactions
ISO
sulforaphane results in increased expression of MYOZ2 mRNA [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of MYOZ2 mRNA
CTD
PMID:30529165
NCBI chr 4:119,135,832...119,187,789
Ensembl chr 4:119,135,832...119,187,789
G
MYPN
myopalladin
decreases expression
EXP
sulforaphane results in decreased expression of MYPN mRNA
CTD
PMID:31838189
NCBI chr10:68,087,897...68,212,017
Ensembl chr10:68,087,897...68,212,017
G
MYRIP
myosin VIIA and Rab interacting protein
decreases expression
EXP
sulforaphane results in decreased expression of MYRIP mRNA
CTD
PMID:31838189
NCBI chr 3:39,808,914...40,260,321
Ensembl chr 3:39,808,914...40,260,321
G
MYSM1
Myb like, SWIRM and MPN domains 1
decreases expression
ISO
sulforaphane results in decreased expression of MYSM1 mRNA
CTD
PMID:30529165
NCBI chr 1:58,654,743...58,700,062
Ensembl chr 1:58,643,440...58,700,090
G
MYT1L
myelin transcription factor 1 like
decreases expression
EXP
sulforaphane results in decreased expression of MYT1L mRNA
CTD
PMID:31838189
NCBI chr 2:1,789,113...2,331,275
Ensembl chr 2:1,789,113...2,331,664
G
NAA30
N-alpha-acetyltransferase 30, NatC catalytic subunit
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of NAA30 mRNA
CTD
PMID:30529165
NCBI chr14:57,390,586...57,415,906
Ensembl chr14:57,390,544...57,415,906
G
NAPSA
napsin A aspartic peptidase
decreases expression
ISO
sulforaphane results in decreased expression of NAPSA mRNA
CTD
PMID:30529165
NCBI chr19:50,358,477...50,365,639
Ensembl chr19:50,358,472...50,365,830
G
NAT14
N-acetyltransferase 14 (putative)
decreases expression
EXP
sulforaphane results in decreased expression of NAT14 mRNA
CTD
PMID:31838189
NCBI chr19:55,485,188...55,487,566
Ensembl chr19:55,485,188...55,487,568
G
NCAM2
neural cell adhesion molecule 2
decreases expression
EXP
sulforaphane results in decreased expression of NCAM2 mRNA
CTD
PMID:26833863
NCBI chr21:20,998,409...21,543,329
Ensembl chr21:20,998,409...21,543,329
G
NCCRP1
NCCRP1, F-box associated domain containing
decreases expression
EXP
sulforaphane results in decreased expression of NCCRP1 mRNA
CTD
PMID:31838189
NCBI chr19:39,196,964...39,201,884
Ensembl chr19:39,196,964...39,201,884
G
NCF1
neutrophil cytosolic factor 1
increases expression
EXP
sulforaphane results in increased expression of NCF1 mRNA
CTD
PMID:26833863
NCBI chr 7:74,774,011...74,789,315
Ensembl chr 7:74,774,011...74,789,315
G
NCF2
neutrophil cytosolic factor 2
increases expression
EXP
sulforaphane results in increased expression of NCF2 mRNA
CTD
PMID:26833863
NCBI chr 1:183,555,562...183,601,849
Ensembl chr 1:183,554,461...183,590,905
G
NCOR2
nuclear receptor corepressor 2
multiple interactions
EXP
sulforaphane inhibits the reaction [NCOR2 protein binds to NR1I2 protein]
CTD
PMID:29356861
NCBI chr12:124,324,415...124,567,612
Ensembl chr12:124,324,415...124,567,612
G
NDRG1
N-myc downstream regulated 1
increases expression
EXP
sulforaphane results in increased expression of NDRG1 mRNA
CTD
PMID:17937621
NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022
G
NDRG3
NDRG family member 3
decreases expression
EXP
sulforaphane results in decreased expression of NDRG3 mRNA
CTD
PMID:31838189
NCBI chr20:36,651,771...36,746,090
Ensembl chr20:36,651,766...36,746,090
G
NDRG4
NDRG family member 4
increases expression
ISO
sulforaphane results in increased expression of NDRG4 mRNA
CTD
PMID:30529165
NCBI chr16:58,463,715...58,515,387
Ensembl chr16:58,462,846...58,513,628
G
NDUFA1
NADH:ubiquinone oxidoreductase subunit A1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of NDUFA1 mRNA
CTD
PMID:30529165
NCBI chr X:119,871,832...119,876,662
Ensembl chr X:119,871,832...119,876,662
G
NDUFA10
NADH:ubiquinone oxidoreductase subunit A10
increases expression
ISO
sulforaphane results in increased expression of NDUFA10 mRNA
CTD
PMID:30529165
NCBI chr 2:239,892,442...240,025,342
Ensembl chr 2:239,892,450...240,025,743
G
NDUFA11
NADH:ubiquinone oxidoreductase subunit A11
increases expression
ISO
sulforaphane results in increased expression of NDUFA11 mRNA
CTD
PMID:30529165
NCBI chr19:5,891,229...5,903,790
Ensembl chr19:5,891,276...5,904,006
G
NDUFA5
NADH:ubiquinone oxidoreductase subunit A5
increases expression
ISO
sulforaphane results in increased expression of NDUFA5 mRNA
CTD
PMID:30529165
NCBI chr 7:123,536,997...123,601,651
Ensembl chr 7:123,536,997...123,557,904
G
NDUFA9
NADH:ubiquinone oxidoreductase subunit A9
increases expression
ISO
sulforaphane results in increased expression of NDUFA9 mRNA
CTD
PMID:30529165
NCBI chr12:4,649,114...4,694,317
Ensembl chr12:4,649,095...4,694,317
G
NDUFAB1
NADH:ubiquinone oxidoreductase subunit AB1
increases expression
ISO
sulforaphane results in increased expression of NDUFAB1 mRNA
CTD
PMID:30529165
NCBI chr16:23,581,014...23,596,316
Ensembl chr16:23,581,014...23,596,316
G
NDUFB8
NADH:ubiquinone oxidoreductase subunit B8
multiple interactions increases expression
ISO
NFE2L2 protein affects the reaction [sulforaphane promotes the reaction [Oxygen results in increased expression of NDUFB8 protein]]; sulforaphane promotes the reaction [Oxygen results in increased expression of NDUFB8 protein] sulforaphane results in increased expression of NDUFB8 mRNA
CTD
PMID:30529165
NCBI chr10:100,523,729...100,529,923
Ensembl chr10:100,523,740...100,530,000
G
NDUFB9
NADH:ubiquinone oxidoreductase subunit B9
increases expression
ISO
sulforaphane results in increased expression of NDUFB9 mRNA
CTD
PMID:30529165
NCBI chr 8:124,539,123...124,549,979
Ensembl chr 8:124,539,101...124,580,648
G
NDUFS1
NADH:ubiquinone oxidoreductase core subunit S1
increases expression
ISO
sulforaphane results in increased expression of NDUFS1 mRNA
CTD
PMID:30529165
NCBI chr 2:206,114,817...206,159,444
Ensembl chr 2:206,114,817...206,159,509
G
NDUFV3
NADH:ubiquinone oxidoreductase subunit V3
increases expression
ISO
sulforaphane results in increased expression of NDUFV3 mRNA
CTD
PMID:30529165
NCBI chr21:42,893,309...42,913,299
Ensembl chr21:42,879,644...42,913,304
G
NEBL
nebulette
decreases expression
EXP
sulforaphane results in decreased expression of NEBL mRNA
CTD
PMID:31838189
NCBI chr10:20,779,973...21,293,050
Ensembl chr10:20,779,973...21,293,011
G
NECAB2
N-terminal EF-hand calcium binding protein 2
increases expression
EXP
sulforaphane results in increased expression of NECAB2 mRNA
CTD
PMID:31838189
NCBI chr16:83,965,177...84,002,776
Ensembl chr16:83,968,244...84,002,776
G
NEIL1
nei like DNA glycosylase 1
decreases expression
EXP
sulforaphane results in decreased expression of NEIL1 mRNA
CTD
PMID:31838189
NCBI chr15:75,347,039...75,357,115
Ensembl chr15:75,346,955...75,357,115
G
NEIL3
nei like DNA glycosylase 3
increases expression
EXP
sulforaphane results in increased expression of NEIL3 mRNA
CTD
PMID:31838189
NCBI chr 4:177,309,874...177,371,268
Ensembl chr 4:177,309,874...177,362,936
G
NEK2
NIMA related kinase 2
increases expression
EXP
sulforaphane results in increased expression of NEK2 mRNA
CTD
PMID:31838189
NCBI chr 1:211,658,256...211,675,621
Ensembl chr 1:211,658,657...211,675,630
G
NES
nestin
decreases expression
EXP
sulforaphane results in decreased expression of NES mRNA
CTD
PMID:31838189
NCBI chr 1:156,668,763...156,677,407
Ensembl chr 1:156,668,763...156,677,407
G
NEUROG3
neurogenin 3
decreases expression
EXP
sulforaphane results in decreased expression of NEUROG3 mRNA
CTD
PMID:26833863
NCBI chr10:69,571,485...69,573,422
Ensembl chr10:69,571,698...69,573,422
G
NFE2L2
NFE2 like bZIP transcription factor 2
multiple interactions decreases expression increases activity increases expression affects localization decreases phosphorylation increases localization increases response to substance affects response to substance affects activity decreases response to substance
ISO EXP
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein]; [NFE2L2 protein affects the susceptibility to sulforaphane] affects the reaction [Oxygen deficiency results in increased expression of CCN2 protein]; [NFE2L2 protein affects the susceptibility to sulforaphane] affects the reaction [Oxygen deficiency results in increased expression of SERPINE1 protein]; [NFE2L2 protein affects the susceptibility to sulforaphane] affects the reaction [Oxygen deficiency results in increased expression of VCAM1 protein]; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of A4GALT mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of ADAM19 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of ADAMTS15 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of ADH7 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of AREG mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of CALCR mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of CCL11 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of CCL20 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of CHIA mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of CYP26B1 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of DEDD2 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of DNAJB1 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of FAM13C mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of FRRS1 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of GSTT1 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of IZUMO4 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of KLRA16 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of KRTAP17-1 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of ME3 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of METAP1D mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of MLIP mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of MTR mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of MYLK3 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of MYOZ2 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of PLEKHJ1 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of PRMT8 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of PTGS2 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of PTPRG mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of S100G mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of SEC16B mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of TINAG mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of TLE6 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of TRMT61B mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of TUBB1 mRNA; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of USP2 mRNA; [Streptozocin co-treated with sulforaphane] results in increased expression of NFE2L2; [sulforaphane co-treated with Dibutyl Phthalate] results in increased expression of NFE2L2 protein; Buthionine Sulfoximine affects the reaction [[NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Acrolein]; Buthionine Sulfoximine affects the reaction [[NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Chlorambucil]; Buthionine Sulfoximine inhibits the reaction [NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to Acrolein]]; Buthionine Sulfoximine inhibits the reaction [NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to Chlorambucil]]; Buthionine Sulfoximine inhibits the reaction [NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to cumene hydroperoxide]]; NFE2L2 gene mutant form inhibits the reaction [sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of CCN2 protein]]; NFE2L2 gene mutant form inhibits the reaction [sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of NPPA protein]]; NFE2L2 gene mutant form inhibits the reaction [sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of SERPINE1 protein]]; NFE2L2 gene mutant form inhibits the reaction [sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of TNF protein]]; NFE2L2 gene mutant form inhibits the reaction [sulforaphane results in increased expression of ABCC1 mRNA]; NFE2L2 gene mutant form inhibits the reaction [sulforaphane results in increased expression of and results in increased activity of ABCC1 protein]; NFE2L2 gene mutant form inhibits the reaction [sulforaphane results in increased expression of HMOX1 protein]; NFE2L2 gene mutant form inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein]; NFE2L2 gene mutant form inhibits the reaction [sulforaphane results in increased expression of NQO1 protein]; NFE2L2 mutant form inhibits the reaction [sulforaphane results in increased expression of HMOX1 protein]; NFE2L2 mutant form inhibits the reaction [sulforaphane results in increased expression of NQO1 protein]; NFE2L2 protein affects the reaction [[sulforaphane co-treated with Oxygen] results in increased expression of COX1 protein]; NFE2L2 protein affects the reaction [Oxygen inhibits the reaction [sulforaphane results in increased expression of SDHB protein]]; NFE2L2 protein affects the reaction [sulforaphane affects the reaction [1,2-Dimethylhydrazine affects the expression of HDAC3 protein]]; NFE2L2 protein affects the reaction [sulforaphane inhibits the reaction [Oxygen results in increased activity of RELA protein]]; NFE2L2 protein affects the reaction [sulforaphane inhibits the reaction [Oxygen results in increased secretion of MUC5AC protein]]; NFE2L2 protein affects the reaction [sulforaphane promotes the reaction [Oxygen results in increased expression of NDUFB8 protein]]; NFE2L2 protein affects the reaction [sulforaphane promotes the reaction [Oxygen results in increased expression of PLN protein]]; NFE2L2 protein affects the reaction [sulforaphane promotes the reaction [Oxygen results in increased expression of VDAC1 protein]]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of LAMP2 protein alternative form]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of PLN protein]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of SDHB protein]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of SQSTM1 protein]; NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to 1,2-naphthoquinone]; NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to 4-nitrobenzaldehyde]; NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to Acrolein]; NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to allyl isothiocyanate]; NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to benzyl isothiocyanate]; NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to Cadmium Chloride]; NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to Chlorambucil]; NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to chromous chloride]; NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to cumene hydroperoxide]; NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to Ethacrynic Acid]; NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to sodium arsenite]; NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to Vitamin K 3]; NFE2L2 protein promotes the reaction [sulforaphane results in increased expression of GCLC mRNA]; NFE2L2 protein promotes the reaction [sulforaphane results in increased expression of GCLM mRNA]; NFE2L2 protein promotes the reaction [sulforaphane results in increased expression of GSTA1 mRNA]; NFE2L2 protein promotes the reaction [sulforaphane results in increased expression of GSTM1 mRNA]; NFE2L2 protein promotes the reaction [sulforaphane results in increased expression of GSTP1 mRNA]; NFE2L2 protein promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]; Nitroprusside inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein]; sulforaphane affects the reaction [NFE2L2 affects the abundance of Glutathione]; sulforaphane affects the reaction [NFE2L2 protein affects the secretion of MUC5AC protein]; sulforaphane inhibits the reaction [[NFE2L2 protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of CDKN2A mRNA]; sulforaphane inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 mRNA]; sulforaphane inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of NFE2L2 protein]; sulforaphane inhibits the reaction [AGT protein modified form results in decreased expression of NFE2L2 mRNA]; sulforaphane inhibits the reaction [AGT protein modified form results in decreased expression of NFE2L2 protein modified form]; sulforaphane inhibits the reaction [AGT protein modified form results in decreased expression of NFE2L2 protein]; sulforaphane inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein]; sulforaphane inhibits the reaction [Carbon Tetrachloride results in decreased expression of NFE2L2 protein]; sulforaphane inhibits the reaction [Dinitrochlorobenzene results in decreased expression of NFE2L2 mRNA]; sulforaphane inhibits the reaction [Oxygen affects the localization of NFE2L2 protein]; sulforaphane inhibits the reaction [Oxygen deficiency results in decreased expression of NFE2L2 protein]; sulforaphane inhibits the reaction [Streptozocin results in decreased expression of and results in decreased phosphorylation of NFE2L2 protein]; sulforaphane inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 mRNA]; sulforaphane inhibits the reaction [Trichloroethylene results in decreased expression of NFE2L2 mRNA]; sulforaphane inhibits the reaction [Trichloroethylene results in decreased expression of NFE2L2 protein]; sulforaphane promotes the reaction [Methamphetamine results in increased expression of NFE2L2 protein]; sulforaphane results in increased expression of and affects the localization of NFE2L2 protein; sulforaphane results in increased expression of and results in increased phosphorylation of NFE2L2 protein sulforaphane results in decreased expression of NFE2L2 protein sulforaphane results in increased activity of NFE2L2 protein sulforaphane results in increased expression of NFE2L2; sulforaphane results in increased expression of NFE2L2 mRNA; sulforaphane results in increased expression of NFE2L2 protein; sulforaphane results in increased expression of NFE2L2 protein modified form 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sulforaphane affects the localization of NFE2L2 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein]; [HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]; [Hydrocortisone results in increased activity of NR3C1 protein] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]; [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]]; [sulforaphane results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Cisplatin; [sulforaphane results in increased activity of NFE2L2 protein] which results in increased expression of CYP2A6 mRNA; [sulforaphane results in increased expression of and results in increased activity of NFE2L2 protein] which results in decreased susceptibility to Benzo(a)pyrene; Acetylcysteine inhibits the reaction [sulforaphane affects the localization of NFE2L2 protein]; Acetylcysteine inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [sulforaphane results in increased phosphorylation of and results in increased activity of NFE2L2 protein]; ammonium metavanadate affects the reaction [sulforaphane affects the localization of NFE2L2 mRNA]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [sulforaphane results in increased expression of NFE2L2 protein]; cyanoginosin LR promotes the reaction [sulforaphane affects the localization of NFE2L2 protein]; Cycloheximide inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein]; Dactinomycin inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein]; KEAP1 protein mutant form inhibits the reaction [sulforaphane results in increased expression of and results in increased activity of NFE2L2 protein]; KEAP1 protein promotes the reaction [sulforaphane results in increased expression of and results in increased activity of NFE2L2 protein]; NFE2L2 mutant form inhibits the reaction [sulforaphane results in increased expression of GCLC mRNA]; NFE2L2 mutant form inhibits the reaction [sulforaphane results in increased expression of HMOX1 protein]; NFE2L2 mutant form inhibits the reaction [sulforaphane results in increased expression of NQO1 mRNA]; NFE2L2 mutant form inhibits the reaction [sulforaphane results in increased expression of NQO1 protein]; NFE2L2 mutant form inhibits the reaction [sulforaphane results in increased expression of TXNRD1 mRNA]; NFE2L2 mutant form inhibits the reaction [sulforaphane results in increased expression of TXNRD1 protein]; NFE2L2 protein affects the reaction [sulforaphane inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B protein]]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of AKR1C1 mRNA]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of ALDH2 protein]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of AR protein]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of CES1 mRNA alternative form]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of GCLM protein]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of HMOX1]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of TXNRD1 protein]; Reactive Oxygen Species affects the reaction [sulforaphane promotes the reaction [NFE2L2 protein results in increased expression of HMOX1 protein]]; Staurosporine inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein]; sulforaphane affects the localization of and results in increased activity of NFE2L2 protein; sulforaphane affects the localization of and results in increased expression of NFE2L2 protein; sulforaphane binds to and results in increased activity of NFE2L2 protein; sulforaphane metabolite promotes the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased activity of NFE2L2 protein]; sulforaphane promotes the reaction [3,3'-diindolylmethane results in increased expression of NFE2L2 mRNA]; sulforaphane promotes the reaction [3,3'-diindolylmethane results in increased expression of NFE2L2 protein]; sulforaphane promotes the reaction [[NFE2L2 protein binds to CES1 promoter] which results in increased expression of CES1 mRNA alternative form]; sulforaphane promotes the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased activity of NFE2L2 protein]; sulforaphane promotes the reaction [KEAP1 protein binds to NFE2L2 protein]; sulforaphane promotes the reaction [NFE2L2 protein binds to CES1 promoter]; sulforaphane promotes the reaction [NFE2L2 protein binds to EPHX1 enhancer]; sulforaphane promotes the reaction [NFE2L2 protein binds to KEAP1 protein]; sulforaphane promotes the reaction [NFE2L2 protein results in increased expression of HMOX1 protein]; sulforaphane promotes the reaction [NFE2L2 protein results in increased expression of SREBF1 mRNA]; sulforaphane promotes the reaction [SLC39A2 protein results in increased activity of NFE2L2 protein]; sulforaphane results in decreased ubiquitination of and results in increased expression of and affects the localization of NFE2L2 protein; sulforaphane results in increased expression of and affects the localization of NFE2L2 protein; sulforaphane results in increased expression of and results in decreased degradation of NFE2L2 protein; sulforaphane results in increased expression of and results in increased activity of NFE2L2 protein; sulforaphane results in increased phosphorylation of and results in increased activity of NFE2L2 protein sulforaphane results in decreased phosphorylation of NFE2L2 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein]; [sulforaphane promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]] which results in increased expression of GSTP1 mRNA; benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [sulforaphane results in increased activity of NFE2L2 protein]; Hydrocortisone inhibits the reaction [Hydrogen Peroxide promotes the reaction [sulforaphane results in increased expression of NFE2L2 protein]]; Hydrocortisone inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]; Hydrocortisone inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein]; Hydrogen Peroxide promotes the reaction [sulforaphane results in increased activity of NFE2L2 protein]; Hydrogen Peroxide promotes the reaction [sulforaphane results in increased expression of NFE2L2 protein]; NFE2L2 protein affects the reaction [[sulforaphane co-treated with Diatrizoate Meglumine] results in increased activity of CASP3 protein]; NFE2L2 protein affects the reaction [sulforaphane inhibits the reaction [Diatrizoate Meglumine results in increased expression of IL6 protein]]; Nitroprusside inhibits the reaction [sulforaphane results in increased expression of NFE2L2 protein]; sulforaphane inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NFE2L2 protein]; sulforaphane inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 mRNA]; sulforaphane inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein]; sulforaphane promotes the reaction [NFE2L2 protein binds to GSTP1 enhancer]; sulforaphane promotes the reaction [NFE2L2 protein binds to KEAP1 protein]; sulforaphane results in increased expression of and results in decreased degradation of NFE2L2 protein sulforaphane results in increased localization of NFE2L2 protein sulforaphane affects the localization of NFE2L2 mRNA; sulforaphane affects the localization of NFE2L2 protein NFE2L2 protein mutant form results in increased susceptibility to sulforaphane; NFE2L2 protein results in increased susceptibility to sulforaphane [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to 1,2-naphthoquinone; [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Acrolein; [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to benzyl isothiocyanate; [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Cadmium Chloride; [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Carmustine; [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Chlorambucil; [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Cisplatin; [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to cumene hydroperoxide; [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Diamide; [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Dinitrochlorobenzene; [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Doxorubicin; [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Ethacrynic Acid; [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Hydrogen Peroxide; [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Mercuric Chloride; [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to sodium arsenite; [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to Vitamin K 3; [NFE2L2 affects the susceptibility to sulforaphane] which affects the susceptibility to zinc chloride; [NFE2L2 protein affects the susceptibility to 1,2-Dimethylhydrazine] which affects the susceptibility to sulforaphane; [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the susceptibility to Oxygen deficiency; NFE2L2 affects the susceptibility to sulforaphane; NFE2L2 protein affects the susceptibility to sulforaphane NFE2L2 protein results in increased susceptibility to sulforaphane; NFE2L2 results in increased susceptibility to sulforaphane sulforaphane affects the activity of NFE2L2 protein NFE2L2 gene mutant form results in decreased susceptibility to sulforaphane; NFE2L2 protein results in decreased susceptibility to sulforaphane
CTD
PMID:11309284 PMID:16890772 PMID:18385089 PMID:18417180 PMID:19071154 PMID:19303893 PMID:19558496 PMID:19715681 PMID:20237067 PMID:20599494 PMID:20600217 PMID:20806931 PMID:20868228 PMID:20887713 PMID:20932822 PMID:21177068 PMID:21382770 PMID:21684301 PMID:21723306 PMID:22019695 PMID:22023613 PMID:22192953 PMID:22558124 PMID:22606287 PMID:22664424 PMID:22746536 PMID:22807314 PMID:23583297 PMID:23589329 PMID:23899529 PMID:23958496 PMID:24161444 PMID:24704207 PMID:24707343 PMID:24967692 PMID:25111660 PMID:25159039 PMID:25466015 PMID:26388957 PMID:26454883 PMID:27993529 PMID:28295950 PMID:28733231 PMID:28790194 PMID:28796629 PMID:28959534 PMID:29155359 PMID:29353218 PMID:29792947 PMID:29950142 PMID:29964319 PMID:30096613 PMID:30529165 PMID:30672058 PMID:30703377 PMID:30835071 PMID:30965051 PMID:31173751 PMID:31299238 PMID:31518892 PMID:31746589 PMID:32073640 PMID:32238698 PMID:32387680 PMID:32416107 PMID:32682831 PMID:32937103 PMID:33007382 PMID:33814512 PMID:34651546 PMID:35227738 PMID:35724838 PMID:37385402 PMID:37567421 More...
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NFIA
nuclear factor I A
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of NFIA mRNA
CTD
PMID:25450479
NCBI chr 1:61,077,227...61,462,788
Ensembl chr 1:60,865,259...61,462,788
G
NFKB1
nuclear factor kappa B subunit 1
multiple interactions
ISO EXP
sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of NFKB1 protein]; sulforaphane inhibits the reaction [Dinitrochlorobenzene results in increased expression of NFKB1 mRNA]; sulforaphane inhibits the reaction [Lipopolysaccharides promotes the reaction [NFKB1 protein binds to RELA protein]]
CTD
PMID:16890772 PMID:19071154 PMID:34651546
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
NFKBIA
NFKB inhibitor alpha
multiple interactions decreases expression
ISO EXP
sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased phosphorylation of NFKBIA protein]; sulforaphane inhibits the reaction [Cyclosporine results in increased phosphorylation of NFKBIA protein] sulforaphane inhibits the reaction [IL1B protein affects the localization of NFKBIA protein]; sulforaphane inhibits the reaction [TNF protein affects the localization of NFKBIA protein] sulforaphane results in decreased expression of NFKBIA mRNA
CTD
PMID:19071154 PMID:23958496 PMID:31838189 PMID:35724838
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NFKBIB
NFKB inhibitor beta
multiple interactions
EXP
sulforaphane inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIB protein]
CTD
PMID:16890772
NCBI chr19:38,899,666...38,908,889
Ensembl chr19:38,899,700...38,908,893
G
NFKBIE
NFKB inhibitor epsilon
decreases expression
EXP
sulforaphane results in decreased expression of NFKBIE mRNA
CTD
PMID:35724838
NCBI chr 6:44,258,166...44,265,551
Ensembl chr 6:44,258,166...44,265,788
G
NFKBIZ
NFKB inhibitor zeta
decreases expression
EXP
sulforaphane results in decreased expression of NFKBIZ mRNA
CTD
PMID:31838189
NCBI chr 3:101,827,990...101,861,022
Ensembl chr 3:101,827,991...101,861,022
G
NGF
nerve growth factor
multiple interactions
EXP
NGF protein inhibits the reaction [sulforaphane results in decreased phosphorylation of AKT1 protein]; NGF protein inhibits the reaction [sulforaphane results in increased activity of CASP3 protein]; NGF protein inhibits the reaction [sulforaphane results in increased expression of NGFR mRNA]; NGF protein inhibits the reaction [sulforaphane results in increased expression of NTRK1 mRNA]
CTD
PMID:29407470
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
NGFR
nerve growth factor receptor
increases expression multiple interactions
EXP
sulforaphane results in increased expression of NGFR mRNA NGF protein inhibits the reaction [sulforaphane results in increased expression of NGFR mRNA]
CTD
PMID:29407470
NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008
G
NHLRC2
NHL repeat containing 2
decreases expression
ISO
sulforaphane results in decreased expression of NHLRC2 mRNA
CTD
PMID:30529165
NCBI chr10:113,854,661...113,917,194
Ensembl chr10:113,854,661...113,917,194
G
NHSL1
NHS like 1
increases expression
EXP
sulforaphane results in increased expression of NHSL1 mRNA
CTD
PMID:31838189
NCBI chr 6:138,422,043...138,693,212
Ensembl chr 6:138,422,043...138,692,571
G
NIPSNAP3A
nipsnap homolog 3A
decreases expression
EXP
sulforaphane results in decreased expression of NIPSNAP3A mRNA
CTD
PMID:31838189
NCBI chr 9:104,747,683...104,760,120
Ensembl chr 9:104,747,683...104,760,120
G
NKD1
NKD inhibitor of WNT signaling pathway 1
decreases expression
ISO
sulforaphane results in decreased expression of NKD1 mRNA
CTD
PMID:30529165
NCBI chr16:50,548,396...50,649,249
Ensembl chr16:50,548,396...50,649,249
G
NLRC5
NLR family CARD domain containing 5
decreases expression
EXP
sulforaphane results in decreased expression of NLRC5 mRNA
CTD
PMID:31838189
NCBI chr16:56,989,557...57,083,520
Ensembl chr16:56,989,485...57,083,531
G
NLRP3
NLR family pyrin domain containing 3
multiple interactions
ISO
sulforaphane inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NLRP3 protein]
CTD
PMID:36988325
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,332,331...247,449,108
G
NME1
NME/NM23 nucleoside diphosphate kinase 1
affects binding
EXP
NME1 protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr17:51,153,559...51,162,168
Ensembl chr17:51,153,559...51,162,428
G
NME2P1
NME2 pseudogene 1
affects binding
EXP
NME2P1 protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr12:120,282,218...120,282,856
Ensembl chr12:120,282,303...120,282,716
G
NME5
NME/NM23 family member 5
increases expression
ISO
sulforaphane results in increased expression of NME5 mRNA
CTD
PMID:30529165
NCBI chr 5:138,115,175...138,139,428
Ensembl chr 5:138,115,175...138,139,443
G
NMNAT1
nicotinamide nucleotide adenylyltransferase 1
increases expression
EXP
sulforaphane results in increased expression of NMNAT1 mRNA
CTD
PMID:31838189
NCBI chr 1:9,942,923...9,996,892
Ensembl chr 1:9,943,428...9,985,501
G
NMNAT3
nicotinamide nucleotide adenylyltransferase 3
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of NMNAT3 mRNA
CTD
PMID:25450479
NCBI chr 3:139,560,180...139,678,050
Ensembl chr 3:139,560,180...139,678,017
G
NNMT
nicotinamide N-methyltransferase
increases expression
ISO
sulforaphane results in increased expression of NNMT mRNA
CTD
PMID:30529165
NCBI chr11:114,257,806...114,313,536
Ensembl chr11:114,257,787...114,313,536
G
NOG
noggin
decreases expression
EXP
sulforaphane results in decreased expression of NOG mRNA
CTD
PMID:26833863
NCBI chr17:56,593,699...56,595,611
Ensembl chr17:56,593,699...56,595,611
G
NOS2
nitric oxide synthase 2
multiple interactions
ISO
sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of NOS2 protein]; sulforaphane inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]; sulforaphane inhibits the reaction [Trichloroethylene results in increased expression of NOS2 protein]
CTD
PMID:18838692 PMID:19071154 PMID:32073640
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOTCH1
notch receptor 1
multiple interactions
EXP
sulforaphane inhibits the reaction [Gemcitabine results in increased expression of NOTCH1 protein]
CTD
PMID:20940707
NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
G
NOTCH3
notch receptor 3
increases expression
EXP
sulforaphane results in increased expression of NOTCH3 mRNA
CTD
PMID:31838189
NCBI chr19:15,159,038...15,200,995
Ensembl chr19:15,159,038...15,200,995
G
NOTCH4
notch receptor 4
decreases expression
ISO
sulforaphane results in decreased expression of NOTCH4 mRNA
CTD
PMID:30529165
NCBI chr 6:32,194,843...32,224,067
Ensembl chr 6:32,194,843...32,224,067
G
NOTUM
notum, palmitoleoyl-protein carboxylesterase
decreases expression
EXP
sulforaphane results in decreased expression of NOTUM mRNA
CTD
PMID:31838189
NCBI chr17:81,952,507...81,961,187
Ensembl chr17:81,952,507...81,961,840
G
NOX4
NADPH oxidase 4
decreases expression
ISO
sulforaphane results in decreased expression of NOX4 mRNA
CTD
PMID:30529165
NCBI chr11:89,324,353...89,589,557
Ensembl chr11:89,324,353...89,498,187
G
NPC1
NPC intracellular cholesterol transporter 1
decreases expression increases expression
ISO EXP
sulforaphane results in decreased expression of NPC1 mRNA sulforaphane results in increased expression of NPC1 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr18:23,506,184...23,586,506
Ensembl chr18:23,506,184...23,586,506
G
NPPA
natriuretic peptide A
increases expression multiple interactions
ISO
sulforaphane results in increased expression of NPPA mRNA NFE2L2 gene mutant form inhibits the reaction [sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of NPPA protein]]; sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of NPPA mRNA]; sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of NPPA protein]
CTD
PMID:29353218 PMID:30529165
NCBI chr 1:11,845,709...11,847,783
Ensembl chr 1:11,845,709...11,848,345
G
NPR2
natriuretic peptide receptor 2
increases expression
EXP
sulforaphane results in increased expression of NPR2 mRNA
CTD
PMID:31838189
NCBI chr 9:35,791,591...35,809,731
Ensembl chr 9:35,791,003...35,809,732
G
NPR3
natriuretic peptide receptor 3
decreases expression
ISO
sulforaphane results in decreased expression of NPR3 mRNA
CTD
PMID:30529165
NCBI chr 5:32,690,872...32,791,720
Ensembl chr 5:32,689,070...32,791,724
G
NPTX1
neuronal pentraxin 1
decreases expression
ISO EXP
sulforaphane results in decreased expression of NPTX1 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr17:80,466,834...80,476,607
Ensembl chr17:80,466,834...80,477,843
G
NPY4R
neuropeptide Y receptor Y4
decreases expression
EXP
sulforaphane results in decreased expression of NPY4R mRNA
CTD
PMID:31838189
NCBI chr10:46,461,099...46,470,668
Ensembl chr10:46,461,099...46,465,958
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases activity decreases expression increases expression multiple interactions affects localization
EXP ISO
sulforaphane results in increased activity of NQO1 protein sulforaphane results in decreased expression of NQO1 mRNA sulforaphane metabolite results in increased expression of NQO1 mRNA; sulforaphane results in increased expression of NQO1 mRNA; sulforaphane results in increased expression of NQO1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sulforaphane results in increased expression of NQO1 protein]; Hydrocortisone inhibits the reaction [Hydrogen Peroxide promotes the reaction [sulforaphane results in increased expression of NQO1 protein]]; Hydrocortisone inhibits the reaction [sulforaphane results in increased expression of NQO1 mRNA]; Hydrocortisone inhibits the reaction [sulforaphane results in increased expression of NQO1 protein]; Hydrogen Peroxide promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]; Hydrogen Peroxide promotes the reaction [sulforaphane results in increased expression of NQO1 protein]; Nitroprusside inhibits the reaction [sulforaphane results in increased expression of NQO1 protein] sulforaphane results in increased expression of NQO1; sulforaphane results in increased expression of NQO1 mRNA; sulforaphane results in increased expression of NQO1 protein 3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]; Acetylcysteine inhibits the reaction [sulforaphane results in increased expression of NQO1 mRNA]; AHR mutant form inhibits the reaction [3,3'-diindolylmethane promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]]; AHR mutant form inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]]; ammonium metavanadate inhibits the reaction [sulforaphane results in increased expression of and results in increased activity of NQO1 protein]; ammonium metavanadate inhibits the reaction [sulforaphane results in increased expression of NQO1 mRNA]; Cacodylic Acid promotes the reaction [sulforaphane results in increased expression of and results in increased activity of NQO1 protein]; Cacodylic Acid promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]; cyanoginosin LR promotes the reaction [sulforaphane results in increased expression of NQO1 protein]; Estradiol inhibits the reaction [sulforaphane results in increased expression of NQO1 mRNA]; Mercuric Chloride promotes the reaction [sulforaphane results in increased expression of and results in increased activity of NQO1 protein]; Mercuric Chloride promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]; monomethylarsonic acid promotes the reaction [sulforaphane results in increased expression of and results in increased activity of NQO1 protein]; monomethylarsonic acid promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]; NFE2L2 mutant form inhibits the reaction [sulforaphane results in increased expression of NQO1 mRNA]; NFE2L2 mutant form inhibits the reaction [sulforaphane results in increased expression of NQO1 protein]; sulforaphane inhibits the reaction [2,2-dichloroacetyl chloride results in decreased expression of NQO1 protein]; sulforaphane metabolite promotes the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of NQO1 mRNA]; sulforaphane promotes the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of NQO1 mRNA]; sulforaphane promotes the reaction [Cisplatin results in increased expression of NQO1 mRNA]; sulforaphane results in increased expression of and results in increased activity of NQO1 protein; Tetrachlorodibenzodioxin promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]; trimethylarsine oxide promotes the reaction [sulforaphane results in increased expression of and results in increased activity of NQO1 protein]; trimethylarsine oxide promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA] sulforaphane affects the localization of NQO1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sulforaphane results in increased expression of NQO1 protein]; [Streptozocin co-treated with sulforaphane] results in increased expression of NQO1; [sulforaphane co-treated with Dibutyl Phthalate] results in increased expression of NQO1 protein; NFE2L2 gene mutant form inhibits the reaction [sulforaphane results in increased expression of NQO1 protein]; NFE2L2 mutant form inhibits the reaction [sulforaphane results in increased expression of NQO1 protein]; NFE2L2 protein promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]; Nitroprusside inhibits the reaction [sulforaphane results in increased expression of NQO1 protein]; sulforaphane inhibits the reaction [AGT protein modified form results in decreased expression of NQO1 mRNA]; sulforaphane inhibits the reaction [AGT protein modified form results in decreased expression of NQO1 protein]; sulforaphane inhibits the reaction [Carbon Tetrachloride results in decreased expression of NQO1 protein]; sulforaphane inhibits the reaction [fenamidone results in increased expression of NQO1 mRNA]; sulforaphane inhibits the reaction [Oxygen deficiency results in decreased expression of NQO1 mRNA]; sulforaphane inhibits the reaction [Oxygen deficiency results in decreased expression of NQO1 protein]; sulforaphane inhibits the reaction [Streptozocin results in decreased expression of NQO1 mRNA]; sulforaphane inhibits the reaction [Streptozocin results in decreased expression of NQO1 protein]; sulforaphane results in increased expression of and results in increased activity of NQO1 protein; Vanadium inhibits the reaction [sulforaphane affects the localization of NQO1 protein]; Vanadium inhibits the reaction [sulforaphane results in increased activity of NQO1 protein]; Vanadium inhibits the reaction [sulforaphane results in increased expression of NQO1 mRNA]; Vanadium inhibits the reaction [sulforaphane results in increased expression of NQO1 protein]
CTD
PMID:11264000 PMID:11309284 PMID:15672752 PMID:15896333 PMID:15906351 PMID:16905640 PMID:17923278 PMID:18417180 PMID:18838692 PMID:19033392 PMID:19071154 PMID:19303893 PMID:19367690 PMID:20442190 PMID:20599494 PMID:20600217 PMID:20833222 PMID:20868228 PMID:20932822 PMID:21464939 PMID:21539383 PMID:21684301 PMID:21803983 PMID:21843634 PMID:22023613 PMID:22558124 PMID:22606287 PMID:22664424 PMID:22807314 PMID:23583297 PMID:24161444 PMID:24184564 PMID:24383545 PMID:24603300 PMID:24646717 PMID:24967692 PMID:25841332 PMID:26473469 PMID:26623679 PMID:26833863 PMID:27029645 PMID:27562236 PMID:27777014 PMID:28295950 PMID:28790194 PMID:28959534 PMID:29353218 PMID:29964319 PMID:30096613 PMID:30684530 PMID:30703377 PMID:30940547 PMID:31299238 PMID:31518892 PMID:31746589 PMID:31838189 PMID:32111854 PMID:32238698 PMID:32387680 PMID:32682831 PMID:33814512 PMID:33930529 PMID:35227738 PMID:35724838 PMID:37385402 More...
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NQO2
N-ribosyldihydronicotinamide:quinone dehydrogenase 2
increases expression
EXP
sulforaphane results in increased expression of NQO2 mRNA
CTD
PMID:26833863
NCBI chr 6:2,999,894...3,019,755
Ensembl chr 6:2,987,987...3,019,755
G
NR1D2
nuclear receptor subfamily 1 group D member 2
increases expression
EXP
sulforaphane results in increased expression of NR1D2 mRNA
CTD
PMID:31838189
NCBI chr 3:23,945,286...23,980,617
Ensembl chr 3:23,945,286...23,980,617
G
NR1I2
nuclear receptor subfamily 1 group I member 2
multiple interactions decreases expression decreases activity
ISO EXP
N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [sulforaphane results in decreased expression of NR1I2 mRNA]; sulforaphane inhibits the reaction [N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of NR1I2 mRNA]; sulforaphane inhibits the reaction [Pregnenolone Carbonitrile results in increased activity of NR1I2 protein] sulforaphane results in decreased activity of NR1I2 protein sulforaphane inhibits the reaction [3,3',4,5'-tetrahydroxystilbene results in increased activity of NR1I2 protein]; sulforaphane inhibits the reaction [acacetin results in increased activity of NR1I2 protein]; sulforaphane inhibits the reaction [alpha-methylepinine results in decreased expression of NR1I2 mRNA]; sulforaphane inhibits the reaction [Genistein results in increased activity of NR1I2 protein]; sulforaphane inhibits the reaction [NCOR2 protein binds to NR1I2 protein]; sulforaphane inhibits the reaction [Resveratrol results in increased activity of NR1I2 protein]; sulforaphane inhibits the reaction [Rifampin results in increased activity of NR1I2 protein]
CTD
PMID:21402137 PMID:21871945 PMID:29356861 PMID:29933105
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
G
NR3C1
nuclear receptor subfamily 3 group C member 1
multiple interactions
EXP
[Hydrocortisone results in increased activity of NR3C1 protein] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]; [Mifepristone binds to and results in decreased activity of NR3C1 protein] inhibits the reaction [[HSD11B1 protein results in increased activity of Cortisone] inhibits the reaction [sulforaphane results in increased activity of NFE2L2 protein]]
CTD
PMID:22606287
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
NR4A1
nuclear receptor subfamily 4 group A member 1
increases expression
ISO
sulforaphane results in increased expression of NR4A1 mRNA
CTD
PMID:30529165
NCBI chr12:52,022,832...52,059,503
Ensembl chr12:52,022,832...52,059,507
G
NR4A3
nuclear receptor subfamily 4 group A member 3
decreases expression
EXP
sulforaphane results in decreased expression of NR4A3 mRNA
CTD
PMID:31838189
NCBI chr 9:99,821,885...99,866,891
Ensembl chr 9:99,821,855...99,866,891
G
NR5A2
nuclear receptor subfamily 5 group A member 2
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of NR5A2 mRNA
CTD
PMID:25450479
NCBI chr 1:200,027,710...200,177,415
Ensembl chr 1:200,027,614...200,177,420
G
NREP
neuronal regeneration related protein
decreases expression
EXP
sulforaphane results in decreased expression of NREP mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr 5:111,728,802...111,976,932
Ensembl chr 5:111,662,621...111,997,464
G
NRF1
nuclear respiratory factor 1
increases expression
EXP
sulforaphane results in increased expression of NRF1 protein
CTD
PMID:27993529
NCBI chr 7:129,611,720...129,757,076
Ensembl chr 7:129,611,720...129,757,082
G
NRG1
neuregulin 1
increases expression
EXP
sulforaphane results in increased expression of NRG1 mRNA
CTD
PMID:31838189
NCBI chr 8:31,639,245...32,774,046
Ensembl chr 8:31,639,222...32,855,666
G
NRXN3
neurexin 3
decreases expression
EXP
sulforaphane results in decreased expression of NRXN3 mRNA
CTD
PMID:31838189
NCBI chr14:78,170,373...79,868,291
Ensembl chr14:78,170,373...79,868,291
G
NT5DC3
5'-nucleotidase domain containing 3
increases expression
EXP
sulforaphane results in increased expression of NT5DC3 mRNA
CTD
PMID:31838189
NCBI chr12:103,746,315...103,841,234
Ensembl chr12:103,770,453...103,841,234
G
NTRK1
neurotrophic receptor tyrosine kinase 1
increases expression multiple interactions
EXP
sulforaphane results in increased expression of NTRK1 mRNA NGF protein inhibits the reaction [sulforaphane results in increased expression of NTRK1 mRNA]
CTD
PMID:29407470
NCBI chr 1:156,815,750...156,881,850
Ensembl chr 1:156,815,636...156,881,850
G
NTRK2
neurotrophic receptor tyrosine kinase 2
multiple interactions increases expression
EXP
sulforaphane inhibits the reaction [Pyruvaldehyde results in decreased expression of NTRK2 protein] sulforaphane results in increased expression of NTRK2 protein
CTD
PMID:25933243
NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751
G
NUAK1
NUAK family kinase 1
decreases expression
EXP
sulforaphane results in decreased expression of NUAK1 mRNA
CTD
PMID:31838189
NCBI chr12:106,063,345...106,138,954
Ensembl chr12:106,063,345...106,138,954
G
NUDT7
nudix hydrolase 7
decreases expression
EXP
sulforaphane results in decreased expression of NUDT7 mRNA
CTD
PMID:26833863
NCBI chr16:77,722,514...77,742,260
Ensembl chr16:77,722,492...77,742,260
G
NUDT8
nudix hydrolase 8
increases expression
ISO
sulforaphane results in increased expression of NUDT8 mRNA
CTD
PMID:30529165
NCBI chr11:67,627,938...67,629,937
Ensembl chr11:67,627,938...67,629,937
G
NUMBL
NUMB like endocytic adaptor protein
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of NUMBL mRNA
CTD
PMID:30529165
NCBI chr19:40,665,905...40,690,651
Ensembl chr19:40,665,905...40,690,972
G
NUP160
nucleoporin 160
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of NUP160 mRNA
CTD
PMID:30529165
NCBI chr11:47,778,118...47,848,544
Ensembl chr11:47,778,087...47,848,555
G
NXNL2
nucleoredoxin like 2
decreases expression
EXP
sulforaphane results in decreased expression of NXNL2 mRNA
CTD
PMID:31838189
NCBI chr 9:88,535,178...88,584,510
Ensembl chr 9:88,534,033...88,584,274
G
NYAP2
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2
decreases expression
EXP
sulforaphane results in decreased expression of NYAP2 mRNA
CTD
PMID:31838189
NCBI chr 2:225,397,939...225,703,654
Ensembl chr 2:225,399,710...225,729,887
G
OBSCN
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
increases expression
ISO
sulforaphane results in increased expression of OBSCN mRNA
CTD
PMID:30529165
NCBI chr 1:228,208,044...228,378,876
Ensembl chr 1:228,208,044...228,378,876
G
OGA
O-GlcNAcase
increases expression
EXP
sulforaphane results in increased expression of OGA mRNA
CTD
PMID:31838189
NCBI chr10:101,784,450...101,818,444
Ensembl chr10:101,784,443...101,818,465
G
OGN
osteoglycin
decreases expression
ISO
sulforaphane results in decreased expression of OGN mRNA
CTD
PMID:30529165
NCBI chr 9:92,383,268...92,404,699
Ensembl chr 9:92,383,268...92,404,696
G
OLFM4
olfactomedin 4
decreases expression
EXP
sulforaphane results in decreased expression of OLFM4 mRNA
CTD
PMID:31838189
NCBI chr13:53,028,813...53,052,057
Ensembl chr13:53,028,813...53,052,057
G
OLFML1
olfactomedin like 1
decreases expression
EXP
sulforaphane results in decreased expression of OLFML1 mRNA
CTD
PMID:31838189
NCBI chr11:7,485,506...7,511,377
Ensembl chr11:7,485,388...7,511,377
G
OLFML2A
olfactomedin like 2A
decreases expression
EXP
sulforaphane results in decreased expression of OLFML2A mRNA
CTD
PMID:31838189
NCBI chr 9:124,777,133...124,814,882
Ensembl chr 9:124,777,133...124,814,885
G
OLFML2B
olfactomedin like 2B
increases expression decreases expression
ISO EXP
sulforaphane results in increased expression of OLFML2B mRNA sulforaphane results in decreased expression of OLFML2B mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 1:161,983,192...162,023,869
Ensembl chr 1:161,983,192...162,023,869
G
OLR1
oxidized low density lipoprotein receptor 1
decreases expression increases expression
ISO EXP
sulforaphane results in decreased expression of OLR1 mRNA sulforaphane results in increased expression of OLR1 mRNA
CTD
PMID:30529165 PMID:35724838
NCBI chr12:10,158,301...10,176,266
Ensembl chr12:10,158,301...10,172,138
G
OPLAH
5-oxoprolinase, ATP-hydrolysing
decreases expression
EXP
sulforaphane results in decreased expression of OPLAH mRNA
CTD
PMID:31838189
NCBI chr 8:144,050,322...144,063,961
Ensembl chr 8:144,051,266...144,063,965
G
OPN3
opsin 3
increases expression
EXP
sulforaphane results in increased expression of OPN3 mRNA
CTD
PMID:31838189
NCBI chr 1:241,593,124...241,640,369
Ensembl chr 1:241,590,102...241,677,376 Ensembl chr 1:241,590,102...241,677,376
G
OR2H2
olfactory receptor family 2 subfamily H member 2
increases expression
EXP
sulforaphane results in increased expression of OR2H2 mRNA
CTD
PMID:26833863
NCBI chr 6:29,585,121...29,590,500
Ensembl chr 6:29,585,121...29,590,500
G
OR2T4
olfactory receptor family 2 subfamily T member 4
decreases expression
EXP
sulforaphane results in decreased expression of OR2T4 mRNA
CTD
PMID:26833863
NCBI chr 1:248,361,665...248,362,627
Ensembl chr 1:248,361,665...248,362,627
G
ORM1
orosomucoid 1
increases expression
ISO
sulforaphane results in increased expression of ORM1 mRNA
CTD
PMID:30529165
NCBI chr 9:114,323,098...114,326,479
Ensembl chr 9:114,323,098...114,326,479
G
OSBP2
oxysterol binding protein 2
decreases expression
EXP
sulforaphane results in decreased expression of OSBP2 mRNA
CTD
PMID:31838189
NCBI chr22:30,693,782...30,907,813
Ensembl chr22:30,693,782...30,907,824
G
OSBPL6
oxysterol binding protein like 6
increases expression
EXP
sulforaphane results in increased expression of OSBPL6 mRNA
CTD
PMID:31838189
NCBI chr 2:178,193,774...178,402,893
Ensembl chr 2:178,194,481...178,402,893
G
OSBPL7
oxysterol binding protein like 7
decreases expression
EXP
sulforaphane results in decreased expression of OSBPL7 mRNA
CTD
PMID:31838189
NCBI chr17:47,807,372...47,821,794
Ensembl chr17:47,807,372...47,821,803
G
OSGIN1
oxidative stress induced growth inhibitor 1
increases expression
EXP
sulforaphane results in increased expression of OSGIN1 mRNA
CTD
PMID:31838189
NCBI chr16:83,953,240...83,966,332
Ensembl chr16:83,931,311...83,966,332
G
OSGIN2
oxidative stress induced growth inhibitor family member 2
increases expression
EXP
sulforaphane results in increased expression of OSGIN2 mRNA
CTD
PMID:31838189
NCBI chr 8:89,901,868...89,927,888
Ensembl chr 8:89,901,849...89,927,888
G
OSTM1
osteoclastogenesis associated transmembrane protein 1
increases expression
EXP
sulforaphane results in increased expression of OSTM1 mRNA
CTD
PMID:31838189
NCBI chr 6:108,041,409...108,074,741
Ensembl chr 6:108,029,245...108,165,854
G
OTUD7A
OTU deubiquitinase 7A
decreases expression
EXP
sulforaphane results in decreased expression of OTUD7A mRNA
CTD
PMID:31838189
NCBI chr15:31,475,398...31,870,673
Ensembl chr15:31,475,398...31,870,789
G
OTULINL
OTU deubiquitinase with linear linkage specificity like
decreases expression
EXP
sulforaphane results in decreased expression of OTULINL mRNA
CTD
PMID:31838189
NCBI chr 5:14,581,792...14,616,180
Ensembl chr 5:14,581,792...14,616,180
G
P2RX3
purinergic receptor P2X 3
decreases expression
EXP
sulforaphane results in decreased expression of P2RX3 mRNA
CTD
PMID:31838189
NCBI chr11:57,335,950...57,372,396
Ensembl chr11:57,338,352...57,372,396
G
P2RY11
purinergic receptor P2Y11
increases expression
EXP
sulforaphane results in increased expression of P2RY11 mRNA
CTD
PMID:31838189
NCBI chr19:10,111,693...10,115,372
Ensembl chr19:10,111,693...10,115,372
G
P2RY2
purinergic receptor P2Y2
decreases expression
EXP
sulforaphane results in decreased expression of P2RY2 mRNA
CTD
PMID:31838189
NCBI chr11:73,218,281...73,242,427
Ensembl chr11:73,218,281...73,242,427
G
P2RY6
pyrimidinergic receptor P2Y6
decreases expression
EXP
sulforaphane results in decreased expression of P2RY6 mRNA
CTD
PMID:31838189
NCBI chr11:73,264,506...73,298,625
Ensembl chr11:73,264,498...73,305,103
G
P4HB
prolyl 4-hydroxylase subunit beta
affects binding
EXP
P4HB protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr17:81,843,166...81,860,535
Ensembl chr17:81,843,159...81,860,856
G
PACC1
proton activated chloride channel 1
increases expression
EXP
sulforaphane results in increased expression of PACC1 mRNA
CTD
PMID:31838189
NCBI chr 1:212,363,928...212,414,886
Ensembl chr 1:212,363,928...212,414,901
G
PADI4
peptidyl arginine deiminase 4
increases expression
EXP
sulforaphane results in increased expression of PADI4 mRNA
CTD
PMID:26833863
NCBI chr 1:17,308,197...17,364,004
Ensembl chr 1:17,308,195...17,364,004
G
PAFAH1B3
platelet activating factor acetylhydrolase 1b catalytic subunit 3
decreases expression
EXP
sulforaphane results in decreased expression of PAFAH1B3 mRNA
CTD
PMID:31838189
NCBI chr19:42,297,033...42,302,800
Ensembl chr19:42,297,033...42,303,546
G
PALM
paralemmin
decreases expression
EXP
sulforaphane results in decreased expression of PALM mRNA
CTD
PMID:31838189
NCBI chr19:708,935...748,329
Ensembl chr19:708,935...748,329
G
PALMD
palmdelphin
decreases expression
EXP
sulforaphane results in decreased expression of PALMD mRNA
CTD
PMID:31838189
NCBI chr 1:99,646,113...99,694,535
Ensembl chr 1:99,646,113...99,694,541
G
PANK4
pantothenate kinase 4 (inactive)
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PANK4 mRNA
CTD
PMID:30529165
NCBI chr 1:2,508,537...2,526,596
Ensembl chr 1:2,508,537...2,526,597
G
PANX2
pannexin 2
increases expression
EXP
sulforaphane results in increased expression of PANX2 mRNA
CTD
PMID:31838189
NCBI chr22:50,170,731...50,180,295
Ensembl chr22:50,170,731...50,180,295
G
PAOX
polyamine oxidase
decreases expression
EXP
sulforaphane results in decreased expression of PAOX mRNA
CTD
PMID:31838189
NCBI chr10:133,379,262...133,391,694
Ensembl chr10:133,379,261...133,391,694
G
PAPSS1
3'-phosphoadenosine 5'-phosphosulfate synthase 1
decreases expression
EXP
sulforaphane results in decreased expression of PAPSS1 mRNA
CTD
PMID:31838189
NCBI chr 4:107,613,666...107,720,234
Ensembl chr 4:107,590,276...107,720,234
G
PAQR9
progestin and adipoQ receptor family member 9
increases expression
ISO
sulforaphane results in increased expression of PAQR9 mRNA
CTD
PMID:30529165
NCBI chr 3:142,949,164...142,964,008
Ensembl chr 3:142,949,164...142,963,674
G
PARD3
par-3 family cell polarity regulator
decreases expression
ISO
sulforaphane results in decreased expression of PARD3 mRNA
CTD
PMID:30529165
NCBI chr10:34,109,561...34,815,296
Ensembl chr10:34,109,560...34,815,325
G
PARM1
prostate androgen-regulated mucin-like protein 1
increases expression
ISO
sulforaphane results in increased expression of PARM1 mRNA
CTD
PMID:30529165
NCBI chr 4:74,933,116...75,050,113
Ensembl chr 4:74,933,095...75,050,115
G
PARP1
poly(ADP-ribose) polymerase 1
multiple interactions increases expression
ISO EXP
sulforaphane inhibits the reaction [cyanoginosin LR results in increased cleavage of PARP1 protein] sulforaphane results in increased expression of PARP1 protein modified form [sulforaphane co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein; [sulforaphane co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein; Acetylcysteine inhibits the reaction [[sulforaphane co-treated with Arsenic Trioxide] results in increased cleavage of PARP1 protein]
CTD
PMID:21684301 PMID:22922937 PMID:29792947 PMID:33894213
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
G
PARP2
poly(ADP-ribose) polymerase 2
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PARP2 mRNA
CTD
PMID:30529165
NCBI chr14:20,343,635...20,357,904
Ensembl chr14:20,343,615...20,357,904
G
PBX1
PBX homeobox 1
decreases expression
EXP
sulforaphane results in decreased expression of PBX1 mRNA
CTD
PMID:31838189
NCBI chr 1:164,559,184...164,886,047
Ensembl chr 1:164,555,584...164,899,296
G
PC
pyruvate carboxylase
decreases expression
EXP
sulforaphane results in decreased expression of PC mRNA
CTD
PMID:31838189
NCBI chr11:66,848,420...66,958,383
Ensembl chr11:66,848,417...66,958,386
G
PCBP4
poly(rC) binding protein 4
decreases expression
EXP
sulforaphane results in decreased expression of PCBP4 mRNA
CTD
PMID:31838189
NCBI chr 3:51,957,454...51,967,466
Ensembl chr 3:51,957,454...51,974,016
G
PCDH10
protocadherin 10
decreases expression
EXP
sulforaphane results in decreased expression of PCDH10 mRNA
CTD
PMID:31838189
NCBI chr 4:133,149,294...133,208,606
Ensembl chr 4:133,149,294...133,208,606
G
PCDH7
protocadherin 7
increases expression
ISO
sulforaphane results in increased expression of PCDH7 mRNA
CTD
PMID:30529165
NCBI chr 4:30,720,369...31,146,800
Ensembl chr 4:30,720,369...31,146,805
G
PCDHB7
protocadherin beta 7
decreases expression
ISO
sulforaphane results in decreased expression of PCDHB7 mRNA
CTD
PMID:30529165
NCBI chr 5:141,172,644...141,176,383
Ensembl chr 5:141,172,644...141,176,383
G
PCED1B
PC-esterase domain containing 1B
decreases expression
EXP
sulforaphane results in decreased expression of PCED1B mRNA
CTD
PMID:31838189
NCBI chr12:47,079,621...47,236,660
Ensembl chr12:47,079,603...47,236,662
G
PCK1
phosphoenolpyruvate carboxykinase 1
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of PCK1 mRNA
CTD
PMID:25450479
NCBI chr20:57,561,110...57,568,121
Ensembl chr20:57,561,080...57,568,121
G
PCK2
phosphoenolpyruvate carboxykinase 2, mitochondrial
increases expression
EXP
sulforaphane results in increased expression of PCK2 mRNA
CTD
PMID:31838189
NCBI chr14:24,094,171...24,104,125
Ensembl chr14:24,094,053...24,110,598
G
PCLAF
PCNA clamp associated factor
decreases expression
EXP
sulforaphane results in decreased expression of PCLAF mRNA
CTD
PMID:31838189
NCBI chr15:64,364,304...64,387,687
Ensembl chr15:64,364,304...64,387,687
G
PCNA
proliferating cell nuclear antigen
affects binding
EXP
PCNA protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
G
PCNP
PEST proteolytic signal containing nuclear protein
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PCNP mRNA
CTD
PMID:30529165
NCBI chr 3:101,574,094...101,594,465
Ensembl chr 3:101,574,180...101,594,465
G
PCOLCE
procollagen C-endopeptidase enhancer
decreases expression
EXP
sulforaphane results in decreased expression of PCOLCE mRNA
CTD
PMID:31838189
NCBI chr 7:100,602,363...100,608,175
Ensembl chr 7:100,602,363...100,608,175
G
PCOLCE2
procollagen C-endopeptidase enhancer 2
decreases expression
ISO
sulforaphane results in decreased expression of PCOLCE2 mRNA
CTD
PMID:30529165
NCBI chr 3:142,817,874...142,889,083
Ensembl chr 3:142,815,922...142,889,206
G
PCP4L1
Purkinje cell protein 4 like 1
increases expression
ISO
sulforaphane results in increased expression of PCP4L1 mRNA
CTD
PMID:30529165
NCBI chr 1:161,258,745...161,285,450
Ensembl chr 1:161,258,745...161,285,450
G
PCSK1
proprotein convertase subtilisin/kexin type 1
decreases expression
EXP
sulforaphane results in decreased expression of PCSK1 mRNA
CTD
PMID:31838189
NCBI chr 5:96,390,333...96,433,248
Ensembl chr 5:96,390,333...96,434,143
G
PDE1A
phosphodiesterase 1A
decreases expression
EXP
sulforaphane results in decreased expression of PDE1A mRNA
CTD
PMID:31838189
NCBI chr 2:182,140,041...182,716,797
Ensembl chr 2:182,139,968...182,523,359
G
PDE3A
phosphodiesterase 3A
decreases expression
EXP
sulforaphane results in decreased expression of PDE3A mRNA
CTD
PMID:31838189
NCBI chr12:20,368,537...20,688,583
Ensembl chr12:20,368,537...20,688,583
G
PDE4B
phosphodiesterase 4B
increases expression decreases expression
EXP
sulforaphane results in increased expression of PDE4B mRNA sulforaphane results in decreased expression of PDE4B mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr 1:65,792,510...66,374,579
Ensembl chr 1:65,792,514...66,374,579
G
PDE5A
phosphodiesterase 5A
decreases expression
EXP
sulforaphane results in decreased expression of PDE5A mRNA
CTD
PMID:31838189
NCBI chr 4:119,494,403...119,628,804
Ensembl chr 4:119,494,397...119,628,804
G
PDE7B
phosphodiesterase 7B
decreases expression
EXP
sulforaphane results in decreased expression of PDE7B mRNA
CTD
PMID:31838189
NCBI chr 6:135,851,701...136,195,574
Ensembl chr 6:135,851,701...136,195,574
G
PDE8B
phosphodiesterase 8B
decreases expression
ISO EXP
sulforaphane results in decreased expression of PDE8B mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 5:77,086,715...77,428,256
Ensembl chr 5:77,210,449...77,428,256 Ensembl chr 5:77,210,449...77,428,256
G
PDE9A
phosphodiesterase 9A
decreases expression
EXP
sulforaphane results in decreased expression of PDE9A mRNA
CTD
PMID:31838189
NCBI chr21:42,653,621...42,775,509
Ensembl chr21:42,653,621...42,775,509
G
PDGFB
platelet derived growth factor subunit B
increases expression
EXP
sulforaphane results in increased expression of PDGFB mRNA
CTD
PMID:35724838
NCBI chr22:39,223,359...39,244,982
Ensembl chr22:39,223,359...39,244,982
G
PDGFC
platelet derived growth factor C
increases expression
EXP
sulforaphane results in increased expression of PDGFC mRNA
CTD
PMID:31838189
NCBI chr 4:156,760,454...156,971,799
Ensembl chr 4:156,760,454...156,971,799
G
PDGFRB
platelet derived growth factor receptor beta
decreases expression
EXP
sulforaphane results in decreased expression of PDGFRB mRNA
CTD
PMID:31838189
NCBI chr 5:150,113,839...150,155,845
Ensembl chr 5:150,113,839...150,155,872
G
PDHB
pyruvate dehydrogenase E1 subunit beta
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of PDHB mRNA
CTD
PMID:25450479
NCBI chr 3:58,427,630...58,433,832
Ensembl chr 3:58,427,630...58,433,857
G
PDLIM1
PDZ and LIM domain 1
decreases expression
EXP
sulforaphane results in decreased expression of PDLIM1 mRNA
CTD
PMID:26833863
NCBI chr10:95,237,572...95,291,003
Ensembl chr10:95,237,572...95,291,012
G
PDZD2
PDZ domain containing 2
decreases expression
EXP
sulforaphane results in decreased expression of PDZD2 mRNA
CTD
PMID:31838189
NCBI chr 5:31,639,131...32,110,932
Ensembl chr 5:31,639,131...32,110,932
G
PDZK1IP1
PDZK1 interacting protein 1
decreases expression
EXP
sulforaphane results in decreased expression of PDZK1IP1 mRNA
CTD
PMID:31838189
NCBI chr 1:47,183,582...47,190,036
Ensembl chr 1:47,183,582...47,191,044
G
PEG10
paternally expressed 10
decreases expression
EXP
sulforaphane results in decreased expression of PEG10 mRNA
CTD
PMID:31838189
NCBI chr 7:94,656,325...94,669,695
Ensembl chr 7:94,656,325...94,669,695
G
PELI1
pellino E3 ubiquitin protein ligase 1
increases expression
EXP
sulforaphane results in increased expression of PELI1 mRNA
CTD
PMID:26833863
NCBI chr 2:64,092,652...64,144,420
Ensembl chr 2:64,092,652...64,144,420
G
PENK
proenkephalin
increases expression
ISO
sulforaphane results in increased expression of PENK mRNA
CTD
PMID:30529165
NCBI chr 8:56,440,957...56,446,641
Ensembl chr 8:56,436,674...56,446,671
G
PER2
period circadian regulator 2
decreases expression
ISO
sulforaphane results in decreased expression of PER2 mRNA
CTD
PMID:30529165
NCBI chr 2:238,244,044...238,300,065
Ensembl chr 2:238,244,044...238,290,102
G
PFKFB1
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1
increases expression
ISO
sulforaphane results in increased expression of PFKFB1 mRNA
CTD
PMID:30529165
NCBI chr X:54,932,961...54,998,789
Ensembl chr X:54,932,961...54,998,534
G
PGAP1
post-GPI attachment to proteins inositol deacylase 1
decreases expression
ISO
sulforaphane results in decreased expression of PGAP1 mRNA
CTD
PMID:30529165
NCBI chr 2:196,833,004...196,926,707
Ensembl chr 2:196,833,004...196,927,796
G
PGD
phosphogluconate dehydrogenase
increases expression
EXP
sulforaphane results in increased expression of PGD mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr 1:10,399,064...10,420,511
Ensembl chr 1:10,398,592...10,420,511
G
PGM5
phosphoglucomutase 5
decreases expression
EXP
sulforaphane results in decreased expression of PGM5 mRNA
CTD
PMID:31838189
NCBI chr 9:68,356,611...68,531,061
Ensembl chr 9:68,328,308...68,531,061
G
PGP
phosphoglycolate phosphatase
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PGP mRNA
CTD
PMID:30529165
NCBI chr16:2,211,593...2,214,840
Ensembl chr16:2,211,593...2,214,840
G
PHACTR2
phosphatase and actin regulator 2
increases expression
EXP
sulforaphane results in increased expression of PHACTR2 mRNA
CTD
PMID:26833863
NCBI chr 6:143,536,878...143,831,185
Ensembl chr 6:143,536,845...143,831,185
G
PHGDH
phosphoglycerate dehydrogenase
increases expression
ISO EXP
sulforaphane results in increased expression of PHGDH mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 1:119,711,934...119,744,215
Ensembl chr 1:119,648,411...119,744,218
G
PHKA1
phosphorylase kinase regulatory subunit alpha 1
increases expression
EXP
sulforaphane results in increased expression of PHKA1 mRNA
CTD
PMID:31838189
NCBI chr X:72,578,814...72,714,306
Ensembl chr X:72,578,814...72,714,319
G
PHPT1
phosphohistidine phosphatase 1
decreases expression
EXP
sulforaphane results in decreased expression of PHPT1 mRNA
CTD
PMID:31838189
NCBI chr 9:136,849,409...136,851,024
Ensembl chr 9:136,848,724...136,851,027
G
PHYH
phytanoyl-CoA 2-hydroxylase
increases expression
ISO
sulforaphane results in increased expression of PHYH mRNA
CTD
PMID:30529165
NCBI chr10:13,277,799...13,300,064
Ensembl chr10:13,277,796...13,302,412
G
PHYHIP
phytanoyl-CoA 2-hydroxylase interacting protein
decreases expression
EXP
sulforaphane results in decreased expression of PHYHIP mRNA
CTD
PMID:31838189
NCBI chr 8:22,219,703...22,232,099
Ensembl chr 8:22,219,703...22,232,101
G
PI4KB
phosphatidylinositol 4-kinase beta
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PI4KB mRNA
CTD
PMID:30529165
NCBI chr 1:151,291,797...151,327,715
Ensembl chr 1:151,291,797...151,327,715
G
PIGR
polymeric immunoglobulin receptor
increases expression
ISO
sulforaphane results in increased expression of PIGR mRNA
CTD
PMID:30529165
NCBI chr 1:206,928,522...206,946,466
Ensembl chr 1:206,928,522...206,946,466
G
PIK3C2A
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PIK3C2A mRNA
CTD
PMID:30529165
NCBI chr11:17,086,575...17,207,986
Ensembl chr11:17,077,730...17,207,986
G
PIK3CD
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
decreases expression
EXP
sulforaphane results in decreased expression of PIK3CD mRNA
CTD
PMID:31838189
NCBI chr 1:9,627,258...9,729,114
Ensembl chr 1:9,629,889...9,729,114
G
PIK3R3
phosphoinositide-3-kinase regulatory subunit 3
decreases expression
EXP
sulforaphane results in decreased expression of PIK3R3 mRNA
CTD
PMID:31838189
NCBI chr 1:46,040,140...46,174,901
Ensembl chr 1:46,040,140...46,133,036
G
PILRA
paired immunoglobin like type 2 receptor alpha
increases expression
EXP
sulforaphane results in increased expression of PILRA mRNA
CTD
PMID:26833863
NCBI chr 7:100,371,291...100,400,096
Ensembl chr 7:100,367,530...100,400,096
G
PINK1
PTEN induced kinase 1
increases expression decreases expression
EXP
sulforaphane results in increased expression of PINK1 mRNA sulforaphane results in decreased expression of PINK1 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr 1:20,633,458...20,651,511
Ensembl chr 1:20,633,458...20,651,511
G
PIP5K1B
phosphatidylinositol-4-phosphate 5-kinase type 1 beta
decreases expression
EXP
sulforaphane results in decreased expression of PIP5K1B mRNA
CTD
PMID:31838189
NCBI chr 9:68,705,240...69,009,176
Ensembl chr 9:68,705,240...69,009,176
G
PIR
pirin
increases expression
EXP
sulforaphane results in increased expression of PIR mRNA
CTD
PMID:31838189
NCBI chr X:15,384,799...15,493,333
Ensembl chr X:15,384,799...15,493,564
G
PITX1
paired like homeodomain 1
decreases expression
EXP
sulforaphane results in decreased expression of PITX1 mRNA
CTD
PMID:31838189
NCBI chr 5:135,027,734...135,034,789
Ensembl chr 5:135,027,734...135,034,813
G
PITX3
paired like homeodomain 3
increases methylation
EXP
sulforaphane results in increased methylation of PITX3 gene
CTD
PMID:31838189
NCBI chr10:102,230,189...102,241,512
Ensembl chr10:102,230,189...102,241,512
G
PKDCC
protein kinase domain containing, cytoplasmic
decreases expression
EXP
sulforaphane results in decreased expression of PKDCC mRNA
CTD
PMID:31838189
NCBI chr 2:42,048,021...42,058,517
Ensembl chr 2:42,048,021...42,058,517
G
PKIG
cAMP-dependent protein kinase inhibitor gamma
decreases expression
EXP
sulforaphane results in decreased expression of PKIG mRNA
CTD
PMID:31838189
NCBI chr20:44,531,875...44,619,037
Ensembl chr20:44,531,785...44,624,247
G
PKLR
pyruvate kinase L/R
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of PKLR mRNA
CTD
PMID:25450479
NCBI chr 1:155,289,293...155,308,654
Ensembl chr 1:155,289,293...155,301,438
G
PLA2G1B
phospholipase A2 group IB
decreases expression
ISO
sulforaphane results in decreased expression of PLA2G1B mRNA
CTD
PMID:30529165
NCBI chr12:120,322,115...120,327,779
Ensembl chr12:120,322,115...120,327,779
G
PLA2R1
phospholipase A2 receptor 1
decreases expression
EXP
sulforaphane results in decreased expression of PLA2R1 mRNA
CTD
PMID:31838189
NCBI chr 2:159,923,933...160,062,615
Ensembl chr 2:159,932,006...160,062,615
G
PLAAT2
phospholipase A and acyltransferase 2
decreases expression
EXP
sulforaphane results in decreased expression of PLAAT2 mRNA
CTD
PMID:31838189
NCBI chr11:63,552,770...63,565,070
Ensembl chr11:63,552,770...63,563,379
G
PLAAT3
phospholipase A and acyltransferase 3
increases expression
ISO
sulforaphane results in increased expression of PLAAT3 mRNA
CTD
PMID:30529165
NCBI chr11:63,574,462...63,616,927
Ensembl chr11:63,573,195...63,616,883
G
PLAC8
placenta associated 8
decreases expression
EXP
sulforaphane results in decreased expression of PLAC8 mRNA
CTD
PMID:31838189
NCBI chr 4:83,090,048...83,114,729
Ensembl chr 4:83,090,048...83,137,075
G
PLAC8L1
PLAC8 like 1
decreases expression
EXP
sulforaphane results in decreased expression of PLAC8L1 mRNA
CTD
PMID:26833863
NCBI chr 5:146,084,313...146,105,577
Ensembl chr 5:146,084,313...146,105,577
G
PLAT
plasminogen activator, tissue type
multiple interactions decreases expression
EXP
sulforaphane results in decreased activity of and results in decreased secretion of PLAT protein sulforaphane results in decreased expression of PLAT mRNA
CTD
PMID:32238698
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
G
PLAU
plasminogen activator, urokinase
increases expression
EXP
sulforaphane results in increased expression of PLAU mRNA
CTD
PMID:35724838
NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
G
PLCE1
phospholipase C epsilon 1
decreases expression
EXP
sulforaphane results in decreased expression of PLCE1 mRNA
CTD
PMID:31838189
NCBI chr10:93,993,931...94,332,823
Ensembl chr10:93,993,931...94,332,823
G
PLCH2
phospholipase C eta 2
decreases expression
EXP
sulforaphane results in decreased expression of PLCH2 mRNA
CTD
PMID:31838189
NCBI chr 1:2,415,943...2,505,532
Ensembl chr 1:2,425,980...2,505,532
G
PLCL1
phospholipase C like 1 (inactive)
decreases expression
EXP
sulforaphane results in decreased expression of PLCL1 mRNA
CTD
PMID:31838189
NCBI chr 2:197,804,593...198,149,863
Ensembl chr 2:197,804,593...198,572,581
G
PLD1
phospholipase D1
decreases expression
EXP
sulforaphane results in decreased expression of PLD1 mRNA
CTD
PMID:31838189
NCBI chr 3:171,600,404...171,810,483
Ensembl chr 3:171,600,404...171,810,950
G
PLD4
phospholipase D family member 4
decreases expression
EXP
sulforaphane results in decreased expression of PLD4 mRNA
CTD
PMID:26833863
NCBI chr14:104,924,879...104,937,785
Ensembl chr14:104,924,713...104,937,761
G
PLD6
phospholipase D family member 6
increases expression
EXP
sulforaphane results in increased expression of PLD6 mRNA
CTD
PMID:31838189
NCBI chr17:17,200,995...17,206,333
Ensembl chr17:17,200,995...17,206,333
G
PLEKHJ1
pleckstrin homology domain containing J1
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of PLEKHJ1 mRNA
CTD
PMID:30529165
NCBI chr19:2,229,981...2,236,329
Ensembl chr19:2,230,084...2,237,704
G
PLIN4
perilipin 4
increases expression
ISO
sulforaphane results in increased expression of PLIN4 mRNA
CTD
PMID:30529165
NCBI chr19:4,502,192...4,518,486
Ensembl chr19:4,502,192...4,518,486
G
PLIN5
perilipin 5
increases expression
ISO
sulforaphane results in increased expression of PLIN5 mRNA
CTD
PMID:30529165
NCBI chr19:4,522,531...4,535,224
Ensembl chr19:4,522,531...4,535,224
G
PLK1
polo like kinase 1
increases expression
EXP
sulforaphane results in increased expression of PLK1 mRNA
CTD
PMID:31838189
NCBI chr16:23,678,889...23,690,367
Ensembl chr16:23,677,656...23,690,367
G
PLK3
polo like kinase 3
increases expression
EXP
sulforaphane results in increased expression of PLK3 mRNA
CTD
PMID:31838189
NCBI chr 1:44,800,377...44,805,990
Ensembl chr 1:44,800,377...44,805,990
G
PLN
phospholamban
multiple interactions increases expression
ISO
NFE2L2 protein affects the reaction [sulforaphane promotes the reaction [Oxygen results in increased expression of PLN protein]]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of PLN protein]; sulforaphane promotes the reaction [Oxygen results in increased expression of PLN protein] sulforaphane results in increased expression of PLN mRNA; sulforaphane results in increased expression of PLN protein
CTD
PMID:30529165
NCBI chr 6:118,548,296...118,561,716
Ensembl chr 6:118,548,296...118,561,716
G
PLPP1
phospholipid phosphatase 1
decreases expression
EXP
sulforaphane results in decreased expression of PLPP1 mRNA
CTD
PMID:31838189
NCBI chr 5:55,424,854...55,534,964
Ensembl chr 5:55,424,854...55,534,969
G
PLXDC2
plexin domain containing 2
increases expression
EXP
sulforaphane results in increased expression of PLXDC2 mRNA
CTD
PMID:26833863
NCBI chr10:19,816,432...20,289,856
Ensembl chr10:19,816,239...20,289,856
G
PMEPA1
prostate transmembrane protein, androgen induced 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PMEPA1 mRNA
CTD
PMID:30529165
NCBI chr20:57,648,396...57,711,472
Ensembl chr20:57,648,392...57,711,536
G
PNCK
pregnancy up-regulated nonubiquitous CaM kinase
increases expression
EXP
sulforaphane results in increased expression of PNCK mRNA
CTD
PMID:31838189
NCBI chr X:153,669,733...153,687,771
Ensembl chr X:153,669,733...153,689,010
G
POPDC2
popeye domain containing 2
increases expression
ISO
sulforaphane results in increased expression of POPDC2 mRNA
CTD
PMID:30529165
NCBI chr 3:119,642,056...119,660,883
Ensembl chr 3:119,636,457...119,665,324
G
POPDC3
popeye domain containing 3
increases expression
EXP
sulforaphane results in increased expression of POPDC3 mRNA
CTD
PMID:31838189
NCBI chr 6:105,157,900...105,180,014
Ensembl chr 6:105,157,900...105,180,014
G
POR
cytochrome p450 oxidoreductase
increases expression
EXP
sulforaphane results in increased expression of POR mRNA
CTD
PMID:31838189
NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855
G
PPA1
inorganic pyrophosphatase 1
increases expression
ISO
sulforaphane results in increased expression of PPA1 mRNA
CTD
PMID:30529165
NCBI chr10:70,202,835...70,233,429
Ensembl chr10:70,202,835...70,233,911
G
PPARG
peroxisome proliferator activated receptor gamma
increases expression multiple interactions
EXP ISO
sulforaphane results in increased expression of PPARG mRNA sulforaphane inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]
CTD
PMID:26833863 PMID:36670177
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
PPARGC1A
PPARG coactivator 1 alpha
increases expression
EXP ISO
sulforaphane results in increased expression of PPARGC1A protein sulforaphane results in increased expression of PPARGC1A mRNA
CTD
PMID:27993529 PMID:30529165
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
G
PPARGC1B
PPARG coactivator 1 beta
increases expression
ISO
sulforaphane results in increased expression of PPARGC1B mRNA
CTD
PMID:30529165
NCBI chr 5:149,730,310...149,857,959
Ensembl chr 5:149,730,298...149,855,022
G
PPIF
peptidylprolyl isomerase F
increases expression
EXP
sulforaphane results in increased expression of PPIF mRNA
CTD
PMID:31838189
NCBI chr10:79,347,469...79,355,334
Ensembl chr10:79,347,469...79,355,334
G
PPP1R36
protein phosphatase 1 regulatory subunit 36
increases expression
ISO
sulforaphane results in increased expression of PPP1R36 mRNA
CTD
PMID:30529165
NCBI chr14:64,549,961...64,589,381
Ensembl chr14:64,549,920...64,589,381
G
PPP1R3C
protein phosphatase 1 regulatory subunit 3C
decreases expression
EXP
sulforaphane results in decreased expression of PPP1R3C mRNA
CTD
PMID:31838189
NCBI chr10:91,628,442...91,633,071
Ensembl chr10:91,628,442...91,633,071
G
PPP1R9A
protein phosphatase 1 regulatory subunit 9A
decreases expression
ISO
sulforaphane results in decreased expression of PPP1R9A mRNA
CTD
PMID:30529165
NCBI chr 7:94,907,236...95,296,415
Ensembl chr 7:94,907,202...95,296,415
G
PPP2R2B
protein phosphatase 2 regulatory subunit Bbeta
decreases expression
EXP
sulforaphane results in decreased expression of PPP2R2B mRNA
CTD
PMID:31838189
NCBI chr 5:146,580,742...147,081,520
Ensembl chr 5:146,580,742...147,084,784
G
PRDM1
PR/SET domain 1
decreases expression
ISO EXP
sulforaphane results in decreased expression of PRDM1 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 6:105,992,690...106,109,938
Ensembl chr 6:105,993,463...106,109,939
G
PRDM4
PR/SET domain 4
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PRDM4 mRNA
CTD
PMID:30529165
NCBI chr12:107,732,871...107,761,137
Ensembl chr12:107,732,871...107,761,272
G
PRDX1
peroxiredoxin 1
increases expression decreases methylation
EXP
sulforaphane results in increased expression of PRDX1 mRNA sulforaphane results in decreased methylation of PRDX1 gene
CTD
PMID:31838189
NCBI chr 1:45,511,051...45,522,890
Ensembl chr 1:45,510,914...45,542,732
G
PRDX3
peroxiredoxin 3
affects binding
EXP
PRDX3 protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr10:119,167,720...119,178,812
Ensembl chr10:119,167,720...119,178,812
G
PRELP
proline and arginine rich end leucine rich repeat protein
decreases expression
ISO
sulforaphane results in decreased expression of PRELP mRNA
CTD
PMID:30529165
NCBI chr 1:203,475,806...203,491,352
Ensembl chr 1:203,475,806...203,491,352
G
PRG2
proteoglycan 2, pro eosinophil major basic protein
decreases expression
EXP
sulforaphane results in decreased expression of PRG2 mRNA
CTD
PMID:26833863
NCBI chr11:57,386,780...57,390,650
Ensembl chr11:57,386,780...57,390,650
G
PRICKLE1
prickle planar cell polarity protein 1
decreases expression
EXP
sulforaphane results in decreased expression of PRICKLE1 mRNA
CTD
PMID:31838189
NCBI chr12:42,456,757...42,589,746
Ensembl chr12:42,456,757...42,590,355
G
PRKAG2
protein kinase AMP-activated non-catalytic subunit gamma 2
decreases expression
EXP
sulforaphane results in decreased expression of PRKAG2 mRNA
CTD
PMID:35724838
NCBI chr 7:151,556,127...151,877,115
Ensembl chr 7:151,556,124...151,877,214
G
PRKCA
protein kinase C alpha
increases expression
EXP
sulforaphane results in increased expression of PRKCA mRNA
CTD
PMID:26833863
NCBI chr17:66,302,613...66,810,743
Ensembl chr17:66,302,613...66,810,743
G
PRKCB
protein kinase C beta
increases expression
EXP
sulforaphane results in increased expression of PRKCB mRNA
CTD
PMID:26833863
NCBI chr16:23,835,983...24,220,611
Ensembl chr16:23,835,983...24,220,611
G
PRKCI
protein kinase C iota
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of PRKCI mRNA
CTD
PMID:25450479
NCBI chr 3:170,222,424...170,305,977
Ensembl chr 3:170,222,424...170,305,977
G
PRLR
prolactin receptor
decreases expression
EXP
sulforaphane results in decreased expression of PRLR mRNA
CTD
PMID:26833863
NCBI chr 5:35,048,756...35,230,487
Ensembl chr 5:35,048,756...35,230,487
G
PRMT8
protein arginine methyltransferase 8
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of PRMT8 mRNA
CTD
PMID:30529165
NCBI chr12:3,381,349...3,593,973
Ensembl chr12:3,381,349...3,593,973
G
PROM2
prominin 2
decreases expression
EXP
sulforaphane results in decreased expression of PROM2 mRNA
CTD
PMID:31838189
NCBI chr 2:95,274,449...95,291,302
Ensembl chr 2:95,274,449...95,291,308
G
PRPH
peripherin
affects binding
EXP
PRPH protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr12:49,295,147...49,298,686
Ensembl chr12:49,295,147...49,298,686
G
PRPS2
phosphoribosyl pyrophosphate synthetase 2
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PRPS2 mRNA
CTD
PMID:30529165
NCBI chr X:12,791,412...12,824,222
Ensembl chr X:12,791,355...12,824,222
G
PRR14
proline rich 14
decreases expression
ISO
sulforaphane results in decreased expression of PRR14 mRNA
CTD
PMID:30529165
NCBI chr16:30,650,778...30,656,413
Ensembl chr16:30,650,717...30,656,413
G
PRR5L
proline rich 5 like
decreases expression
EXP
sulforaphane results in decreased expression of PRR5L mRNA
CTD
PMID:31838189
NCBI chr11:36,296,288...36,465,204
Ensembl chr11:36,296,288...36,465,204
G
PRRG4
proline rich and Gla domain 4
decreases expression
EXP
sulforaphane results in decreased expression of PRRG4 mRNA
CTD
PMID:31838189
NCBI chr11:32,829,789...32,858,120
Ensembl chr11:32,829,927...32,858,120
G
PRRX2
paired related homeobox 2
decreases expression
EXP
sulforaphane results in decreased expression of PRRX2 mRNA
CTD
PMID:31838189
NCBI chr 9:129,665,647...129,722,674
Ensembl chr 9:129,665,647...129,722,674
G
PRSS56
serine protease 56
decreases expression
EXP
sulforaphane results in decreased expression of PRSS56 mRNA
CTD
PMID:31838189
NCBI chr 2:232,520,388...232,525,716
Ensembl chr 2:232,520,388...232,525,716
G
PRTN3
proteinase 3
decreases expression
EXP
sulforaphane results in decreased expression of PRTN3 mRNA
CTD
PMID:26833863
NCBI chr19:840,999...848,175
Ensembl chr19:840,999...848,175
G
PSAT1
phosphoserine aminotransferase 1
increases expression
EXP
sulforaphane results in increased expression of PSAT1 mRNA
CTD
PMID:31838189
NCBI chr 9:78,297,125...78,330,093
Ensembl chr 9:78,297,125...78,330,093
G
PSMB6
proteasome 20S subunit beta 6
multiple interactions
EXP
sulforaphane inhibits the reaction [epoxomicin results in increased expression of PSMB6 mRNA]
CTD
PMID:27345029
NCBI chr17:4,796,164...4,798,495
Ensembl chr17:4,796,144...4,798,502
G
PSMB8
proteasome 20S subunit beta 8
decreases expression
EXP
sulforaphane results in decreased expression of PSMB8 mRNA
CTD
PMID:31838189
NCBI chr 6:32,840,717...32,844,679
Ensembl chr 6:32,840,717...32,844,679
G
PSMC3IP
PSMC3 interacting protein
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PSMC3IP mRNA
CTD
PMID:30529165
NCBI chr17:42,572,310...42,577,831
Ensembl chr17:42,572,310...42,577,831
G
PSMD3
proteasome 26S subunit, non-ATPase 3
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PSMD3 mRNA
CTD
PMID:30529165
NCBI chr17:39,980,807...39,997,959
Ensembl chr17:39,980,807...39,997,959
G
PTER
phosphotriesterase related
increases expression
EXP
sulforaphane results in increased expression of PTER mRNA
CTD
PMID:31838189
NCBI chr10:16,437,010...16,519,020
Ensembl chr10:16,436,943...16,513,745
G
PTGDS
prostaglandin D2 synthase
increases expression
ISO
sulforaphane results in increased expression of PTGDS mRNA
CTD
PMID:30529165
NCBI chr 9:136,977,504...136,981,742
Ensembl chr 9:136,975,092...136,981,742
G
PTGER3
prostaglandin E receptor 3
increases expression
ISO
sulforaphane results in increased expression of PTGER3 mRNA
CTD
PMID:30529165
NCBI chr 1:70,852,358...71,047,816
Ensembl chr 1:70,852,353...71,047,816
G
PTGES3L
prostaglandin E synthase 3 like
increases expression
ISO
sulforaphane results in increased expression of PTGES3L mRNA
CTD
PMID:30529165
NCBI chr17:42,968,103...42,980,080
Ensembl chr17:42,968,088...42,980,433
G
PTGR1
prostaglandin reductase 1
multiple interactions increases expression
ISO EXP
[sulforaphane co-treated with dibenzoylmethane] results in increased expression of PTGR1 mRNA sulforaphane results in increased expression of PTGR1 mRNA
CTD
PMID:17942926 PMID:31838189
NCBI chr 9:111,549,722...111,599,647
Ensembl chr 9:111,549,722...111,599,893
G
PTGS1
prostaglandin-endoperoxide synthase 1
decreases expression
EXP
sulforaphane results in decreased expression of PTGS1 mRNA
CTD
PMID:31838189
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
G
PTGS2
prostaglandin-endoperoxide synthase 2
decreases expression multiple interactions
ISO
sulforaphane results in decreased expression of PTGS2 protein [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of PTGS2 mRNA; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of PTGS2 mRNA]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased expression of PTGS2 protein]; sulforaphane inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of PTGS2 protein]
CTD
PMID:17942926 PMID:19071154 PMID:24337631 PMID:30529165
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PTK2B
protein tyrosine kinase 2 beta
decreases expression
EXP
sulforaphane results in decreased expression of PTK2B mRNA
CTD
PMID:31838189
NCBI chr 8:27,310,506...27,459,391
Ensembl chr 8:27,311,482...27,459,391
G
PTOV1
PTOV1 extended AT-hook containing adaptor protein
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PTOV1 mRNA
CTD
PMID:30529165
NCBI chr19:49,850,705...49,860,742
Ensembl chr19:49,850,735...49,860,744
G
PTPA
protein phosphatase 2 phosphatase activator
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PPP2R4 mRNA
CTD
PMID:30529165
NCBI chr 9:129,110,950...129,148,946
Ensembl chr 9:129,110,950...129,148,946
G
PTPN12
protein tyrosine phosphatase non-receptor type 12
increases expression
EXP
sulforaphane results in increased expression of PTPN12 mRNA
CTD
PMID:26833863
NCBI chr 7:77,537,295...77,640,069
Ensembl chr 7:77,537,295...77,640,069
G
PTPN22
protein tyrosine phosphatase non-receptor type 22
increases expression
EXP
sulforaphane results in increased expression of PTPN22 mRNA
CTD
PMID:26833863
NCBI chr 1:113,813,811...113,871,759
Ensembl chr 1:113,813,811...113,871,753
G
PTPRG
protein tyrosine phosphatase receptor type G
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of PTPRG mRNA
CTD
PMID:30529165
NCBI chr 3:61,561,571...62,297,609
Ensembl chr 3:61,561,569...62,297,609
G
PTTG1
PTTG1 regulator of sister chromatid separation, securin
increases expression
EXP
sulforaphane results in increased expression of PTTG1 mRNA
CTD
PMID:31838189
NCBI chr 5:160,421,855...160,428,744
Ensembl chr 5:160,421,855...160,428,739
G
PTX3
pentraxin 3
increases expression
EXP
sulforaphane results in increased expression of PTX3 mRNA
CTD
PMID:26833863
NCBI chr 3:157,436,850...157,443,633
Ensembl chr 3:157,436,850...157,443,633
G
PUS7
pseudouridine synthase 7
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PUS7 mRNA
CTD
PMID:30529165
NCBI chr 7:105,456,501...105,522,271
Ensembl chr 7:105,439,661...105,522,271
G
PXMP2
peroxisomal membrane protein 2
increases expression
ISO
sulforaphane results in increased expression of PXMP2 mRNA
CTD
PMID:30529165
NCBI chr12:132,687,587...132,704,985
Ensembl chr12:132,687,587...132,704,985
G
PXYLP1
2-phosphoxylose phosphatase 1
decreases expression
EXP
sulforaphane results in decreased expression of PXYLP1 mRNA
CTD
PMID:31838189
NCBI chr 3:141,231,825...141,294,924
Ensembl chr 3:141,228,726...141,367,753
G
PYCARD
PYD and CARD domain containing
multiple interactions
ISO
sulforaphane inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PYCARD protein]
CTD
PMID:36988325
NCBI chr16:31,201,486...31,202,760
Ensembl chr16:31,201,486...31,203,450
G
PYGB
glycogen phosphorylase B
multiple interactions increases expression
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of PYGB mRNA sulforaphane results in increased expression of PYGB mRNA
CTD
PMID:30529165
NCBI chr20:25,248,085...25,298,012
Ensembl chr20:25,248,085...25,298,012
G
QPCT
glutaminyl-peptide cyclotransferase
increases expression
EXP
sulforaphane results in increased expression of QPCT mRNA
CTD
PMID:26833863
NCBI chr 2:37,344,630...37,373,322
Ensembl chr 2:37,342,827...37,373,322
G
QRICH2
glutamine rich 2
increases expression
EXP
sulforaphane results in increased expression of QRICH2 mRNA
CTD
PMID:31838189
NCBI chr17:76,274,049...76,310,964
Ensembl chr17:76,274,049...76,308,276
G
QSOX1
quiescin sulfhydryl oxidase 1
increases expression
ISO
sulforaphane results in increased expression of QSOX1 mRNA
CTD
PMID:30529165
NCBI chr 1:180,154,869...180,204,030
Ensembl chr 1:180,154,869...180,204,030
G
QTRT2
queuine tRNA-ribosyltransferase accessory subunit 2
decreases expression
ISO
sulforaphane results in decreased expression of QTRT2 mRNA
CTD
PMID:30529165
NCBI chr 3:114,056,737...114,088,422
Ensembl chr 3:114,005,833...114,088,422
G
RAB10
RAB10, member RAS oncogene family
increases expression
EXP
sulforaphane results in increased expression of RAB10 mRNA
CTD
PMID:31838189
NCBI chr 2:26,033,285...26,137,454
Ensembl chr 2:26,034,084...26,137,454
G
RAB20
RAB20, member RAS oncogene family
decreases expression
EXP
sulforaphane results in decreased expression of RAB20 mRNA
CTD
PMID:31838189
NCBI chr13:110,523,066...110,561,722
Ensembl chr13:110,523,066...110,561,722
G
RAB26
RAB26, member RAS oncogene family
decreases expression
EXP
sulforaphane results in decreased expression of RAB26 mRNA
CTD
PMID:31838189
NCBI chr16:2,148,144...2,154,165
Ensembl chr16:2,140,803...2,154,165
G
RAB2B
RAB2B, member RAS oncogene family
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of RAB2B mRNA
CTD
PMID:30529165
NCBI chr14:21,459,020...21,476,959
Ensembl chr14:21,459,020...21,476,960
G
RAB3D
RAB3D, member RAS oncogene family
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of RAB3D mRNA
CTD
PMID:30529165
NCBI chr19:11,322,068...11,339,657
Ensembl chr19:11,322,068...11,346,270
G
RAB42
RAB42, member RAS oncogene family
decreases expression
EXP
sulforaphane results in decreased expression of RAB42 mRNA
CTD
PMID:31838189
NCBI chr 1:28,592,265...28,596,666
Ensembl chr 1:28,592,200...28,595,449
G
RAB8B
RAB8B, member RAS oncogene family
increases expression
EXP
sulforaphane results in increased expression of RAB8B mRNA
CTD
PMID:26833863
NCBI chr15:63,189,606...63,267,776
Ensembl chr15:63,189,560...63,267,776
G
RADIL
Rap associating with DIL domain
decreases expression
ISO
sulforaphane results in decreased expression of RADIL mRNA
CTD
PMID:30529165
NCBI chr 7:4,797,055...4,883,716
Ensembl chr 7:4,797,055...4,883,716
G
RAE1
ribonucleic acid export 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of RAE1 mRNA
CTD
PMID:30529165
NCBI chr20:57,351,255...57,379,202
Ensembl chr20:57,351,223...57,379,211
G
RANGRF
RAN guanine nucleotide release factor
increases expression
ISO
sulforaphane results in increased expression of RANGRF mRNA
CTD
PMID:30529165
NCBI chr17:8,288,670...8,290,087
Ensembl chr17:8,288,654...8,290,092
G
RAP1GAP
RAP1 GTPase activating protein
increases expression
EXP
sulforaphane results in increased expression of RAP1GAP mRNA
CTD
PMID:31838189
NCBI chr 1:21,596,221...21,669,357
Ensembl chr 1:21,596,221...21,669,357
G
RAPGEF4
Rap guanine nucleotide exchange factor 4
decreases expression
ISO
sulforaphane results in decreased expression of RAPGEF4 mRNA
CTD
PMID:30529165
NCBI chr 2:172,735,318...173,052,893
Ensembl chr 2:172,735,274...173,052,893
G
RAPGEF5
Rap guanine nucleotide exchange factor 5
decreases expression
ISO
sulforaphane results in decreased expression of RAPGEF5 mRNA
CTD
PMID:30529165
NCBI chr 7:22,118,236...22,357,154
Ensembl chr 7:22,118,236...22,357,154
G
RARRES1
retinoic acid receptor responder 1
increases expression
ISO
sulforaphane results in increased expression of RARRES1 mRNA
CTD
PMID:30529165
NCBI chr 3:158,696,892...158,732,457
Ensembl chr 3:158,696,892...158,732,489
G
RASD1
ras related dexamethasone induced 1
increases expression
ISO
sulforaphane results in increased expression of RASD1 mRNA
CTD
PMID:30529165
NCBI chr17:17,494,437...17,496,395
Ensembl chr17:17,494,437...17,496,395
G
RASGRP3
RAS guanyl releasing protein 3
decreases expression
EXP
sulforaphane results in decreased expression of RASGRP3 mRNA
CTD
PMID:31838189
NCBI chr 2:33,436,348...33,564,731
Ensembl chr 2:33,436,324...33,564,750
G
RASL10B
RAS like family 10 member B
increases expression
ISO
sulforaphane results in increased expression of RASL10B mRNA
CTD
PMID:30529165
NCBI chr17:35,731,639...35,743,521
Ensembl chr17:35,731,639...35,743,521
G
RASL11A
RAS like family 11 member A
decreases expression
EXP
sulforaphane results in decreased expression of RASL11A mRNA
CTD
PMID:31838189
NCBI chr13:27,270,830...27,275,192
Ensembl chr13:27,270,830...27,275,192
G
RASSF2
Ras association domain family member 2
decreases expression
EXP
sulforaphane results in decreased expression of RASSF2 mRNA
CTD
PMID:31838189
NCBI chr20:4,780,023...4,823,608
Ensembl chr20:4,780,023...4,823,608
G
RASSF5
Ras association domain family member 5
decreases expression
EXP
sulforaphane results in decreased expression of RASSF5 mRNA
CTD
PMID:31838189
NCBI chr 1:206,507,531...206,589,448
Ensembl chr 1:206,507,531...206,589,448
G
RB1
RB transcriptional corepressor 1
increases phosphorylation
EXP
sulforaphane results in increased phosphorylation of RB1 protein
CTD
PMID:15231455
NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
G
RBBP4
RB binding protein 4, chromatin remodeling factor
affects binding
EXP
RBBP4 protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr 1:32,651,208...32,686,211
Ensembl chr 1:32,651,142...32,686,211
G
RBBP8
RB binding protein 8, endonuclease
increases acetylation
EXP
Sulforaphane increases acetylation of RBBP8 protein in colon cancer cells
RGD
PMID:23770684
RGD:401940171
NCBI chr18:22,914,139...23,026,486
Ensembl chr18:22,798,261...23,026,488
G
RBBP9
RB binding protein 9, serine hydrolase
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of RBBP9 mRNA
CTD
PMID:30529165
NCBI chr20:18,486,540...18,497,225
Ensembl chr20:18,486,540...18,497,225
G
RBM20
RNA binding motif protein 20
increases expression
ISO
sulforaphane results in increased expression of RBM20 mRNA
CTD
PMID:30529165
NCBI chr10:110,643,245...110,839,468
Ensembl chr10:110,644,336...110,839,468
G
RBM24
RNA binding motif protein 24
increases expression
ISO
sulforaphane results in increased expression of RBM24 mRNA
CTD
PMID:30529165
NCBI chr 6:17,281,361...17,293,871
Ensembl chr 6:17,281,361...17,293,871
G
RBM47
RNA binding motif protein 47
increases expression
EXP
sulforaphane results in increased expression of RBM47 mRNA
CTD
PMID:26833863
NCBI chr 4:40,423,280...40,630,852
Ensembl chr 4:40,423,267...40,630,875
G
RBM48
RNA binding motif protein 48
decreases expression
ISO
sulforaphane results in decreased expression of RBM48 mRNA
CTD
PMID:30529165
NCBI chr 7:92,528,795...92,540,481
Ensembl chr 7:92,528,773...92,540,481
G
RBMS3
RNA binding motif single stranded interacting protein 3
decreases expression
EXP
sulforaphane results in decreased expression of RBMS3 mRNA
CTD
PMID:31838189
NCBI chr 3:29,281,071...30,010,395
Ensembl chr 3:28,574,791...30,010,391
G
RBP7
retinol binding protein 7
increases expression
ISO
sulforaphane results in increased expression of RBP7 mRNA
CTD
PMID:30529165
NCBI chr 1:9,997,228...10,016,021
Ensembl chr 1:9,997,206...10,016,021
G
RBPJL
recombination signal binding protein for immunoglobulin kappa J region like
decreases expression
ISO
sulforaphane results in decreased expression of RBPJL mRNA
CTD
PMID:30529165
NCBI chr20:45,306,840...45,317,824
Ensembl chr20:45,306,840...45,317,824
G
RCAN2
regulator of calcineurin 2
decreases expression
EXP
sulforaphane results in decreased expression of RCAN2 mRNA
CTD
PMID:31838189
NCBI chr 6:46,220,736...46,491,970
Ensembl chr 6:46,220,736...46,491,972
G
RCOR2
REST corepressor 2
decreases expression
EXP
sulforaphane results in decreased expression of RCOR2 mRNA
CTD
PMID:31838189
NCBI chr11:63,911,230...63,927,762
Ensembl chr11:63,911,230...63,917,164
G
RDH10
retinol dehydrogenase 10
decreases expression
EXP
sulforaphane results in decreased expression of RDH10 mRNA
CTD
PMID:31838189
NCBI chr 8:73,294,602...73,325,281
Ensembl chr 8:73,294,602...73,325,281
G
REEP4
receptor accessory protein 4
increases expression
EXP
sulforaphane results in increased expression of REEP4 mRNA
CTD
PMID:31838189
NCBI chr 8:22,138,020...22,141,907
Ensembl chr 8:22,138,020...22,141,951
G
REEP6
receptor accessory protein 6
decreases expression
EXP
sulforaphane results in decreased expression of REEP6 mRNA
CTD
PMID:31838189
NCBI chr19:1,491,181...1,497,927
Ensembl chr19:1,491,166...1,497,927
G
REL
REL proto-oncogene, NF-kB subunit
multiple interactions decreases expression
EXP
sulforaphane promotes the reaction [Gemcitabine results in decreased expression of REL protein] sulforaphane results in decreased expression of REL protein
CTD
PMID:20940707
NCBI chr 2:60,881,574...60,931,612
Ensembl chr 2:60,881,491...60,931,612
G
RELA
RELA proto-oncogene, NF-kB subunit
affects expression multiple interactions increases expression
ISO EXP
sulforaphane affects the expression of RELA protein sulforaphane inhibits the reaction [IL1B protein affects the localization of RELA protein]; sulforaphane inhibits the reaction [Lipopolysaccharides promotes the reaction [NFKB1 protein binds to RELA protein]]; sulforaphane inhibits the reaction [TNF protein affects the localization of RELA protein] NFE2L2 protein affects the reaction [sulforaphane inhibits the reaction [Oxygen results in increased activity of RELA protein]]; sulforaphane inhibits the reaction [[IL1B protein co-treated with IFNG protein] affects the localization of RELA protein]; sulforaphane inhibits the reaction [Lipopolysaccharides promotes the reaction [NFKB1 protein binds to RELA protein]]; sulforaphane inhibits the reaction [Oxygen results in increased activity of RELA protein]; sulforaphane inhibits the reaction [Trichloroethylene results in increased expression of and results in increased phosphorylation of RELA protein]; sulforaphane inhibits the reaction [Trichloroethylene results in increased expression of RELA protein modified form] sulforaphane results in increased expression of RELA protein
CTD
PMID:15090468 PMID:16890772 PMID:17898303 PMID:19071154 PMID:30529165 PMID:32073640 PMID:33007382 PMID:35724838 More...
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
REM1
RRAD and GEM like GTPase 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of REM1 mRNA
CTD
PMID:30529165
NCBI chr20:31,475,288...31,484,895
Ensembl chr20:31,475,288...31,484,895
G
RERG
RAS like estrogen regulated growth inhibitor
decreases expression
EXP
sulforaphane results in decreased expression of RERG mRNA
CTD
PMID:31838189
NCBI chr12:15,107,783...15,221,417
Ensembl chr12:15,107,783...15,348,675
G
RETN
resistin
increases expression
EXP ISO
sulforaphane results in increased expression of RETN mRNA
CTD
PMID:26833863 PMID:30529165
NCBI chr19:7,669,049...7,670,455
Ensembl chr19:7,669,049...7,670,455
G
REV1
REV1 DNA directed polymerase
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of REV1 mRNA
CTD
PMID:30529165
NCBI chr 2:99,400,477...99,490,202
Ensembl chr 2:99,400,475...99,490,035
G
RFLNB
refilin B
increases expression
EXP
sulforaphane results in increased expression of RFLNB mRNA
CTD
PMID:31838189
NCBI chr17:439,978...445,940
Ensembl chr17:439,978...445,939
G
RGL1
ral guanine nucleotide dissociation stimulator like 1
decreases expression
EXP
sulforaphane results in decreased expression of RGL1 mRNA
CTD
PMID:26833863
NCBI chr 1:183,636,109...183,928,532
Ensembl chr 1:183,636,085...183,928,532
G
RGS2
regulator of G protein signaling 2
decreases expression
EXP
sulforaphane results in decreased expression of RGS2 mRNA
CTD
PMID:31838189
NCBI chr 1:192,809,039...192,812,275
Ensembl chr 1:192,809,039...192,812,275
G
RGS5
regulator of G protein signaling 5
increases expression
ISO
sulforaphane results in increased expression of RGS5 mRNA
CTD
PMID:30529165
NCBI chr 1:163,142,299...163,321,735
Ensembl chr 1:163,111,121...163,321,791
G
RHBDF2
rhomboid 5 homolog 2
increases expression
EXP
sulforaphane results in increased expression of RHBDF2 mRNA
CTD
PMID:31838189
NCBI chr17:76,470,893...76,501,427
Ensembl chr17:76,470,891...76,501,790
G
RHBDL1
rhomboid like 1
increases expression
EXP
sulforaphane results in increased expression of RHBDL1 mRNA
CTD
PMID:31838189
NCBI chr16:675,671...678,268
Ensembl chr16:675,671...678,268
G
RHEBL1
RHEB like 1
increases expression
EXP
sulforaphane results in increased expression of RHEBL1 mRNA
CTD
PMID:31838189
NCBI chr12:49,064,676...49,069,979
Ensembl chr12:49,064,676...49,070,025
G
RHO
rhodopsin
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of RHO mRNA
CTD
PMID:30529165
NCBI chr 3:129,528,639...129,535,344
Ensembl chr 3:129,528,639...129,535,344
G
RHOB
ras homolog family member B
decreases expression
EXP
sulforaphane results in decreased expression of RHOB mRNA
CTD
PMID:31838189
NCBI chr 2:20,447,074...20,449,440
Ensembl chr 2:20,447,074...20,449,440
G
RHOF
ras homolog family member F, filopodia associated
decreases expression
EXP
sulforaphane results in decreased expression of RHOF mRNA
CTD
PMID:31838189
NCBI chr12:121,777,754...121,793,688
Ensembl chr12:121,777,754...121,803,403
G
RHOU
ras homolog family member U
decreases expression
EXP
sulforaphane results in decreased expression of RHOU mRNA
CTD
PMID:31838189
NCBI chr 1:228,644,647...228,746,669
Ensembl chr 1:228,735,479...228,746,664
G
RHOV
ras homolog family member V
decreases expression
EXP
sulforaphane results in decreased expression of RHOV mRNA
CTD
PMID:31838189
NCBI chr15:40,872,214...40,874,234
Ensembl chr15:40,872,214...40,874,234
G
RHPN1
rhophilin Rho GTPase binding protein 1
decreases expression
EXP
sulforaphane results in decreased expression of RHPN1 mRNA
CTD
PMID:31838189
NCBI chr 8:143,364,255...143,384,221
Ensembl chr 8:143,368,876...143,384,221
G
RIGI
RNA sensor RIG-I
increases expression
EXP
sulforaphane results in increased expression of RIGI mRNA
CTD
PMID:31838189
NCBI chr 9:32,455,302...32,526,196
Ensembl chr 9:32,455,302...32,526,348
G
RILPL1
Rab interacting lysosomal protein like 1
increases expression
EXP
sulforaphane results in increased expression of RILPL1 mRNA
CTD
PMID:31838189
NCBI chr12:123,470,054...123,533,719
Ensembl chr12:123,470,054...123,533,719
G
RINL
Ras and Rab interactor like
decreases expression
EXP
sulforaphane results in decreased expression of RINL mRNA
CTD
PMID:31838189
NCBI chr19:38,867,830...38,878,275
Ensembl chr19:38,867,830...38,878,275
G
RIT1
Ras like without CAAX 1
increases expression
EXP
sulforaphane results in increased expression of RIT1 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr 1:155,897,808...155,911,349
Ensembl chr 1:155,897,808...155,911,404
G
RNA5SP366
RNA, 5S ribosomal pseudogene 366
increases expression
EXP
sulforaphane results in increased expression of RNA5SP366 mRNA
CTD
PMID:26833863
NCBI chr12:99,083,783...99,083,905
Ensembl chr12:99,083,783...99,083,905
G
RNA5SP63
RNA, 5S ribosomal pseudogene 63
increases expression
EXP
sulforaphane results in increased expression of RNA5SP63 mRNA
CTD
PMID:26833863
NCBI chr 1:163,509,484...163,509,595
Ensembl chr 1:163,509,484...163,509,595
G
RNA5SP74
RNA, 5S ribosomal pseudogene 74
decreases expression
EXP
sulforaphane results in decreased expression of RNA5SP74 mRNA
CTD
PMID:26833863
NCBI chr 1:204,562,413...204,562,521
Ensembl chr 1:204,562,413...204,562,521
G
RNASE3
ribonuclease A family member 3
decreases expression
ISO
sulforaphane results in decreased expression of EAR1 mRNA
CTD
PMID:30529165
NCBI chr14:20,891,385...20,892,348
Ensembl chr14:20,891,385...20,892,348
G
RNF103
ring finger protein 103
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of RNF103 mRNA
CTD
PMID:30529165
NCBI chr 2:86,603,393...86,623,877
Ensembl chr 2:86,603,398...86,623,866
G
RNF112
ring finger protein 112
increases expression
EXP
sulforaphane results in increased expression of RNF112 mRNA
CTD
PMID:31838189
NCBI chr17:19,411,232...19,417,276
Ensembl chr17:19,411,125...19,417,276
G
RNF128
ring finger protein 128
increases expression
ISO
sulforaphane results in increased expression of RNF128 mRNA
CTD
PMID:30529165
NCBI chr X:106,693,838...106,797,016
Ensembl chr X:106,693,794...106,797,016
G
RNF144B
ring finger protein 144B
decreases expression
EXP
sulforaphane results in decreased expression of RNF144B mRNA
CTD
PMID:31838189
NCBI chr 6:18,387,350...18,468,870
Ensembl chr 6:18,387,350...18,468,870
G
RNF150
ring finger protein 150
decreases expression
EXP
sulforaphane results in decreased expression of RNF150 mRNA
CTD
PMID:31838189
NCBI chr 4:140,859,807...141,212,900
Ensembl chr 4:140,859,807...141,212,877
G
RNF182
ring finger protein 182
decreases expression
EXP
sulforaphane results in decreased expression of RNF182 mRNA
CTD
PMID:31838189
NCBI chr 6:13,924,446...13,980,310
Ensembl chr 6:13,924,446...13,980,310
G
RNPC3
RNA binding region (RNP1, RRM) containing 3
decreases expression
ISO
sulforaphane results in decreased expression of RNPC3 mRNA
CTD
PMID:30529165
NCBI chr 1:103,525,699...103,555,239
Ensembl chr 1:103,525,691...103,555,239
G
RNU5D-1
RNA, U5D small nuclear 1
decreases expression
EXP
sulforaphane results in decreased expression of RNU5D-1 mRNA
CTD
PMID:26833863
NCBI chr 1:44,731,069...44,731,168
Ensembl chr 1:44,731,055...44,731,170
G
RNU5E-4P
RNA, U5E small nuclear 4, pseudogene
decreases expression
EXP
sulforaphane results in decreased expression of RNU5E-4P mRNA
CTD
PMID:26833863
NCBI chr 1:11,909,808...11,909,927
Ensembl chr 1:11,909,808...11,909,927
G
RNY3P2
RNY3 pseudogene 2
decreases expression
EXP
sulforaphane results in decreased expression of RNY3P2 mRNA
CTD
PMID:26833863
NCBI chr13:49,095,392...49,095,489
Ensembl chr13:49,095,391...49,095,492
G
RNY4P5
RNY4 pseudogene 5
increases expression
EXP
sulforaphane results in increased expression of RNY4P5 mRNA
CTD
PMID:26833863
NCBI chr 8:123,044,717...123,044,811
G
ROGDI
rogdi atypical leucine zipper
decreases expression
EXP
sulforaphane results in decreased expression of ROGDI mRNA
CTD
PMID:31838189
NCBI chr16:4,796,968...4,802,633
Ensembl chr16:4,796,968...4,802,880
G
RORC
RAR related orphan receptor C
decreases expression
EXP
sulforaphane results in decreased expression of RORC mRNA
CTD
PMID:31838189
NCBI chr 1:151,806,071...151,831,802
Ensembl chr 1:151,806,071...151,831,845
G
RPL7A
ribosomal protein L7a
decreases expression
EXP
sulforaphane results in decreased expression of RPL7A mRNA
CTD
PMID:26833863
NCBI chr 9:133,348,218...133,351,426
Ensembl chr 9:133,348,218...133,351,426
G
RPRM
reprimo, TP53 dependent G2 arrest mediator homolog
decreases expression
ISO EXP
sulforaphane results in decreased expression of RPRM mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 2:153,477,338...153,478,762
Ensembl chr 2:153,477,338...153,478,762
G
RPS6
ribosomal protein S6
multiple interactions
EXP
sulforaphane inhibits the reaction [INS protein results in increased phosphorylation of RPS6 protein]
CTD
PMID:28790194
NCBI chr 9:19,375,715...19,380,236
Ensembl chr 9:19,375,715...19,380,236
G
RPSA
ribosomal protein SA
affects binding
EXP
RPSA protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr 3:39,406,720...39,412,542
Ensembl chr 3:39,406,716...39,426,255
G
RRAD
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
increases expression
ISO
sulforaphane results in increased expression of RRAD mRNA
CTD
PMID:30529165
NCBI chr16:66,921,685...66,925,535
Ensembl chr16:66,921,685...66,925,535
G
RSPO3
R-spondin 3
increases expression
EXP
sulforaphane results in increased expression of RSPO3 mRNA
CTD
PMID:31838189
NCBI chr 6:127,118,671...127,199,481
Ensembl chr 6:127,118,671...127,199,481
G
RSRC1
arginine and serine rich coiled-coil 1
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of RSRC1 mRNA
CTD
PMID:25450479
NCBI chr 3:158,110,089...158,545,730
Ensembl chr 3:158,105,855...158,545,730
G
RTL10
retrotransposon Gag like 10
decreases expression
EXP
sulforaphane results in decreased expression of RTL10 mRNA
CTD
PMID:31838189
NCBI chr22:19,846,146...19,854,874
Ensembl chr22:19,846,138...19,854,896
G
RTL8B
retrotransposon Gag like 8B
decreases expression
EXP
sulforaphane results in decreased expression of RTL8B mRNA
CTD
PMID:31838189
NCBI chr X:135,020,513...135,022,542
Ensembl chr X:135,020,513...135,022,542
G
RTN2
reticulon 2
decreases expression
EXP
sulforaphane results in decreased expression of RTN2 mRNA
CTD
PMID:31838189
NCBI chr19:45,485,294...45,497,047
Ensembl chr19:45,485,294...45,497,055
G
RXFP1
relaxin family peptide receptor 1
decreases expression
EXP
sulforaphane results in decreased expression of RXFP1 mRNA
CTD
PMID:26833863
NCBI chr 4:158,521,714...158,653,372
Ensembl chr 4:158,315,311...158,653,372
G
RXRG
retinoid X receptor gamma
increases expression
ISO
sulforaphane results in increased expression of RXRG mRNA
CTD
PMID:30529165
NCBI chr 1:165,400,922...165,445,126
Ensembl chr 1:165,400,922...165,445,355
G
RYR2
ryanodine receptor 2
increases expression decreases expression
ISO EXP
sulforaphane results in increased expression of RYR2 mRNA sulforaphane results in decreased expression of RYR2 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 1:237,042,184...237,833,988
Ensembl chr 1:237,042,184...237,833,988
G
S100A1
S100 calcium binding protein A1
increases expression
ISO
sulforaphane results in increased expression of S100A1 mRNA
CTD
PMID:30529165
NCBI chr 1:153,628,434...153,632,039
Ensembl chr 1:153,627,926...153,632,039
G
S100A4
S100 calcium binding protein A4
decreases expression
EXP
sulforaphane results in decreased expression of S100A4 mRNA
CTD
PMID:31838189
NCBI chr 1:153,543,621...153,545,806
Ensembl chr 1:153,543,613...153,550,136
G
S100A8
S100 calcium binding protein A8
increases expression
EXP
sulforaphane results in increased expression of S100A8 mRNA
CTD
PMID:26833863
NCBI chr 1:153,390,032...153,422,583
Ensembl chr 1:153,390,032...153,391,073
G
S100A9
S100 calcium binding protein A9
increases expression
EXP
sulforaphane results in increased expression of S100A9 mRNA
CTD
PMID:26833863
NCBI chr 1:153,357,854...153,361,023
Ensembl chr 1:153,357,854...153,361,023
G
S100G
S100 calcium binding protein G
multiple interactions decreases expression
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of S100G mRNA sulforaphane results in decreased expression of S100G mRNA
CTD
PMID:30529165
NCBI chr X:16,650,158...16,654,670
Ensembl chr X:16,650,158...16,654,670
G
S1PR1
sphingosine-1-phosphate receptor 1
multiple interactions decreases expression
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of S1PR1 mRNA sulforaphane results in decreased expression of S1PR1 mRNA
CTD
PMID:30529165
NCBI chr 1:101,236,899...101,242,313
Ensembl chr 1:101,236,865...101,243,713
G
S1PR5
sphingosine-1-phosphate receptor 5
decreases expression
ISO
sulforaphane results in decreased expression of S1PR5 mRNA
CTD
PMID:30529165
NCBI chr19:10,512,742...10,517,965
Ensembl chr19:10,512,742...10,517,931
G
SAA1
serum amyloid A1
decreases expression
EXP
sulforaphane results in decreased expression of SAA1 mRNA
CTD
PMID:31838189
NCBI chr11:18,266,264...18,269,967
Ensembl chr11:18,266,260...18,269,977
G
SALL4
spalt like transcription factor 4
decreases expression
EXP
sulforaphane results in decreased expression of SALL4 mRNA
CTD
PMID:31838189
NCBI chr20:51,782,331...51,802,521
Ensembl chr20:51,782,331...51,802,521
G
SAMD11
sterile alpha motif domain containing 11
decreases expression
EXP
sulforaphane results in decreased expression of SAMD11 mRNA
CTD
PMID:31838189
NCBI chr 1:923,923...944,574
Ensembl chr 1:923,923...944,575
G
SAMD4A
sterile alpha motif domain containing 4A
decreases expression
EXP
sulforaphane results in decreased expression of SAMD4A mRNA
CTD
PMID:31838189
NCBI chr14:54,565,316...54,793,315
Ensembl chr14:54,566,117...54,793,315
G
SAPCD2
suppressor APC domain containing 2
increases expression
EXP
sulforaphane results in increased expression of SAPCD2 mRNA
CTD
PMID:31838189
NCBI chr 9:137,062,127...137,070,557
Ensembl chr 9:137,062,127...137,070,557
G
SARS2
seryl-tRNA synthetase 2, mitochondrial
decreases expression
EXP
sulforaphane results in decreased expression of SARS2 mRNA
CTD
PMID:31838189
NCBI chr19:38,915,266...38,930,763
Ensembl chr19:38,915,266...38,930,763
G
SAT1
spermidine/spermine N1-acetyltransferase 1
increases expression
EXP
sulforaphane results in increased expression of SAT1 mRNA
CTD
PMID:26833863
NCBI chr X:23,783,173...23,786,210
Ensembl chr X:23,783,173...23,786,210
G
SATB1
SATB homeobox 1
decreases expression increases methylation
EXP
sulforaphane results in decreased expression of SATB1 mRNA sulforaphane results in increased methylation of SATB1 gene
CTD
PMID:31838189
NCBI chr 3:18,345,377...18,445,592
Ensembl chr 3:18,345,377...18,445,621
G
SAXO4
stabilizer of axonemal microtubules 4
increases expression
ISO
sulforaphane results in increased expression of SAXO4 mRNA
CTD
PMID:30529165
NCBI chr11:61,481,120...61,490,928
Ensembl chr11:61,481,120...61,490,931
G
SCARA3
scavenger receptor class A member 3
increases expression
ISO
sulforaphane results in increased expression of SCARA3 mRNA
CTD
PMID:30529165
NCBI chr 8:27,633,463...27,734,141
Ensembl chr 8:27,633,868...27,676,776
G
SCARA5
scavenger receptor class A member 5
increases expression
ISO
sulforaphane results in increased expression of SCARA5 mRNA
CTD
PMID:30529165
NCBI chr 8:27,869,883...27,992,673
Ensembl chr 8:27,869,883...27,992,673
G
SCD
stearoyl-CoA desaturase
decreases expression
ISO EXP
sulforaphane results in decreased expression of SCD2 mRNA sulforaphane results in decreased expression of SCD mRNA
CTD
PMID:30529165 PMID:34767876
NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
G
SCEL
sciellin
decreases expression
ISO
sulforaphane results in decreased expression of SCEL mRNA
CTD
PMID:30529165
NCBI chr13:77,535,706...77,645,263
Ensembl chr13:77,535,674...77,645,263
G
SCG2
secretogranin II
increases expression
ISO
sulforaphane results in increased expression of SCG2 mRNA
CTD
PMID:30529165
NCBI chr 2:223,596,940...223,602,361
Ensembl chr 2:223,596,940...223,602,361
G
SCIN
scinderin
increases expression
ISO
sulforaphane results in increased expression of SCIN mRNA
CTD
PMID:30529165
NCBI chr 7:12,570,720...12,660,182
Ensembl chr 7:12,570,577...12,660,182
G
SCN1A
sodium voltage-gated channel alpha subunit 1
decreases expression
EXP
sulforaphane results in decreased expression of SCN1A mRNA
CTD
PMID:31838189
NCBI chr 2:165,984,641...166,149,161
Ensembl chr 2:165,984,641...166,182,806
G
SCN5A
sodium voltage-gated channel alpha subunit 5
increases expression
ISO
sulforaphane results in increased expression of SCN5A mRNA
CTD
PMID:30529165
NCBI chr 3:38,548,062...38,649,687
Ensembl chr 3:38,548,057...38,649,743
G
SCNN1A
sodium channel epithelial 1 subunit alpha
decreases expression
EXP
sulforaphane results in decreased expression of SCNN1A mRNA
CTD
PMID:31838189
NCBI chr12:6,346,847...6,377,359
Ensembl chr12:6,346,843...6,377,730
G
SDC2
syndecan 2
decreases expression
EXP
sulforaphane results in decreased expression of SDC2 mRNA
CTD
PMID:31838189
NCBI chr 8:96,493,813...96,611,790
Ensembl chr 8:96,493,813...96,611,790
G
SDCBP
syndecan binding protein
increases expression
EXP
sulforaphane results in increased expression of SDCBP mRNA
CTD
PMID:26833863
NCBI chr 8:58,553,261...58,582,858
Ensembl chr 8:58,552,924...58,582,859
G
SDE2
SDE2 telomere maintenance homolog
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SDE2 mRNA
CTD
PMID:30529165
NCBI chr 1:225,982,702...225,999,343
Ensembl chr 1:225,982,702...225,999,343
G
SDHB
succinate dehydrogenase complex iron sulfur subunit B
increases expression multiple interactions
ISO
sulforaphane results in increased expression of SDHB mRNA; sulforaphane results in increased expression of SDHB protein NFE2L2 protein affects the reaction [Oxygen inhibits the reaction [sulforaphane results in increased expression of SDHB protein]]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of SDHB protein]; Oxygen inhibits the reaction [sulforaphane results in increased expression of SDHB protein]
CTD
PMID:30529165
NCBI chr 1:17,018,722...17,054,032
Ensembl chr 1:17,018,664...17,054,151
G
SDK2
sidekick cell adhesion molecule 2
decreases expression
EXP
sulforaphane results in decreased expression of SDK2 mRNA
CTD
PMID:26833863
NCBI chr17:73,334,384...73,644,445
Ensembl chr17:73,334,384...73,644,445
G
SDR16C5
short chain dehydrogenase/reductase family 16C member 5
decreases expression
EXP
sulforaphane results in decreased expression of SDR16C5 mRNA
CTD
PMID:31838189
NCBI chr 8:56,300,005...56,320,175
Ensembl chr 8:56,300,005...56,320,776
G
SEC16B
SEC16 homolog B, endoplasmic reticulum export factor
decreases expression multiple interactions
ISO
sulforaphane results in decreased expression of SEC16B mRNA [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of SEC16B mRNA
CTD
PMID:30529165
NCBI chr 1:177,928,788...177,984,284
Ensembl chr 1:177,923,956...177,984,303
G
SECISBP2L
SECIS binding protein 2 like
decreases expression
ISO
sulforaphane results in decreased expression of SECISBP2L mRNA
CTD
PMID:30529165
NCBI chr15:48,988,638...49,046,446
Ensembl chr15:48,988,476...49,046,447
G
SEL1L3
SEL1L family member 3
increases expression
EXP
sulforaphane results in increased expression of SEL1L3 mRNA
CTD
PMID:31838189
NCBI chr 4:25,713,964...25,863,566
Ensembl chr 4:25,747,433...25,863,760
G
SELENBP1
selenium binding protein 1
decreases expression
EXP
sulforaphane results in decreased expression of SELENBP1 mRNA
CTD
PMID:31838189
NCBI chr 1:151,364,304...151,372,705
Ensembl chr 1:151,364,304...151,372,707
G
SELENOH
selenoprotein H
decreases expression
EXP
sulforaphane results in decreased expression of SELENOH mRNA
CTD
PMID:31838189
NCBI chr11:57,741,491...57,743,550
Ensembl chr11:57,741,491...57,743,554
G
SELENOM
selenoprotein M
decreases expression
EXP
sulforaphane results in decreased expression of SELENOM mRNA
CTD
PMID:31838189
NCBI chr22:31,104,777...31,107,568
Ensembl chr22:31,104,772...31,120,069
G
SELENOP
selenoprotein P
decreases expression
EXP
sulforaphane results in decreased expression of SELENOP mRNA
CTD
PMID:31838189
NCBI chr 5:42,799,880...42,811,892
Ensembl chr 5:42,799,880...42,887,392
G
SELP
selectin P
increases expression
ISO
sulforaphane results in increased expression of SELP mRNA
CTD
PMID:30529165
NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193
G
SEMA3B
semaphorin 3B
decreases expression
EXP
sulforaphane results in decreased expression of SEMA3B mRNA
CTD
PMID:31838189
NCBI chr 3:50,267,652...50,277,546
Ensembl chr 3:50,267,558...50,277,546
G
SEMA3C
semaphorin 3C
decreases expression
EXP
sulforaphane results in decreased expression of SEMA3C mRNA
CTD
PMID:31838189
NCBI chr 7:80,742,538...80,922,389
Ensembl chr 7:80,742,538...80,922,359
G
SEMA3F
semaphorin 3F
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SEMA3F mRNA
CTD
PMID:30529165
NCBI chr 3:50,155,058...50,189,075
Ensembl chr 3:50,155,045...50,189,075
G
SEMA7A
semaphorin 7A (JohnMiltonHagen blood group)
decreases expression
EXP
sulforaphane results in decreased expression of SEMA7A mRNA
CTD
PMID:31838189
NCBI chr15:74,409,289...74,433,958
Ensembl chr15:74,409,289...74,433,958
G
SEPTIN3
septin 3
decreases expression
EXP
sulforaphane results in decreased expression of SEPTIN3 mRNA
CTD
PMID:31838189
NCBI chr22:41,969,443...41,998,221
Ensembl chr22:41,969,443...41,998,221
G
SEPTIN6
septin 6
decreases expression
EXP
sulforaphane results in decreased expression of SEPTIN6 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr X:119,615,724...119,693,168
Ensembl chr X:119,615,724...119,693,370
G
SERINC5
serine incorporator 5
decreases expression
EXP
sulforaphane results in decreased expression of SERINC5 mRNA
CTD
PMID:26833863
NCBI chr 5:80,111,225...80,256,048
Ensembl chr 5:80,111,651...80,256,048
G
SERPINE1
serpin family E member 1
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] affects the reaction [Oxygen deficiency results in increased expression of SERPINE1 protein]; NFE2L2 gene mutant form inhibits the reaction [sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of SERPINE1 protein]]; sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of SERPINE1 protein]; sulforaphane inhibits the reaction [Oxygen deficiency results in increased expression of SERPINE1 protein]; sulforaphane inhibits the reaction [Streptozocin results in increased expression of SERPINE1 protein]
CTD
PMID:24967692 PMID:29353218 PMID:30096613
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SERPINE2
serpin family E member 2
increases expression
EXP
sulforaphane results in increased expression of SERPINE2 mRNA
CTD
PMID:31838189
NCBI chr 2:223,975,045...224,039,286
Ensembl chr 2:223,975,045...224,039,318
G
SERPING1
serpin family G member 1
affects binding
EXP
SERPING1 protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr11:57,597,685...57,614,848
Ensembl chr11:57,597,387...57,619,171
G
SESTD1
SEC14 and spectrin domain containing 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SESTD1 mRNA
CTD
PMID:30529165
NCBI chr 2:179,101,678...179,264,832
Ensembl chr 2:179,101,678...179,264,832
G
SF3B5
splicing factor 3b subunit 5
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SF3B5 mRNA
CTD
PMID:30529165
NCBI chr 6:144,094,884...144,095,573
Ensembl chr 6:144,094,884...144,095,573
G
SFN
stratifin
affects binding
EXP
SFN protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr 1:26,863,149...26,864,456
Ensembl chr 1:26,863,149...26,864,456
G
SFRP1
secreted frizzled related protein 1
increases expression
ISO
sulforaphane results in increased expression of SFRP1 mRNA
CTD
PMID:30529165
NCBI chr 8:41,261,962...41,309,473
Ensembl chr 8:41,261,962...41,309,473
G
SGCA
sarcoglycan alpha
increases expression
ISO
sulforaphane results in increased expression of SGCA mRNA
CTD
PMID:30529165
NCBI chr17:50,166,005...50,175,928
Ensembl chr17:50,164,214...50,175,928
G
SGK1
serum/glucocorticoid regulated kinase 1
increases expression
EXP
sulforaphane results in increased expression of SGK1 mRNA
CTD
PMID:26833863
NCBI chr 6:134,169,256...134,318,112
Ensembl chr 6:134,169,248...134,318,112
G
SGMS2
sphingomyelin synthase 2
increases expression
EXP
sulforaphane results in increased expression of SGMS2 mRNA
CTD
PMID:26833863
NCBI chr 4:107,824,563...107,915,047
Ensembl chr 4:107,824,563...107,915,047
G
SGO2
shugoshin 2
increases expression
EXP
sulforaphane results in increased expression of SGO2 mRNA
CTD
PMID:31838189
NCBI chr 2:200,526,142...200,584,096
Ensembl chr 2:200,510,008...200,584,096
G
SGPP2
sphingosine-1-phosphate phosphatase 2
decreases expression
ISO
sulforaphane results in decreased expression of SGPP2 mRNA
CTD
PMID:30529165
NCBI chr 2:222,423,988...222,562,621
Ensembl chr 2:222,424,543...222,562,621
G
SH2D5
SH2 domain containing 5
increases expression
EXP
sulforaphane results in increased expression of SH2D5 mRNA
CTD
PMID:31838189
NCBI chr 1:20,719,731...20,732,703
Ensembl chr 1:20,719,731...20,732,837
G
SH3D19
SH3 domain containing 19
decreases expression
ISO
sulforaphane results in decreased expression of SH3D19 mRNA
CTD
PMID:30529165
NCBI chr 4:151,120,281...151,325,605
Ensembl chr 4:151,102,751...151,325,605
G
SH3PXD2A
SH3 and PX domains 2A
increases methylation decreases expression
EXP
sulforaphane results in increased methylation of SH3PXD2A gene sulforaphane results in decreased expression of SH3PXD2A mRNA
CTD
PMID:31838189
NCBI chr10:103,594,027...103,855,576
Ensembl chr10:103,594,027...103,855,584
G
SH3RF3
SH3 domain containing ring finger 3
increases expression
EXP
sulforaphane results in increased expression of SH3RF3 mRNA
CTD
PMID:31838189
NCBI chr 2:109,129,205...109,504,634
Ensembl chr 2:109,129,205...109,504,634
G
SH3TC2
SH3 domain and tetratricopeptide repeats 2
increases expression
EXP
sulforaphane results in increased expression of SH3TC2 mRNA
CTD
PMID:31838189
NCBI chr 5:148,982,150...149,063,062
Ensembl chr 5:148,923,639...149,063,163
G
SHE
Src homology 2 domain containing E
decreases expression
ISO
sulforaphane results in decreased expression of SHE mRNA
CTD
PMID:30529165
NCBI chr 1:154,469,637...154,502,412
Ensembl chr 1:154,469,772...154,502,412
G
SIGLEC10
sialic acid binding Ig like lectin 10
increases expression
EXP
sulforaphane results in increased expression of SIGLEC10 mRNA
CTD
PMID:26833863
NCBI chr19:51,410,020...51,417,642
Ensembl chr19:51,410,020...51,417,803
G
SIGLEC5
sialic acid binding Ig like lectin 5
increases expression decreases expression
EXP ISO
sulforaphane results in increased expression of SIGLEC5 mRNA sulforaphane results in decreased expression of SIGLEC5 mRNA
CTD
PMID:26833863 PMID:30529165
NCBI chr19:51,610,960...51,630,401
Ensembl chr19:51,610,960...51,630,401 Ensembl chr19:51,610,960...51,630,401
G
SIGLEC6
sialic acid binding Ig like lectin 6
decreases expression
EXP
sulforaphane results in decreased expression of SIGLEC6 mRNA
CTD
PMID:26833863
NCBI chr19:51,517,819...51,531,670
Ensembl chr19:51,517,819...51,531,856
G
SIGLEC9
sialic acid binding Ig like lectin 9
increases expression
EXP
sulforaphane results in increased expression of SIGLEC9 mRNA
CTD
PMID:26833863
NCBI chr19:51,119,778...51,136,263
Ensembl chr19:51,124,906...51,136,651
G
SIPA1L1
signal induced proliferation associated 1 like 1
increases expression
EXP
sulforaphane results in increased expression of SIPA1L1 mRNA
CTD
PMID:26833863
NCBI chr14:71,320,476...71,741,209
Ensembl chr14:71,320,449...71,741,229
G
SIRPD
signal regulatory protein delta
increases expression
EXP
sulforaphane results in increased expression of SIRPD mRNA
CTD
PMID:26833863
NCBI chr20:1,534,251...1,557,705
Ensembl chr20:1,534,251...1,557,705
G
SIRT1
sirtuin 1
increases expression
EXP
sulforaphane results in increased expression of SIRT1 protein
CTD
PMID:33894213
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
G
SKA2
spindle and kinetochore associated complex subunit 2
decreases expression
EXP
sulforaphane results in decreased expression of SKA2 mRNA
CTD
PMID:31838189
NCBI chr17:59,109,857...59,155,186
Ensembl chr17:59,109,857...59,155,260
G
SKIL
SKI like proto-oncogene
increases expression
EXP
sulforaphane results in increased expression of SKIL mRNA
CTD
PMID:26833863
NCBI chr 3:170,357,715...170,396,849
Ensembl chr 3:170,357,342...170,396,835
G
SLAMF6
SLAM family member 6
decreases expression
EXP
sulforaphane results in decreased expression of SLAMF6 mRNA
CTD
PMID:26833863
NCBI chr 1:160,485,036...160,523,255
Ensembl chr 1:160,485,030...160,523,262
G
SLC10A1
solute carrier family 10 member 1
decreases expression
EXP
sulforaphane results in decreased expression of SLC10A1 mRNA
CTD
PMID:34767876
NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
G
SLC10A6
solute carrier family 10 member 6
decreases expression
ISO
sulforaphane results in decreased expression of SLC10A6 mRNA
CTD
PMID:30529165
NCBI chr 4:86,823,468...86,849,384
Ensembl chr 4:86,823,468...86,849,384
G
SLC12A3
solute carrier family 12 member 3
decreases expression
EXP
sulforaphane results in decreased expression of SLC12A3 mRNA
CTD
PMID:31838189
NCBI chr16:56,865,207...56,915,850
Ensembl chr16:56,865,207...56,915,850
G
SLC12A7
solute carrier family 12 member 7
increases expression
EXP
sulforaphane results in increased expression of SLC12A7 mRNA
CTD
PMID:31838189
NCBI chr 5:1,050,384...1,155,899
Ensembl chr 5:1,050,384...1,112,063
G
SLC12A8
solute carrier family 12 member 8
increases expression
EXP
sulforaphane results in increased expression of SLC12A8 mRNA
CTD
PMID:31838189
NCBI chr 3:125,082,644...125,212,748
Ensembl chr 3:125,082,636...125,212,864
G
SLC13A1
solute carrier family 13 member 1
increases expression
EXP
sulforaphane results in increased expression of SLC13A1 mRNA
CTD
PMID:31838189
NCBI chr 7:123,113,531...123,199,971
Ensembl chr 7:123,113,531...123,199,972
G
SLC16A14
solute carrier family 16 member 14
increases expression
EXP
sulforaphane results in increased expression of SLC16A14 mRNA
CTD
PMID:31838189
NCBI chr 2:230,034,982...230,068,924
Ensembl chr 2:230,034,982...230,068,993
G
SLC16A4
solute carrier family 16 member 4
decreases expression
EXP
sulforaphane results in decreased expression of SLC16A4 mRNA
CTD
PMID:31838189
NCBI chr 1:110,362,857...110,391,026
Ensembl chr 1:110,362,851...110,391,082
G
SLC1A3
solute carrier family 1 member 3
increases expression
EXP
sulforaphane results in increased expression of SLC1A3 mRNA
CTD
PMID:31838189
NCBI chr 5:36,606,606...36,688,334
Ensembl chr 5:36,596,588...36,688,334
G
SLC1A5
solute carrier family 1 member 5
increases expression
EXP
sulforaphane results in increased expression of SLC1A5 mRNA
CTD
PMID:31838189
NCBI chr19:46,774,883...46,788,594
Ensembl chr19:46,774,883...46,788,594
G
SLC20A1
solute carrier family 20 member 1
increases expression
EXP
sulforaphane results in increased expression of SLC20A1 mRNA
CTD
PMID:31838189
NCBI chr 2:112,645,939...112,663,825
Ensembl chr 2:112,645,939...112,663,825
G
SLC22A23
solute carrier family 22 member 23
increases expression
EXP
sulforaphane results in increased expression of SLC22A23 mRNA
CTD
PMID:31838189
NCBI chr 6:3,268,973...3,457,050
Ensembl chr 6:3,268,962...3,457,050
G
SLC22A8
solute carrier family 22 member 8
affects expression
ISO
sulforaphane affects the expression of SLC22A8 protein
CTD
PMID:24958931
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
G
SLC25A29
solute carrier family 25 member 29
decreases expression
EXP
sulforaphane results in decreased expression of SLC25A29 mRNA
CTD
PMID:31838189
NCBI chr14:100,278,567...100,306,444
Ensembl chr14:100,291,116...100,306,547
G
SLC25A51
solute carrier family 25 member 51
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SLC25A51 mRNA
CTD
PMID:30529165
NCBI chr 9:37,877,575...37,904,127
Ensembl chr 9:37,879,400...37,904,353
G
SLC26A2
solute carrier family 26 member 2
increases expression
EXP
sulforaphane results in increased expression of SLC26A2 mRNA
CTD
PMID:31838189
NCBI chr 5:149,960,758...149,987,400
Ensembl chr 5:149,960,758...149,993,455
G
SLC27A1
solute carrier family 27 member 1
increases expression
ISO
sulforaphane results in increased expression of SLC27A1 mRNA
CTD
PMID:30529165
NCBI chr19:17,468,767...17,506,168
Ensembl chr19:17,468,769...17,506,168
G
SLC27A2
solute carrier family 27 member 2
increases expression
ISO
sulforaphane results in increased expression of SLC27A2 mRNA
CTD
PMID:30529165
NCBI chr15:50,182,196...50,236,385
Ensembl chr15:50,182,196...50,236,385
G
SLC27A4
solute carrier family 27 member 4
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SLC27A4 mRNA
CTD
PMID:30529165
NCBI chr 9:128,340,527...128,361,470
Ensembl chr 9:128,340,527...128,361,470
G
SLC28A3
solute carrier family 28 member 3
decreases expression
EXP
sulforaphane results in decreased expression of SLC28A3 mRNA
CTD
PMID:31838189
NCBI chr 9:84,275,457...84,368,727
Ensembl chr 9:84,275,457...84,340,758
G
SLC2A3
solute carrier family 2 member 3
increases expression
EXP
sulforaphane results in increased expression of SLC2A3 mRNA
CTD
PMID:26833863
NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...8,019,007
G
SLC2A4
solute carrier family 2 member 4
increases expression
ISO
sulforaphane results in increased expression of SLC2A4 mRNA
CTD
PMID:30529165
NCBI chr17:7,281,718...7,288,257
Ensembl chr17:7,281,718...7,288,257
G
SLC2A5
solute carrier family 2 member 5
decreases expression
EXP
sulforaphane results in decreased expression of SLC2A5 mRNA
CTD
PMID:31838189
NCBI chr 1:9,035,106...9,094,195
Ensembl chr 1:9,035,106...9,088,478
G
SLC35G2
solute carrier family 35 member G2
increases expression
EXP
sulforaphane results in increased expression of SLC35G2 mRNA
CTD
PMID:31838189
NCBI chr 3:136,819,126...136,855,888
Ensembl chr 3:136,818,647...136,855,888
G
SLC37A3
solute carrier family 37 member 3
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SLC37A3 mRNA
CTD
PMID:30529165
NCBI chr 7:140,333,752...140,398,530
Ensembl chr 7:140,293,693...140,404,433
G
SLC38A3
solute carrier family 38 member 3
decreases expression
EXP
sulforaphane results in decreased expression of SLC38A3 mRNA
CTD
PMID:31838189
NCBI chr 3:50,205,271...50,221,486
Ensembl chr 3:50,205,246...50,221,486
G
SLC38A4
solute carrier family 38 member 4
decreases expression
ISO
sulforaphane results in decreased expression of SLC38A4 mRNA
CTD
PMID:30529165
NCBI chr12:46,764,761...46,832,431
Ensembl chr12:46,764,761...46,832,408
G
SLC38A6
solute carrier family 38 member 6
increases expression
EXP
sulforaphane results in increased expression of SLC38A6 mRNA
CTD
PMID:31838189
NCBI chr14:60,981,245...61,083,733
Ensembl chr14:60,981,114...61,114,316
G
SLC39A2
solute carrier family 39 member 2
multiple interactions
EXP
sulforaphane promotes the reaction [SLC39A2 protein results in increased activity of NFE2L2 protein]
CTD
PMID:18385089
NCBI chr14:20,999,293...21,001,871
Ensembl chr14:20,999,255...21,001,871
G
SLC3A2
solute carrier family 3 member 2
decreases expression
EXP
sulforaphane results in decreased expression of SLC3A2 mRNA
CTD
PMID:35724838
NCBI chr11:62,856,109...62,888,860
Ensembl chr11:62,856,004...62,888,880
G
SLC40A1
solute carrier family 40 member 1
multiple interactions increases expression
ISO
sulforaphane inhibits the reaction [Busulfan results in decreased expression of SLC40A1 protein]; sulforaphane inhibits the reaction [Lipopolysaccharides results in decreased expression of SLC40A1 mRNA] sulforaphane results in increased expression of SLC40A1 protein
CTD
PMID:21303654 PMID:32416107
NCBI chr 2:189,560,590...189,580,786
Ensembl chr 2:189,560,590...189,583,758
G
SLC43A3
solute carrier family 43 member 3
decreases expression
ISO
sulforaphane results in decreased expression of SLC43A3 mRNA
CTD
PMID:30529165
NCBI chr11:57,406,954...57,427,580
Ensembl chr11:57,406,954...57,427,580
G
SLC44A4
solute carrier family 44 member 4
increases expression
ISO
sulforaphane results in increased expression of SLC44A4 mRNA
CTD
PMID:30529165
NCBI chr 6:31,863,192...31,878,997
Ensembl chr 6:31,863,192...31,879,046
G
SLC47A1
solute carrier family 47 member 1
increases expression
EXP
sulforaphane results in increased expression of SLC47A1 mRNA
CTD
PMID:31838189
NCBI chr17:19,533,854...19,579,034
Ensembl chr17:19,495,385...19,579,034
G
SLC48A1
solute carrier family 48 member 1
increases expression
EXP
sulforaphane results in increased expression of SLC48A1 mRNA
CTD
PMID:31838189
NCBI chr12:47,753,934...47,782,751
Ensembl chr12:47,753,916...47,782,751
G
SLC4A3
solute carrier family 4 member 3
increases expression
ISO
sulforaphane results in increased expression of SLC4A3 mRNA
CTD
PMID:30529165
NCBI chr 2:219,627,630...219,641,971
Ensembl chr 2:219,627,394...219,641,980
G
SLC4A8
solute carrier family 4 member 8
decreases expression
EXP
sulforaphane results in decreased expression of SLC4A8 mRNA
CTD
PMID:31838189
NCBI chr12:51,391,446...51,515,763
Ensembl chr12:51,391,317...51,515,763
G
SLC51A
solute carrier family 51 member A
decreases expression
EXP
sulforaphane results in decreased expression of SLC51A mRNA
CTD
PMID:34767876
NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178
G
SLC6A6
solute carrier family 6 member 6
increases expression
EXP
sulforaphane results in increased expression of SLC6A6 mRNA
CTD
PMID:31838189
NCBI chr 3:14,402,576...14,489,349
Ensembl chr 3:14,402,576...14,489,349
G
SLC7A11
solute carrier family 7 member 11
increases expression
EXP
sulforaphane results in increased expression of SLC7A11 mRNA
CTD
PMID:31838189 PMID:34767876
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
SLCO2A1
solute carrier organic anion transporter family member 2A1
decreases expression
EXP
sulforaphane results in decreased expression of SLCO2A1 mRNA
CTD
PMID:31838189
NCBI chr 3:133,932,701...134,029,925
Ensembl chr 3:133,932,701...134,052,184
G
SLCO3A1
solute carrier organic anion transporter family member 3A1
decreases expression
EXP
sulforaphane results in decreased expression of SLCO3A1 mRNA
CTD
PMID:31838189
NCBI chr15:91,853,708...92,172,435
Ensembl chr15:91,853,708...92,172,435
G
SLCO4C1
solute carrier organic anion transporter family member 4C1
increases expression
EXP
sulforaphane results in increased expression of SLCO4C1 mRNA
CTD
PMID:26833863
NCBI chr 5:102,233,986...102,296,284
Ensembl chr 5:102,233,986...102,296,284
G
SLF1
SMC5-SMC6 complex localization factor 1
decreases expression
EXP
sulforaphane results in decreased expression of SLF1 mRNA
CTD
PMID:31838189
NCBI chr 5:94,618,231...94,697,621
Ensembl chr 5:94,618,669...94,739,436
G
SLURP1
secreted LY6/PLAUR domain containing 1
increases expression
ISO
sulforaphane results in increased expression of SLURP1 mRNA
CTD
PMID:30529165
NCBI chr 8:142,740,949...142,742,406
Ensembl chr 8:142,740,949...142,742,406
G
SMIM6
small integral membrane protein 6
multiple interactions increases expression
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SMIM6 mRNA sulforaphane results in increased expression of SMIM6 mRNA
CTD
PMID:30529165
NCBI chr17:75,646,251...75,647,974
Ensembl chr17:75,646,243...75,647,975
G
SMOC1
SPARC related modular calcium binding 1
increases expression
ISO
sulforaphane results in increased expression of SMOC1 mRNA
CTD
PMID:30529165
NCBI chr14:69,879,416...70,032,366
Ensembl chr14:69,854,131...70,032,366
G
SMOX
spermine oxidase
increases expression
EXP
sulforaphane results in increased expression of SMOX mRNA
CTD
PMID:31838189
NCBI chr20:4,148,828...4,187,727
Ensembl chr20:4,120,980...4,187,747
G
SMPDL3B
sphingomyelin phosphodiesterase acid like 3B
decreases expression
EXP
sulforaphane results in decreased expression of SMPDL3B mRNA
CTD
PMID:31838189
NCBI chr 1:27,935,000...27,959,152
Ensembl chr 1:27,935,000...27,959,157
G
SMPX
small muscle protein X-linked
increases expression
ISO
sulforaphane results in increased expression of SMPX mRNA
CTD
PMID:30529165
NCBI chr X:21,705,978...21,758,116
Ensembl chr X:21,705,978...21,758,116
G
SMYD1
SET and MYND domain containing 1
increases expression
ISO
sulforaphane results in increased expression of SMYD1 mRNA
CTD
PMID:30529165
NCBI chr 2:88,067,825...88,113,384
Ensembl chr 2:88,067,825...88,113,384
G
SNAI1
snail family transcriptional repressor 1
multiple interactions
ISO
sulforaphane inhibits the reaction [Paraquat results in increased expression of SNAI1 protein]
CTD
PMID:28624451
NCBI chr20:49,982,980...49,988,886
Ensembl chr20:49,982,980...49,988,886
G
SNAI2
snail family transcriptional repressor 2
decreases expression
EXP
sulforaphane results in decreased expression of SNAI2 mRNA
CTD
PMID:31838189
NCBI chr 8:48,917,598...48,921,429
Ensembl chr 8:48,917,598...48,921,740
G
SNAP25
synaptosome associated protein 25
decreases expression
EXP
sulforaphane results in decreased expression of SNAP25 mRNA
CTD
PMID:31838189
NCBI chr20:10,218,830...10,307,418
Ensembl chr20:10,172,395...10,308,258
G
SNAPC3
small nuclear RNA activating complex polypeptide 3
decreases expression multiple interactions
ISO
sulforaphane results in decreased expression of SNAPC3 mRNA [sulforaphane affects the susceptibility to Oxygen] which affects the expression of SNAPC3 mRNA
CTD
PMID:30529165
NCBI chr 9:15,422,876...15,466,735
Ensembl chr 9:15,422,734...15,465,953
G
SNAPIN
SNAP associated protein
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SNAPIN mRNA
CTD
PMID:30529165
NCBI chr 1:153,658,654...153,661,852
Ensembl chr 1:153,658,703...153,661,852
G
SNCG
synuclein gamma
decreases expression
EXP
sulforaphane results in decreased expression of SNCG mRNA
CTD
PMID:31838189
NCBI chr10:86,955,759...86,963,258
Ensembl chr10:86,958,599...86,963,258
G
SND1
staphylococcal nuclease and tudor domain containing 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SND1 mRNA
CTD
PMID:30529165
NCBI chr 7:127,652,194...128,092,593
Ensembl chr 7:127,652,194...128,092,609
G
SNHG11
small nucleolar RNA host gene 11
decreases expression
ISO
sulforaphane results in decreased expression of SNHG11 mRNA
CTD
PMID:30529165
NCBI chr20:38,446,654...38,450,921
Ensembl chr20:38,446,343...38,450,940
G
SNORA2A
small nucleolar RNA, H/ACA box 2A
decreases expression
EXP
sulforaphane results in decreased expression of SNORA2A mRNA
CTD
PMID:26833863
NCBI chr12:48,656,648...48,656,782
Ensembl chr12:48,656,648...48,656,782
G
SNORA3A
small nucleolar RNA, H/ACA box 3A
increases expression
EXP
sulforaphane results in increased expression of SNORA3A mRNA
CTD
PMID:26833863
NCBI chr11:8,684,227...8,684,356
Ensembl chr11:8,684,227...8,684,356
G
SNORD116-13
small nucleolar RNA, C/D box 116-13
decreases expression
EXP
sulforaphane results in decreased expression of SNORD116-13 mRNA
CTD
PMID:26833863
NCBI chr15:25,079,057...25,079,150
Ensembl chr15:25,079,058...25,079,149
G
SNORD116-2
small nucleolar RNA, C/D box 116-2
decreases expression
EXP
sulforaphane results in decreased expression of SNORD116-2 mRNA
CTD
PMID:26833863
NCBI chr15:25,054,209...25,054,305
Ensembl chr15:25,054,210...25,054,304
G
SNORD1B
small nucleolar RNA, C/D box 1B
decreases expression
EXP
sulforaphane results in decreased expression of SNORD1B mRNA
CTD
PMID:26833863
NCBI chr17:76,561,108...76,561,193
Ensembl chr17:76,561,109...76,561,192
G
SNRK
SNF related kinase
decreases expression
ISO
sulforaphane results in decreased expression of SNRK mRNA
CTD
PMID:30529165
NCBI chr 3:43,286,540...43,351,143
Ensembl chr 3:43,286,512...43,424,764
G
SNRNP48
small nuclear ribonucleoprotein U11/U12 subunit 48
decreases expression
ISO
sulforaphane results in decreased expression of SNRNP48 mRNA
CTD
PMID:30529165
NCBI chr 6:7,590,198...7,611,967
Ensembl chr 6:7,590,198...7,611,967
G
SNX25
sorting nexin 25
decreases expression
ISO
sulforaphane results in decreased expression of SNX25 mRNA
CTD
PMID:30529165
NCBI chr 4:185,204,237...185,378,642
Ensembl chr 4:185,204,237...185,370,185
G
SOD1
superoxide dismutase 1
increases expression multiple interactions
EXP ISO
sulforaphane results in increased expression of SOD1 protein sulforaphane inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SOD1 mRNA] sulforaphane inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of SOD1 mRNA]; sulforaphane inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of SOD1 protein]
CTD
PMID:24707343 PMID:25111660 PMID:30835071
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SOD2
superoxide dismutase 2
multiple interactions increases expression
ISO
sulforaphane inhibits the reaction [Oxygen deficiency results in decreased expression of SOD2 mRNA]; sulforaphane inhibits the reaction [Oxygen deficiency results in decreased expression of SOD2 protein] sulforaphane results in increased expression of SOD2 mRNA; sulforaphane results in increased expression of SOD2 protein
CTD
PMID:30096613
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SORBS2
sorbin and SH3 domain containing 2
increases expression decreases expression
ISO EXP
sulforaphane results in increased expression of SORBS2 mRNA sulforaphane results in decreased expression of SORBS2 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 4:185,585,523...185,956,372
Ensembl chr 4:185,585,444...185,956,652
G
SORCS2
sortilin related VPS10 domain containing receptor 2
decreases expression
EXP
sulforaphane results in decreased expression of SORCS2 mRNA
CTD
PMID:31838189
NCBI chr 4:7,192,538...7,742,827
Ensembl chr 4:7,192,538...7,742,827
G
SORL1
sortilin related receptor 1
decreases expression
EXP
sulforaphane results in decreased expression of SORL1 mRNA
CTD
PMID:31838189
NCBI chr11:121,452,314...121,633,763
Ensembl chr11:121,452,314...121,633,763
G
SOX15
SRY-box transcription factor 15
decreases expression
EXP
sulforaphane results in decreased expression of SOX15 mRNA
CTD
PMID:31838189
NCBI chr17:7,588,178...7,590,094
Ensembl chr17:7,588,178...7,590,094
G
SOX4
SRY-box transcription factor 4
decreases expression
EXP
sulforaphane results in decreased expression of SOX4 mRNA
CTD
PMID:31838189
NCBI chr 6:21,593,751...21,598,619
Ensembl chr 6:21,593,751...21,598,619
G
SOX9
SRY-box transcription factor 9
increases expression
EXP
sulforaphane results in increased expression of SOX9 mRNA; sulforaphane results in increased expression of SOX9 protein
CTD
PMID:32682831
NCBI chr17:72,121,020...72,126,416
Ensembl chr17:72,121,020...72,126,416
G
SPACA6
sperm acrosome associated 6
decreases expression
EXP
sulforaphane results in decreased expression of SPACA6 mRNA
CTD
PMID:31838189
NCBI chr19:51,682,686...51,713,143
Ensembl chr19:51,688,346...51,712,387
G
SPART-AS1
SPART antisense RNA 1
decreases expression
EXP
sulforaphane results in decreased expression of SPART-AS1 mRNA
CTD
PMID:26833863
NCBI chr13:36,346,431...36,369,735
Ensembl chr13:36,346,431...36,369,601
G
SPATA17
spermatogenesis associated 17
increases expression
EXP
sulforaphane results in increased expression of SPATA17 mRNA
CTD
PMID:31838189
NCBI chr 1:217,631,344...217,871,696
Ensembl chr 1:217,631,324...217,871,696
G
SPATA24
spermatogenesis associated 24
increases expression
ISO
sulforaphane results in increased expression of SPATA24 mRNA
CTD
PMID:30529165
NCBI chr 5:139,392,500...139,404,089
Ensembl chr 5:139,396,563...139,404,089
G
SPINK13
serine peptidase inhibitor Kazal type 13
decreases expression
EXP
sulforaphane results in decreased expression of SPINK13 mRNA
CTD
PMID:31838189
NCBI chr 5:148,268,794...148,286,255
Ensembl chr 5:148,268,180...148,286,255
G
SPINT1
serine peptidase inhibitor, Kunitz type 1
decreases expression
EXP
sulforaphane results in decreased expression of SPINT1 mRNA
CTD
PMID:31838189
NCBI chr15:40,844,048...40,858,207
Ensembl chr15:40,844,018...40,858,207
G
SPON2
spondin 2
decreases expression
EXP
sulforaphane results in decreased expression of SPON2 mRNA
CTD
PMID:31838189
NCBI chr 4:1,166,932...1,208,844
Ensembl chr 4:1,166,932...1,208,962
G
SPP1
secreted phosphoprotein 1
increases expression
EXP
sulforaphane results in increased expression of SPP1 mRNA
CTD
PMID:26833863 PMID:27562236
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
SPRED1
sprouty related EVH1 domain containing 1
increases expression
EXP
sulforaphane results in increased expression of SPRED1 mRNA
CTD
PMID:31838189
NCBI chr15:38,252,836...38,357,249
Ensembl chr15:38,252,836...38,357,249
G
SPRED2
sprouty related EVH1 domain containing 2
increases expression
EXP
sulforaphane results in increased expression of SPRED2 mRNA
CTD
PMID:31838189
NCBI chr 2:65,307,175...65,432,599
Ensembl chr 2:65,310,851...65,432,637
G
SPRED3
sprouty related EVH1 domain containing 3
increases expression
EXP
sulforaphane results in increased expression of SPRED3 mRNA
CTD
PMID:31838189
NCBI chr19:38,388,697...38,399,587
Ensembl chr19:38,388,421...38,399,587
G
SPRR1A
small proline rich protein 1A
increases expression
ISO
sulforaphane results in increased expression of SPRR1A mRNA
CTD
PMID:30529165
NCBI chr 1:152,984,081...152,985,814
Ensembl chr 1:152,984,081...152,985,814
G
SPRY4
sprouty RTK signaling antagonist 4
increases expression
EXP
sulforaphane results in increased expression of SPRY4 mRNA
CTD
PMID:31838189
NCBI chr 5:142,310,430...142,325,021
Ensembl chr 5:142,310,427...142,326,455
G
SPSB1
splA/ryanodine receptor domain and SOCS box containing 1
increases expression
EXP
sulforaphane results in increased expression of SPSB1 mRNA
CTD
PMID:31838189
NCBI chr 1:9,292,894...9,369,532
Ensembl chr 1:9,292,894...9,369,532
G
SPTLC3
serine palmitoyltransferase long chain base subunit 3
decreases expression
EXP
sulforaphane results in decreased expression of SPTLC3 mRNA
CTD
PMID:31838189
NCBI chr20:13,008,972...13,169,103
Ensembl chr20:13,008,972...13,169,103
G
SQSTM1
sequestosome 1
multiple interactions decreases expression increases expression
EXP ISO
sulforaphane inhibits the reaction [sodium arsenite affects the localization of SQSTM1 protein] sulforaphane results in decreased expression of SQSTM1 mRNA sulforaphane results in increased expression of SQSTM1 protein NFE2L2 protein affects the reaction [sulforaphane results in increased expression of SQSTM1 protein] sulforaphane results in increased expression of SQSTM1 mRNA; sulforaphane results in increased expression of SQSTM1 protein
CTD
PMID:23589329 PMID:29950142 PMID:31838189 PMID:33894213 PMID:35724838
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
G
SRD5A3
steroid 5 alpha-reductase 3
decreases expression
EXP
sulforaphane results in decreased expression of SRD5A3 mRNA
CTD
PMID:26833863
NCBI chr 4:55,346,242...55,373,100
Ensembl chr 4:55,346,213...55,373,100
G
SREBF1
sterol regulatory element binding transcription factor 1
multiple interactions decreases expression
ISO EXP
[sulforaphane co-treated with Aflatoxin B1] affects the expression of SREBF1 mRNA sulforaphane inhibits the reaction [bisphenol A results in increased expression of SREBF1 mRNA] sulforaphane results in decreased expression of SREBF1 mRNA sulforaphane inhibits the reaction [bisphenol A results in increased expression of SREBF1 mRNA]; sulforaphane promotes the reaction [NFE2L2 protein results in increased expression of SREBF1 mRNA]
CTD
PMID:25450479 PMID:28796629 PMID:31838189 PMID:34767876 PMID:36670177
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
G
SRGAP3
SLIT-ROBO Rho GTPase activating protein 3
decreases expression
EXP
sulforaphane results in decreased expression of SRGAP3 mRNA
CTD
PMID:31838189
NCBI chr 3:8,980,591...9,363,027
Ensembl chr 3:8,980,591...9,363,053
G
SRGN
serglycin
multiple interactions increases expression
ISO EXP
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SRGN mRNA sulforaphane results in increased expression of SRGN mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr10:69,087,603...69,104,811
Ensembl chr10:69,088,103...69,104,805
G
SRL
sarcalumenin
increases expression
ISO
sulforaphane results in increased expression of SRL mRNA
CTD
PMID:30529165
NCBI chr16:4,189,374...4,242,080
Ensembl chr16:4,189,374...4,242,080
G
SRXN1
sulfiredoxin 1
increases expression decreases expression
EXP
sulforaphane results in increased expression of SRXN1 mRNA; sulforaphane results in increased expression of SRXN1 protein sulforaphane results in decreased expression of SRXN1 mRNA
CTD
PMID:26833863 PMID:31838189 PMID:35724838
NCBI chr20:646,615...653,200
Ensembl chr20:646,615...653,200
G
SSBP2
single stranded DNA binding protein 2
decreases expression
EXP
sulforaphane results in decreased expression of SSBP2 mRNA
CTD
PMID:31838189
NCBI chr 5:81,412,804...81,751,807
Ensembl chr 5:81,412,804...81,751,797
G
ST6GALNAC2
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
decreases expression
ISO
sulforaphane results in decreased expression of ST6GALNAC2 mRNA
CTD
PMID:30529165
NCBI chr17:76,565,377...76,585,860
Ensembl chr17:76,565,377...76,586,956
G
ST8SIA6
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6
increases expression
ISO
sulforaphane results in increased expression of ST8SIA6 mRNA
CTD
PMID:30529165
NCBI chr10:17,315,421...17,454,595
Ensembl chr10:17,315,421...17,454,595
G
STAB1
stabilin 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of STAB1 mRNA
CTD
PMID:30529165
NCBI chr 3:52,495,338...52,524,495
Ensembl chr 3:52,495,338...52,524,495
G
STAC2
SH3 and cysteine rich domain 2
decreases expression
EXP
sulforaphane results in decreased expression of STAC2 mRNA
CTD
PMID:31838189
NCBI chr17:39,210,541...39,225,945
Ensembl chr17:39,210,541...39,225,945
G
STAMBPL1
STAM binding protein like 1
increases expression
EXP
sulforaphane results in increased expression of STAMBPL1 mRNA
CTD
PMID:31838189
NCBI chr10:88,880,245...88,923,487
Ensembl chr10:88,879,734...88,975,153
G
STARD10
StAR related lipid transfer domain containing 10
decreases expression
EXP
sulforaphane results in decreased expression of STARD10 mRNA
CTD
PMID:31838189
NCBI chr11:72,754,729...72,794,047
Ensembl chr11:72,754,729...72,794,047
G
STARD13
StAR related lipid transfer domain containing 13
decreases expression
ISO
sulforaphane results in decreased expression of STARD13 mRNA
CTD
PMID:30529165
NCBI chr13:33,103,137...33,676,794
Ensembl chr13:33,103,137...33,350,630
G
STAT3
signal transducer and activator of transcription 3
decreases expression
EXP
sulforaphane results in decreased expression of STAT3 mRNA
CTD
PMID:31838189
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
G
STEAP1
STEAP family member 1
increases expression
EXP
sulforaphane results in increased expression of STEAP1 mRNA
CTD
PMID:31838189
NCBI chr 7:90,154,469...90,164,827
Ensembl chr 7:90,154,456...90,164,829
G
STEAP4
STEAP4 metalloreductase
increases expression decreases expression
ISO EXP
sulforaphane results in increased expression of STEAP4 mRNA sulforaphane results in decreased expression of STEAP4 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 7:88,270,892...88,306,894
Ensembl chr 7:88,270,892...88,306,894
G
STK17A
serine/threonine kinase 17a
increases expression
EXP
sulforaphane results in increased expression of STK17A mRNA
CTD
PMID:26833863
NCBI chr 7:43,583,108...43,627,379
Ensembl chr 7:43,582,758...43,650,713
G
STON1
stonin 1
decreases expression
EXP
sulforaphane results in decreased expression of STON1 mRNA
CTD
PMID:31838189
NCBI chr 2:48,530,154...48,598,513
Ensembl chr 2:48,529,383...48,598,513
G
STOX2
storkhead box 2
decreases expression
EXP
sulforaphane results in decreased expression of STOX2 mRNA
CTD
PMID:31838189
NCBI chr 4:183,798,022...184,023,530
Ensembl chr 4:183,797,692...184,023,526
G
STRIP2
striatin interacting protein 2
increases expression
ISO
sulforaphane results in increased expression of STRIP2 mRNA
CTD
PMID:30529165
NCBI chr 7:129,434,432...129,488,399
Ensembl chr 7:129,434,432...129,488,399
G
STX12
syntaxin 12
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of STX12 mRNA
CTD
PMID:30529165
NCBI chr 1:27,773,219...27,824,443
Ensembl chr 1:27,773,219...27,824,443
G
SUCNR1
succinate receptor 1
increases expression
EXP
sulforaphane results in increased expression of SUCNR1 mRNA
CTD
PMID:26833863
NCBI chr 3:151,873,643...151,884,619
Ensembl chr 3:151,873,643...151,884,619
G
SULF2
sulfatase 2
increases expression
EXP
sulforaphane results in increased expression of SULF2 mRNA
CTD
PMID:26833863
NCBI chr20:47,657,406...47,786,627
Ensembl chr20:47,656,197...47,786,616
G
SULT1D1P
sulfotransferase family 1D member 1, pseudogene
increases expression
ISO
sulforaphane results in increased expression of SULT1D1 mRNA
CTD
PMID:30529165
NCBI chr 4:69,791,873...69,813,872
Ensembl chr 4:69,791,872...69,813,888
G
SUPT20H
SPT20 homolog, SAGA complex component
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SUPT20 mRNA
CTD
PMID:30529165
NCBI chr13:37,009,312...37,059,688
Ensembl chr13:37,009,312...37,059,713
G
SV2B
synaptic vesicle glycoprotein 2B
decreases expression
EXP
sulforaphane results in decreased expression of SV2B mRNA
CTD
PMID:31838189
NCBI chr15:91,099,588...91,302,565
Ensembl chr15:91,099,950...91,302,565
G
SWT1
SWT1 RNA endoribonuclease homolog
increases expression
EXP
sulforaphane results in increased expression of SWT1 mRNA
CTD
PMID:31838189
NCBI chr 1:185,157,060...185,291,781
Ensembl chr 1:185,157,080...185,291,781
G
SYNGR1
synaptogyrin 1
decreases expression
EXP
sulforaphane results in decreased expression of SYNGR1 mRNA
CTD
PMID:31838189
NCBI chr22:39,349,991...39,385,575
Ensembl chr22:39,349,925...39,385,575
G
SYNGR2
synaptogyrin 2
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SYNGR2 mRNA
CTD
PMID:30529165
NCBI chr17:78,168,545...78,172,964
Ensembl chr17:78,168,581...78,173,527
G
SYNGR3
synaptogyrin 3
decreases expression
EXP
sulforaphane results in decreased expression of SYNGR3 mRNA
CTD
PMID:31838189
NCBI chr16:1,989,970...1,994,275
Ensembl chr16:1,989,660...1,994,275
G
SYNM
synemin
decreases expression
ISO
sulforaphane results in decreased expression of SYNM mRNA
CTD
PMID:30529165
NCBI chr15:99,105,080...99,141,767
Ensembl chr15:99,098,217...99,135,593
G
SYNPO
synaptopodin
decreases expression increases methylation
EXP
sulforaphane results in decreased expression of SYNPO mRNA sulforaphane results in increased methylation of SYNPO gene
CTD
PMID:31838189
NCBI chr 5:150,586,010...150,659,207
Ensembl chr 5:150,601,080...150,659,207
G
SYT12
synaptotagmin 12
decreases expression
EXP
sulforaphane results in decreased expression of SYT12 mRNA
CTD
PMID:31838189
NCBI chr11:67,006,771...67,050,863
Ensembl chr11:67,006,778...67,050,863
G
SYT7
synaptotagmin 7
decreases expression
EXP
sulforaphane results in decreased expression of SYT7 mRNA
CTD
PMID:31838189
NCBI chr11:61,513,714...61,588,387
Ensembl chr11:61,513,714...61,581,148
G
SZT2
SZT2 subunit of KICSTOR complex
decreases expression
ISO
sulforaphane results in decreased expression of SZT2 mRNA
CTD
PMID:30529165
NCBI chr 1:43,389,899...43,454,247
Ensembl chr 1:43,389,882...43,454,247
G
TACSTD2
tumor associated calcium signal transducer 2
increases expression
ISO
sulforaphane results in increased expression of TACSTD2 mRNA
CTD
PMID:30529165
NCBI chr 1:58,575,433...58,577,252
Ensembl chr 1:58,575,433...58,577,252
G
TAGLN2
transgelin 2
decreases expression
EXP
sulforaphane results in decreased expression of TAGLN2 mRNA
CTD
PMID:31838189
NCBI chr 1:159,918,111...159,925,507
Ensembl chr 1:159,918,107...159,925,507
G
TALDO1
transaldolase 1
increases expression
EXP
sulforaphane results in increased expression of TALDO1 mRNA
CTD
PMID:31838189
NCBI chr11:747,464...765,012
Ensembl chr11:747,415...765,012
G
TANC2
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2
decreases expression
EXP
sulforaphane results in decreased expression of TANC2 mRNA
CTD
PMID:31838189
NCBI chr17:62,966,235...63,427,703
Ensembl chr17:62,966,235...63,427,703
G
TAP1
transporter 1, ATP binding cassette subfamily B member
increases expression
EXP
sulforaphane results in increased expression of TAP1 mRNA
CTD
PMID:35724838
NCBI chr 6:32,845,209...32,853,704
Ensembl chr 6:32,845,209...32,853,816
G
TASL
TLR adaptor interacting with endolysosomal SLC15A4
decreases expression
EXP
sulforaphane results in decreased expression of TASL mRNA
CTD
PMID:26833863
NCBI chr X:30,558,809...30,577,766
Ensembl chr X:30,558,809...30,577,766
G
TBC1D30
TBC1 domain family member 30
decreases expression
EXP
sulforaphane results in decreased expression of TBC1D30 mRNA
CTD
PMID:26833863
NCBI chr12:64,759,484...64,881,033
Ensembl chr12:64,759,484...64,881,033
G
TBCB
tubulin folding cofactor B
affects binding decreases expression
EXP
TBCB protein binds to sulforaphane sulforaphane results in decreased expression of TBCB mRNA
CTD
PMID:21838287 PMID:31838189
NCBI chr19:36,114,967...36,125,941
Ensembl chr19:36,114,289...36,125,947
G
TBL3
transducin beta like 3
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of TBL3 mRNA
CTD
PMID:30529165
NCBI chr16:1,972,053...1,982,929
Ensembl chr16:1,972,053...1,982,929
G
TBX1
T-box transcription factor 1
decreases expression
EXP
sulforaphane results in decreased expression of TBX1 mRNA
CTD
PMID:31838189
NCBI chr22:19,756,703...19,783,593
Ensembl chr22:19,756,703...19,783,593
G
TBX15
T-box transcription factor 15
decreases methylation
EXP
sulforaphane results in decreased methylation of TBX15 gene
CTD
PMID:31838189
NCBI chr 1:118,883,047...118,989,510
Ensembl chr 1:118,883,046...118,989,556
G
TBXA2R
thromboxane A2 receptor
decreases expression
EXP
sulforaphane results in decreased expression of TBXA2R mRNA
CTD
PMID:31838189
NCBI chr19:3,594,507...3,606,875
Ensembl chr19:3,594,507...3,606,875
G
TCEAL3
transcription elongation factor A like 3
decreases expression
EXP
sulforaphane results in decreased expression of TCEAL3 mRNA
CTD
PMID:31838189
NCBI chr X:103,607,963...103,609,927
Ensembl chr X:103,607,451...103,629,690
G
TCF19
transcription factor 19
decreases expression
EXP
sulforaphane results in decreased expression of TCF19 mRNA
CTD
PMID:31838189
NCBI chr 6:31,158,589...31,164,215
Ensembl chr 6:31,158,331...31,167,159
G
TCF21
transcription factor 21
decreases expression
ISO
sulforaphane results in decreased expression of TCF21 mRNA
CTD
PMID:30529165
NCBI chr 6:133,889,113...133,895,537
Ensembl chr 6:133,889,113...133,895,553
G
TCF7L1
transcription factor 7 like 1
decreases expression
EXP
sulforaphane results in decreased expression of TCF7L1 mRNA
CTD
PMID:31838189
NCBI chr 2:85,133,392...85,310,387
Ensembl chr 2:85,133,392...85,310,387
G
TCIM
transcriptional and immune response regulator
decreases expression
EXP
sulforaphane results in decreased expression of TCIM mRNA
CTD
PMID:31838189
NCBI chr 8:40,153,482...40,155,310
Ensembl chr 8:40,153,482...40,155,310
G
TCP11L1
t-complex 11 like 1
decreases expression
EXP
sulforaphane results in decreased expression of TCP11L1 mRNA
CTD
PMID:31838189
NCBI chr11:33,039,572...33,073,563
Ensembl chr11:33,039,417...33,105,943
G
TEAD2
TEA domain transcription factor 2
decreases expression
EXP
sulforaphane results in decreased expression of TEAD2 mRNA
CTD
PMID:31838189
NCBI chr19:49,340,595...49,362,416
Ensembl chr19:49,340,595...49,362,457
G
TECRL
trans-2,3-enoyl-CoA reductase like
increases expression
ISO
sulforaphane results in increased expression of TECRL mRNA
CTD
PMID:30529165
NCBI chr 4:64,276,298...64,409,460
Ensembl chr 4:64,275,257...64,409,468
G
TEKT4
tektin 4
increases expression
ISO
sulforaphane results in increased expression of TEKT4 mRNA
CTD
PMID:30529165
NCBI chr 2:94,871,430...94,876,823
Ensembl chr 2:94,871,430...94,876,823
G
TENT5B
terminal nucleotidyltransferase 5B
decreases expression
EXP
sulforaphane results in decreased expression of TENT5B mRNA
CTD
PMID:31838189
NCBI chr 1:27,005,020...27,012,850
Ensembl chr 1:27,005,020...27,012,850
G
TERT
telomerase reverse transcriptase
decreases expression
EXP
sulforaphane results in decreased expression of TERT mRNA
CTD
PMID:26833863
NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
G
TEX11
testis expressed 11
decreases expression
ISO
sulforaphane results in decreased expression of TEX11 mRNA
CTD
PMID:30529165
NCBI chr X:70,511,227...70,908,711
Ensembl chr X:70,528,940...70,908,711
G
TFAM
transcription factor A, mitochondrial
increases expression
EXP
sulforaphane results in increased expression of TFAM protein
CTD
PMID:27993529
NCBI chr10:58,385,410...58,399,220
Ensembl chr10:58,385,345...58,399,220
G
TFE3
transcription factor binding to IGHM enhancer 3
increases expression
EXP
sulforaphane results in increased expression of TFE3 mRNA
CTD
PMID:26833863
NCBI chr X:49,028,726...49,043,357
Ensembl chr X:49,028,726...49,043,410
G
TFEC
transcription factor EC
decreases expression
ISO
sulforaphane results in decreased expression of TFEC mRNA
CTD
PMID:30529165
NCBI chr 7:115,935,152...116,159,896
Ensembl chr 7:115,935,148...116,159,896
G
TFF2
trefoil factor 2
increases expression
ISO
sulforaphane results in increased expression of TFF2 mRNA
CTD
PMID:30529165
NCBI chr21:42,346,357...42,350,994
Ensembl chr21:42,346,357...42,350,997
G
TFRC
transferrin receptor
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of TFRC mRNA
CTD
PMID:25450479
NCBI chr 3:196,049,284...196,082,090
Ensembl chr 3:196,012,511...196,082,153
G
TGFB1
transforming growth factor beta 1
multiple interactions
ISO
sulforaphane inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of TGFB1 protein]; sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of TGFB1 protein]; sulforaphane inhibits the reaction [Streptozocin results in increased expression of TGFB1 protein]
CTD
PMID:24707343 PMID:24967692 PMID:29353218
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TGFB3
transforming growth factor beta 3
decreases expression
EXP
sulforaphane results in decreased expression of TGFB3 mRNA
CTD
PMID:31838189
NCBI chr14:75,958,097...75,983,011
Ensembl chr14:75,958,097...75,983,011
G
TGFBR1
transforming growth factor beta receptor 1
affects methylation
EXP
sulforaphane affects the methylation of TGFBR1 promoter
CTD
PMID:24466240
NCBI chr 9:99,103,647...99,154,192
Ensembl chr 9:99,104,038...99,154,192
G
TGM1
transglutaminase 1
decreases expression
EXP
sulforaphane results in decreased expression of TGM1 mRNA
CTD
PMID:31838189
NCBI chr14:24,249,114...24,263,177
Ensembl chr14:24,249,114...24,264,432
G
TH
tyrosine hydroxylase
multiple interactions
ISO
sulforaphane inhibits the reaction [Oxidopamine results in decreased expression of TH protein]
CTD
PMID:23518299
NCBI chr11:2,163,929...2,171,815
Ensembl chr11:2,163,929...2,171,815
G
THAP1
THAP domain containing 1
increases methylation
EXP
sulforaphane results in increased methylation of THAP1 gene
CTD
PMID:31838189
NCBI chr 8:42,836,674...42,843,325
Ensembl chr 8:42,836,674...42,843,325
G
THEMIS2
thymocyte selection associated family member 2
increases expression
EXP
sulforaphane results in increased expression of THEMIS2 mRNA
CTD
PMID:26833863
NCBI chr 1:27,872,544...27,886,675
Ensembl chr 1:27,872,543...27,886,685
G
THRSP
thyroid hormone responsive
multiple interactions increases expression
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of THRSP mRNA sulforaphane results in increased expression of THRSP mRNA
CTD
PMID:25450479 PMID:30529165
NCBI chr11:78,063,861...78,068,351
Ensembl chr11:78,063,861...78,068,351
G
TIMP1
TIMP metallopeptidase inhibitor 1
increases expression
EXP
sulforaphane results in increased expression of TIMP1 mRNA
CTD
PMID:26833863
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
G
TIMP2
TIMP metallopeptidase inhibitor 2
increases expression
EXP
sulforaphane results in increased expression of TIMP2 mRNA
CTD
PMID:26833863
NCBI chr17:78,852,977...78,925,387
Ensembl chr17:78,852,977...78,925,387
G
TIMP4
TIMP metallopeptidase inhibitor 4
increases expression
ISO EXP
sulforaphane results in increased expression of TIMP4 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 3:12,153,068...12,158,912
Ensembl chr 3:12,153,068...12,158,912
G
TINAG
tubulointerstitial nephritis antigen
decreases expression multiple interactions
ISO
sulforaphane results in decreased expression of TINAG mRNA [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of TINAG mRNA
CTD
PMID:30529165
NCBI chr 6:54,307,862...54,390,142
Ensembl chr 6:54,307,859...54,390,142
G
TJP3
tight junction protein 3
decreases expression
EXP
sulforaphane results in decreased expression of TJP3 mRNA
CTD
PMID:31838189
NCBI chr19:3,708,384...3,750,813
Ensembl chr19:3,708,362...3,750,813
G
TLE6
TLE family member 6, subcortical maternal complex member
multiple interactions
ISO
[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of TLE6 mRNA
CTD
PMID:30529165
NCBI chr19:2,977,401...2,995,179
Ensembl chr19:2,977,538...2,995,179
G
TLL1
tolloid like 1
decreases expression
EXP
sulforaphane results in decreased expression of TLL1 mRNA
CTD
PMID:31838189
NCBI chr 4:165,873,237...166,104,457
Ensembl chr 4:165,873,237...166,104,457
G
TLR4
toll like receptor 4
increases expression multiple interactions
EXP ISO
sulforaphane results in increased expression of TLR4 mRNA sulforaphane inhibits the reaction [Trichloroethylene results in increased expression of TLR4 protein]
CTD
PMID:26833863 PMID:31838189 PMID:33007382
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
G
TLR6
toll like receptor 6
increases expression
EXP
sulforaphane results in increased expression of TLR6 mRNA
CTD
PMID:26833863 PMID:31838189
NCBI chr 4:38,822,897...38,868,390
Ensembl chr 4:38,822,897...38,856,817
G
TM6SF1
transmembrane 6 superfamily member 1
increases expression
EXP
sulforaphane results in increased expression of TM6SF1 mRNA
CTD
PMID:26833863
NCBI chr15:83,107,645...83,137,408
Ensembl chr15:83,107,572...83,144,854
G
TMBIM1
transmembrane BAX inhibitor motif containing 1
increases expression
EXP
sulforaphane results in increased expression of TMBIM1 mRNA
CTD
PMID:26833863
NCBI chr 2:218,274,197...218,292,503
Ensembl chr 2:218,274,197...218,292,586
G
TMC5
transmembrane channel like 5
decreases expression
EXP
sulforaphane results in decreased expression of TMC5 mRNA
CTD
PMID:31838189
NCBI chr16:19,410,539...19,499,113
Ensembl chr16:19,410,496...19,499,113
G
TMCC2
transmembrane and coiled-coil domain family 2
decreases expression
EXP
sulforaphane results in decreased expression of TMCC2 mRNA
CTD
PMID:31838189
NCBI chr 1:205,227,946...205,273,343
Ensembl chr 1:205,227,946...205,285,632
G
TMEFF2
transmembrane protein with EGF like and two follistatin like domains 2
decreases expression
ISO
sulforaphane results in decreased expression of TMEFF2 mRNA
CTD
PMID:30529165
NCBI chr 2:191,949,046...192,194,933
Ensembl chr 2:191,949,043...192,194,933
G
TMEM100
transmembrane protein 100
decreases expression
ISO
sulforaphane results in decreased expression of TMEM100 mRNA
CTD
PMID:30529165
NCBI chr17:55,719,627...55,732,081
Ensembl chr17:55,719,627...55,732,121
G
TMEM107
transmembrane protein 107
increases expression decreases expression
ISO EXP
sulforaphane results in increased expression of TMEM107 mRNA sulforaphane results in decreased expression of TMEM107 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr17:8,172,457...8,176,380
Ensembl chr17:8,172,457...8,176,399
G
TMEM116
transmembrane protein 116
increases expression
EXP
sulforaphane results in increased expression of TMEM116 mRNA
CTD
PMID:31838189
NCBI chr12:111,931,282...112,013,219
Ensembl chr12:111,931,282...112,013,185
G
TMEM121
transmembrane protein 121
decreases expression
EXP
sulforaphane results in decreased expression of TMEM121 mRNA
CTD
PMID:31838189
NCBI chr14:105,526,583...105,530,198
Ensembl chr14:105,526,583...105,530,198
G
TMEM156
transmembrane protein 156
increases expression
EXP
sulforaphane results in increased expression of TMEM156 mRNA
CTD
PMID:31838189
NCBI chr 4:38,966,744...39,032,409
Ensembl chr 4:38,966,744...39,032,922
G
TMEM160
transmembrane protein 160
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of TMEM160 mRNA
CTD
PMID:30529165
NCBI chr19:47,045,909...47,048,624
Ensembl chr19:47,045,909...47,048,624
G
TMEM178B
transmembrane protein 178B
decreases expression
EXP
sulforaphane results in decreased expression of TMEM178B mRNA
CTD
PMID:31838189
NCBI chr 7:141,074,064...141,511,296
Ensembl chr 7:141,074,064...141,480,380
G
TMEM192
transmembrane protein 192
increases expression
EXP
sulforaphane results in increased expression of TMEM192 mRNA
CTD
PMID:31838189
NCBI chr 4:165,070,608...165,112,860
Ensembl chr 4:165,070,608...165,208,549
G
TMEM232
transmembrane protein 232
increases expression
ISO
sulforaphane results in increased expression of TMEM232 mRNA
CTD
PMID:30529165
NCBI chr 5:110,387,431...110,738,954
Ensembl chr 5:110,289,233...110,738,956
G
TMEM243
transmembrane protein 243
decreases expression
ISO
sulforaphane results in decreased expression of TMEM243 mRNA
CTD
PMID:30529165
NCBI chr 7:87,196,160...87,220,587
Ensembl chr 7:87,196,160...87,220,587
G
TMEM25
transmembrane protein 25
decreases expression
EXP
sulforaphane results in decreased expression of TMEM25 mRNA
CTD
PMID:31838189
NCBI chr11:118,531,192...118,547,286
Ensembl chr11:118,531,041...118,547,280
G
TMEM37
transmembrane protein 37
increases expression
EXP
sulforaphane results in increased expression of TMEM37 mRNA
CTD
PMID:31838189
NCBI chr 2:119,429,895...119,438,504
Ensembl chr 2:119,429,901...119,438,504
G
TMEM45B
transmembrane protein 45B
increases expression
ISO
sulforaphane results in increased expression of TMEM45B mRNA
CTD
PMID:30529165
NCBI chr11:129,815,848...129,860,003
Ensembl chr11:129,815,848...129,860,003
G
TMEM71
transmembrane protein 71
increases expression
EXP
sulforaphane results in increased expression of TMEM71 mRNA
CTD
PMID:26833863
NCBI chr 8:132,705,839...132,775,999
Ensembl chr 8:132,685,007...132,760,712
G
TMEM80
transmembrane protein 80
decreases expression
EXP
sulforaphane results in decreased expression of TMEM80 mRNA
CTD
PMID:31838189
NCBI chr11:695,639...705,028
Ensembl chr11:695,591...705,028
G
TMEM87B
transmembrane protein 87B
increases expression
EXP
sulforaphane results in increased expression of TMEM87B mRNA
CTD
PMID:31838189
NCBI chr 2:112,055,269...112,119,314
Ensembl chr 2:112,055,269...112,119,318
G
TMEM9B
TMEM9 domain family member B
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of TMEM9B mRNA
CTD
PMID:30529165
NCBI chr11:8,947,202...8,964,947
Ensembl chr11:8,947,202...8,965,011
G
TMOD1
tropomodulin 1
decreases expression
EXP
sulforaphane results in decreased expression of TMOD1 mRNA
CTD
PMID:31838189
NCBI chr 9:97,501,180...97,601,743
Ensembl chr 9:97,501,180...97,601,743
G
TMOD2
tropomodulin 2
increases expression
EXP
sulforaphane results in increased expression of TMOD2 mRNA
CTD
PMID:26833863
NCBI chr15:51,751,597...51,816,363
Ensembl chr15:51,751,597...51,816,363
G
TMPRSS3
transmembrane serine protease 3
decreases expression
EXP
sulforaphane results in decreased expression of TMPRSS3 mRNA
CTD
PMID:31838189
NCBI chr21:42,371,890...42,396,052
Ensembl chr21:42,371,887...42,396,091
G
TMT1A
thiol methyltransferase 1A
decreases expression
EXP
sulforaphane results in decreased expression of TMT1A mRNA
CTD
PMID:31838189
NCBI chr12:50,925,015...50,932,508
Ensembl chr12:50,923,472...50,932,510
G
TNC
tenascin C
decreases expression
EXP
sulforaphane results in decreased expression of TNC mRNA
CTD
PMID:31838189
NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207
G
TNF
tumor necrosis factor
multiple interactions decreases expression increases expression
ISO EXP
NFE2L2 gene mutant form inhibits the reaction [sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of TNF protein]]; sulforaphane inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF protein]; sulforaphane inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of TNF protein]; sulforaphane inhibits the reaction [AGT protein modified form results in increased expression of TNF protein]; sulforaphane inhibits the reaction [cyanoginosin LR results in increased expression of TNF mRNA]; sulforaphane inhibits the reaction [Dinitrochlorobenzene results in increased expression of TNF mRNA]; sulforaphane inhibits the reaction [Dinitrochlorobenzene results in increased expression of TNF protein]; sulforaphane inhibits the reaction [Trichloroethylene results in increased expression of TNF mRNA] sulforaphane metabolite results in decreased expression of TNF mRNA; sulforaphane results in decreased expression of TNF mRNA sulforaphane inhibits the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of TNF mRNA]; sulforaphane inhibits the reaction [macrophage stimulatory lipopeptide 2 results in increased secretion of TNF protein]; sulforaphane inhibits the reaction [TNF protein affects the localization of NFKBIA protein]; sulforaphane inhibits the reaction [TNF protein affects the localization of RELA protein]; sulforaphane inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; sulforaphane inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; sulforaphane inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein]; sulforaphane metabolite inhibits the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of TNF mRNA]; tin protoporphyrin IX inhibits the reaction [sulforaphane inhibits the reaction [macrophage stimulatory lipopeptide 2 results in increased secretion of TNF protein]] sulforaphane results in increased expression of TNF mRNA
CTD
PMID:21684301 PMID:24707343 PMID:26833863 PMID:29353218 PMID:30965051 PMID:32387680 PMID:33894213 PMID:33930529 PMID:34651546 PMID:35724838 PMID:36988325 More...
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFAIP2
TNF alpha induced protein 2
increases expression
EXP
sulforaphane results in increased expression of TNFAIP2 mRNA
CTD
PMID:26833863
NCBI chr14:103,121,469...103,137,439
Ensembl chr14:103,121,476...103,137,439
G
TNFAIP3
TNF alpha induced protein 3
decreases expression increases expression multiple interactions
EXP
sulforaphane results in decreased expression of TNFAIP3 mRNA sulforaphane results in increased expression of TNFAIP3 mRNA; sulforaphane results in increased expression of TNFAIP3 protein sulforaphane inhibits the reaction [IL1B protein results in increased expression of TNFAIP3 protein]; sulforaphane inhibits the reaction [TNF protein results in increased expression of TNFAIP3 protein]
CTD
PMID:31838189 PMID:35724838
NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314
G
TNFRSF10A
TNF receptor superfamily member 10a
increases expression
EXP
sulforaphane results in increased expression of TNFRSF10A mRNA
CTD
PMID:31838189
NCBI chr 8:23,190,452...23,225,102
Ensembl chr 8:23,190,452...23,225,102
G
TNFRSF10B
TNF receptor superfamily member 10b
increases expression multiple interactions
EXP
sulforaphane results in increased expression of TNFRSF10B mRNA; sulforaphane results in increased expression of TNFRSF10B protein [sulforaphane co-treated with TNFSF10 protein] results in increased expression of TNFRSF10B protein
CTD
PMID:26833863 PMID:29792947
NCBI chr 8:23,020,133...23,069,031
Ensembl chr 8:23,020,133...23,069,031
G
TNFRSF10D
TNF receptor superfamily member 10d
increases expression
EXP
sulforaphane results in increased expression of TNFRSF10D mRNA
CTD
PMID:26833863
NCBI chr 8:23,135,588...23,164,027
Ensembl chr 8:23,135,588...23,164,027
G
TNFRSF12A
TNF receptor superfamily member 12A
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of TNFRSF12A mRNA
CTD
PMID:25450479
NCBI chr16:3,020,368...3,022,383
Ensembl chr16:3,018,445...3,022,383
G
TNFRSF21
TNF receptor superfamily member 21
increases expression
EXP
sulforaphane results in increased expression of TNFRSF21 mRNA
CTD
PMID:31838189
NCBI chr 6:47,231,532...47,309,905
Ensembl chr 6:47,231,532...47,309,905
G
TNFRSF9
TNF receptor superfamily member 9
increases expression
EXP
sulforaphane results in increased expression of TNFRSF9 mRNA
CTD
PMID:35724838
NCBI chr 1:7,915,871...7,940,839
Ensembl chr 1:7,915,871...7,943,165
G
TNFSF10
TNF superfamily member 10
increases activity multiple interactions
EXP
sulforaphane results in increased activity of TNFSF10 protein [sulforaphane co-treated with TNFSF10 protein] results in decreased expression of CASP3 protein; [sulforaphane co-treated with TNFSF10 protein] results in decreased expression of CASP8 protein; [sulforaphane co-treated with TNFSF10 protein] results in decreased expression of CASP9 protein; [sulforaphane co-treated with TNFSF10 protein] results in increased cleavage of BID protein; [sulforaphane co-treated with TNFSF10 protein] results in increased cleavage of PARP1 protein; [sulforaphane co-treated with TNFSF10 protein] results in increased expression of TNFRSF10B protein
CTD
PMID:29792947
NCBI chr 3:172,505,508...172,523,430
Ensembl chr 3:172,505,508...172,523,475
G
TNFSF14
TNF superfamily member 14
increases expression
EXP
sulforaphane results in increased expression of TNFSF14 mRNA
CTD
PMID:26833863
NCBI chr19:6,661,253...6,670,588
Ensembl chr19:6,661,253...6,670,588
G
TNNC1
troponin C1, slow skeletal and cardiac type
increases expression
ISO
sulforaphane results in increased expression of TNNC1 mRNA
CTD
PMID:30529165
NCBI chr 3:52,451,100...52,454,041
Ensembl chr 3:52,451,100...52,454,041
G
TNNI3
troponin I3, cardiac type
increases expression
ISO
sulforaphane results in increased expression of TNNI3 mRNA
CTD
PMID:30529165
NCBI chr19:55,151,767...55,157,732
Ensembl chr19:55,151,767...55,157,773
G
TNNT2
troponin T2, cardiac type
increases expression decreases expression
ISO EXP
sulforaphane results in increased expression of TNNT2 mRNA sulforaphane results in decreased expression of TNNT2 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 1:201,359,014...201,377,680
Ensembl chr 1:201,359,008...201,377,764
G
TOP6BL
TOP6B like initiator of meiotic double strand breaks
decreases expression
EXP
sulforaphane results in decreased expression of TOP6BL mRNA
CTD
PMID:31838189
NCBI chr11:66,744,736...66,843,516
Ensembl chr11:66,744,451...66,843,516
G
TOX
thymocyte selection associated high mobility group box
decreases expression
EXP
sulforaphane results in decreased expression of TOX mRNA
CTD
PMID:31838189
NCBI chr 8:58,805,412...59,119,147
Ensembl chr 8:58,805,412...59,119,147
G
TP53
tumor protein p53
multiple interactions decreases expression
ISO EXP
sulforaphane inhibits the reaction [TRP53 gene mutant form results in decreased susceptibility to Doxorubicin]; sulforaphane inhibits the reaction [TRP53 gene polymorphism results in decreased susceptibility to Doxorubicin] sulforaphane inhibits the reaction [triptolide results in increased expression of TP53 protein] sulforaphane results in decreased expression of TP53 protein
CTD
PMID:16843502 PMID:17404018 PMID:27878984 PMID:36990132
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
G
TP53I11
tumor protein p53 inducible protein 11
decreases expression
EXP
sulforaphane results in decreased expression of TP53I11 mRNA
CTD
PMID:31838189
NCBI chr11:44,932,348...44,951,306
Ensembl chr11:44,885,903...44,951,306
G
TP73
tumor protein p73
increases expression
EXP
sulforaphane results in increased expression of TP73 protein
CTD
PMID:27878984
NCBI chr 1:3,652,516...3,736,201
Ensembl chr 1:3,652,516...3,736,201
G
TPM1
tropomyosin 1
affects binding increases expression
EXP ISO
TPM1 protein binds to sulforaphane sulforaphane results in increased expression of TPM1 mRNA
CTD
PMID:21838287 PMID:30529165
NCBI chr15:63,042,747...63,071,915
Ensembl chr15:63,042,620...63,071,915
G
TPM4
tropomyosin 4
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of TPM4 mRNA
CTD
PMID:30529165
NCBI chr19:16,067,538...16,103,002
Ensembl chr19:16,067,021...16,103,002
G
TRAF1
TNF receptor associated factor 1
decreases expression
ISO
sulforaphane results in decreased expression of TRAF1 mRNA
CTD
PMID:30529165
NCBI chr 9:120,902,393...120,929,171
Ensembl chr 9:120,902,393...120,929,173
G
TRAFD1
TRAF-type zinc finger domain containing 1
decreases expression
EXP
sulforaphane results in decreased expression of TRAFD1 mRNA
CTD
PMID:31838189
NCBI chr12:112,125,560...112,153,604
Ensembl chr12:112,125,538...112,153,604
G
TRE-TTC9-1
tRNA-Glu (anticodon TTC) 9-1
decreases expression
EXP
sulforaphane results in decreased expression of TRE-TTC9-1 mRNA
CTD
PMID:26833863
NCBI chr 2:203,364,408...203,364,478
G
TREM1
triggering receptor expressed on myeloid cells 1
increases expression
EXP
sulforaphane results in increased expression of TREM1 mRNA
CTD
PMID:26833863
NCBI chr 6:41,267,385...41,286,682
Ensembl chr 6:41,267,926...41,286,682
G
TREML2
triggering receptor expressed on myeloid cells like 2
increases expression
EXP
sulforaphane results in increased expression of TREML2 mRNA
CTD
PMID:26833863
NCBI chr 6:41,189,749...41,201,149
Ensembl chr 6:41,189,749...41,201,149
G
TRG-CCC6-1
tRNA-Gly (CCC) 6-1
decreases expression
EXP
sulforaphane results in decreased expression of TRG-CCC6-1 mRNA
CTD
PMID:26833863
NCBI chr 1:121,016,845...121,016,915
G
TRIB2
tribbles pseudokinase 2
decreases expression
ISO
sulforaphane results in decreased expression of TRIB2 mRNA
CTD
PMID:30529165
NCBI chr 2:12,716,936...12,742,734
Ensembl chr 2:12,716,910...12,742,734
G
TRIB3
tribbles pseudokinase 3
decreases expression
EXP
sulforaphane results in decreased expression of TRIB3 mRNA
CTD
PMID:35724838
NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559
G
TRIM16
tripartite motif containing 16
increases expression
EXP
sulforaphane results in increased expression of TRIM16 mRNA
CTD
PMID:31838189
NCBI chr17:15,627,966...15,684,311
Ensembl chr17:15,627,960...15,684,311
G
TRIM16L
tripartite motif containing 16 like (pseudogene)
increases expression
EXP
sulforaphane results in increased expression of TRIM16L mRNA
CTD
PMID:31838189
NCBI chr17:18,697,998...18,736,112
Ensembl chr17:18,722,237...18,735,460 Ensembl chr17:18,722,237...18,735,460
G
TRIM22
tripartite motif containing 22
decreases expression
EXP
sulforaphane results in decreased expression of TRIM22 mRNA
CTD
PMID:26833863
NCBI chr11:5,689,790...5,710,863
Ensembl chr11:5,689,610...5,737,089
G
TRIM29
tripartite motif containing 29
decreases expression
EXP
sulforaphane results in decreased expression of TRIM29 mRNA
CTD
PMID:31838189
NCBI chr11:120,111,286...120,138,113
Ensembl chr11:120,111,286...120,185,529
G
TRIM5
tripartite motif containing 5
decreases expression
EXP
sulforaphane results in decreased expression of TRIM5 mRNA
CTD
PMID:31838189
NCBI chr11:5,588,635...5,685,074
Ensembl chr11:5,663,195...5,938,619
G
TRIM54
tripartite motif containing 54
increases expression
EXP
sulforaphane results in increased expression of TRIM54 mRNA
CTD
PMID:31838189
NCBI chr 2:27,282,429...27,307,435
Ensembl chr 2:27,282,429...27,307,439
G
TRIP13
thyroid hormone receptor interactor 13
multiple interactions
ISO
[sulforaphane co-treated with Aflatoxin B1] affects the expression of TRIP13 mRNA
CTD
PMID:25450479
NCBI chr 5:892,884...919,348
Ensembl chr 5:892,884...919,357
G
TRMT13
tRNA methyltransferase 13 homolog
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of TRMT13 mRNA
CTD
PMID:30529165
NCBI chr 1:100,133,163...100,150,496
Ensembl chr 1:100,133,150...100,150,496
G
TRPC6
transient receptor potential cation channel subfamily C member 6
decreases expression
ISO
sulforaphane results in decreased expression of TRPC6 mRNA
CTD
PMID:30529165
NCBI chr11:101,451,564...101,584,007
Ensembl chr11:101,451,564...101,872,562
G
TRPS1
transcriptional repressor GATA binding 1
increases expression
EXP
sulforaphane results in increased expression of TRPS1 mRNA
CTD
PMID:26833863
NCBI chr 8:115,408,496...115,668,975
Ensembl chr 8:115,408,496...115,809,673
G
TRY-GTA11-1
tRNA-Tyr (anticodon GTA) 11-1
increases expression
EXP
sulforaphane results in increased expression of TRY-GTA11-1 mRNA
CTD
PMID:26833863
NCBI chr 7:149,356,654...149,356,729
G
TSC22D3
TSC22 domain family member 3
decreases expression
ISO
sulforaphane results in decreased expression of TSC22D3 mRNA
CTD
PMID:30529165
NCBI chr X:107,713,221...107,775,988
Ensembl chr X:107,713,221...107,777,342
G
TSHZ2
teashirt zinc finger homeobox 2
decreases expression
EXP
sulforaphane results in decreased expression of TSHZ2 mRNA
CTD
PMID:31838189
NCBI chr20:52,972,358...53,495,330
Ensembl chr20:52,972,358...53,495,330
G
TSPAN1
tetraspanin 1
increases expression
ISO
sulforaphane results in increased expression of TSPAN1 mRNA
CTD
PMID:30529165
NCBI chr 1:46,175,087...46,196,489
Ensembl chr 1:46,175,073...46,185,962
G
TSPAN14
tetraspanin 14
increases expression
EXP
sulforaphane results in increased expression of TSPAN14 mRNA
CTD
PMID:26833863
NCBI chr10:80,454,310...80,522,631
Ensembl chr10:80,454,265...80,533,124
G
TSPAN2
tetraspanin 2
decreases expression
ISO
sulforaphane results in decreased expression of TSPAN2 mRNA
CTD
PMID:30529165
NCBI chr 1:115,048,011...115,089,503
Ensembl chr 1:115,048,011...115,089,503
G
TSPOAP1
TSPO associated protein 1
decreases expression
EXP
sulforaphane results in decreased expression of TSPOAP1 mRNA
CTD
PMID:26833863
NCBI chr17:58,301,231...58,328,795
Ensembl chr17:58,301,228...58,328,795
G
TTC39A
tetratricopeptide repeat domain 39A
increases expression
ISO
sulforaphane results in increased expression of TTC39A mRNA
CTD
PMID:30529165
NCBI chr 1:51,287,258...51,345,116
Ensembl chr 1:51,287,258...51,345,116
G
TTC7A
tetratricopeptide repeat domain 7A
decreases expression
EXP
sulforaphane results in decreased expression of TTC7A mRNA
CTD
PMID:31838189
NCBI chr 2:46,915,866...47,076,123
Ensembl chr 2:46,915,869...47,076,137
G
TTK
TTK protein kinase
increases expression
EXP
sulforaphane results in increased expression of TTK mRNA
CTD
PMID:31838189
NCBI chr 6:80,004,649...80,042,527
Ensembl chr 6:80,003,887...80,042,527
G
TTLL7
tubulin tyrosine ligase like 7
decreases expression
ISO
sulforaphane results in decreased expression of TTLL7 mRNA
CTD
PMID:30529165
NCBI chr 1:83,865,024...83,999,132
Ensembl chr 1:83,865,024...83,999,150
G
TTN
titin
increases expression
ISO
sulforaphane results in increased expression of TTN mRNA
CTD
PMID:30529165
NCBI chr 2:178,525,989...178,807,423
Ensembl chr 2:178,525,989...178,830,802
G
TTPA
alpha tocopherol transfer protein
decreases expression
EXP
sulforaphane results in decreased expression of TTPA mRNA
CTD
PMID:31838189
NCBI chr 8:63,058,409...63,086,053
Ensembl chr 8:63,048,553...63,086,053
G
TUBA1A
tubulin alpha 1a
affects binding
EXP
TUBA1A protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr12:49,184,795...49,189,080
Ensembl chr12:49,184,686...49,189,324
G
TUBA3D
tubulin alpha 3d
affects binding
EXP
TUBA3D protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr 2:131,476,119...131,482,934
Ensembl chr 2:131,476,119...131,482,934
G
TUBA4A
tubulin alpha 4a
increases acetylation increases expression affects binding
EXP
sulforaphane results in increased acetylation of TUBA4A protein sulforaphane results in increased expression of TUBA4A mRNA TUBA4A protein binds to sulforaphane
CTD
PMID:19805354 PMID:21838287 PMID:26833863 PMID:31838189
NCBI chr 2:219,249,710...219,254,740
Ensembl chr 2:219,249,710...219,277,902
G
TUBB1
tubulin beta 1 class VI
affects binding multiple interactions
EXP ISO
TUBB1 protein binds to sulforaphane [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of TUBB1 mRNA
CTD
PMID:21838287 PMID:30529165
NCBI chr20:59,016,438...59,026,654
Ensembl chr20:59,019,429...59,026,654
G
TUBB4A
tubulin beta 4A class IVa
decreases expression
EXP
sulforaphane results in decreased expression of TUBB4A mRNA
CTD
PMID:31838189
NCBI chr19:6,494,319...6,502,848
Ensembl chr19:6,494,319...6,502,848
G
TUBB4B
tubulin beta 4B class IVb
affects binding increases expression
EXP
TUBB4B protein binds to sulforaphane sulforaphane results in increased expression of TUBB4B mRNA
CTD
PMID:21838287 PMID:31838189
NCBI chr 9:137,241,287...137,243,707
Ensembl chr 9:137,241,287...137,243,707
G
TVP23A
trans-golgi network vesicle protein 23 homolog A
increases expression
EXP
sulforaphane results in increased expression of TVP23A mRNA
CTD
PMID:31838189
NCBI chr16:10,757,318...10,818,794
Ensembl chr16:10,760,919...10,818,794
G
TXLNB
taxilin beta
increases expression
ISO
sulforaphane results in increased expression of TXLNB mRNA
CTD
PMID:30529165
NCBI chr 6:139,159,162...139,323,950
Ensembl chr 6:139,240,061...139,291,998
G
TXLNG
taxilin gamma
decreases expression
ISO
sulforaphane results in decreased expression of TXLNG mRNA
CTD
PMID:30529165
NCBI chr X:16,786,466...16,844,519
Ensembl chr X:16,786,432...16,844,519
G
TXN
thioredoxin
increases expression multiple interactions decreases methylation
EXP
sulforaphane metabolite results in increased expression of TXN mRNA; sulforaphane results in increased expression of TXN mRNA; sulforaphane results in increased expression of TXN protein sulforaphane metabolite promotes the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of TXN mRNA]; sulforaphane promotes the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of TXN mRNA] sulforaphane results in decreased methylation of TXN gene
CTD
PMID:19123792 PMID:20442190 PMID:25683455 PMID:31838189 PMID:32387680
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
G
TXNRD1
thioredoxin reductase 1
multiple interactions decreases expression increases expression decreases activity increases activity
EXP ISO
1-(5-isoquinolinylsulfonyl)-3-methylpiperazine inhibits the reaction [sulforaphane results in increased expression of TXNRD1 mRNA]; [sulforaphane co-treated with Selenium] results in increased activity of TXNRD1 protein; [sulforaphane co-treated with Sodium Selenite] results in increased activity of TXNRD1 protein; Buthionine Sulfoximine inhibits the reaction [sulforaphane results in increased expression of TXNRD1 mRNA]; Cycloheximide inhibits the reaction [sulforaphane results in increased expression of TXNRD1 mRNA]; Dactinomycin inhibits the reaction [sulforaphane results in increased expression of TXNRD1 mRNA]; NFE2L2 mutant form inhibits the reaction [sulforaphane results in increased expression of TXNRD1 mRNA]; NFE2L2 mutant form inhibits the reaction [sulforaphane results in increased expression of TXNRD1 protein]; NFE2L2 protein affects the reaction [sulforaphane results in increased expression of TXNRD1 protein]; Selenium promotes the reaction [sulforaphane results in increased expression of and results in increased activity of TXNRD1 protein]; Sodium Selenite promotes the reaction [sulforaphane results in increased activity of TXNRD1 protein]; Sodium Selenite promotes the reaction [sulforaphane results in increased expression of TXNRD1 mRNA]; Sodium Selenite promotes the reaction [sulforaphane results in increased expression of TXNRD1 protein]; sulforaphane metabolite promotes the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of TXNRD1 mRNA]; sulforaphane promotes the reaction [[Tobacco Smoke Pollution co-treated with Particulate Matter] results in increased expression of TXNRD1 mRNA]; sulforaphane results in increased expression of and results in increased activity of TXNRD1 protein sulforaphane results in decreased expression of TXNRD1 mRNA sulforaphane metabolite results in increased expression of TXNRD1 mRNA; sulforaphane results in increased expression of TXNRD1 mRNA; sulforaphane results in increased expression of TXNRD1 protein sulforaphane results in decreased activity of TXNRD1 protein
CTD
PMID:12663510 PMID:12949356 PMID:15740016 PMID:17150329 PMID:17937621 PMID:19303893 PMID:20442190 PMID:22807314 PMID:31838189 PMID:32387680 PMID:34767876 PMID:35227738 PMID:35724838 More...
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
TYR
tyrosinase
decreases expression
ISO
sulforaphane results in decreased expression of TYR mRNA
CTD
PMID:21071833
NCBI chr11:89,177,875...89,295,759
Ensembl chr11:89,177,875...89,295,759
G
TYROBP
transmembrane immune signaling adaptor TYROBP
increases expression
EXP
sulforaphane results in increased expression of TYROBP mRNA
CTD
PMID:26833863
NCBI chr19:35,904,403...35,908,295
Ensembl chr19:35,904,401...35,908,295
G
UBE2D3
ubiquitin conjugating enzyme E2 D3
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of UBE2D3 mRNA
CTD
PMID:30529165
NCBI chr 4:102,794,383...102,868,895
Ensembl chr 4:102,794,383...102,868,896
G
UBE2S
ubiquitin conjugating enzyme E2 S
increases expression
EXP
sulforaphane results in increased expression of UBE2S mRNA
CTD
PMID:31838189
NCBI chr19:55,399,745...55,407,788
Ensembl chr19:55,399,745...55,407,788
G
UBXN2A
UBX domain protein 2A
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of UBXN2A mRNA
CTD
PMID:30529165
NCBI chr 2:23,927,278...24,004,909
Ensembl chr 2:23,927,285...24,004,909
G
UGDH
UDP-glucose 6-dehydrogenase
increases expression
EXP
sulforaphane results in increased expression of UGDH mRNA
CTD
PMID:31838189
NCBI chr 4:39,498,755...39,527,439
Ensembl chr 4:39,498,755...39,528,311
G
UGT1A1
UDP glucuronosyltransferase family 1 member A1
multiple interactions increases expression decreases expression
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sulforaphane results in increased expression of UGT1A1 mRNA]; [sulforaphane co-treated with Apigenin] results in increased expression of UGT1A1 mRNA sulforaphane results in increased expression of UGT1A1 mRNA; sulforaphane results in increased expression of UGT1A1 protein sulforaphane results in decreased expression of UGT1A1 mRNA
CTD
PMID:12151360 PMID:12756216 PMID:12949046 PMID:15090468 PMID:15896333
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
G
UNKL
unk like zinc finger
increases expression
EXP
sulforaphane results in increased expression of UNKL mRNA
CTD
PMID:31838189
NCBI chr16:1,363,205...1,414,704
Ensembl chr16:1,363,205...1,414,751
G
UPK3B
uroplakin 3B
decreases expression
EXP
sulforaphane results in decreased expression of UPK3B mRNA
CTD
PMID:31838189
NCBI chr 7:76,510,552...76,516,522
Ensembl chr 7:76,510,525...76,516,522
G
UPP1
uridine phosphorylase 1
increases expression
EXP
sulforaphane results in increased expression of UPP1 mRNA
CTD
PMID:31838189
NCBI chr 7:48,088,704...48,108,736
Ensembl chr 7:48,088,628...48,108,736
G
UQCR11
ubiquinol-cytochrome c reductase, complex III subunit XI
increases expression
ISO
sulforaphane results in increased expression of UQCR11 mRNA
CTD
PMID:30529165
NCBI chr19:1,597,169...1,605,462
Ensembl chr19:1,597,169...1,605,473
G
UQCRC1
ubiquinol-cytochrome c reductase core protein 1
increases expression
ISO
sulforaphane results in increased expression of UQCRC1 mRNA
CTD
PMID:30529165
NCBI chr 3:48,599,002...48,609,646
Ensembl chr 3:48,599,002...48,610,976
G
UQCRFS1
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
increases expression
ISO
sulforaphane results in increased expression of UQCRFS1 mRNA
CTD
PMID:30529165
NCBI chr19:29,205,320...29,213,151
Ensembl chr19:29,205,320...29,213,151
G
UQCRQ
ubiquinol-cytochrome c reductase complex III subunit VII
increases expression
ISO
sulforaphane results in increased expression of UQCRQ mRNA
CTD
PMID:30529165
NCBI chr 5:132,866,642...132,868,847
Ensembl chr 5:132,866,630...132,868,847
G
USH1C
USH1 protein network component harmonin
decreases expression
EXP
sulforaphane results in decreased expression of USH1C mRNA
CTD
PMID:31838189
NCBI chr11:17,493,900...17,544,416
Ensembl chr11:17,493,895...17,544,416
G
USP12
ubiquitin specific peptidase 12
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of USP12 mRNA
CTD
PMID:30529165
NCBI chr13:27,066,156...27,171,811
Ensembl chr13:27,066,156...27,171,811
G
USP2
ubiquitin specific peptidase 2
decreases expression multiple interactions
EXP ISO
sulforaphane results in decreased expression of USP2 mRNA [NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of USP2 mRNA
CTD
PMID:26833863 PMID:30529165
NCBI chr11:119,355,215...119,381,690
Ensembl chr11:119,355,215...119,381,711
G
USP33
ubiquitin specific peptidase 33
decreases expression
ISO
sulforaphane results in decreased expression of USP33 mRNA
CTD
PMID:30529165
NCBI chr 1:77,695,987...77,759,852
Ensembl chr 1:77,695,987...77,759,852
G
USP43
ubiquitin specific peptidase 43
decreases expression
EXP
sulforaphane results in decreased expression of USP43 mRNA
CTD
PMID:31838189
NCBI chr17:9,645,260...9,729,687
Ensembl chr17:9,644,698...9,729,687
G
USP5
ubiquitin specific peptidase 5
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of USP5 mRNA
CTD
PMID:30529165
NCBI chr12:6,852,150...6,866,632
Ensembl chr12:6,852,148...6,866,632
G
VASH2
vasohibin 2
decreases expression
EXP
sulforaphane results in decreased expression of VASH2 mRNA
CTD
PMID:31838189
NCBI chr 1:212,950,541...212,991,585
Ensembl chr 1:212,950,520...212,992,037
G
VCAM1
vascular cell adhesion molecule 1
multiple interactions increases expression
ISO EXP
[NFE2L2 protein affects the susceptibility to sulforaphane] affects the reaction [Oxygen deficiency results in increased expression of VCAM1 protein]; sulforaphane inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of VCAM1 protein]; sulforaphane inhibits the reaction [Oxygen deficiency results in increased expression of VCAM1 protein] sulforaphane results in increased expression of VCAM1 mRNA
CTD
PMID:24707343 PMID:30096613 PMID:35724838
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
G
VCP
valosin containing protein
affects binding
EXP
VCP protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr 9:35,056,064...35,072,625
Ensembl chr 9:35,053,928...35,072,668
G
VDAC1
voltage dependent anion channel 1
multiple interactions
ISO
NFE2L2 protein affects the reaction [sulforaphane promotes the reaction [Oxygen results in increased expression of VDAC1 protein]]; sulforaphane promotes the reaction [Oxygen results in increased expression of VDAC1 protein]
CTD
PMID:30529165
NCBI chr 5:133,971,871...134,114,540
Ensembl chr 5:133,971,871...134,004,975
G
VEGFA
vascular endothelial growth factor A
decreases expression
EXP
sulforaphane results in decreased expression of VEGFA mRNA
CTD
PMID:35724838
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VEGFB
vascular endothelial growth factor B
increases expression
ISO
sulforaphane results in increased expression of VEGFB mRNA
CTD
PMID:30529165
NCBI chr11:64,234,584...64,239,264
Ensembl chr11:64,234,584...64,239,264
G
VEGFD
vascular endothelial growth factor D
decreases expression
ISO
sulforaphane results in decreased expression of VEGFD mRNA
CTD
PMID:30529165
NCBI chr X:15,345,596...15,384,413
Ensembl chr X:15,345,596...15,384,413
G
VGLL3
vestigial like family member 3
decreases expression
EXP
sulforaphane results in decreased expression of VGLL3 mRNA
CTD
PMID:31838189
NCBI chr 3:86,937,973...86,991,149
Ensembl chr 3:86,876,388...86,991,149
G
VILL
villin like
increases expression
ISO
sulforaphane results in increased expression of VILL mRNA
CTD
PMID:30529165
NCBI chr 3:37,987,978...38,007,185
Ensembl chr 3:37,988,059...38,007,188
G
VIM
vimentin
affects binding multiple interactions
EXP ISO
VIM protein binds to sulforaphane sulforaphane inhibits the reaction [Paraquat results in increased expression of VIM protein]
CTD
PMID:21838287 PMID:28624451
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
G
VIPR2
vasoactive intestinal peptide receptor 2
decreases expression
ISO EXP
sulforaphane results in decreased expression of VIPR2 mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 7:159,028,175...159,144,867
Ensembl chr 7:159,028,175...159,144,867
G
VIT
vitrin
increases expression decreases expression
ISO EXP
sulforaphane results in increased expression of VIT mRNA sulforaphane results in decreased expression of VIT mRNA
CTD
PMID:30529165 PMID:31838189
NCBI chr 2:36,696,707...36,814,794
Ensembl chr 2:36,696,690...36,814,794
G
VSIG2
V-set and immunoglobulin domain containing 2
decreases expression
ISO
sulforaphane results in decreased expression of VSIG2 mRNA
CTD
PMID:30529165
NCBI chr11:124,747,474...124,752,255
Ensembl chr11:124,747,474...124,752,255
G
VSIR
V-set immunoregulatory receptor
decreases expression
EXP
sulforaphane results in decreased expression of VSIR mRNA
CTD
PMID:31838189
NCBI chr10:71,747,556...71,773,520
Ensembl chr10:71,747,556...71,773,520
G
VTN
vitronectin
decreases expression
EXP
sulforaphane results in decreased expression of VTN mRNA
CTD
PMID:31838189
NCBI chr17:28,367,284...28,370,307
Ensembl chr17:28,367,284...28,373,091
G
VWA5A
von Willebrand factor A domain containing 5A
decreases expression
EXP
sulforaphane results in decreased expression of VWA5A mRNA
CTD
PMID:31838189
NCBI chr11:124,115,450...124,147,721
Ensembl chr11:124,115,404...124,147,721
G
VWA7
von Willebrand factor A domain containing 7
decreases expression
EXP
sulforaphane results in decreased expression of VWA7 mRNA
CTD
PMID:31838189
NCBI chr 6:31,765,590...31,777,328
Ensembl chr 6:31,765,590...31,777,328
G
WASF2
WASP family member 2
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of WASF2 mRNA
CTD
PMID:30529165
NCBI chr 1:27,404,230...27,490,167
Ensembl chr 1:27,404,230...27,490,167
G
WDR3
WD repeat domain 3
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of WDR3 mRNA
CTD
PMID:30529165
NCBI chr 1:117,929,739...117,966,543
Ensembl chr 1:117,929,720...117,966,543
G
WDR44
WD repeat domain 44
decreases expression
EXP
sulforaphane results in decreased expression of WDR44 mRNA
CTD
PMID:31838189
NCBI chr X:118,346,073...118,449,961
Ensembl chr X:118,346,073...118,449,961
G
WDR54
WD repeat domain 54
decreases expression
EXP
sulforaphane results in decreased expression of WDR54 mRNA
CTD
PMID:31838189
NCBI chr 2:74,421,730...74,425,755
Ensembl chr 2:74,421,678...74,425,755
G
WDR75
WD repeat domain 75
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of WDR75 mRNA
CTD
PMID:30529165
NCBI chr 2:189,441,474...189,475,552
Ensembl chr 2:189,441,446...189,475,552
G
WDR76
WD repeat domain 76
decreases expression
EXP
sulforaphane results in decreased expression of WDR76 mRNA
CTD
PMID:31838189
NCBI chr15:43,827,002...43,868,412
Ensembl chr15:43,826,980...43,868,412
G
WNT6
Wnt family member 6
decreases expression
EXP
sulforaphane results in decreased expression of WNT6 mRNA
CTD
PMID:31838189
NCBI chr 2:218,859,805...218,874,233
Ensembl chr 2:218,859,805...218,874,233
G
XAF1
XIAP associated factor 1
decreases expression
EXP
sulforaphane results in decreased expression of XAF1 mRNA
CTD
PMID:26833863
NCBI chr17:6,755,447...6,775,647
Ensembl chr17:6,755,447...6,775,647
G
XAGE2
X antigen family member 2
decreases expression
EXP
sulforaphane results in decreased expression of XAGE2 mRNA
CTD
PMID:31838189
NCBI chr X:52,369,021...52,375,680
Ensembl chr X:52,369,021...52,375,680
G
XBP1
X-box binding protein 1
multiple interactions
EXP ISO
sulforaphane inhibits the reaction [bisphenol A results in increased expression of XBP1 protein alternative form]; sulforaphane promotes the reaction [Arsenic Trioxide results in increased splicing of XBP1 mRNA]
CTD
PMID:22922937 PMID:36670177
NCBI chr22:28,794,560...28,800,569
Ensembl chr22:28,794,555...28,800,597
G
XIAP
X-linked inhibitor of apoptosis
decreases expression
EXP
sulforaphane results in decreased expression of XIAP protein
CTD
PMID:26833863
NCBI chr X:123,859,708...123,913,972
Ensembl chr X:123,859,712...123,913,972
G
XPOT
exportin for tRNA
increases expression
EXP
sulforaphane results in increased expression of XPOT mRNA
CTD
PMID:31838189
NCBI chr12:64,404,392...64,451,125
Ensembl chr12:64,404,392...64,451,125
G
YARS1
tyrosyl-tRNA synthetase 1
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of YARS1 mRNA
CTD
PMID:30529165
NCBI chr 1:32,775,239...32,817,358
Ensembl chr 1:32,775,237...32,818,031
G
YIPF7
Yip1 domain family member 7
increases expression
ISO
sulforaphane results in increased expression of YIPF7 mRNA
CTD
PMID:30529165
NCBI chr 4:44,622,088...44,662,199
Ensembl chr 4:44,622,088...44,678,556
G
YJEFN3
YjeF N-terminal domain containing 3
increases expression
EXP
sulforaphane results in increased expression of YJEFN3 mRNA
CTD
PMID:31838189
NCBI chr19:19,528,911...19,537,581
Ensembl chr19:19,528,861...19,537,581
G
YPEL3
yippee like 3
decreases expression
EXP
sulforaphane results in decreased expression of YPEL3 mRNA
CTD
PMID:31838189
NCBI chr16:30,092,314...30,096,213
Ensembl chr16:30,092,314...30,096,915
G
YWHAB
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta
affects binding
EXP
YWHAB protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr20:44,885,705...44,908,532
Ensembl chr20:44,885,702...44,908,532
G
YWHAE
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon
affects binding
EXP
YWHAE protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr17:1,344,275...1,400,222
Ensembl chr17:1,344,275...1,400,222
G
YWHAQ
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta
affects binding
EXP
YWHAQ protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr 2:9,583,967...9,630,997
Ensembl chr 2:9,583,967...9,630,997
G
ZBED10P
zinc finger BED-type containing 10, pseudogene
decreases expression
EXP
sulforaphane results in decreased expression of ZBED10P mRNA
CTD
PMID:31838189
NCBI chr 7:150,330,183...150,332,721
Ensembl chr 7:150,329,871...150,331,115
G
ZBTB18
zinc finger and BTB domain containing 18
increases expression
EXP
sulforaphane results in increased expression of ZBTB18 mRNA
CTD
PMID:31838189
NCBI chr 1:244,048,491...244,057,476
Ensembl chr 1:244,048,547...244,057,476
G
ZC3H4
zinc finger CCCH-type containing 4
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ZC3H4 mRNA
CTD
PMID:30529165
NCBI chr19:47,064,187...47,113,776
Ensembl chr19:47,064,187...47,113,776
G
ZDHHC11
zinc finger DHHC-type containing 11
increases expression
EXP
sulforaphane results in increased expression of ZDHHC11 mRNA
CTD
PMID:31838189
NCBI chr 5:795,605...860,563
Ensembl chr 5:795,605...858,973
G
ZDHHC16
zinc finger DHHC-type palmitoyltransferase 16
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ZDHHC16 mRNA
CTD
PMID:30529165
NCBI chr10:97,446,175...97,457,370
Ensembl chr10:97,446,170...97,457,370
G
ZDHHC3
zinc finger DHHC-type palmitoyltransferase 3
increases expression decreases expression
EXP ISO
sulforaphane results in increased expression of ZDHHC3 mRNA sulforaphane results in decreased expression of ZDHHC3 mRNA
CTD
PMID:26833863 PMID:30529165
NCBI chr 3:44,915,261...44,976,174
Ensembl chr 3:44,915,257...44,976,185
G
ZEB1
zinc finger E-box binding homeobox 1
increases expression
EXP
sulforaphane results in increased expression of ZEB1 mRNA
CTD
PMID:26833863
NCBI chr10:31,318,417...31,529,804
Ensembl chr10:31,318,495...31,529,814
G
ZEB2
zinc finger E-box binding homeobox 2
decreases expression
EXP
sulforaphane results in decreased expression of ZEB2 mRNA
CTD
PMID:26833863
NCBI chr 2:144,384,081...144,520,119
Ensembl chr 2:144,364,364...144,521,057
G
ZER1
zyg-11 related cell cycle regulator
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ZER1 mRNA
CTD
PMID:30529165
NCBI chr 9:128,729,786...128,772,486
Ensembl chr 9:128,729,786...128,772,414
G
ZFAND2A
zinc finger AN1-type containing 2A
decreases expression
EXP
sulforaphane results in decreased expression of ZFAND2A mRNA
CTD
PMID:35724838
NCBI chr 7:1,148,850...1,160,196
Ensembl chr 7:1,152,071...1,160,759
G
ZFP62
ZFP62 zinc finger protein
decreases expression
ISO
sulforaphane results in decreased expression of ZFP62 mRNA
CTD
PMID:30529165
NCBI chr 5:180,826,870...180,861,276
Ensembl chr 5:180,847,611...180,861,285
G
ZFP92
ZFP92 zinc finger protein
increases expression
EXP
sulforaphane results in increased expression of ZFP92 mRNA
CTD
PMID:26833863
NCBI chr X:153,411,472...153,426,481
Ensembl chr X:153,411,472...153,426,481
G
ZMAT3
zinc finger matrin-type 3
multiple interactions decreases expression
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ZMAT3 mRNA sulforaphane results in decreased expression of ZMAT3 mRNA
CTD
PMID:30529165
NCBI chr 3:179,017,223...179,072,513
Ensembl chr 3:178,960,121...179,072,215
G
ZMYND12
zinc finger MYND-type containing 12
decreases expression
EXP
sulforaphane results in decreased expression of ZMYND12 mRNA
CTD
PMID:26833863
NCBI chr 1:42,430,329...42,456,022
Ensembl chr 1:42,430,329...42,456,253
G
ZNF20
zinc finger protein 20
increases expression
EXP
sulforaphane results in increased expression of ZNF20 mRNA
CTD
PMID:26833863
NCBI chr19:12,131,350...12,140,350
Ensembl chr19:12,092,843...12,140,355
G
ZNF23
zinc finger protein 23
decreases expression
ISO
sulforaphane results in decreased expression of ZFP612 mRNA
CTD
PMID:30529165
NCBI chr16:71,447,597...71,462,247
Ensembl chr16:71,447,597...71,463,095
G
ZNF275
zinc finger protein 275
increases expression
EXP
sulforaphane results in increased expression of ZNF275 mRNA
CTD
PMID:31838189
NCBI chr X:153,334,153...153,352,926
Ensembl chr X:153,334,147...153,360,110
G
ZNF28
zinc finger protein 28
increases expression
EXP
sulforaphane results in increased expression of ZNF28 mRNA
CTD
PMID:31838189
NCBI chr19:52,797,408...52,821,633
Ensembl chr19:52,797,408...52,857,600
G
ZNF33B
zinc finger protein 33B
decreases expression
EXP
sulforaphane results in decreased expression of ZNF33B mRNA
CTD
PMID:31838189
NCBI chr10:42,574,169...42,638,570
Ensembl chr10:42,574,185...42,638,570
G
ZNF429
zinc finger protein 429
affects binding
EXP
ZNF429 protein binds to sulforaphane
CTD
PMID:21838287
NCBI chr19:21,505,602...21,540,668
Ensembl chr19:21,496,682...21,556,270
G
ZNF462
zinc finger protein 462
decreases expression
EXP
sulforaphane results in decreased expression of ZNF462 mRNA
CTD
PMID:31838189
NCBI chr 9:106,860,158...107,013,634
Ensembl chr 9:106,863,166...107,013,634
G
ZNF521
zinc finger protein 521
decreases expression
EXP
sulforaphane results in decreased expression of ZNF521 mRNA
CTD
PMID:31838189
NCBI chr18:25,061,924...25,352,166
Ensembl chr18:25,061,924...25,352,190
G
ZNF608
zinc finger protein 608
decreases expression
EXP
sulforaphane results in decreased expression of ZNF608 mRNA
CTD
PMID:26833863
NCBI chr 5:124,636,915...124,748,824
Ensembl chr 5:124,636,913...124,748,807
G
ZNF644
zinc finger protein 644
decreases expression
ISO
sulforaphane results in decreased expression of ZFP644 mRNA
CTD
PMID:30529165
NCBI chr 1:90,915,304...91,022,035
Ensembl chr 1:90,915,298...91,022,272
G
ZNF746
zinc finger protein 746
increases expression
EXP
sulforaphane results in increased expression of ZNF746 mRNA
CTD
PMID:31838189
NCBI chr 7:149,472,696...149,497,809
Ensembl chr 7:149,472,696...149,497,817
G
ZNF831
zinc finger protein 831
decreases expression
EXP
sulforaphane results in decreased expression of ZNF831 mRNA
CTD
PMID:31838189
NCBI chr20:59,123,388...59,259,113
Ensembl chr20:59,123,381...59,259,113
G
ZP3
zona pellucida glycoprotein 3
increases expression
EXP
sulforaphane results in increased expression of ZP3 mRNA
CTD
PMID:31838189
NCBI chr 7:76,397,522...76,442,069
Ensembl chr 7:76,397,518...76,442,071
G
ZSCAN5B
zinc finger and SCAN domain containing 5B
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ZSCAN5B mRNA
CTD
PMID:30529165
NCBI chr19:56,189,686...56,197,890
Ensembl chr19:56,189,686...56,197,815
G
ZWINT
ZW10 interacting kinetochore protein
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ZWINT mRNA
CTD
PMID:30529165
NCBI chr10:56,357,227...56,361,273
Ensembl chr10:56,357,227...56,361,273
G
ZXDC
ZXD family zinc finger C
multiple interactions
ISO
[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ZXDA mRNA
CTD
PMID:30529165
NCBI chr 3:126,437,601...126,475,891
Ensembl chr 3:126,437,601...126,475,891
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all